0001437749-21-005171.txt : 20210305 0001437749-21-005171.hdr.sgml : 20210305 20210305172026 ACCESSION NUMBER: 0001437749-21-005171 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210305 DATE AS OF CHANGE: 20210305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SAFEGUARD SCIENTIFICS INC CENTRAL INDEX KEY: 0000086115 STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799] IRS NUMBER: 231609753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05620 FILM NUMBER: 21719619 BUSINESS ADDRESS: STREET 1: 150 NORTH RADNOR-CHESTER ROAD STREET 2: SUITE F-200 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 610 293 0600 MAIL ADDRESS: STREET 1: 150 NORTH RADNOR-CHESTER ROAD STREET 2: SUITE F-200 CITY: RADNOR STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: SAFEGUARD INDUSTRIES INC DATE OF NAME CHANGE: 19810525 FORMER COMPANY: FORMER CONFORMED NAME: SAFEGUARD CORP DATE OF NAME CHANGE: 19690521 10-K 1 sfe20201231_10k.htm FORM 10-K sfe20201231_10k.htm
0000086115 SAFEGUARD SCIENTIFICS INC false --12-31 FY 2020 0.10 0.10 1,000 1,000 0.10 0.10 83,333 83,333 21,573 21,573 688 930 0.5 0.6 1.8 2 0.5 1 0 0 1 0 0 0 4 8 0 0.0 0 0 2 4 1 0.0 21.0 0 0.0 These entities were sold subsequent to December 31, 2020. See Note 16 - Subsequent Events, of the consolidated financials statements. The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results. Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts may not add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts may not add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests. 00000861152020-01-012020-12-31 iso4217:USD 00000861152020-06-30 xbrli:shares 00000861152021-02-26 thunderdome:item 00000861152020-12-31 00000861152019-12-31 iso4217:USDxbrli:shares 00000861152019-01-012019-12-31 00000861152018-12-31 0000086115us-gaap:RetainedEarningsMember2018-12-31 0000086115us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-31 0000086115us-gaap:CommonStockMember2018-12-31 0000086115us-gaap:AdditionalPaidInCapitalMember2018-12-31 0000086115us-gaap:TreasuryStockMember2018-12-31 0000086115us-gaap:RetainedEarningsMember2019-01-012019-12-31 0000086115us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-31 0000086115us-gaap:CommonStockMember2019-01-012019-12-31 0000086115us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-31 0000086115us-gaap:TreasuryStockMember2019-01-012019-12-31 0000086115us-gaap:RetainedEarningsMember2019-12-31 0000086115us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-31 0000086115us-gaap:CommonStockMember2019-12-31 0000086115us-gaap:AdditionalPaidInCapitalMember2019-12-31 0000086115us-gaap:TreasuryStockMember2019-12-31 0000086115us-gaap:RetainedEarningsMember2020-01-012020-12-31 0000086115us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-31 0000086115us-gaap:CommonStockMember2020-01-012020-12-31 0000086115us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-31 0000086115us-gaap:TreasuryStockMember2020-01-012020-12-31 0000086115us-gaap:RetainedEarningsMember2020-12-31 0000086115us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31 0000086115us-gaap:CommonStockMember2020-12-31 0000086115us-gaap:AdditionalPaidInCapitalMember2020-12-31 0000086115us-gaap:TreasuryStockMember2020-12-31 xbrli:pure utr:M 00000861152019-04-30 0000086115us-gaap:RevolvingCreditFacilityMember2020-12-31 0000086115us-gaap:AccountingStandardsUpdate201409Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2020-01-01 0000086115us-gaap:AccountingStandardsUpdate201409Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:NoncontrollingInterestMember2020-01-01 0000086115us-gaap:AccountingStandardsUpdate201409Membersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-01-012020-12-31 0000086115srt:PartnershipInterestMember2020-12-31 0000086115srt:PartnershipInterestMember2019-12-31 0000086115us-gaap:PrivateEquityFundsMember2020-12-31 0000086115us-gaap:PrivateEquityFundsMember2019-12-31 0000086115sfe:SonobiMember2020-09-012020-09-30 0000086115sfe:WebLincIncQuanticMindIncAndSonobiIncMember2020-01-012020-12-31 0000086115sfe:TrexGroupIncMember2020-01-012020-12-31 0000086115sfe:FlashtalkingIncMember2020-01-012020-12-31 0000086115sfe:OwnershipInterestOtherMember2020-01-012020-12-31 0000086115sfe:NovaSomMember2019-01-012019-12-31 0000086115sfe:PropellerMember2019-01-012019-01-31 0000086115sfe:PropellerMember2020-01-012020-12-31 0000086115sfe:TransactisMember2019-05-012019-05-31 0000086115sfe:HighTractionStageMember2020-12-31 0000086115sfe:HighTractionStageMember2019-12-31 0000086115us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2020-01-012020-12-31 0000086115us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2019-01-012019-12-31 0000086115sfe:IntangibleAssetsMember2020-12-31 0000086115us-gaap:GoodwillMember2020-12-31 0000086115sfe:AktanaIncMember2020-07-012020-09-30 0000086115sfe:AktanaIncMember2020-09-30 0000086115sfe:SyapseIncMember2020-01-012020-06-30 0000086115sfe:SyapseIncMember2020-01-012020-03-31 0000086115sfe:SyapseIncMember2020-06-30 0000086115sfe:meQuilibriumMember2020-01-012020-03-31 0000086115sfe:meQuilibriumMember2020-03-31 0000086115sfe:TriceMedicalIncMember2020-01-012020-06-30 0000086115sfe:TriceMedicalIncMember2020-06-30 0000086115sfe:ClutchHoldingsMember2020-04-012020-06-30 0000086115sfe:ClutchHoldingsMember2020-06-30 0000086115sfe:QuanticMindMember2020-01-012020-03-31 0000086115sfe:QuanticMindMember2020-03-31 0000086115sfe:WebLincIncMember2020-01-012020-03-31 0000086115sfe:WebLincIncMember2020-03-31 0000086115sfe:SyapseIncMember2019-01-012019-12-31 0000086115sfe:MoxeHealthCorporationMember2019-01-012019-12-31 0000086115sfe:MoxeHealthCorporationMember2019-12-31 0000086115sfe:AktanaIncMember2019-01-012019-12-31 0000086115sfe:meQuilibriumMember2019-01-012019-12-31 0000086115sfe:ZipnosisMember2019-01-012019-12-31 0000086115sfe:ZipnosisMember2019-12-31 0000086115sfe:ClutchHoldingsMember2019-01-012019-12-31 0000086115sfe:SonobiMember2019-01-012019-12-31 0000086115sfe:SonobiMember2019-12-31 0000086115sfe:WebLincIncMember2019-01-012019-12-31 0000086115sfe:NovaSomMember2019-12-31 0000086115sfe:QuanticMindMember2019-01-012019-12-31 0000086115us-gaap:RevolvingCreditFacilityMembersfe:CreditFacilityMembersfe:PayableOnTheLastDayOfTheOneTwoOrThreeMonthInterestPeriodMemberus-gaap:LondonInterbankOfferedRateLIBORMember2018-05-312018-05-31 0000086115us-gaap:RevolvingCreditFacilityMembersfe:CreditFacilityMembersrt:MinimumMembersfe:PayableOnTheLastDayOfTheOneTwoOrThreeMonthInterestPeriodMemberus-gaap:LondonInterbankOfferedRateLIBORMember2018-05-31 0000086115us-gaap:RevolvingCreditFacilityMembersfe:CreditFacilityMembersrt:MinimumMembersfe:PayableMonthlyInArrearsMember2018-05-31 0000086115us-gaap:RevolvingCreditFacilityMembersfe:CreditFacilityMembersfe:PayableMonthlyInArrearsMember2018-05-312018-05-31 0000086115us-gaap:RevolvingCreditFacilityMembersfe:CreditFacilityMembersfe:PayableMonthlyInArrearsMemberus-gaap:FederalFundsEffectiveSwapRateMember2018-05-312018-05-31 0000086115us-gaap:RevolvingCreditFacilityMembersfe:CreditFacilityMembersfe:PayableMonthlyInArrearsMemberus-gaap:PrimeRateMember2018-05-312018-05-31 0000086115sfe:AmendedCreditFacilityMember2018-12-31 0000086115sfe:AmendedCreditFacilityMember2019-04-152019-04-15 0000086115sfe:AmendedCreditFacilityMember2019-07-312019-07-31 0000086115sfe:AmendedCreditFacilityMember2018-05-31 0000086115us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-01-012020-12-31 0000086115us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-12-31 00000861152015-07-31 00000861152018-02-28 00000861152019-11-07 00000861152019-11-072019-11-07 0000086115sfe:EquityCompensationPlanMember2020-12-31 0000086115us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-31 0000086115us-gaap:GeneralAndAdministrativeExpenseMember2019-01-012019-12-31 0000086115us-gaap:PerformanceSharesMember2020-01-012020-12-31 0000086115us-gaap:PerformanceSharesMember2019-01-012019-12-31 0000086115us-gaap:PerformanceSharesMember2020-12-31 utr:Y 0000086115sfe:ServiceBasedAwardMember2020-01-012020-12-31 0000086115sfe:ServiceBasedAwardMember2019-01-012019-12-31 0000086115srt:DirectorMember2020-01-012020-12-31 0000086115srt:DirectorMember2020-12-31 0000086115srt:DirectorMember2019-12-31 0000086115us-gaap:RestrictedStockMember2019-01-012019-12-31 0000086115us-gaap:EmployeeStockOptionMember2018-12-31 0000086115us-gaap:EmployeeStockOptionMember2019-01-012019-12-31 0000086115us-gaap:EmployeeStockOptionMember2019-12-31 0000086115us-gaap:EmployeeStockOptionMember2020-01-012020-12-31 0000086115us-gaap:EmployeeStockOptionMember2020-12-31 0000086115sfe:PerformanceStockUnitMember2020-12-31 0000086115sfe:PerformanceStockUnitMember2020-01-012020-12-31 0000086115sfe:PerformanceStockUnitMember2019-01-012019-12-31 0000086115us-gaap:RestrictedStockMember2020-01-012020-12-31 0000086115us-gaap:RestrictedStockMembersrt:MinimumMember2020-01-012020-12-31 0000086115us-gaap:RestrictedStockMembersrt:MaximumMember2020-01-012020-12-31 0000086115sfe:DeferredStockUnitsMember2020-01-012020-12-31 0000086115sfe:DeferredStockUnitsMember2019-01-012019-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2020-01-012020-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2019-01-012019-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2020-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2018-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2019-12-31 0000086115us-gaap:EmployeeStockOptionMember2020-01-012020-12-31 0000086115us-gaap:EmployeeStockOptionMember2019-01-012019-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2020-01-012020-12-31 0000086115sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember2019-01-012019-12-31 0000086115sfe:ConvertibleSeniorDebenturesDue2018Member2019-01-012019-12-31 00000861152001-10-31 0000086115us-gaap:EmployeeSeveranceMember2020-12-31 0000086115srt:MinimumMember2020-01-012020-12-31 0000086115srt:MinimumMember2019-01-012019-12-31 0000086115srt:MaximumMember2020-01-012020-12-31 0000086115sfe:AktanaIncMember2020-12-31 0000086115sfe:AktanaIncMember2019-12-31 0000086115sfe:ClutchHoldingsMember2020-12-31 0000086115sfe:ClutchHoldingsMember2019-12-31 0000086115sfe:FlashtalkingIncMember2020-12-31 0000086115sfe:FlashtalkingIncMember2019-12-31 0000086115sfe:InfoBionicIncMember2020-12-31 0000086115sfe:InfoBionicIncMember2019-12-31 0000086115sfe:LumesisIncMember2020-12-31 0000086115sfe:LumesisIncMember2019-12-31 0000086115sfe:MediaMathIncMember2020-12-31 0000086115sfe:MediaMathIncMember2019-12-31 0000086115sfe:meQuilibriumMember2020-12-31 0000086115sfe:meQuilibriumMember2019-12-31 0000086115sfe:MoxeHealthCorporationMember2020-12-31 0000086115sfe:PrognosHealthIncMember2020-12-31 0000086115sfe:PrognosHealthIncMember2019-12-31 0000086115sfe:QuanticMindMember2020-12-31 0000086115sfe:QuanticMindMember2019-12-31 0000086115sfe:SyapseIncMember2020-12-31 0000086115sfe:SyapseIncMember2019-12-31 0000086115sfe:TrexGroupIncMember2020-12-31 0000086115sfe:TrexGroupIncMember2019-12-31 0000086115sfe:TriceMedicalIncMember2020-12-31 0000086115sfe:TriceMedicalIncMember2019-12-31 0000086115sfe:WebLincIncMember2020-12-31 0000086115sfe:WebLincIncMember2019-12-31 0000086115sfe:ZipnosisMember2020-12-31 00000861152020-01-012020-03-31 00000861152020-04-012020-06-30 00000861152020-07-012020-09-30 00000861152020-10-012020-12-31 00000861152019-01-012019-03-31 00000861152019-04-012019-06-30 00000861152019-07-012019-09-30 00000861152019-10-012019-12-31 0000086115sfe:EquityMethodInvestmentIncomeAdjustmentMember2019-10-012019-12-31 0000086115sfe:WebLincIncMemberus-gaap:SubsequentEventMember2021-01-012021-01-31 0000086115sfe:QuanticMindMemberus-gaap:SubsequentEventMember2021-01-012021-01-31 0000086115sfe:SyapseIncMemberus-gaap:SubsequentEventMember2021-02-012021-02-28 0000086115sfe:SyapseIncMemberus-gaap:SubsequentEventMember2021-02-28
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

(Mark One)

☑

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

or

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ___________

 

Commission File Number 1-5620

 Safeguard Scientifics, Inc.

(Exact name of registrant as specified in its charter)

Pennsylvania

 

23-1609753

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer Identification No.)

   

150 N. Radnor Chester Road

Suite F-200

Radnor, PA

 

19087

(Address of principal executive offices)

 

(Zip Code)

(610) 293-0600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock ($.10 par value)

SFE

New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☐    No  ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐    No  ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ☐

Accelerated filer  ☐

 

Smaller reporting company ☑

Non-accelerated filer   ☑

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No  ☒

 

As of June 30, 2020, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was $136,021,431 based on the closing sale price as reported on the New York Stock Exchange.

 

The number of shares outstanding of the registrant’s common stock as of February 26, 2021 was 20,944,305.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the definitive proxy statement (the “Definitive Proxy Statement”) to be filed with the Securities and Exchange Commission for the Company’s 2021 Annual Meeting of Shareholders are incorporated by reference into Part III of this report.

 

 
Table of Contents
 

 

 

SAFEGUARD SCIENTIFICS, INC.

FORM 10-K

December 31, 2020

 

 

Page

PART I

Item 1. Business

3

Item 1A. Risk Factors

8

Item 1B. Unresolved Staff Comments

13

Item 2. Properties

13

Item 3. Legal Proceedings

13

Item 4. Mine Safety Disclosures

13

PART II

Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

14

Item 6. Selected Consolidated Financial Data

15

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

20

Item 8. Financial Statements and Supplementary Data

21

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

45

Item 9A. Controls and Procedures

45

Item 9B. Other Information

45

PART III

Item 10. Directors, Executive Officers and Corporate Governance

46

Item 11. Executive Compensation

46

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

46

Item 13. Certain Relationships and Related Transactions, and Director Independence

47

Item 14. Principal Accountant Fees and Services

47

PART IV

Item 15. Exhibits and Financial Statement Schedules

48

 

2
Table of Contents

 

 

 

 

PART I

 

Cautionary Note Concerning Forward-Looking Statements

 

This Annual Report on Form 10-K contains forward-looking statements that are based on current expectations, estimates, forecasts and projections about Safeguard Scientifics, Inc. (“Safeguard” or “we”), the industries in which we operate and other matters, as well as management's beliefs and assumptions and other statements regarding matters that are not historical facts.  These statements include, in particular, statements about our plans, strategies and prospects.  For example, when we use words such as “projects,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “should,” “would,” “could,” “will,” “opportunity,” “potential” or “may,” variations of such words or other words that convey uncertainty of future events or outcomes, we are making forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Our forward-looking statements are subject to risks and uncertainties.  Factors that could cause actual results to differ materially include, among others, our ability to make good decisions about the deployment of capital, the fact that our ownership interests may vary from period to period, our substantial capital requirements and absence of liquidity from our ownership interests, fluctuations in the market prices of our publicly traded ownership interests, competition, our inability to obtain maximum value for our ownership interests, our ability to attract and retain qualified employees, our ability to execute our strategy, market valuations in sectors in which our companies operate, our inability to control our ownership interests, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our ownership interests and their performance, including the fact that most of our ownership interests have a limited history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which our ownership interests operate, compliance with government regulation and legal liabilities, all of which are discussed in Item 1A. “Risk Factors.” Many of these factors are beyond our ability to predict or control. In addition, as a result of these and other factors, our past financial performance should not be relied on as an indication of future performance. All forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by this cautionary statement. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this report might not occur.

 

Item 1. Business

 

Business Overview

 

Over the recent past, Safeguard has provided capital and relevant expertise to fuel the growth of technology-driven businesses. In many, but not all cases, we are actively involved, influencing development through board representation and management support, in addition to the influence we exert through our equity ownership. We also continue to hold relatively small equity interests in other enterprises where we do not exert significant influence and do not participate in management activities. In some cases, those ownership interests relate to residual interests from prior larger interests or from companies that acquired companies in which we had ownership interests.

 

In January 2018, Safeguard announced that we would not deploy any capital into new opportunities and will focus on supporting our existing companies and maximizing monetization opportunities to enable returning value to shareholders. In that context, we have, are and will consider initiatives including, among others: the sale of our ownership interests, the sale of certain or all of our ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value. We initiated the return of value to shareholders in 2019 with a $1.00 per share special dividend. We anticipate additional actions could occur in the future, once significant dispositions occur, in the form of stock repurchases and/or special dividends based on available cash resources, prevailing market conditions and other factors.

 

During 2020, Safeguard was impacted by the circumstances of COVID-19 and the related economic impacts.  In addition to a slowed mergers and acquisitions environment, our companies have been impacted in a variety of operational ways including general declines in the markets in which they operate, reduced access to customers or prospective customers, reduced or delayed collections of amounts due from customers and different ways to work with their employee base.  Our companies have also been negatively impacted in their ability to access debt or equity capital.  The management teams of the entities in which the Company holds such ownership interests are continuing to take actions to respond to the rapidly changing environment, including implementing cost reduction efforts, securing additional capital or other actions, which could mitigate some of the expected impacts.  There are uncertainties as to if these actions will be successful or adequate in this uncertain economic environment.  

 

3
Table of Contents

 

We incorporated in the Commonwealth of Pennsylvania in 1953. Our corporate headquarters are located at 150 N. Radnor Chester Road, Suite F-200, Radnor, Pennsylvania 19087.

 

Our Strategy

 

Founded in 1953, Safeguard has a distinguished track record of building market leaders by providing capital and operational support to entrepreneurs across an evolving and innovative spectrum of industries. Over the recent past, Safeguard has provided capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. Safeguard's existing group of companies consists of companies that are capitalizing on the next wave of enabling technologies. Since January 2018, Safeguard is no longer deploying capital into new companies. Safeguard remains focused on managing and financially supporting its existing ownership interests, with the goal of pursuing monetization opportunities and maximizing the value returned to shareholders.

 

Helping Our Companies Build Value

 

We offer strategic, operational and management support to certain of our ownership interests.

 

Strategic Support. We play an active role in developing the strategic direction to certain of our ownership interests, which include:

 

•

defining short and long-term strategic goals;
 

•

identifying and planning for the critical success factors to reach these goals;
 

•

identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals;
 

•

identifying and implementing the business measurements that we and others will apply to measure a company’s success; and
 

•

identifying sources of and providing capital to drive growth.

 

Management and Operational Support. Our executives serve on the boards of directors of certain of our companies, working with them to develop and implement strategic and operating plans. We measure and monitor achievement of these plans through regular review of operational and financial performance measurements.

 

Realizing Value

 

Since January 2018, Safeguard ceased deploying capital into new companies. Safeguard remains focused on managing and financially supporting its existing companies, with the goal of pursuing monetization opportunities and maximizing the value returned to shareholders. We have, are and will consider initiatives including, among others: the sale of our ownership interests, the sale of certain or all of our ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value.

 

From time to time, we engage in discussions with other companies interested in our ownership interests, either in response to inquiries or as part of a process we initiate. To the extent we believe that a company’s further growth and development can best be supported by a different ownership structure or if we otherwise believe it is in our shareholders’ best interests, we will seek to sell some or all of our position in the company. These sales may take the form of privately negotiated sales of stock or assets, mergers and acquisitions, public offerings of the company’s securities and, in the case of publicly traded companies, sales of their securities in the open market. In the past, we have taken companies public through rights offerings and directed share subscription programs. We will continue to consider these (or similar) programs and the sale of certain company interests in secondary market transactions to maximize value for our shareholders.

 

Given our strategy, the value of Safeguard is now dependent upon the value of our existing ownership interests and our ability to translate that value into cash as efficiently as possible and to return that capital to our shareholders in the form of stock repurchases and/or special dividends to shareholders.

 

Our Ownership Interests

 

An understanding of our ownership interests is important to understanding Safeguard. We categorize our ownership interests that we account for under the equity method and certain companies where we do not have significant influence but whose value is a substantial portion of our portfolio into stages based upon revenue generation. The Initial Revenue Stage is made up of businesses that have revenues of $1 million or less. The Expansion Stage is made up of companies that have revenue in the range of $1 million to $5 million. The Traction Stage is made up of companies that have revenue in the range of $5 million to $10 million. The High Traction Stage is made up of companies that have revenue in the range of $10 million to $15 million. Additionally, as some of our companies have grown we have added additional categories for our companies with revenues of $20 million to $50 million and greater than $50 million.  The Company reflects revenue categories based on a one quarter lag.

 

4
Table of Contents

 

The ownership percentages indicated below are presented as of December 31, 2020 for certain companies in which we held ownership interests at February 26, 2021 and reflect the percentage of the vote we were entitled to cast at that date based on issued and outstanding voting securities (on a common stock equivalent basis), excluding the effect of options, warrants and convertible debt (primary ownership).

 

Initial Revenue Stage: Up to $1 million

 

There are no companies in which we have an ownership interest and account for under the equity method that are within this stage of growth. However, see section below regarding Other Ownership Interests.

 

Expansion Stage: $1 million to $5 million

 

Moxe Health Corporation

Expansion

(Safeguard Ownership: 27.6%)

 

Headquartered in Madison, Wisconsin, Moxe Health provides a clinical data clearinghouse that connects health systems with their network of health plans.  Moxe’s key products, Substrate and Convergence, allow for bi-directional data flow between payors and providers to complete various risk adjustment, quality, and prior authorization use cases. www.moxehealth.com

 

Traction Stage: $5 million to $10 million

 

Clutch Holdings, Inc.

Traction

(Safeguard Ownership: 42.3%)

 

Headquartered in Ambler, Pennsylvania, Clutch has revolutionized how marketing teams for premier brands develop and foster relationships with their customers. Clutch’s advanced marketing platform serves as a customer hub, delivering deep intelligence derived from real-time behaviors and transactions across in-store, online, mobile and social channels. www.clutch.com

 

meQuilibrium

Traction

(Safeguard Ownership: 32.0%)

 

Headquartered in Boston, Massachusetts, meQuilibrium is an engagement and performance platform that leverages behavioral psychology and data science to improve workforce resilience, agility, and adaptive capacity.  The Company offers solutions for managers, teams, and individual employees. www.mequilibrium.com

 

Trice Medical, Inc.

Traction

(Safeguard Ownership: 16.6%)

 

Headquartered in Malvern, Pennsylvania, Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician and payor by providing instant, eyes-on, answers. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physician's office. Trice's mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system. www.tricemedical.com

 

Zipnosis, Inc.

Traction

(Safeguard Ownership: 37.2%)

 

Headquartered in Minneapolis, Minnesota, Zipnosis provides health systems with a white-labeled, fully integrated virtual care platform. Through Zipnosis’ tech-enabled treatment and triage tools, clients can offer convenient access to care while improving clinician efficiency. Currently, patients may be treated for more than 90 conditions via such treatment and triage tools. www.zipnosis.com

 

5
Table of Contents

 

Lumesis, Inc.

Traction

(Safeguard Ownership: 43.4%)

 

Headquartered in Stamford, Connecticut, Lumesis is a financial technology company focused on providing business efficiency, data and regulatory solutions to the municipal bond marketplace. Lumesis’ DIVER platform helps more than 500 firms with more than 43,000 users efficiently meet credit, regulatory and risk needs. www.lumesis.com

 

High Traction Stage: $10 million to $15 million

 

InfoBionic, Inc.

High Traction

(Safeguard Ownership: 25.2%)

 

Headquartered in Waltham, Massachusetts, InfoBionic is an emerging digital health company focused on creating patient monitoring solutions for cardiac arrhythmias. InfoBionic’s MoMe® Kardia cloud-based, remote patient monitoring platform delivers on-demand, actionable monitoring data and analytics directly to the physicians themselves. www.infobionic.com

 

Revenue of $20 million to $50 million

 

Aktana, Inc.

 $20 million to $50 million

(Safeguard Ownership: 15.1%)

 

Headquartered in San Francisco, California, Aktana is a pioneer in decision support for global life science sales teams. Aktana helps its customers improve their commercial effectiveness by delivering data-driven insights and suggestions directly to sales reps, coordinating multi-channel actions and providing insight regarding which strategies work best for which customers under which conditions. www.aktana.com

  

Prognos Health Inc.

$20 million to $50 million

(Safeguard Ownership: 28.5%)

 

Headquartered in New York, New York, Prognos is a healthcare platform company transforming the ability to access, manage and analyze healthcare data in partnership with Life Sciences brands, payers, and clinical diagnostics organizations. Prognos’ innovations enhance the value of laboratory results and clinical diagnostic data through advanced analytics and artificial intelligence techniques. www.prognos.ai

 

 

Syapse, Inc.

$20 million to $50 million

(Safeguard Ownership: 18.9%)

 

Headquartered in Palo Alto, California, Syapse is on a mission to deliver the best care for every cancer patient through precision medicine. Syapse’s platform, data sharing network, and industry partnerships enable healthcare providers to bring precision cancer care to every patient who needs it. www.syapse.com

 

Greater than $50 million

 

Flashtalking, Inc.

Greater than $50 million

(Safeguard Ownership: 13.4%)

 

Headquartered in New York, New York, Flashtalking is a data-driven ad management and analytics technology company that uses data to personalize advertising in real-time, analyze its effectiveness and enable optimization that drives better engagement and ROI for sophisticated global brands. Spongecell, Inc. merged into Flashtalking in January 2018. www.flashtalking.com

 

MediaMath, Inc.

Greater than $50 million

(Safeguard Ownership: 13.3%)

 

Headquartered in New York, New York, MediaMath is a global technology company that is leading the movement to revolutionize traditional marketing and drive transformative results for marketers through its TerminalOne Marketing Operating System®. MediaMath empowers marketers with an extensible, open platform that activates data, automates execution and optimizes interactions across all addressable media, delivering superior performance, transparency and control to all marketers and better, more individualized experiences for consumers. www.mediamath.com

 

6
Table of Contents

 

Other ownership interests

 

In addition to the above companies, we also have smaller ownership interests in a variety of other companies where we do not exert significant influence and do not participate in any management activities. In some cases, these ownership interests generally are the result of previous positions that have been diluted or residual interests resulting from the acquisition of companies where we had an ownership interest.

 

Britepool: Provider of digital marketing and advertising services created to serve a free website, online newspapers and magazines. The company specializes in identity verification, advertising and privacy, digital marketing and data for its clients, enabling its clients to inherently collect and match identities with large quantities of personal information for targeted advertising. www.britepool.com

 

b8ta: Operator of a software-powered retail showroom designed to make physical retail accessible for all. The company's showrooms are software-driven brick-and-mortar stores that help consumers to buy hardware, internet of things and other technology products, enabling customers to discover, try and buy the latest tech products. The company is headquartered in San Francisco, California. www.b8ta.com

 

Hoopla Software, Inc.: Headquartered in San Jose, California, Hoopla provides cloud-based software that helps sales organizations inspire and motivate sales team performance. Hoopla's Sales Motivation Platform combines modern game mechanics, data analytics and broadcast-quality video in a cloud application that makes it easy for managers to motivate team performance and score more wins. www.hoopla.net

 

MedCrypt: Developer of a data security platform designed to protect medical devices. The company's platform enables functions such as authenticating users, encrypting data and cryptographically sign settings and patient prescriptions, as well as has the ability to monitor transactions between clinicians and devices for malicious behavior, enabling hospitals and health systems to prevent unauthorized access and misuse of their medical devices. www.medcrypt.co

 

T-REX Group, Inc.: Headquartered in New York, New York, T-REX is an enterprise solutions provider for the complex financing of esoteric asset backed securities (“ABS”) and energy project finance. T-REX’s SaaS platform supplants manually-generated financial models, driving transparency, standardization, collaboration, efficiency and access in energy project finance and asset backed securitization. www.trexgroup.com

 

WellTrackONE: Provider of wellness program services intended to offer a comprehensive baseline report for detailing modifiable risk factors, preventative goals and measurable data. The company's services include scheduling, screening and documentation that provide valuable data for outcomes and clinical measurements while at the same time help to generate significant revenue, enabling healthcare professionals to offer wellness visits to their patients and help them to get services for all their medical needs. www.welltrackone.co

 

Velano Vascular: Developer of a needle-free blood collection medical device intended to reduce the risk and inefficiencies of vascular access practices. The company's flagship products single-use, sterile device, temporarily attaches to a peripheral IV catheter to collect a fresh venous sample to combat the urgent challenge of vascular access, enabling hospitals to deliver painless and secure healthcare solutions for inpatients. www.velanovascular.com

 

We also have residual interests in a variety of private funds that are in the process of winding down and other companies.  

 

FINANCIAL INFORMATION ABOUT OPERATING SEGMENTS

 

We operate as one operating segment based upon the similar nature of our technology-driven companies, the functional alignment of the organizational structure and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 

OTHER INFORMATION

 

The operations of Safeguard and the companies in which it has ownership interests are subject to environmental laws and regulations. Safeguard does not believe that expenditures relating to those laws and regulations will have a material adverse effect on the business, financial condition or results of operations of Safeguard.

 

AVAILABLE INFORMATION

 

Safeguard is subject to the informational requirements of the Securities Exchange Act of 1934, as amended. Therefore, we file our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and proxy statements and other information with, and furnish other reports to, the Securities and Exchange Commission (“SEC”). You can read and copy such documents at the SEC’s public reference facilities in Washington, D.C., New York, New York and Chicago, Illinois. You may obtain information on the operation of the SEC’s public reference facilities by calling the SEC at 1-800-SEC-0330. Such material may also be accessed electronically by means of the SEC’s home page on the Internet at www.sec.gov or through Safeguard’s website at www.safeguard.com. Such documents are available as soon as reasonably practicable after electronic filing of the material with the SEC. Copies of these reports (excluding exhibits) also may be obtained free of charge, upon written request to: Investor Relations, Safeguard Scientifics, Inc., 150 N. Radnor Chester Road, Suite F-200, Radnor, Pennsylvania 19087.

 

The Internet website addresses for Safeguard and its ownership interests are included in this report for identification purposes. The information contained therein or connected thereto is not intended to be incorporated into this Annual Report on Form 10-K.

 

The following corporate governance documents are available free of charge on Safeguard’s website: the charters of our Audit, Compensation and Nominating & Corporate Governance Committees, our Corporate Governance Guidelines and our Code of Business Conduct and Ethics. We also will post on our website any amendments to or waivers of our Code of Business Conduct and Ethics that relate to our directors and executive officers.

 

7
Table of Contents

 

Item 1A. Risk Factors

 

You should carefully consider the information set forth below. The following risk factors describe situations in which our business, financial condition and/or results of operations could be materially harmed, and the value of our securities may be adversely affected. You should also refer to other information included or incorporated by reference in this report.

 

The COVID-19 pandemic is adversely affecting the businesses, financial conditions and operating results of the companies in which we have an ownership interest, as well as our ability to monetize such interests, and it may also cause us to increase the amount of additional capital we will need to provide to such companies.

 

The current economic and market conditions caused by the COVID-19 pandemic are negatively impacting the companies in which we have ownership interests, including, without limitation, their operations, supply chains, sales infrastructures and the demand for their products and services.  This is negatively affecting their businesses, financial conditions and operating results.  As a result, we may be required to provide additional capital to such companies, which may cause us to face liquidity issues that will constrain our ability to execute our business strategy and limit our ability to provide financial support to all of our existing companies in the amounts that we desire.  We are also experiencing a more challenging mergers and acquisitions market in general for such companies, which has resulted in lower valuation expectations and extended exit timelines for such companies, which, in turn, could negatively affect the amount and timing of the monetization opportunities for such companies and our ability to return value to shareholders.  

 

The intended monetization of our company interests and the return of value to shareholders are subject to factors beyond our control.

 

In January 2018, we announced that we will not deploy any capital into new companies.  We will instead focus on supporting, and maximizing monetization opportunities for, our existing company interests to return value to shareholders.  However, this strategic plan may require providing additional capital and operational support to such existing companies and we may not be able to sell our company interests during any specific time frame or otherwise on desirable terms, if at all, and there can be no assurance as to how long this process will take or the results that this process will yield.  There can be no assurance as to whether we will realize the value of escrowed proceeds, holdbacks or other contingent consideration, if any, associated with the sale of our company interests.  Additionally, there can be no assurance that we will be able to satisfy our liabilities during this process.  Further, the method, timing and amount of any return of value resulting from the monetization of existing company interests will be at the discretion of our Board of Directors and will depend on market and business conditions and our overall liabilities, capital structure and liquidity position.

 

A disposition of one or more of our company interests may occur at a time that will yield less value than if we held such interests for a longer period of time.

 

Our companies are at various stages in their lifecycles. The value of our interests in our companies at any point in time is highly dependent on the progress and success such companies have made at such time with respect to the development and marketing of their products and services and that value may fluctuate significantly. In order to effect our strategy of monetizing our interests in our companies, we may dispose of such interests at a time prior to the applicable company reaching its maximum value. Doing so will result in a return of value to shareholders that is less than that which may have been returned if we retained our interests in such company for a longer period of time

 

Our principal business strategy depends upon our ability to make good decisions regarding the deployment of capital into, and subsequent disposition of, our existing company interests and, ultimately, the performance of such companies, which is uncertain.

 

If we make poor decisions regarding the deployment of capital into, and subsequent disposition of, our existing companies, our business strategy will not succeed. If such companies do not succeed, the value of our assets could be significantly reduced and require substantial impairments or write-offs and our results of operations and the price of our common stock would be adversely affected. The risks relating to our companies include:

 

 

•

most of our companies have a history of operating losses and/or limited operating history;
 

•

the intense competition affecting the products and services our companies offer could adversely affect their businesses, financial condition, results of operations and prospects for growth;
 

•

the inability to adapt to changing marketplaces;
 

•

the inability to manage growth;
 

•

the need for additional capital to fund their operations, which we may not be able to fund or which may not be available from third parties on acceptable terms, if at all;
 

•

the inability to protect their proprietary rights and/or infringing on the proprietary rights of others;
 

•

that our companies could face legal liabilities from claims made against them based upon their operations, products or work;
 

•

the impact of economic downturns on their operations, results and growth prospects;
 

•

the inability to attract and retain qualified personnel;
 

•

the existence of government regulations and legal uncertainties may place financial burdens on the businesses of our companies; and
 

•

the inability to plan for and manage catastrophic events.

 

8
Table of Contents

 

These and other risks are discussed in detail under the caption “Risks Related to Our Companies” below.

 

As we execute against our strategy, a significant amount of our deployed capital may be concentrated in companies operating in the same or similar industries, limiting our diversification.

 

Our capital deployments could be concentrated in several companies that operate in the same or similar industries. This may cause us to be more susceptible to any single economic, regulatory or other occurrence affecting those particular industries than we would otherwise be if our companies operated in more diversified industries.

 

Our business model does not rely upon, or plan for, the receipt of operating cash flows from our companies. Our companies do not provide us with cash flow from their operations. We rely on cash on hand, liquidity events and our ability to generate cash from capital raising activities to finance our operations.

 

We need capital to fund the capital needs of our existing companies. We also need cash to finance our corporate overhead and meet our existing funding commitments. As a result, we have substantial cash requirements. Our companies do not provide us with cash flow from their operations. To the extent our companies generate any cash from operations, they generally retain the funds to develop their own businesses. As a result, we must rely on cash on hand, company liquidity events and new capital raising activities to meet our cash needs. If we are unable to find ways of monetizing our holdings of company interests or raising additional capital on attractive terms, we may face liquidity issues that will require us to constrain our ability to execute our business strategy and limit our ability to provide financial support to our existing companies.

 

We may be unable to obtain maximum value for our holdings or to sell our holdings on a timely basis.

 

We hold significant positions in our companies. If we were to divest all or part of our holdings in a company, we may have to sell our interests at a relative discount to intrinsic value. For companies with publicly traded stock, we may be unable to sell our holdings at then-quoted market prices. The trading volume and public float in the common stock of a publicly traded company in which we have an interest may be small relative to our holdings. As a result, any significant open-market divestiture by us of our holdings in such a company, if possible at all, would likely have a material adverse effect on the market price of its common stock and on our proceeds from such a divestiture. Additionally, we may not be able to take our companies public as a means of monetizing our position or creating shareholder value. Registration and other requirements under applicable securities laws and contractual restrictions also may adversely affect our ability to dispose of our company holdings on a timely basis.

 

Our success is dependent on our senior management.

 

Our success is dependent on our senior management team’s ability to execute our strategy. In connection with our new strategy announced in 2018, we made a series of management changes intended to streamline our organizational structure and reduce our operating costs and since then we have made, and may make, further management changes from time to time.  A loss of one or more of the remaining members of our senior management team without adequate replacement could have a material adverse effect on us.

 

Our business strategy may not be successful if valuations in the market sectors in which our companies participate decline.

 

Our strategy involves creating value for our shareholders by helping our companies build value and, if appropriate, accessing the public and private capital markets. Therefore, our success is dependent on the value of our companies as determined by the public and private capital markets. Many factors, including reduced market interest, may cause the market value of our companies to decline. If valuations in the market sectors in which our companies participate decline, their access to the public and private capital markets on terms acceptable to them may be limited.

 

Our companies could make business decisions that are not in our best interests or with which we do not agree, which could impair the value of our holdings.

 

Although we currently own a significant, influential interest in some of our companies, we do not maintain a controlling interest in any of our companies. Acquisitions of interests in companies in which we share or have no control, and the dilution of our interests in or a further reduction of our control of companies, will involve additional risks that could cause the performance of our interests and our operating results to suffer, including:

 

 

•

the management teams or other equity or debt holders of our companies having economic or business interests or objectives that are different from ours; and

 

 

 

 

•

the companies not taking our advice with respect to the financial or operating issues they may encounter.

 

Our inability to control our companies also could prevent us from assisting them, financially or otherwise, or could prevent us from liquidating our interests in them at a time or at a price that is favorable to us. Additionally, our companies may not act in ways that are consistent with our business strategy. These factors could hamper our ability to maximize returns on our interests and cause us to incur losses on our interests in these companies.

 

We may have to buy, sell or retain assets when we would otherwise not wish to do so in order to avoid registration under the Investment Company Act.

 

The Investment Company Act of 1940 regulates companies which are engaged primarily in the business of investing, reinvesting, owning, holding or trading in securities. Under the Investment Company Act, a company may be deemed to be an investment company if it owns investment securities with a value exceeding 40% of the value of its total assets (excluding government securities and cash items) on an unconsolidated basis, unless an exemption or safe harbor applies. We refer to this test as the “40% Test.” Securities issued by companies other than consolidated companies are generally considered “investment securities” for purposes of the Investment Company Act, unless other circumstances exist which actively involve the company holding such interests in the management of the underlying company. We are a company that partners with growth-stage companies to build value; we are not engaged primarily in the business of investing, reinvesting or trading in securities. We are in compliance with the 40% Test. Consequently, we do not believe that we are an investment company under the Investment Company Act.

 

9
Table of Contents

 

We monitor our compliance with the 40% Test and seek to conduct our business activities to comply with this test. It is not feasible for us to be regulated as an investment company because the Investment Company Act rules are inconsistent with our strategy of actively helping our companies in their efforts to build value. In order to continue to comply with the 40% Test, we may need to take various actions which we would otherwise not pursue. For example, we may be limited in the manner or timing in which we sell our interests in a company. Our ownership levels also may be affected if our companies are acquired by third parties or if our companies issue stock which dilutes our ownership interest. The actions we may need to take to address these issues while maintaining compliance with the 40% Test could adversely affect our ability to create and realize value at our companies.

 

The COVID-19 pandemic may adversely affect parties with obligations to us, including the subtenant of our previous office space.

 

In March 2019, we entered into a sublease of our prior corporate headquarters office space beginning in June 2019. The term of the sublease is through April 2026, the same as our underlying lease. Fixed sublease payments to us are escalating over the term of the sublease.  We remain obligated under the original lease for such office space and, in the event the subtenant of such office space fails to satisfy its obligations under the sublease, we would be required to satisfy our obligations directly to the landlord under such original lease.

 

Risks Related to Our Companies

 

Most of our companies have a history of operating losses and/or limited operating history and may never be profitable.

 

Most of our companies have a history of operating losses and/or limited operating history, have significant historical losses and may never be profitable. Many have incurred substantial costs to develop and market their products, have incurred net losses and cannot fund their cash needs from operations. We expect that the operating expenses of certain of our companies will increase substantially in the foreseeable future as they continue to develop products and services, increase sales and marketing efforts, and expand operations.

 

Our companies face intense competition, which could adversely affect their business, financial condition, results of operations and prospects for growth.

 

There is intense competition in the technology marketplaces, and we expect competition to intensify in the future. Our business, financial condition, and results of operations will be materially adversely affected if our companies are not able to compete successfully. Many of the present and potential competitors may have greater financial, technical, marketing and other resources than those of our companies. This may place our companies at a disadvantage in responding to the offerings of their competitors, technological changes or changes in client requirements. Also, our companies may be at a competitive disadvantage because many of their competitors have greater name recognition, more extensive client bases and a broader range of product offerings. In addition, our companies may compete against one another.

 

The success or failure of many of our companies is dependent upon the ultimate effectiveness of newly-created technologies, medical devices, financial services, healthcare diagnostics, etc.

 

Our companies’ business strategies are often highly dependent upon the successful launch and commercialization of an innovative technology or device, including, without limitation, technologies or devices used in healthcare, financial services or digital media.  Despite all of our efforts to understand the research and development underlying the innovation or creation of such technologies and devices before we deploy capital into a company, sometimes the performance of the technology or device does not match our expectations or those of such company. In those situations, it is likely that we will incur a partial or total loss of the capital which we deployed in such company.

 

Our companies may fail if they do not adapt to changing marketplaces.

 

If our companies fail to adapt to changes in technology and customer and supplier demands, they may not become or remain profitable. There is no assurance that the products and services of our companies will achieve or maintain market penetration or commercial success, or that the businesses of our companies will be successful.

 

The technology marketplaces are characterized by:

 

•

rapidly changing technology;
 

•

evolving industry standards;
 

•

frequent introduction of new products and services;
 

•

shifting distribution channels;
 

•

evolving government regulation;
 

•

frequently changing intellectual property landscapes; and
 

•

changing customer demands.

 

Our future success will depend on our companies’ ability to adapt to these evolving marketplaces. They may not be able to adequately or economically adapt their products and services, develop new products and services or establish and maintain effective distribution channels for their products and services. If our companies are unable to offer competitive products and services or maintain effective distribution channels, they will sell fewer products and services and forego potential revenue, possibly causing them to lose money. In addition, we and our companies may not be able to respond to the marketplace changes in an economically efficient manner, and our companies may become or remain unprofitable.

 

10
Table of Contents

 

Our companies may grow rapidly, including through acquisitions of other businesses, and may be unable to manage their growth.

 

We expect some of our companies to grow rapidly, including through acquisitions of other businesses. Such growth often places considerable operational, managerial, integration and financial strain on a business. To successfully manage such growth, our companies must, among other things:

 

 

•

improve, upgrade and expand their business infrastructures;
  • successfully integrate and operate any newly acquired businesses;
 

•

scale up production operations;
 

•

develop appropriate financial reporting controls;
 

•

attract and retain qualified personnel; and
 

•

maintain appropriate levels of liquidity.

 

If our companies are unable to manage their growth successfully, their ability to respond effectively to competition and to achieve or maintain profitability will be adversely affected.

 

Based on our business model, some or all of our companies will need to raise additional capital to fund their operations at any given time. We may not be able to, or decline to, fund some or all of such amounts and such amounts may not be available from third parties on acceptable terms, if at all. Further, if our companies do raise additional capital from third parties, either debt or equity, such capital may rank senior to, or dilute, our interests in such companies.

 

We cannot be certain that our companies will be able to obtain additional financing on favorable terms when needed, if at all. We may not be able to, or decline to, provide our companies with sufficient capital resources to enable them to reach a cash-flow positive position or a sale of the company. General economic disruptions and downturns may also negatively affect the ability of some of our companies to fund their operations from other stockholders and capital sources. We also may fail to accurately project the capital needs of companies. If our companies need capital, but are not able to raise capital from us or other outside sources, they may need to cease or scale back operations. In such event, our interest in any such company will become less valuable. If our companies raise additional capital from third parties, either debt or equity, such capital may be dilutive, making our interests less valuable or if such capital ranks senior to the capital we have deployed, such capital may entitle its holders to receive returns of capital before we are entitled to receive any return of our deployed capital. Also, in the event of any insolvency, liquidation, dissolution, reorganization or bankruptcy of one or more our companies, holders of such company’s instruments that rank senior to our deployed capital will typically be entitled to receive payment in full before we receive any return of our deployed capital. After returning such senior capital, such company may not have any remaining assets to use for returning capital to us, causing us to lose some or all of our deployed capital in such company.

 

Economic disruptions and downturns may negatively affect our companies’ plans and their results of operations.

 

Many of our companies are largely dependent upon outside sources of capital to fund their operations. Disruptions in the availability of capital from such sources will negatively affect the ability of such companies to pursue their business models and will force such companies to revise their growth and development plans accordingly. Any such changes will, in turn, negatively affect our ability to realize the value of our capital deployments in such companies.

 

In addition, downturns in the economy as well as possible governmental responses to such downturns and/or to specific situations in the economy could affect the business prospects of certain of our companies, including, but not limited to, in the following ways: weaknesses in the financial services industries; reduced business and/or consumer spending; and/or systemic changes in the ways the healthcare system operates in the United States.

 

Some of our companies may be unable to protect their proprietary rights and may infringe on the proprietary rights of others.

 

Our companies assert various forms of intellectual property protection. Intellectual property may constitute an important part of our companies’ assets and competitive strengths. Federal law, most typically copyright, patent, trademark and trade secret laws, generally protects intellectual property rights. Although we expect that our companies will take reasonable efforts to protect the rights to their intellectual property, third parties may develop similar intellectual property independently. Moreover, the complexity of international trade secret, copyright, trademark and patent law, coupled with the limited resources of our companies and the demands of quick delivery of products and services to market, create a risk that our companies’ efforts to prevent misappropriation of their technology will prove inadequate.

 

Some of our companies also license intellectual property from third parties and it is possible that they could become subject to infringement actions based upon their use of the intellectual property licensed from those third parties. Our companies generally obtain representations as to the origin and ownership of such licensed intellectual property. However, this may not adequately protect them. Any claims against our companies’ proprietary rights, with or without merit, could subject the companies to costly litigation and divert their technical and management personnel from other business concerns. If our companies incur costly litigation and their personnel are not effectively deployed, the expenses and losses incurred by our companies will increase and their profits, if any, will decrease.

 

Third parties have and may assert infringement or other intellectual property claims against our companies based on their patents or other intellectual property claims. Even though we believe our companies’ products do not infringe any third party’s patents, they may have to pay substantial damages, possibly including treble damages, if it is ultimately determined that they do. They may have to obtain a license to sell their products if it is determined that their products infringe on another person’s intellectual property. Our companies might be prohibited from selling their products before they obtain a license, which, if available at all, may require them to pay substantial royalties. Even if infringement claims against our companies are without merit, defending these types of lawsuits takes significant time, is expensive and may divert management attention from other business concerns.

 

11
Table of Contents

 

Certain of our companies could face legal liabilities from claims made against their operations, products or work.

 

Because the manufacture and sale of certain company products entail an inherent risk of product liability, certain of our companies maintain product liability insurance. Although none of our current companies have experienced any material losses in this regard, there can be no assurance that they will be able to maintain or acquire adequate product liability insurance in the future and any product liability claim could have a material adverse effect on a company’s financial stability, revenues and results of operations. In addition, many of the engagements of our companies involve projects that are critical to the operation of their clients’ businesses. If our companies fail to meet their contractual obligations, they could be subject to legal liability, which could adversely affect their business, operating results and financial condition. Our companies’ contracts typically include provisions designed to limit their exposure to legal claims relating to their services and products. However, these provisions may not protect our companies or may not be enforceable. Also, some of our companies depend on their relationships with their clients and their reputation for high-quality services and integrity to retain and attract clients. As a result, claims made against our companies’ work may damage their reputation, which in turn could impact their ability to compete for new work and negatively impact their revenue and profitability.

 

Our companies’ success depends on their ability to attract and retain qualified personnel.

 

Our companies depend upon their ability to attract and retain senior management and key personnel, including trained technical and marketing personnel. Our companies also will need to continue to hire additional personnel as they expand. Although our current companies have not been the subject of a work stoppage, any future work stoppage could have a material adverse effect on their respective operations. A shortage in the availability of the requisite qualified personnel or work stoppage would limit the ability of our companies to grow, to increase sales of their existing products and services, and to launch new products and services.

 

Government regulations and legal uncertainties may place financial burdens on the businesses of our companies.

 

Manufacturers of medical diagnostic devices and operators of laboratory facilities are subject to strict federal and state regulation regarding validation and the quality of manufacturing and laboratory facilities. Failure to comply with these quality regulation systems requirements could result in civil or criminal penalties or enforcement proceedings, including the recall of a product or a “cease distribution” order. The enactment of any additional laws or regulations that affect healthcare insurance policy and reimbursement (including Medicare reimbursement) could negatively affect some of our companies. If Medicare or private payers change the rates at which our companies or their customers are reimbursed by insurance providers for their products, such changes could adversely impact our companies.

 

Some of our companies may be subject to significant environmental, health, data security and safety regulation.

 

Some of our companies may be subject to licensing and regulation under federal, state and local laws and regulations relating to the protection of the environment and human health and safety, including laws and regulations relating to the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials, as well as to the safety and health of manufacturing and laboratory employees. In addition, some of our companies are subject to federal, state and local financial securities and data security regulations, including, without limitation, the Health Insurance Portability and Accountability Act of 1996, as amended, the California Consumer Privacy Act and the European General Data Protection Regulation, which impose varying degrees of additional obligations, costs and risks upon such companies, including the imposition of significant penalties in the event of any non-compliance. Further, the federal Occupational Safety and Health Administration has established extensive requirements relating to workplace safety. Compliance with such regulations could increase operating costs at certain of our companies, and the failure to comply could negatively affect the operations and results of some of our companies.

 

Catastrophic events may disrupt our companies’ businesses.

 

Some of our companies are highly automated businesses and rely on their network infrastructure, various software applications and many internal technology systems and data networks for their customer support, development, sales and marketing and accounting and finance functions. Further, some of our companies provide services to their customers from data center facilities in multiple locations. Some of these data centers are operated by third parties, and the companies have limited control over those facilities. A disruption or failure of these systems or data centers in the event of a natural disaster, telecommunications failure, power outage, cyber-attack, war, terrorist attack or other catastrophic event could cause system interruptions, reputational harm, delays in product development, breaches of data security and loss of critical data. Such an event could also prevent the companies from fulfilling customer orders or maintaining certain service level requirements, particularly in respect of their SaaS offerings. While certain of our companies have developed certain disaster recovery plans and maintain backup systems to reduce the potentially adverse effect of such events, a catastrophic event that resulted in the destruction or disruption of any of their data centers or their critical business or information technology systems could severely affect their ability to conduct normal business operations and, as a result, their business, operating results and financial condition could be adversely affected.

 

We cannot provide assurance that our companies’ disaster recovery plans will address all of the issues they may encounter in the event of a disaster or other unanticipated issue, and their business interruption insurance may not adequately compensate them for losses that may occur from any of the foregoing. In the event that a natural disaster, terrorist attack or other catastrophic event were to destroy any part of their facilities or interrupt their operations for any extended period of time, or if harsh weather or health conditions prevent them from delivering products in a timely manner, their business, financial condition and operating results could be adversely affected.

 

Risks Related to an Investment in our Securities

 

Fluctuations in the price of the common stock of our publicly traded holdings may affect the price of our common stock.

 

From time to time, we may hold equity interests in companies that are publicly traded. Fluctuations in the market prices of the common stock of publicly traded holdings may affect the price of our common stock. Historically, the market prices of our publicly traded holdings have been highly volatile and subject to fluctuations unrelated or disproportionate to operating performance.

 

12
Table of Contents

 

The continuing costs and burdens associated with being a public company will constitute a much larger percentage of our expenses and we may in the future delist our common stock with the New York Stock Exchange and seek to deregister our common stock with the SEC.

 

We will remain a public company and will continue to be subject to the listing standards of the New York Stock Exchange and SEC rules and regulations, including the Dodd-Frank Wall Street Reform and Consumer Protection Act and the Sarbanes-Oxley Act of 2002.  The costs and burdens of being a public company will be a significant and continually increasing portion of our expenses if we are able to monetize our company interests.  As part of such monetization efforts, we will likely in the future, once the majority of our company interests have been monetized, delist our common stock from the New York Stock Exchange and seek to deregister our common stock with the SEC.  However, there can be no assurance as to the timing of such transactions, or whether such transactions will be completed at all, and we will continue to face the costs and burdens of being a public company until such time as our common stock is delisted with the New York Stock Exchange and deregistered with the SEC.

 

Economic disruptions and downturns may have negative repercussions for us.

 

Events in the United States and international capital markets, debt markets and economies may negatively impact our stock price and our ability to pursue certain tactical and strategic initiatives, such as accessing additional public or private equity or debt financing for us or for our companies and selling our interests in companies on terms acceptable to us and in time frames consistent with our expectations.

 

We cannot provide assurance that material weaknesses in our internal control over financial reporting will not be identified in the future.

 

We cannot assure you that material weaknesses in our internal control over financial reporting will not be identified in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in a material weakness, or could result in material misstatements in our Consolidated Financial Statements. These misstatements could result in a restatement of our Consolidated Financial Statements, cause us to fail to meet our reporting obligations and/or cause investors to lose confidence in our reported financial information, leading to a decline in our stock price.

 

Item 1B. Unresolved Staff Comments

 

None.

 

Item 2. Properties

 

Our current corporate headquarters and administrative offices in Radnor, Pennsylvania is approximately 100 square feet of office space in one building.  The initial lease term expires in November 2021.  The sublease for our previous corporate headquarters and administrative offices for approximately 4,000 square feet of office space in Radnor, Pennsylvania expired in November 2020 (from a company in which we have an equity interest).

 

 Additionally, we have additional administrative offices located in Radnor, Pennsylvania comprising approximately 15,600 square feet, that have been sublet to an unaffiliated party through April, 2026, the remainder of the lease term.

 

Item 3. Legal Proceedings

 

We, as well as our companies in which we hold ownership interests, are from time to time involved in various claims and legal actions arising in the ordinary course of business. While in the current opinion of management, the ultimate disposition of any of these matters which are currently pending will not have a material adverse effect on our consolidated financial position or results of operations, no assurance can be given as to the outcome of these situations, and one or more adverse dispositions could have a material adverse effect on our consolidated financial position and results of operations, or that of our companies. See Note 12 to the Consolidated Financial Statements for a discussion of ongoing claims and legal actions.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

ANNEX TO PART I — EXECUTIVE OFFICERS OF THE REGISTRANT

 

Name

Age

 

Position

 

Executive Officer Since

Eric C. Salzman

53

 

Chief Executive Officer

 

2020

Mark A. Herndon

51

 

Senior Vice President and Chief Financial Officer

 

2018

 

Mr. Salzman joined Safeguard as Chief Restructuring Officer in April 2020.  Mr. Salzman began serving as the Chief Executive Officer in December 2020.  Mr. Salzman has a 25-year track record partnering with growth companies as an investor, board member and strategic advisor.  He has worked in M&A, restructuring, growth and special situations investing at a number of investment banks and private equity funds, including Credit Suisse and Lehman Brothers.  Mr. Salzman helped oversee the monetization of a $2 billion portfolio of illiquid assets in the Lehman Brothers Bankruptcy Estate and subsequently advised several investment funds on value-maximization strategies for their respective portfolios.  He currently serves as a director on a number of Safeguard portfolio companies as well as an independent director at publicly traded 8x8, Inc.  Mr. Salzman earned a B.A. Honors from the University of Michigan and an MBA from Harvard University

 

Mr. Herndon joined Safeguard as Senior Vice President and Chief Financial Officer in September 2018. Prior to joining Safeguard, Mr. Herndon served in a variety of client service and national office roles at PricewaterhouseCoopers from 1991 to 2018, including his position as Assurance Partner from 2006 until 2018.

 

13
Table of Contents

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Our common stock is listed on the New York Stock Exchange (Symbol: SFE). The high and low sale prices reported within each quarter of 2020 and 2019 were as follows: 

 

   

High

    

Low

  

Fiscal year 2020:

                

First quarter

   $ 11.11     $ 4.43  

Second quarter

     7.87       4.92  

Third quarter

     7.12       5.15  

Fourth quarter

     7.25       5.33  

Fiscal year 2019:

                

First quarter

   $ 11.66     $ 8.36  

Second quarter

     12.91       10.59  

Third quarter

     12.79       10.92  

Fourth quarter

     12.43       10.57  

 

The high and low sale prices reported in the first quarter of 2021 through February 26, 2021 were $8.59 and $6.35 respectively, and the last sale price reported on February 26, 2021, was $7.65.  As of February 26, 2021, there were approximately 10,487 beneficial holders of our common stock.

 

 

Special Dividend

 

On November 7, 2019, the Board of Directors declared a special cash dividend of $1.00 per share, payable on December 30, 2019 to shareholders of record as of the close of business on December 23, 2019.

 

Issuer Purchases of Equity Securities

 

The following table provides information about our purchases of equity securities during the quarter ended December 31, 2020 registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"):

 

Period

   Total Number of Shares Purchased (a)     Average Price Paid Per Share    

Total Number of Shares Purchased as Part of Publicly Announced Plan (b)

    

Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plan (b)

  

October 1, 2020 - October 31, 2020

     —     $ —       —     $ 14,636,135  

November 1, 2020 - November 30, 2020

     —     $ —       —     $ 14,636,135  

December 1, 2020 - December 31, 2020

     1,456     $ 6.74       —     $ 14,636,135  

Total

     1,456     $ 6.74       —          

 

(a) During the fourth quarter of 2020, we repurchased an aggregate of approximately 1 thousand shares of our common stock initially issued as restricted stock awards to employees and subsequently withheld from employees to satisfy the statutory withholding tax liability upon the vesting of such restricted stock awards.

 

(b) In July 2015, our Board of Directors authorized us to repurchase shares of our outstanding common stock with an aggregate value of up to $25.0 million.  These repurchases may be made in open market or privately negotiated transactions, including under plans complying with Rule 10b5-1 of the Exchange Act, based on market conditions, stock price, and other factors.  The share repurchase program does not obligate us to acquire any specific number of shares.

 

14
Table of Contents

 

Item 6. Selected Consolidated Financial Data

 

Not applicable for a smaller reporting company.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Note Concerning Forward-Looking Statements

 

This Annual Report on Form 10-K contains forward-looking statements that are based on current expectations, estimates, forecasts and projections about Safeguard Scientifics, Inc. (“Safeguard” or “we”), the industries in which we operate and other matters, as well as management's beliefs and assumptions and other statements regarding matters that are not historical facts.  These statements include, in particular, statements about our plans, strategies and prospects.  For example, when we use words such as “projects,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “should,” “would,” “could,” “will,” “opportunity,” “potential” or “may,” variations of such words or other words that convey uncertainty of future events or outcomes, we are making forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Our forward-looking statements are subject to risks and uncertainties.  Factors that could cause actual results to differ materially include, among others, our ability to make good decisions about the deployment of capital, the fact that our ownership interests may vary from period to period, our substantial capital requirements and absence of liquidity from our holdings, competition, our inability to obtain maximum value for our ownership interests, our ability to attract and retain qualified employees, our ability to execute our strategy, market valuations in sectors in which our ownership interests operate, our inability to control our ownership interests companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our ownership interests and their performance, including the fact that most of the companies in which we have an ownership interest have a limited history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which they operate, compliance with government regulation and legal liabilities, all of which are discussed in Item 1A. “Risk Factors.” Many of these factors are beyond our ability to predict or control. In addition, as a result of these and other factors, our past financial performance should not be relied on as an indication of future performance. All forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by this cautionary statement. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this report might not occur.

 

Overview

 

Over the recent past, Safeguard has provided capital and relevant expertise to fuel the growth of technology-driven businesses. In many, but not all cases, we are actively involved, influencing development through board representation and management support, in addition to the influence we exert through our equity ownership. We also continue to hold relatively small equity interests in other enterprises where we do not exert significant influence and do not participate in management activities. In some cases, those interests relate to residual interests from prior larger interests or from companies that acquired companies in which we had ownership interests.

 

In January 2018, Safeguard announced that we will not deploy any capital into new opportunities and will focus on supporting our existing companies and maximizing monetization opportunities to enable returning value to shareholders. In that context, we have, are and will consider initiatives including, among others: the sale of our ownership interests, the sale of certain or all ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value. We initiated the return of value to shareholders in 2019 with a $1.00 per share special dividend. Moving forward, we anticipate additional actions in the form of stock repurchases and/or special dividends based on available cash resources, prevailing market conditions and other factors.

 

Principles of Accounting for Ownership Interests

 

We account for our ownership interests using one of the following methods: Equity or Other. The accounting method applied is generally determined by the degree of our influence over the entity, primarily determined by our voting interest in the entity.

 

Equity Method. We account for companies whose results are not consolidated, but over whom we exercise significant influence, using the equity method of accounting. We also account for our interests in some private equity funds under the equity method of accounting, based on our non-controlling general and/or limited partner interests. Under the equity method of accounting, our share of the income or loss of the company is reflected in Equity income (loss), net in the Consolidated Statements of Operations. We report our share of the income or loss of the equity method companies on a one quarter lag. We include the carrying value of equity method companies in Ownership interests and advances on the Consolidated Balance Sheets.

 

When the carrying value of our holdings in an equity method company is reduced to zero, no further losses are recorded in our Consolidated Statements of Operations unless we have outstanding guarantee obligations or have committed additional funding to the equity method company. When the equity method company subsequently reports income, we will not record our share of such income until it equals the amount of our share of losses not previously recognized.

 

15
Table of Contents

 

Other Method. We account for our equity interests in companies which are not accounted for under the equity method or fair value method as equity securities without readily determinable fair values. We account for these securities based on our original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar securities of the same issuer. Under this method, our share of the income or losses of such companies is not included in our Consolidated Statements of Operations. We include the carrying value of these investments in Ownership interests and advances on the Consolidated Balance Sheets.

 

Critical Accounting Policies and Estimates

 

Accounting policies, methods and estimates are an integral part of the Consolidated Financial Statements prepared by management and are based upon management’s current judgments. These judgments are normally based on knowledge and experience with regard to past and current events and assumptions about future events. Certain accounting policies, methods and estimates are particularly important because of their significance to the financial statements and because of the possibility that future events affecting them may differ from management’s current judgments. While there are a number of accounting policies, methods and estimates affecting our financial statements as described in Note 1 to our Consolidated Financial Statements, the most significant relate to impairment of ownership interests and advances.

 

Impairment of Ownership Interests and Advances

 

On a periodic basis, but no less frequently than at the end of each quarter, we evaluate the carrying value of our ownership interests for possible impairment based on achievement of business plan objectives and milestones, the financial condition and prospects of the company, market conditions and other relevant factors. The business plan objectives and milestones we consider include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are not primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships. We then determine whether there has been an other than temporary decline in the value of our ownership interest in the company. Any impairment to be recognized is measured as the amount by which the carrying value of an asset exceeds its fair value. The adjusted carrying value of an ownership interest is not increased if circumstances suggest the value of the company has subsequently recovered.

 

The fair value of privately held companies is generally determined based on the value at which independent third parties have invested or have committed to invest in these companies, or based on other valuation methods including discounted cash flows, valuations of comparable public companies and valuations of acquisitions of comparable companies.

 

Our companies operate in industries which are rapidly evolving and extremely competitive. It is reasonably possible that our accounting estimates with respect to the ultimate recoverability of the carrying value of ownership interests and advances could change in the near term and that the effect of such changes on our Consolidated Financial Statements could be material. While we believe that the current recorded carrying values of our equity and other method companies are not impaired, there can be no assurance that our future results will confirm this assessment or that a significant write-down or write-off will not be required in the future.

 

Total impairment charges related to our Ownership interests and advances were as follows: 

 

   

Year Ended December 31,

  

Accounting Method

  

2020

    

2019

  
   

(In thousands)

  

Equity

   $ 11,282     $ 2,965  

Other

     8,757       47  

Total

   $ 20,039     $ 3,012  

 

Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to other investments are included in Other income (loss), net in the Consolidated Statements of Operations.

 

16
Table of Contents

 

Results of Operations

 

We operate as one operating segment based upon the similar nature of our technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 

There is intense competition in the markets in which our companies operate. Additionally, the markets in which these companies operate are characterized by rapidly changing technology, evolving industry standards, frequent introduction of new products and services, shifting distribution channels, evolving government regulation, frequently changing intellectual property landscapes and changing customer demands. Their future success depends on each company’s ability to execute its business plan and to adapt to its respective rapidly changing market.

 

The following is a listing of certain of our ownership interests as of December 31, 2020 and December 31, 2019.

 

    Safeguard Primary Ownership as of December 31,    

Company Name

  

2020

  

2019

  

Accounting Method

Aktana, Inc.

     15.1 %     17.8 %  

Equity

Clutch Holdings, Inc.

     42.3 %     41.2 %  

Equity

Flashtalking

     13.4 %     10.1 %  

Other

InfoBionic, Inc.

     25.2 %     25.2 %  

Equity

Lumesis, Inc.

     43.4 %     43.5 %  

Equity

MediaMath, Inc.

     13.3 %     13.3 %  

Other

meQuilibrium

     32.0 %     32.7 %  

Equity

Moxe Health Corporation

     27.6 %     29.9 %  

Equity

Prognos Health Inc.

     28.5 %     28.7 %  

Equity

QuanticMind, Inc. *

     24.2 %     24.2 %  

Equity

Syapse, Inc.

     18.9 %     20.0 %  

Equity

T-REX Group, Inc.

     13.5 %     13.7 %  

Other

Trice Medical, Inc.

     16.6 %     16.6 %  

Equity

WebLinc, Inc. *

     39.9 %     38.5 %  

Equity

Zipnosis, Inc

     37.2 %     37.7 %  

Equity

 

* These entities were sold subsequent to December 31, 2020.  See Note 16 - Subsequent Events, of the consolidated financial statements.

 

Year ended December 31, 2020 versus year ended December 31, 2019

 

   

Year Ended December 31,

  
   

2020

    

2019

    

Variance

  
   

(In thousands)

  

General and administrative expense

   $ (9,466 )   $ (9,982 )   $ 516  

Other income (loss), net

     (7,708 )     12,255       (19,963 )

Interest income

     261       2,044       (1,783 )

Interest expense

     —       (14,023 )     14,023  

Equity income (loss), net

     (20,702 )     64,267       (84,969 )

Net income (loss)

   $ (37,615 )   $ 54,561     $ (92,176 )

 

General and Administrative Expense. Our general and administrative expenses consist primarily of employee compensation, insurance, office costs, travel-related costs, depreciation, office rent and professional services such as consulting, legal, and accounting. General and administrative expense also includes stock-based compensation expense which consists primarily of expense related to grants of stock options, restricted stock and deferred stock units to our employees and directors. General and administrative expense decreased $0.5 million for the year ended December 31, 2020 compared to the prior year primarily due to decreases in depreciation of $0.8 million, employee compensation of $0.4 million, stock-based compensation of $0.3 million, lower office rental costs of $0.2 million, lower professional fees of $0.4 million, certain 2019 retirement costs that did not recur of $0.2 million and other various costs, which were partially offset by $1.8 million of higher severance charges and higher insurance costs of $0.3 million.  General and administrative expenses include amounts estimated for the Transaction Bonus Plan (the "LTIP"), which is a component of employee compensation.  As described in Note 12 in the accompany consolidated financial statements, the LTIP provides a cash bonus pool to employees based upon meeting certain thresholds of sales of the Company's ownership interests.  Expense recognized pursuant to the LTIP was $1.3 million and $0.5 million during the years ended December 31, 2020 and 2019, respectively.  No amounts have been paid yet according to the terms of the LTIP, however $1.5 million is presented as a current liability at December 31, 2020.  General and administrative expense also includes stock based compensation expense of $965,000 for the year ended December 31, 2020 as compared to $1,237,000 for the year ended December 31, 2019.  Stock based compensation for the year ended December 31, 2020 includes the impact of a larger proportion of management's compensation, including a portion of previously existing accruals under the management incentive plan, that are to be settled in vested stock as well as Director compensation, which in 2020 was settled entirely in vested stock.

 

17
Table of Contents

 

Other income (loss), net. Other income (loss), net decreased by $20.0 million for the year ended December 31, 2020, compared to the prior year.  During the year ended December 31, 2020, the Company recorded impairments of $8.8 million related to the ownership interests of T-REX, b8ta and others accounted for under the Other method. The impairments were determined based on declines in the fair value of our ownership interests resulting from reduced valuation expectations and extended exit timelines resulting from the more challenging mergers and acquisitions environment related to COVID-19 and the related uncertain economic impact.  The Company also recorded a $0.3 million reduction in the carrying value of an other equity security based on an observable price change. Partially offsetting these impairments, was a $1.5 million non-cash gain for the increase in the fair value our ownership interest in Flashtalking based upon an observable price change. Other income (loss), net for the year ended December 31, 2019 included $4.5 million of non-cash gains on the increase in the value of certain equity securities based upon observable price changes, $5.1 million of income related to the decrease in the fair value of the Credit Facility repayment feature liability and a $1.7 million gain resulting from the elimination of the remaining estimated liability established related to the retirement for a former Chairman and CEO of the Company. The Credit Facility was repaid in full during 2019 resulting in the elimination of the Credit Facility repayment feature liability.

 

Interest Income. Interest income decreased $1.8 million for the year ended December 31, 2020 compared to the prior year primarily attributable to lower average notes receivable, lower average investment and cash equivalent balances at lower rates in 2020.

 

Interest Expense. Interest expense decreased $14.0 million for the year ended December 31, 2020 compared to the prior year due to the pay-off of borrowings under the Credit Facility in 2019.

 

Equity Income (Loss), net. Equity income (loss), net fluctuates with the number of companies accounted for under the equity method, our voting ownership percentage in those companies and the net results of operations of those companies. We recognize our share of losses to the extent we have cost basis in the equity of the company or we have outstanding commitments or guarantees. Certain amounts recorded to reflect our share of the income or losses of our companies accounted for under the equity method are based on estimates and on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities are made final. We report our share of the results of our equity method companies on a one quarter lag basis.

 

Equity income (loss), net decreased $85.0 million for the year ended December 31, 2020 compared to the prior year. The components of equity income (loss), net for the years ended December 31, 2020 and 2019 were as follows:

 

   

Year Ended December 31,

  
   

2020

    

2019

    

Variance

  
   

(In thousands)

  

Gains on sales of ownership interests

   $ 183     $ 90,139     $ (89,956 )

Unrealized dilution gains

     4,246       3,206       1,040  

Loss on impairments

     (11,282 )     (2,965 )     (8,317 )

Share of losses of our equity method companies, net

     (13,849 )     (26,113 )     12,264  
    $ (20,702 )   $ 64,267     $ (84,969 )

 

There were no material gains or losses on sales of ownership interests for the year ended December 31, 2020, however Sonobi was sold resulting in $6.6 million of cash proceeds.  The amounts reported as gains on sales of ownership interests for the year ended December 31, 2019 are comprised primarily of gains related to the sale of Propeller of $35.1 million and Transactis of $50.7 million, but also include the collection of escrow from various prior transactions, including $3.8 million related to Cask Data.

 

The unrealized dilution gains for the year ended December 31, 2020 were the result of Aktana, meQuilibrium, Moxe and Syapse, who each raised additional equity capital that diluted the Company's interest in those entities. The unrealized dilution gains for the year ended December 31, 2019 were related to meQuilibrium, Moxe, Syapse, Trice and T-REX.

 

 

18
Table of Contents

 

During the year ended December 31, 2020 the Company recorded impairments of $11.3 million related to the ownership interests of WebLinc, Inc., QuanticMind, Inc. and Sonobi accounted for under the equity method. The impairments were determined based on declines in the fair value of our ownership interests resulting from reduced valuation expectations and extended exit timelines resulting from the more challenging mergers and acquisitions environment related to COVID-19 and the related uncertain economic impact.  The loss on impairments for the year ended December 31, 2019 is due to NovaSom, Inc.'s August 2019 bankruptcy filing.

 

The decrease in our share of losses of our equity method companies for the 2020 year compared to the prior year period was due to a decrease in the number of ownership interests accounted for under the equity method and a decrease in losses associated with the remaining ownership interests, including the $1.8 million benefit that resulted from the recognition of revenue in the current period at one of our ownership interests upon the adoption of Accounting Standards Update 2014-09, Revenue from Contracts with Customers, which was considered deferred revenue at the beginning of their adoption period under the new standard.

 

Income Tax Benefit (Expense)

 

Income tax benefit (expense) was $0.0 million for the years ended December 31, 2020 and 2019. We have recorded a valuation allowance to reduce our net deferred tax asset to an amount that is more likely than not to be realized in future years. Accordingly, the benefit of the net operating loss that would have been recognized in each year was offset by changes in the valuation allowance.

 

Liquidity And Capital Resources

 

As of December 31, 2020, the Company had $15.6 million of cash and cash equivalents.

 

During April 2019, the Company made a $24.0 million principal payment to its Lender and a related make-whole interest payment of $2.9 million. During July 2019, the Company made a $49.5 million payment to its Lender consisting of $44.5 million of principal, $4.1 million of make-whole interest and $0.9 million of accrued interest, which satisfied all obligations under the Credit Facility.

 

In January 2018, Safeguard announced that, from that date forward, we will not deploy any capital into new opportunities and will focus on supporting our existing companies and maximizing monetization opportunities to return value to shareholders. In that context, we have, are and will consider initiatives including, among others: the sale of our individual ownership interests, the sale of certain ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value.

 

Subsequent to the debt repayment, on November 7, 2019, the Company's Board of Directors declared a special cash dividend of $1.00 per share, payable on December 30, 2019 to shareholders of record as of the close of business on December 23, 2019. We anticipate continuing to return value to shareholders in the form of stock repurchases and/or dividends based on prevailing market conditions and other factors when and if additional liquidity becomes available.

 

In 2015, the Company's Board of Directors authorized us, from time to time and depending on market conditions, to repurchase up to $25.0 million of the Company's outstanding common stock. During the years ended December 31, 2020 and 2019, we did not repurchase any shares under this authorization.

 

Our ability to generate liquidity from transactions involving our ownership interests has been adversely affected from time to time by adverse circumstances in the U.S. capital markets and other factors, including the impact of COVID-19.  We may be required to provide additional capital to our companies, which may cause us to face liquidity issues that will constrain our ability to execute our business strategy and limit our ability to provide financial support to all of our existing companies in the amounts that we desire. The transactions we enter into in pursuit of our strategy could increase or decrease our liquidity at any point in time. As we seek to provide additional funding to existing companies where we have an ownership interest or commit capital to other initiatives, we may be required to expend our cash or incur debt, which will decrease our liquidity. Conversely, as we dispose of our interests in our ownership interests, we may receive proceeds from such sales, which could increase our liquidity. From time to time, we are engaged in discussions concerning deployments and dispositions which, if consummated, could impact our liquidity, perhaps significantly. The Company believes that its cash and cash equivalents at December 31, 2020 will be sufficient to fund operations past one year from the issuance of these financial statements.

 

Analysis of Consolidated Cash Flows

 

Cash flow activity was as follows: 

 

   

Year Ended December 31,

  
   

2020

    

2019

    

Variance

  
   

(In thousands)

          

Net cash used in operating activities

   $ (8,143 )   $ (19,970 )   $ 11,827  

Net cash (used in) provided by investing activities

     (1,269 )     126,303       (127,572 )

Net cash used in financing activities

     (40 )     (89,483 )     89,443  
    $ (9,452 )   $ 16,850     $ (26,302 )

 

19
Table of Contents

 

Net Cash Used In Operating Activities

 

Year ended December 31, 2020 versus year ended December 31, 2019. Net cash used in operating activities decreased by $11.8 million for the year ended December 31, 2020 compared to the prior year. The activity during the year ended December 31, 2020 was primarily the result of various non-cash adjustments to net loss, including the $20.0 million impairment losses and $9.4 million of equity loss, which were partially offset by non-cash gains, net, of $1.2 million for observable price changes.  The Company did not make any cash interest payments for the year ended December 31, 2020 as compared to $11.5 million of cash interest payments for the year ended December 31, 2019. The activity during the year ended December 31, 2019 was primarily the result of various non-cash adjustments to net income, including $67.2 million of equity income, $3.0 million of impairments, a $5.1 million loss from the increase in the fair value of the repayment feature derivative, a $4.5 million gain for an observable price change, depreciation, and amortization of debt discount of $3.5 million.

 

Net Cash (Used in) provided by Investing Activities

 

Year ended December 31, 2020 versus year ended December 31, 2019. Net cash (used in) provided by investing activities decreased by $127.6 million for the year ended December 31, 2020 compared to the prior year.  The decrease primarily related to the prior year's $104.3 million of proceeds from the sale of ownership interests, primarily Propeller and Transactis in the previous year, as compared to the $6.6 million of proceeds from the sale of Sonobi in the third quarter of 2020.  In addition, the Company's investing outflows resulting from acquisitions of ownership interests and advances to ownership interests during the year ended December 31, 2020 were $7.5 million less than the prior year. The Company also did not have any marketable security activity during the year ended December 31, 2020 as compared to $37.9 million of marketable securities sales exceeding purchases during the year ended December 31, 2019.

 

Net Cash Used In Financing Activities

 

Year ended December 31, 2020 versus year ended December 31, 2019. Net cash used in financing activities increased by $89.4 million for the year ended December 31, 2020 compared to the prior year. There were no significant financing activities for the year ended December 31, 2020. The primary financing activities in 2019 were the $20.7 million special dividend and the repayment of the Credit Facility for $68.6 million. 

 

Contractual Cash Obligations and Other Commercial Commitments

 

   

Payments Due by Period

  
   

Total

    

2021

    

2022 and 2023

    

2024 and 2025

    

After 2025

  
   

(In millions)

  

Contractual Cash Obligations:

                                        

Operating leases (a)

   $ 3.2     $ 0.6     $ 1.2     $ 1.2     $ 0.2  

Severance payments

     0.2       0.2       —       —       —  

Total Contractual Cash Obligations (b)

   $ 3.4     $ 0.8     $ 1.2     $ 1.2     $ 0.2  

 

(a)  In 2015, we entered into an agreement for the lease of our former principal executive offices which expires in April 2026.  Payments pursuant to this lease are approximately $3.2 million through expiration, however, in March 2019 we entered into a sublease for this office space which is also expected to result in future aggregate sublease receipts of $3.0 million through April 2026. 

 

(b)  The  maximum aggregate exposure under employment and severance agreements for remaining employees was approximately $2.3 million at December 31, 2020, which includes $0.5 million of annual bonus amounts that will be settled in 2021 in the normal course of business.  We are involved from time to time in various claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of any of these matters which are currently pending will not have a material adverse effect on our consolidated financial position or results of operation.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable for a smaller reporting company.

 

20
Table of Contents

 

Item 8. Financial Statements and Supplementary Data

 

The following Consolidated Financial Statements, and the related Notes thereto, of Safeguard Scientifics, Inc. and the Reports of Independent Registered Public Accounting Firm are filed as a part of this Form 10-K.

 

 

Page

Report of Independent Registered Public Accounting Firm 

22

Consolidated Balance Sheets as of December 31, 2020 and 2019

24

Consolidated Statements of Operations for the years ended December 31, 2020 and 2019

25

Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2020 and 2019

26

Consolidated Statements of Changes in Shareholders' Equity for the years ended December 31, 2020 and 2019

27

Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019

28

Notes to Consolidated Financial Statements

29

 

21
Table of Contents

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Board of Directors
Safeguard Scientifics, Inc.:

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Safeguard Scientifics, Inc. and subsidiaries (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows for the years then ended, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

 

22
Table of Contents

 

Impairment of Ownership interests and advances

 

As discussed in Note 1 and Note 2 to the consolidated financial statements, the Company’s ownership interests and advances balance as of December 31, 2020 was $50.4 million, of which $30.4 million is in equity method companies and $20.0 million is in other method companies and funds.  Impairment losses recognized in equity income (loss), net, and other income (loss), net, were $11.3 million and $8.8 million, respectively, for the year ended December 31, 2020. On a periodic basis, but no less frequently than quarterly, the Company evaluates the carrying value of its ownership interests and advances for impairment based on achievement of business plan objectives and milestones, the estimated fair value of each company relative to its carrying value, the financial condition and prospects of the company, and other relevant factors. The business plan objectives and milestones the company considers include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are not primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships. Based on the above, management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. If it is determined that there has been an other than temporary decline in the value of its ownership interests in the company, impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value. The measurement of fair value of privately held companies is generally determined based on the value at which independent third parties have invested or have committed to invest in these companies or based on other valuation methods, including discounted cash flows, valuation of comparable public companies, and the valuation of acquisitions of similar companies.

 

We identified the evaluation of impairment of ownership interests and advances as a critical audit matter. Specifically, the assessment encompassed the evaluation of management’s determination of the recognition of an other than temporary decline in value of its ownership interest in a company. The assessment also included the evaluation of the measurement of impairment. Both evaluations involved significant auditor judgment and subjectivity in assessing the results of the impairment analysis because the estimated fair value of certain ownership interests and advances approximate their carrying values, indicating a higher risk of impairment due to measurement uncertainty. The impairment analysis also involved evaluating the valuation methods used to estimate the fair value, which included significant assumptions based on future events that are not under the control of management. Those significant assumptions included projected revenues, likelihood of transaction scenarios, the selection of peer companies and their corresponding trading multiples and the weightings of different outcomes in developing the estimated fair value of the ownership interests. Changes to those assumptions could have a significant effect on the fair value.  In addition, the evaluation of impairment required the involvement of professionals with specialized skills and knowledge to assist in evaluating the audit evidence obtained from these procedures.

 

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design of certain internal controls related to the Company’s impairment assessment. This included controls over the recognition of other than temporary declines in value and the impairment analysis, including financial condition, prospects and other factors present at the company as well as the identification and determination of the significant assumptions used in estimating the fair values. We evaluated the valuation methods and tested the significant assumptions used by management including projected revenue, likelihood of transaction scenarios, the selection of peer companies and their corresponding trading multiples, and the weightings of different outcomes in developing the estimated fair value. Evaluating management’s significant assumptions related to the projected revenue involved considering the equity investees’ historical revenues and prospects.  In evaluating the likelihood of transaction scenarios, we considered recent financing activities and proposed transactions. Professionals with specialized skills and knowledge were used to assist in evaluating the methods and assessing the peer companies and their corresponding trading multiples assumptions by considering public companies with similar business models that operate in similar industries and by independently obtaining market data for the corresponding peer companies and comparing key characteristics such as size and growth prospects.

 

/s/ KPMG LLP

 

We have served as the Company’s auditor since 1986.

Philadelphia, Pennsylvania
March 5, 2021

 

23
Table of Contents

 

 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

 

  

As of December 31,

 
  

2020

  

2019

 

ASSETS

        

Current Assets:

        

Cash and cash equivalents

 $15,601  $25,028 

Restricted cash

  —   25 

Prepaid expenses and other current assets

  462   1,297 

Total current assets

  16,063   26,350 

Property and equipment, net

  1,790   2,101 

Ownership interests and advances

  50,398   77,129 

Other assets

  784   1,997 

Total Assets

 $69,035  $107,577 

LIABILITIES AND EQUITY

        

Current Liabilities:

        

Accounts payable

 $56  $39 

Accrued compensation and benefits

  2,677   1,364 

Accrued expenses and other current liabilities

  410   627 

Lease liability - current

  327   399 

Total current liabilities

  3,470   2,429 

Other long-term liabilities

  637   1,027 

Lease liability - non-current

  2,053   2,380 

Total Liabilities

  6,160   5,836 

Commitments and contingencies (Note 12)

          

Equity:

        

Preferred stock, $0.10 par value; 1,000 shares authorized

  —   — 

Common stock, $0.10 par value; 83,333 shares authorized; 21,573 issued at December 31, 2020 and 2019, respectively

  2,157   2,157 

Additional paid-in capital

  807,582   810,856 

Treasury stock, at cost; 688 and 930 shares at December 31, 2020 and 2019, respectively

  (10,200)  (14,024)

Accumulated deficit

  (736,639)  (697,223)

Accumulated other comprehensive loss

  (25)  (25)

Total Equity

  62,875   101,741 

Total Liabilities and Equity

 $69,035  $107,577 

 

See Notes to Consolidated Financial Statements.

 

24
Table of Contents

 

 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

 

  

Year Ended December 31,

 
  

2020

  

2019

 

General and administrative expense

 $9,466  $9,982 

Operating loss

  (9,466)  (9,982)

Other income (loss), net

  (7,708)  12,255 

Interest income

  261   2,044 

Interest expense

  —   (14,023)

Equity income (loss), net

  (20,702)  64,267 

Net income (loss) before income taxes

  (37,615)  54,561 

Income tax benefit (expense)

  —   — 

Net income (loss)

 $(37,615) $54,561 

Net income (loss) per share:

        

Basic

 $(1.81) $2.64 

Diluted

 $(1.81) $2.64 

Weighted average shares used in computing net income (loss) per share:

        

Basic

  20,751   20,636 

Diluted

  20,751   20,636 

 

See Notes to Consolidated Financial Statements.

 

25
Table of Contents

 

 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands)

 

  

Year Ended December 31,

 
  

2020

  

2019

 

Net income (loss)

 $(37,615) $54,561 

Other comprehensive (loss) income:

        

Share of other comprehensive (loss) of equity method investments

  —   (31)

Reclassification adjustment for sale of equity method investments

  —   6 

Total comprehensive income (loss)

 $(37,615) $54,536 

 

See Notes to Consolidated Financial Statements.

 

26
Table of Contents

 

 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(In thousands)

 

      

Accumulated

  

Accumulated Other Comprehensive

  

Common Stock

  

Additional Paid-In

  

Treasury Stock

 
  

Total

  

Deficit

  

Loss

  

Shares

  

Amount

  

Capital

  

Shares

  

Amount

 

Balance — December 31, 2018

 $66,979  $(731,105) $—   21,573  $2,157  $810,928   914  $(15,001)

Net income

  54,561   54,561   —   —   —   —   —   — 

Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net

  (236)  —   —   —   —   (1,213)  16   977 

Stock-based compensation

  1,141   —   —   —   —   1,141   —   — 

Other comprehensive loss

  (25)  —   (25)  —   —   —   —   — 

Dividends paid

  (20,679)  (20,679)  —   —   —   —   —   — 

Balance — December 31, 2019

 $101,741  $(697,223) $(25)  21,573  $2,157  $810,856   930  $(14,024)

Net loss

  (37,615)  (37,615)  —   —   —   —   —   — 

Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net

  (40)  —   —   —   —   (3,864)  (242)  3,824 

Stock-based compensation

  590   —   —   —   —   590   —   — 

Change in accounting at ownership interests

  (1,801)  (1,801)  —   —   —   —   —   — 

Balance — December 31, 2020

 $62,875  $(736,639) $(25)  21,573  $2,157  $807,582   688  $(10,200)

 

See Notes to Consolidated Financial Statements.

 

27
Table of Contents

 

 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

  

Year Ended December 31,

 
  

2020

  

2019

 

Cash Flows from Operating Activities:

        

Net income (loss)

 $(37,615) $54,561 

Adjustments to reconcile to net cash used in operating activities:

        

Depreciation

  —   808 

Amortization of debt discount

  —   3,454 

Amortization of right of use asset

  311   260 

Equity (income) loss, net

  9,420   (67,232)
Impairments of ownership interests and advances  20,039   3,012 

Income from change in fair value of derivative

  —   (5,060)

Gain from observable price changes

  (1,224)  (4,526)

Other, net

  175   (2,315)

Stock-based compensation, including liability classified awards

  965   1,237 

Changes in assets and liabilities:

        

Prepaid expenses and other current assets

  (137)  (823)

Accounts payable, accrued expenses, and other current liabilities

  (77)  (3,346)

Net cash used in operating activities

  (8,143)  (19,970)

Cash Flows from Investing Activities:

        

Acquisitions of ownership interests

  (7,534)  (11,640)

Proceeds from sales and distributions from ownership interests

  7,903   104,302 

Advances and loans to ownership interests

  (1,638)  (5,055)

Repayment of advances and loans from ownership interests

  —   750 

Purchase of marketable securities

  —   (57,243)

Proceeds, from sales and maturities in marketable securities

  —   95,189 

Net cash (used in) provided by investing activities

  (1,269)  126,303 

Cash Flows from Financing Activities:

        

Payment of dividend

  —   (20,679)

Repayments on credit facility

  —   (68,568)

Tax withholdings related to equity-based awards

  (40)  (236)

Net cash used in financing activities

  (40)  (89,483)

Net change in cash, cash equivalents and restricted cash

  (9,452)  16,850 

Cash, cash equivalents and restricted cash equivalents at beginning of period

  25,053   8,203 

Cash, cash equivalents and restricted cash at end of period

 $15,601  $25,053 

 

See Notes to Consolidated Financial Statements.

 

28
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

1. General

 

Liquidity And Capital Resources

 

As of December 31, 2020, Safeguard ("the Company") had $15.6 million of cash and cash equivalents.

 

In January 2018, Safeguard announced that, from that date forward, the Company will not deploy any capital into new opportunities and will focus on supporting our existing companies and maximizing monetization opportunities to return value to shareholders. In that context, the Company has, are and will consider initiatives including, among others: the sale of individual ownership interests, the sale of certain or all ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value.

 

The Company believes that its cash and cash equivalents at December 31, 2020 will be sufficient to fund operations past one year from the issuance of these consolidated financial statements.

 

Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Safeguard and all of its subsidiaries in which a controlling financial interest is maintained. All intercompany accounts and transactions are eliminated in consolidation.

 

Principles of Accounting for Ownership Interests in Companies

 

The Company accounts for its ownership interests using one of the following methods: Equity or Other. The accounting method applied is generally determined by the degree of the Company's influence over the entity, primarily determined by our voting interest in the entity.

 

In addition to holding voting and non-voting equity and debt securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets.

 

Equity Method. The Company accounts for ownership interests whose results are not consolidated, but over which it exercises significant influence, under the equity method of accounting. Whether or not the Company exercises significant influence with respect to an ownership interest depends on an evaluation of several factors including, among others, representation on the board of directors and our ownership level, which is generally a 20% to 50% interest in the voting securities of a company, including voting rights associated with the Company’s holdings in common, preferred and other convertible instruments in the company. Under the equity method of accounting, the Company does not reflect a company’s financial statements within our Consolidated Financial Statements; however, our share of the income or loss of such company is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The Company includes the carrying value of equity method companies in Ownership interests and advances on the Consolidated Balance Sheets. Any excess of the Company’s cost over its underlying interest in the net assets of equity method companies that is allocated to intangible assets is amortized over the estimated useful lives of the related intangible assets. The Company reflects its share of the income or loss of the equity method companies on a one quarter lag. This reporting lag could result in a delay in recognition of the impact of changes in the business or operations of these companies.

 

When the Company’s carrying value in an equity method company is reduced to zero, the Company records no further losses in its Consolidated Statements of Operations unless the Company has an outstanding guarantee obligation or has committed additional funding to such equity method company. When such equity method company subsequently reports income, the Company will not record its share of such income until it exceeds the amount of the Company’s share of losses not previously recognized.

 

Other Method. We account for our equity interests in companies which are not accounted for under the equity method as equity securities without readily determinable fair values. We estimate the fair value of these securities based on our original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Under this method, our share of the income or losses of such companies is not included in our Consolidated Statements of Operations. We include the carrying value of these investments in Ownership interests and advances on the Consolidated Balance Sheets.

 
29
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

Accounting Estimates

 

The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.

 

Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities’ financial statements are completed.

 

It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At December 31, 2020, the Company believes the carrying value of the Company’s ownership interests and advances is not impaired, although there can be no assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future or that a significant loss will not be recorded in the future upon the sale of a company.

 

Cash and Cash Equivalents and Marketable Securities

 

The Company considers all highly liquid instruments with an original maturity of 90 days or less at the time of purchase to be cash equivalents. Cash and cash equivalents consist of deposits that are readily convertible into cash. The Company determines the appropriate classification of marketable securities at the time of purchase and reevaluates such designation as of each balance sheet date. Held-to-maturity securities were carried at amortized cost, which approximated fair value. Marketable securities consisted of held-to-maturity securities, primarily consisting of government agency bonds, commercial paper and certificates of deposits. Marketable securities with a maturity date greater than one year from the balance sheet date would be considered long-term. The Company has not experienced any significant losses on cash equivalents and does not believe it is exposed to any significant credit risk on cash and cash equivalents.

 

Restricted Cash

 

Restricted cash equivalents represents cash required to be set aside by a contractual agreement as a shareholder representative. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets:

 

  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Cash and cash equivalents

 $15,601  $25,028 

Restricted cash

  —   25 

Total cash, cash equivalents and restricted cash

 $15,601  $25,053 

 

Financial Instruments

 

The Company’s financial instruments (principally cash and cash equivalents, marketable securities, accounts receivable, notes receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. 

 

Property and Equipment

 

Property and equipment represents right-of-use assets resulting from the adoption of Accounting Standards Update ("ASU") No. 2016-02, Leases, and other previously existing leasehold improvements. The leasehold improvements were amortized over the shorter of the estimated useful lives or the expected remaining term of the lease. The right-of-use assets are reduced over the remaining term of the applicable lease (principally April 2026) in a manner that results in a straight-line lease expense, when combined with the interest factor on the lease liability.     

 
30
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

Lease liability

 

The initial lease liability represents the present value of the fixed escalating lease payments through April 2026 associated with the Company's prior corporate headquarters operating office lease. The discount rate used to calculate the lease liability was based on the Company's incremental borrowing rate, approximately 12%, at the transition to the guidance of ASU No. 2016-02, Leases. Subsequent values of the lease liability reflect the reduction in the lease liability for operating lease payments less an amount representing interest, which is included in the straight-line lease expense. There is no residual value guarantee associated with this operating lease arrangement. The Company has incurred operating lease expenses and operating cash outflows of $0.5 million for each of the years ended December 31, 2020 and 2019, respectively, and $0.6 million for each of the years ended December 31, 2020 and 2019.

 

In March 2019, the Company entered into a sublease of its prior corporate headquarters office space. The term of the sublease is through April 2026, the same as the Company's underlying lease. Fixed sublease payments to the Company are escalating over the term of the sublease and are reported as a component of general and administrative expenses.

 

In April 2019, the Company entered into a sublease for replacement office space with a related party, an equity method ownership interest, beginning in June 2019. The 18 month term of this sublease expired in 2020. The aggregate payments under this sublease were not material.

 

A summary of the Company's operating lease cash flows at December 31, 2020 follows:

 

  Operating lease payments  

Expected sublease receipts

 
  

(In thousands)

 

2021

 $595  $525 

2022

  601   540 

2023

  607   556 

2024

  613   573 

2025

  619   590 

2026

  208   199 

Thereafter

  —   — 

Total future minimum lease payments

  3,243   2,983 

Less imputed interest

  (863)    

Total operating lease liabilities

 $2,380     

 

Valuation of Credit Facility repayment feature

 

The fair value of the Credit Facility repayment feature (a Level 3 measurement) was determined quarterly based on the present value of make-whole interest payments that were expected to be paid based on cash flow estimates that included a probability weighted estimate of exit transactions, estimated follow-on deployments, estimated quarterly operating cash flows and other cash commitments that would have resulted in qualified cash exceeding the $50 million threshold specified in the Credit Facility. This fair value of the Credit Facility repayment feature was eliminated in July 2019 upon the repayment of the Credit Facility.

 

Impairment of Ownership Interests and Advances

 

On a periodic basis, but no less frequently than quarterly, the Company evaluates the carrying value of its ownership interests and advances for possible impairment based on achievement of business plan objectives and milestones, the estimated fair value of each company relative to its carrying value, the financial condition and prospects of the company and other relevant factors. The business plan objectives and milestones the Company considers include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are not primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships.

 
31
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value.

 

The estimated fair value of privately held companies is generally determined based on the value at which independent third parties have invested or have committed to invest in these companies or based on other valuation methods, including discounted cash flows, valuation of comparable public companies and the valuation of acquisitions of similar companies.

 

Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies and funds are included in Other income (loss), net in the Consolidated Statements of Operations.

 

The reduced cost basis of a previously impaired company accounted for using the Equity method are not written-up if circumstances suggest the value of the company has subsequently recovered.

 

Income Taxes

 

The Company accounts for income taxes under the asset and liability method whereby deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates in effect for the year in which the temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period of the enactment date. The Company provides a valuation allowance against the net deferred tax asset for amounts which are not considered more likely than not to be realized.

 

Net Income (Loss) Per Share

 

The Company computes net income (loss) per share using the weighted average number of common shares outstanding during each year. The Company includes in diluted net income (loss) per share common stock equivalents (unless anti-dilutive) which would arise from the exercise of stock options and conversion of other convertible securities and adjusted, if applicable, for the effect on net income (loss) of such transactions. Diluted net income (loss) per share calculations adjust net income (loss) for the dilutive effect of common stock equivalents and convertible securities issued by the Company’s consolidated or equity method companies.

 

Segment Information

 

The Company operates as one operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 

Recently Adopted Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09"). ASU 2014-09 and related subsequent amendments outline a single comprehensive model to use to account for revenue arising from contracts with customers and supersede most current revenue recognition guidance. For public companies, the guidance was effective for annual periods beginning after December 15, 2017 and any interim periods that fall within that reporting period. For nonpublic companies, the guidance is effective for annual periods beginning after December 15, 2018 and interim periods within annual periods beginning after December 15, 2019 with early adoption permitted. Additionally, on June 3, 2020 the FASB issued ASU 2020-05, which extended the adoption of ASC 606 for all nonpublic business entities that have not issued their 2019 financial statements as of June 3, 2020, until January 1, 2020.

 

As the new standard superseded most existing revenue guidance, it impacted revenue and cost recognition for companies in which we hold an ownership interest. Any change in revenue or cost recognition for companies in which we hold an ownership interest could affect the Company's recognition of its share of the results of its equity method companies. On July 20, 2017, the SEC staff observer at the FASB’s Emerging Issues Task Force ("EITF") meeting announced that the SEC staff will not object if a private company equity method investee meeting the definition of a public business entity that otherwise would not meet the definition of a public business entity except for the inclusion of its financial statements or financial information in another entity’s filings with the SEC, uses private company adoption dates for the new revenue standard.  As a result, the Company's private, calendar year companies adopted the new revenue standard for the year ending December 31, 2019, including a cumulative effect where applicable as of the first day of the 2019 reporting period. 

 

For our ownership interests that have adopted ASU 2014-09, the impact of adoption of the new revenue standard is reflected in the Company’s financial results for the interim and annual reporting periods beginning in 2020 on a one quarter-lag basis.  The impact upon adoption resulted in an increase in accumulated deficit and a decrease in ownership interests of $1.8 million, net, due to the deferral of revenue and certain costs at our underlying ownership interests.  Our results of operations for the year ended December 31, 2020 reflect a benefit of $1.8 million due primarily to the recognition of revenue in 2019 that was previously deferred as a result of the adoption of ASU 2014-09.  Accordingly, the cumulative impact of the adoption of ASU 2014-09 was not significant. 

 
32
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

 

2. Ownership Interests and Advances

 

The following summarizes the carrying value of the Company’s ownership interests and advances.

 

  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Equity Method:

        

Companies

 $27,550  $34,271 

Private equity funds

  271   271 
   27,821   34,542 

Other Method:

        

Companies

  19,683   27,031 

Private equity funds

  268   453 
   19,951   27,484 

Advances to companies (equity method)

  2,626   15,103 
  $50,398  $77,129 

 

In September 2020, Sonobi, Inc. was acquired by another entity for cash. The Company received $6.6 million in cash proceeds in connection with this transaction, excluding holdbacks and escrows. The Company recognized an insignificant gain on the sale, which is included in Equity income (loss), net in the Consolidated Statements of Operations.

 

During the year ended December 31, 2020, the Company recorded impairments of $11.3 million related to the ownership interests of WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. accounted for under the equity method, which are reflected in Equity income (loss), net in the Consolidated Statement of Operations.  During the year ended December 31, 2020, the Company also recorded impairments of $8.8 million related to the ownership interests of T-REX Group, Inc., b8ta and others accounted for under the Other method, which are reflected in Other income (loss), net in the Consolidated Statement of Operations. The impairments were determined based on declines in the fair value of our ownership interests resulting from reduced valuation expectations and extended exit timelines resulting from the more challenging mergers and acquisitions environment related to COVID-19 and the related uncertain economic impact. The measurement of fair value for these impairments was estimated based on evaluating several valuation inputs available for each of the applicable ownership interests, primarily including the value at which independent third parties have invested, the valuation of comparable public companies, the valuation of acquisitions of similar companies and the present value of our expected outcomes. Assumptions considered within these methods include determining which public companies are comparable, projecting forward revenues for the measured ownership interest, discounts to apply for the lack of marketability or lack of comparability, other factors and the relative weight to apply to each valuation input available. Due to the unobservable nature of some of these inputs, we have determined these fair value estimates to be non-recurring Level 3 fair value measurements.

 

During the year ended December 31, 2020, the Company recorded a $1.5 million non-cash gain based upon an observable price change related to our ownership interest in Flashtalking Inc. accounted for under the Other method, which is reflected in Other income (loss), net in the Consolidated Statement of Operations. During the year ended December 31, 2020, the Company also recorded a $0.3 million non-cash Other loss based on an observable price change for another ownership interest accounted for under the Other method.

 

During 2019, the Company recognized an impairment of $3.0 million related to NovaSom, which is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The impairment was the result of NovaSom Inc.'s August 2019 bankruptcy filing.

 

In January 2019, Propeller was acquired by another entity for cash. The Company received $41.5 million in cash proceeds in connection with the transaction, and $0.7 million in 2020 for amounts held in escrow. The Company recognized a gain of $35.1 million, which is included in Equity income (loss), net in the Consolidated Statements of Operations.

 

In January 2019, Brickwork merged into another privately-held company. The Company received a preferred equity interest in the acquiror and accounts for this interest as an equity interest without a readily determinable fair value. The Company did not recognize a gain or loss in 2019 as a result of this transaction.

 

In May 2019, Transactis was acquired by another entity for cash. To date, the Company received $57.5 million in cash proceeds in connection with the transaction, excluding certain amounts that continue to be held in escrow that may be released on various dates on or before May 2020. The Company has recognized gains of $50.7 million, which are included in Equity income (loss), net in the Consolidated Statements of Operations.

 

During 2019, the Company ceased accounting for T-REX Group, Inc. and Hoopla Software, Inc. under the equity method as a result of losing our ability to exercise significant influence.

 

During 2019, the Company recorded $4.5 million of non-cash gains in Other income (loss), net related to the increase in the value of certain equity securities based upon observable price changes.

 

33
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

Summarized Financial Information

 

The following table provides summarized financial information for ownership interests accounted for under the equity method for the periods presented and has been compiled from respective company financial statements, reflect certain historical adjustments, and are reported on a one quarter lag. Results of operations are excluded for periods prior to their acquisition and subsequent to their disposition. Historical results are not adjusted when the Company exits or writes-off a company. 

 

  

As of December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Balance Sheets:

        

Current assets

 $104,024  $91,968 

Non-current assets

  26,352   26,231 

Total assets

 $130,376  $118,199 

Current liabilities

 $72,972  $80,783 

Non-current liabilities

  105,506   87,081 

Shareholders’ deficit

  (48,102)  (49,665)

Total liabilities and shareholders’ deficit

 $130,376  $118,199 
         

Number of equity method ownership interests

  12   13 

 

  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Results of Operations:

        

Revenue

 $153,875  $145,632 

Gross profit

 $92,039  $78,465 

Net loss

 $(82,216) $(127,007)

 

As of December 31, 2020, the Company’s carrying value in equity method companies, in the aggregate, exceeded the Company’s share of the net assets of such companies by approximately $17.9 million. Of this excess, $15.0 million was allocated to goodwill and $2.9 million was allocated to intangible assets.

 
 

3. Acquisitions of Ownership Interests

 

2020 Transactions

 

The Company deployed an additional $2.5 million to Aktana, Inc. during the three month period ended September 30, 2020. The Company had previously deployed an aggregate of $11.7 million. Aktana leverages big data and machine learning to enable pharmaceutical brands to dynamically optimize their strategy and
enhance sales execution.


       The Company deployed an additional $4.4 million to Syapse, Inc. during the six month period ended June 30, 2020, including the $0.6 million of convertible loans deployed in the first quarter of 2020 which was converted to equity in the second quarter. The Company had previously deployed $20.6 million. Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models.

 

The Company deployed an additional $1.0 million to meQuilibrium during the three month period ended March 31, 2020. The Company had previously deployed an aggregate of $13.0 million. meQuilibrium is a digital coaching platform that delivers clinically validated and highly personalized resilience solutions to employers, health plans, wellness providers, and consumers increasing engagement, productivity and performance, as well as improving outcomes in managing stress, health and well-being.

 
34
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

The Company funded an additional $0.7 million of convertible loans to Trice Medical, Inc. during the six month period ended June 30, 2020. The Company had previously deployed an aggregate of $10.2 million. Trice is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.

 

The Company deployed an aggregate of $0.2 million to Clutch Holdings during the three month period ended June 30, 2020. The Company had previously deployed an aggregate of $16.7 million. Clutch provides customer intelligence and personalized engagements that empower consumer-focused businesses to identify, understand and motivate each segment of their customer base.

 

The Company funded an additional $0.2 million of convertible loans to QuanticMind during the three month period ended March 31, 2020. The Company had previously deployed an aggregate of $13.5 million. QuanticMind delivers an intelligent, scalable and fast platform for maximizing digital marketing performance, including paid search and social, for enterprises.  See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 

The Company funded an aggregate of $0.1 million of convertible loans to WebLinc, Inc. during the three month period ended March 31, 2020.  The Company had previously deployed an aggregate of $16.1 million.  WebLinc is an e-commerce platform for online retailers.  See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 

2019 Transactions

 

The Company deployed an additional $5.0 million to Syapse, Inc. 

 

The Company deployed an additional $2.0 million to Moxe Health Corporation, including $0.3 million that was funded initially as a convertible loan. The Company had previously deployed $5.5 million in Moxe Health.

 

The Company deployed an additional $1.5 million to Aktana, Inc. 

 

The Company deployed an additional $1.5 million to meQuilibrium.

 

The Company deployed an additional $1.5 million to Zipnosis, Inc. The Company had previously deployed $8.5 million in Zipnosis. Zipnosis provides health systems with a white-labeled, fully integrated virtual care platform.

 

The Company deployed an aggregate of $0.4 million to Clutch Holdings. 

 

The Company funded an additional $2.0 million of convertible loans to Sonobi, Inc. The Company had previously deployed $11.4 million in Sonobi. Sonobi is an advertising technology developer that was acquired during 2020.  See Note 2 for impairment and sale recorded in 2020.

 

The Company funded an aggregate of $1.1 million of convertible loans to WebLinc, Inc. See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 

The Company funded an aggregate of $1.0 million of convertible loans to NovaSom, Inc. The Company had previously deployed an aggregate of $26.4 million in NovaSom. See Note 2 for impairment recorded during the second quarter of 2019.

 

The Company funded an additional $0.6 million of convertible loans to QuanticMind.  See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 
35
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

 

4. Fair Value Measurements

 

The Company categorizes its financial instruments into a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.

 

Cash equivalents approximate fair value due to their short term nature.  The Company did not have any Level 2 or Level 3 financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 and 2019.

 
 

5. Credit Facility and Convertible Debentures

 

Credit Facility     

 

The Company's credit facility was with HPS Investment Partners, LLC (“Lender”), and was amended in May 2018 ("Credit Facility"). The Credit Facility had a scheduled maturity of May 11, 2020 and interest at a rate of either: (A) LIBOR plus 8.5% (subject to a LIBOR floor of 1%), payable on the last day of the one, two or three month interest period applicable to the LIBOR rate advance, or (B) 7.5% plus the greater of: 2%; the Federal Funds Rate plus 0.5%; LIBOR plus 1%; or the U.S. Prime Rate, payable monthly in arrears. The Credit Facility was secured by all of the Company's assets in accordance with the terms of the Credit Facility.

 

The terms of the Credit Facility included a requirement that if the aggregate amount of the Company’s qualified cash at any quarter end date exceeded $50.0 million, the Company would be required to prepay outstanding principal amounts under the Credit Facility, plus any applicable interest and prepayment fees, in an amount equal to such excess. Based on this requirement, the Company made a principal payment of $24.0 million and a make-whole interest payment of $2.9 million on April 15, 2019 based on the Company's qualified cash at March 31, 2019. Additionally, the Company repaid the remaining principal of $44.5 million and make-whole interest of $4.1 million in July 2019.

 

The Company was subject to certain debt covenants under the Credit Facility including maintaining a specified level of liquidity threshold, maintaining an appraised value of ownership interests, limiting deployments to our remaining ownership interests, limiting certain expenses, and restricting any repurchases of outstanding common stock or issuing dividends until such time as the Credit Facility was repaid in full. The Company was in compliance with all applicable covenants.

 

The Credit Facility required prepayments of outstanding principal and interest amounts when the Company’s qualified cash at any quarter end date exceeded $50.0 million. This provision in the Credit Facility was an embedded derivative that was accounted for separately from the Credit Facility. A liability of $0.5 million was recorded on the 2018 amendment date for the fair value of potential future prepayments based upon management's probability weighted cash forecast. This amount was also included in debt issuance costs and had been amortized over the remaining term of the Credit Facility. The liability was adjusted to fair value at each balance sheet date based upon management's updated probability weighted cash forecast. During 2019, the Company recorded a decrease in the liability of $5.1 million, which is included in Other income (loss), net on the Consolidated Statements of Operations.

 

The Company recorded interest expense under the Credit Facility of $14.0 million for the year ended December 31, 2019. The effective interest rate on the Credit Facility was 15.1%. The Company made interest payments under the Credit Facility of $11.5 million for the year ended December 31, 2019.

 
 

6. Equity

 

In July 2015, the Company's Board of Directors authorized the Company, from time to time and depending on market conditions, to repurchase up to $25.0 million of the Company's outstanding common stock. During the years ended December 31, 2020 and 2019, the Company did not repurchase any shares under the existing authorization. 

 

36
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

In February 2018, the Company's Board of Directors adopted a tax benefits preservation plan (the "Plan") designed to protect and preserve the Company's ability to utilize its net operating loss carryforwards ("NOLs") which was ratified by shareholders at its 2018 Annual Meeting of Shareholders. The purpose of the Plan was to preserve the Company's ability to use its NOLs, which would be substantially limited if the Company experienced an "ownership change" as defined under Section 382 of the Internal Revenue Code. In general, an ownership change would occur if the Company's shareholders who are treated as owning five percent or more of the outstanding shares of Safeguard for purposes of Section 382 ("five-percent shareholders") collectively increase their aggregate ownership in the Company's overall shares outstanding by more than 50 percentage points. Whether this change has occurred would be measured by comparing each five-percent shareholder's current ownership as of the measurement date to such shareholders' lowest ownership percentage during the three-year period preceding the measurement date. To protect the Company's NOLs from being limited or permanently lost under Section 382, the Plan was intended to deter any person or group from acquiring beneficial ownership of 4.99% or more of the Company's outstanding common stock without the approval of the Board, reducing the likelihood of an unintended ownership change. Under the Plan, the Company would issue one preferred stock purchase right (the "Rights") for each share of Safeguard's common stock held by shareholders of record on March 2, 2018. The issuance of the Rights would not be taxable to Safeguard or its shareholders and would not affect Safeguard's reported earnings per share. The Rights would have traded with Safeguard's common shares and would have expired no later than February 19, 2021. Accordingly, the Plan has now expired.  

 

On November 7, 2019, the Board of Directors declared a special cash dividend of $1.00 per share, payable on December 30, 2019 to shareholders of record as of the close of business on December 23, 2019, resulting in total dividends paid of $20.7 million.

 
 

7. Stock-Based Compensation

 

Equity Compensation Plans

 

The 2014 Equity Compensation Plan has 4.1 million shares authorized for issuance. During 2020 and 2019, the Company issued no stock-based awards outside of existing plans. To the extent allowable, service-based options are incentive stock options. Options granted under the plans are at prices equal to or greater than the fair market value at the date of grant. Upon exercise of stock options, the Company issues shares first from treasury stock, if available, then from authorized but unissued shares. At December 31, 2020, the Company had reserved 2.8 million shares of common stock for possible future issuance under its 2014 Equity Compensation Plan and other previously expired equity compensation plans.

 

Classification of Stock-Based Compensation Expense

 

Stock-based compensation expense was recognized in the Consolidated Statements of Operations as follows: 

 

  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

General and administrative expense

 $965  $1,237 
  $965  $1,237 

 

At December 31, 2020, the Company had outstanding options that vest based on two different types of vesting schedules:

 

1) performance-based; and

 

2) service-based.

 

Performance-based awards entitle participants to vest in a number of awards determined by achievement by the Company of target capital returns based on net cash proceeds received by the Company upon the sale, merger or other exit transaction of certain identified companies. Vesting may occur, if at all, once per year. The requisite service periods for the performance-based awards are based on the Company’s estimate of when the performance conditions will be met. Compensation expense is recognized for performance-based awards for which the performance condition is considered probable of achievement. Compensation expense is recognized over the requisite service periods using the straight-line method but is accelerated if capital return targets are achieved earlier than estimated.  The Company did not issue any performance-based units during the years ended December 31, 2020 and 2019.  During the years ended December 31, 2020 and 2019, there were no performance-based options that vested.  During the years ended December 31, 2020 and 2019, respectively, 72 thousand and 174 thousand performance-based options were canceled or forfeited. The Company recorded a reduction of compensation expense related to performance-based options of $0.0 million and $0.1 million for the years ended December 31, 2020 and 2019 respectively. The maximum number of unvested options at December 31, 2020 attainable under these grants was 21 thousand shares.

 

Service-based awards generally vest over four years after the date of grant and expire eight years after the date of grant. Compensation expense is recognized over the requisite service period using the straight-line method. The requisite service period for service-based awards is the period over which the award vests. During the years ended December 31, 2020 and 2019, respectively, the Company issued no service-based options to employees and recorded $0.0 million compensation expense from the vesting of previously issued awards. During the years ended December 31, 2020 and 2019, respectively, 62 thousand and 57 thousand service-based options were canceled or forfeited.  

 

37
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

There were no options granted during 2020 and 2019.

 

Stock-based compensation expense of $1.0 million was recognized during the year ended December 31, 2020 related to Board fees and management bonuses earned in 2020 that were subsequently settled in stock.  The Company had liabilities of $0.5 million and $0.1 million as of December 31, 2020 and 2019, respectively, that were settled through the issuance of common stock in the subsequent period. Compensation expense of $0.1 million was also recognized during the year ended December 31, 2019 related to the dividend payments made to holders of unvested restricted stock awards pursuant to the terms of those instruments.  

 

Option activity of the Company is summarized below: 

 

  

Shares

  Weighted Average Exercise Price  

Weighted Average Remaining Contractual Life

  Aggregate Intrinsic Value 
  

(In thousands)

      

(In years)

  

(In thousands)

 

Outstanding at January 1, 2019

  410   14.66         

Options granted

  —   —         

Options exercised

  —   —         

Options canceled/forfeited

  (231)  14.19         

Outstanding at December 31, 2019

  179   15.27         

Options granted

  —   —         

Options exercised

  —   —         

Options canceled/forfeited

  (134)  14.36         

Outstanding at December 31, 2020

  45   14.20   2.29  $— 

Options exercisable at December 31, 2020

  22   14.48   3.08   — 

Shares available for future grant

  2,515             

 

At December 31, 2020, total unrecognized compensation cost related to non-vested service-based options was immaterial. At December 31, 2020, total unrecognized compensation cost related to non-vested performance-based options was immaterial.

 

Performance-based stock units vest based on achievement by the Company of target capital returns based on net cash proceeds received by the Company on the sale, merger or other exit transaction of certain identified companies, as described above related to performance-based awards. During 2020, the Company also initiated a 2021 CEO bonus award that will be settled in the vesting of performance-based units based on criteria determined by the Board of Directors.  Performance-based stock units represent the right to receive shares of the Company’s common stock, on a one-for-one basis at target or up to 120% for certain specified thresholds.  The maximum fair value associated with this award is $0.7 million, none of which has been recognized during the year ended December 31, 2020.  During the years ended December 31, 2020 and 2019, respectively, 100 thousand and 0 performance-based stock units were issued. No performance-based stock units vested during the years ended December 31, 2020 and 2019. During the years ended December 31, 2020 and 2019, respectively, 129 thousand and 339 thousand performance-based stock units were canceled or forfeited. Under the terms of the 2016 and 2015 performance-based awards, once performance-based stock units are fully vested, participants are entitled to receive cash payments based on their initial performance grant values as target capital returns described above are exceeded. At December 31, 2020, the liability associated with such potential cash payments was $0.0 million.

 

During the years ended December 31, 2020 and 2019, respectively, the Company issued 193 thousand and 31 thousand restricted shares to employees and directors. Restricted shares generally vest over a period of approximately two to four years, or are vested at issuance for directors 65 or older. During the years ended December 31, 2020 and 2019, respectively, 10 thousand and 75 thousand restricted shares were canceled or forfeited.

 

During the years ended December 31, 2020 and 2019, respectively, the Company issued 20 thousand to an employee, and 0 deferred stock units to non-employee directors for annual service grants or fees earned during the preceding quarter. Deferred stock units issued to directors in lieu of directors fees are 100% vested at the grant date; matching deferred stock units equal to 25% of directors’ fees deferred vest one year following the grant date or, if earlier, upon reaching age 65. Deferred stock units are payable in stock on a one-for-one basis. Payments related to the deferred stock units are generally distributable following termination of service, death or permanent disability.

 

Total compensation expense for deferred stock units, performance-based stock units and restricted stock was $0.5 million and $1.2 million, for the years ended December 31, 2020 and 2019, respectively. Unrecognized compensation expense related to deferred stock units, performance stock units and restricted stock at December 31, 2020 was $0.5 million. The total fair value of deferred stock units, performance stock units and restricted stock vested during the years ended December 31, 2020 and 2019 was $1.1 million and $1.2 million, respectively.

 

38
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

Deferred stock unit, performance-based stock unit and restricted stock activity are summarized below: 

 

  

Shares

  Weighted Average Grant Date Fair Value 
  

(In thousands)

     

Unvested at January 1, 2019

  777  $14.08 

Granted

  31   12.12 

Vested

  (107)  11.79 

Forfeited

  (414)  14.28 

Unvested at December 31, 2019

  287   14.44 

Granted

  313   5.89 

Vested

  (174)  7.77 

Forfeited

  (139)  15.24 

Unvested at December 31, 2020

  287   8.78 

 
 

8. Employee Benefit Plan

 

The Company maintains a qualified 401(k) retirement plan for eligible employees. The Plan’s matching formula is 100% of the first 5% of participants’ qualified compensation. Compensation expense related to our matching contributions to the Plan for the years ended December 31, 2020 and 2019, were $0.2 million and $0.2 million, respectively.

 
 

9. Income Taxes

 

The federal and state provision (benefit) for income taxes was $0.0 million for the years ended December 31, 2020 and 2019.

 

The total income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21.0% for the years ended December 31, 2020 and 2019 to net income (loss) before income taxes as a result of the following:

 

  

Year Ended December 31,

 
  

2020

  

2019

 

Statutory tax (benefit) expense

  21.0%  21.0%

Increase (decrease) in taxes resulting from:

        

Nondeductible expenses

  (4.1)  0.4 

Valuation allowance

  (16.9)  (21.4)
   0.0%  0.0%

 

39
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: 

 

  

As of December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Deferred tax asset:

        

Carrying values of ownership interests and other holdings

 $38,361  $32,760 

Tax loss and credit carryforwards

  76,023   70,914 

Disallowed interest carryforwards

  7,292   7,292 

Accrued expenses

  497   213 

Stock-based compensation

  302   432 

Other

  482   604 
   122,957   112,215 

Valuation allowance

  (122,957)  (112,215)

Net deferred tax asset

 $—  $— 

 

As of December 31, 2020, the Company and its subsidiaries had federal net operating and capital loss carryforwards for tax purposes of approximately $362 million, of which approximately $37 million have an indefinite life. These carryforwards expire as follows: 

 

  

Total

 
  

(In thousands)

 

2021

 $3,728 

2022

  48,848 

2023

  52,512 

2024

  50,140 

2025 and thereafter

  170,189 
  $325,417 

 

In assessing the recoverability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that it is more likely than not that certain future tax benefits may not be realized as a result of current and future income. Accordingly, a valuation allowance has been recorded against substantially all of the Company’s deferred tax assets.

 

The Company recognizes in its Consolidated Financial Statements the impact of a tax position if that position is more likely than not to be sustained upon examination, based on the technical merits of the position. All uncertain tax positions relate to unrecognized tax benefits that would impact the effective tax rate when recognized.

 

The Company does not expect any material increase or decrease in its income tax expense, in the next twelve months, related to examinations or changes in uncertain tax positions.

 

There were no changes in the Company’s uncertain tax positions for the years ended December 31, 2020 and 2019.

 

The Company files income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Tax years 2015 and forward remain open for examination for federal tax purposes and the Company’s more significant state tax jurisdictions. To the extent utilized in future years’ tax returns, net operating loss carryforwards at December 31, 2020 will remain subject to examination until the respective tax year is closed. The Company recognizes penalties and interest accrued related to income tax liabilities in income tax benefit (expense) in the Consolidated Statements of Operations.

 

40
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 
 

10. Net Income (Loss) Per Share

 

The calculations of net income (loss) per share were: 

 

  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands, except per share data)

 

Basic:

        

Net income (loss)

 $(37,615) $54,561 

Weighted average common shares outstanding

  20,751   20,636 

Net income (loss) per share

 $(1.81) $2.64 

Diluted:

        

Net income (loss)

 $(37,615) $54,561 

Weighted average common shares outstanding

  20,751   20,636 

Net income (loss) per share

 $(1.81) $2.64 

 

Basic and diluted average common shares outstanding for purposes of computing net income (loss) per share includes outstanding common shares and vested deferred stock units (DSUs).

 

If an equity method company has dilutive stock options, unvested restricted stock, DSUs, or warrants, diluted net income (loss) per share is computed by first deducting from net income (loss) the income attributable to the potential exercise of the dilutive securities of the company from net income (loss). Any impact is shown as an adjustment to net income (loss) for purposes of calculating diluted net income (loss) per share.

 

Diluted income (loss) per share for the years ended December 31, 2020 and 2019 do not reflect the following potential shares of common stock that would have an anti-dilutive effect or have unsatisfied performance or market conditions:

 

 

•

At December 31, 2020 and 2019, options to purchase 45 thousand and 179 thousand shares of common stock, respectively, at prices ranging from $10.37 to $17.11 per share, and $10.37 to $18.45 per share per share, respectively, were excluded from the calculation.

 

 

•

At December 31, 2020 and 2019, unvested restricted stock, performance-based stock units and DSUs convertible into 0.3 million and 0.3 million shares of stock, respectively, were excluded from the calculations.

 

 

•

For the year ended December 31, 2019, 0.8 million shares of common stock, respectively, representing the effect of assumed conversion of the 2019 Debentures were excluded from the calculations.

 
 

11. Related Party Transactions

 

In the normal course of business, the Company’s officers and employees hold board positions with companies in which the Company has a direct or indirect ownership interest.

 
 

12. Commitments and Contingencies

 

The Company and the companies in which it holds ownership interests are involved in various claims and legal actions arising in the ordinary course of business. In the current opinion of the Company, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations, however, no assurance can be given as to the outcome of these actions, and one or more adverse rulings could have a material adverse effect on the Company’s consolidated financial position and results of operations or that of its companies. The Company records costs associated with legal fees as such services are rendered.

 

41
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

The Company had outstanding guarantees of $3.8 million at December 31, 2020 which related to one of the Company's private equity holdings.

 

In October 2001, the Company entered into an agreement with a former Chairman and Chief Executive Officer of the Company, to provide for annual payments of $0.65 million per year and certain health care and other benefits for life. The former executive passed away in 2019. Accordingly, the Company recorded a $1.7 million gain in Other income (loss), net which also eliminated the remaining projected benefits related to this agreement that were previously included in Accrued expenses and other current liabilities and Other long-term liabilities on the Consolidated Balance Sheets.

 

The Company has agreements with certain employees that provide for severance payments to the employee in the event the employee is terminated without cause or an employee terminates his employment for “good reason.” The maximum aggregate exposure under severance agreements for remaining employees is approximately $2.3 million at December 31, 2020.

 

In 2018, the Board of Directors (the “Board”) of the Company adopted a long-term incentive plan, which was amended in February 2019 and June 2020, known as the Amended and Restated Safeguard Scientifics Transaction Bonus Plan (the “LTIP”). The purpose of the LTIP is to promote the interests of the Company and its shareholders by providing an additional incentive to employees to maximize the value of the Company in connection with the execution of the business strategy that the Company adopted and announced in January 2018. The June 2020 amendment lowered the level of the first threshold and the resulting bonus pool percentage as an incentive to employees to accelerate actions consistent with the business strategy.  Under the LTIP, participants, which include certain current and former employees, have received awards that may result in cash payments in connection with sales of the Company’s ownership interests (“Sale Transaction(s)”). The LTIP provides for a bonus pool corresponding to: (i) specified vesting thresholds or (ii) specified events. In the first case, the bonus pool will range from an amount equal to 0.2% (previously 1.0%) of received proceeds at the first threshold to 1.3% at higher thresholds and no bonus pool will be created if the transaction consideration is less than certain minimum thresholds. In the second case, a minimum pool will be created and paid under specified circumstances. The bonus pool will be allocated and paid to participants in the LTIP based on the product of (i) the participant’s applicable bonus pool percentage and (ii) the bonus pool calculated as of the vesting date, minus any previously paid portion of the bonus pool. Any portion of the bonus pool available as of the applicable vesting date that is reserved will be allocated in connection with each vesting date so that the entire bonus pool available as of such vesting date is allocated and payable to participants. Subject to the terms of the LTIP, payments under the LTIP will be paid in cash within 60 days of the applicable vesting date. All current officers and employees of the Company are eligible to participate in the LTIP. The Board, in its sole discretion, will determine the participants to whom awards are granted under the LTIP. The Company has accrued approximately $1.8 million under the LTIP as of   December 31, 2020, which $1.5 million is estimated as current accrued compensation.

 

In June 2011, Advanced BioHealing, Inc. (“ABH”) was acquired by Shire plc (“Shire”).  Prior to the expiration of the escrow period in March 2012, Shire filed a claim against all amounts held in escrow related to the sale based principally upon a United States Department of Justice (“DOJ”) false claims act investigation relating to ABH (the “Investigation”). In connection with the Investigation, in July 2015 the Company received a Civil Investigation Demand-Documentary Material (“CID”) from the DOJ regarding ABH and Safeguard’s relationship with ABH. Pursuant to the CID, the Company provided the requested materials and information.  To the Company’s knowledge, the CID was related to multiple qui tam (“whistleblower”) actions, one of which was filed in 2014 by an ex-employee of ABH that named the Company and one of the Company’s employees along with other entities and individuals as defendants.  At this time, the DOJ has declined to pursue the qui tam action as it relates to the Company and such Company employee. In addition, in connection with the above matters, the Company and other former equity holders in ABH entered into a settlement and release with Shire, which resulted in the release to Shire of all amounts held in escrow related to the sale of ABH.

 
 

13. Supplemental Cash Flow Information

 

During the years ended December 31, 2020 and 2019, the Company converted $6.8 million and $2.3 million, respectively, of advances into ownership interests. Cash paid for interest for the years ended December 31, 2020 and 2019 was $0.0 million and $11.5 million, respectively. Cash paid for taxes in each of the years ended December 31, 2020 and 2019 was $0.0 million.

 

42
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 
 

14. Segment Reporting

 

The Company operates as one operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 

As of December 31, 2020, the Company held ownership interests accounted for using the equity method in 12 non-consolidated companies. During 2019 we ceased using the equity method of accounting for Hoopla Software, Inc. and T-REX Group, Inc. as a result of other new investors diluting our interest. We have retained our ownership interests in those companies under the Other accounting method.

 

Certain of the Company’s ownership interests as of December 31, 2020 and 2019 included the following:

 

  Safeguard Primary Ownership as of December 31,  

Company Name

 

2020

 

2019

 

Accounting Method

Aktana, Inc.

  15.1%  17.8% 

Equity

Clutch Holdings, Inc.

  42.3%  41.2% 

Equity

Flashtalking, Inc.

  13.4%  10.1% 

Other

InfoBionic, Inc.

  25.2%  25.2% 

Equity

Lumesis, Inc.

  43.4%  43.5% 

Equity

MediaMath, Inc.

  13.3%  13.3% 

Other

meQuilibrium

  32.0%  32.7% 

Equity

Moxe Health Corporation

  27.6%  29.9% 

Equity

Prognos Health Inc.

  28.5%  28.7% 

Equity

QuanticMind, Inc. *

  24.2%  24.2% 

Equity

Syapse, Inc.

  18.9%  20.0% 

Equity

T-REX Group, Inc.

  13.5%  13.7% 

Other

Trice Medical, Inc.

  16.6%  16.6% 

Equity

WebLinc, Inc. *

  39.9%  38.5% 

Equity

Zipnosis, Inc

  37.2%  37.7% 

Equity

 

* These entities were sold subsequent to December 31, 2020.  See Note 16 - Subsequent Events, of the consolidated financials statements.

 

As of December 31, 2020 and 2019, all of the Company’s assets were located in the United States.

 

43
Table of Contents

 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

  

 
 

15. Selected Quarterly Financial Information (Unaudited)  

 

  

Three Months Ended

 
  

March 31

  

June 30

  

September 30 (b)

  

December 31 (b)

 
  

(In thousands, except per share data)

 

2020:

                

General and administrative expense

 $3,532  $2,028  $2,275  $1,631 

Operating loss

  (3,532)  (2,028)  (2,275)  (1,631)

Other income (loss), net

  (3,567)  (2,658)  (820)  (663)

Interest income

  105   52   52   52 

Equity income (loss), net

  (9,014)  (5,277)  (1,300)  (5,111)

Net loss before income taxes

  (16,008)  (9,911)  (4,343)  (7,353)

Income tax benefit (expense)

  —   —   —   — 

Net loss

 $(16,008) $(9,911) $(4,343) $(7,353)

Net loss per share (a)

                

Basic

 $(0.77) $(0.48) $(0.21) $(0.35)

Diluted

 $(0.77) $(0.48) $(0.21) $(0.35)

2019:

                

General and administrative expense

 $3,057  $2,603  $2,262  $2,060 

Operating loss

  (3,057)  (2,603)  (2,262)  (2,060)

Other income (loss), net

  (1,885)  3,118   8,777   2,245 

Interest income

  873   763   234   174 

Interest expense

  (2,535)  (5,682)  (5,806)  — 

Equity income (loss), net

  28,267   40,497   (3,440)  (1,057)

Net income (loss) before income taxes

  21,663   36,093   (2,497)  (698)

Income tax benefit (expense)

  —   —   —   — 

Net income (loss)

 $21,663  $36,093  $(2,497) $(698)

Net income (loss) per share (a)

                

Basic

 $1.05  $1.75  $(0.12) $(0.03)

Diluted

 $1.05  $1.75  $(0.12) $(0.03)

 

 

(a)

Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts may not add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts may not add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests.

 

(b)

The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.

 

 
 

16. Subsequent Events

 

In January 2021, WebLinc, Inc. was acquired by another entity.  To date, the Company received $3.2 million in cash proceeds and may receive additional amounts over the next 24 months based on certain transitional performance activities, which could be partially offset by indemnifiable claims.  During February 2021, QuanticMind, Inc. was acquired by another entity, however there were no resultant proceeds.

 

During February 2021, Syapse raised $68 million of preferred capital which reduced our ownership interest to approximately 11%.

 

44
Table of Contents
  
 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to provide reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including the Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Our management, with the participation of our Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2020. Based on that evaluation, the Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures as of December 31, 2020 are functioning effectively.

 

(b) Management’s Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020. In making this assessment, management used the framework established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). As a result of this assessment and based on the criteria in the COSO framework, management has concluded that, as of December 31, 2020, the Company’s internal control over financial reporting was effective.

 

 

(c) Change in Internal Control over Financial Reporting

 

No change in our internal control over financial reporting occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information

 

None.

 

45
Table of Contents

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Incorporated by reference to the portions of our Definitive Proxy Statement entitled “Election of Directors,” “Corporate Governance and Board Matters” and “Section 16(a) Beneficial Ownership Reporting Compliance.” Information about our Executive Officers is included in Annex to Part I above.

 

Item 11. Executive Compensation

 

Incorporated by reference to the portions of our Definitive Proxy Statement entitled “Compensation Discussion and Analysis,” “Compensation Committee Report” and “Executive Compensation.”

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The material features of our equity compensation plans are described in Note 7 to the Consolidated Financial Statements filed as part of our Annual Report on Form 10-K for the year ended December 31, 2020.

 

 

46
Table of Contents

 

 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

Incorporated by reference to the portions of the Definitive Proxy Statement entitled “Corporate Governance Principles and Board Matters – ‘Board Independence’ and “Review and Approval of Transactions with Related Persons.”

 

Item 14. Principal Accountant Fees and Services

 

Incorporated by reference to the portion of the Definitive Proxy Statement entitled “Independent Public Accountant – Audit Fees.”

 

47
Table of Contents

 

PART IV

 

Item 15. Exhibits and Financial Statement Schedules

 

(a) Consolidated Financial Statements and Schedules

 

Incorporated by reference to Item 8 of this Report on Form 10-K.

 

(b) Exhibits

 

The exhibits required to be filed as part of this Report are listed in the exhibit index below.

 

(c) Financial Statement Schedules

 

None.

 

Exhibits

 

The following is a list of exhibits required by Item 601 of Regulation S-K filed as part of this Report. For exhibits that previously have been filed, the Registrant incorporates those exhibits herein by reference. The exhibit table below includes the Form Type and Filing Date of the previous filing and the location of the exhibit in the previous filing which is being incorporated by reference herein. Documents which are incorporated by reference to filings by parties other than the Registrant are identified in footnotes to this table.

 

 

  

 

Incorporated Filing Reference

Exhibit

Number

  

Description

Form Type & Filing

Date

  

Original

Exhibit Number

1.a

 

Description

 

 

 

3.1.1

  

Seconded Amended and Restated Articles of Incorporation of Safeguard Scientifics, Inc.

Form 8-K

10/25/07

  

3.1

3.1.2

  

Amendment to Seconded Amended and Restated Articles of Incorporation of Safeguard Scientifics, Inc.

Form 8-K

8/27/09

  

3.1

3.1.3

  

Statement with Respect to Shares

Form 10-Q

4/25/14

 

3.1

3.1.4

 

Statement of Designation of Series B Junior Participating Preferred Stock

Form 8-K

2/20/18

  

3.1

3.2

  

Third Amended and Restated By-laws of Safeguard Scientifics, Inc.

Form 8-K

2/13/18

 

3.1

10.1*

  

Safeguard Scientifics, Inc. 1999 Equity Compensation Plan, as amended and restated on October 21, 2008

Form 10-Q

11/6/08

 

10.4

10.2

  

Safeguard Scientifics, Inc. 2001 Associates Equity Compensation Plan, as amended and restated on October 21, 2008

Form 10-Q

11/6/08

 

10.5

10.3*

  

Safeguard Scientifics, Inc. 2014 Equity Compensation Plan, as amended and restated on March 5, 2014

Form 10-Q

7/25/14

 

10.1

10.4*

  

Safeguard Scientifics, Inc. Executive Deferred Compensation Plan (amended and restated as of January 1, 2009)

Form 10-K

3/19/09

 

10.4

10.5*

  

Management Incentive Plan

Form 8-K

4/25/08

 

10.1

10.6*

 

Amended and Restated Safeguard Scientifics, Inc. Transaction bonus plan

Form 10-Q

8/12/20

 

10.6

10.7

  

Compensation Summary — Non-employee Directors

Form 10-K

3/5/21

   10.7

10.9.1*

 

General Release and Agreement between Safeguard Scientifics, Inc. and Brian J. Sisko dated April 20, 2020

Form 8-K

4/21/20

 

10.1

10.9.2*

 

 Letter Agreement between Safeguard Scientifics, Inc. and Eric Salzman dated October 1, 2020

Form 8-K

10/1/20

 

10.1

 

48
Table of Contents

 

10.12*

 

Compensation Agreement by and between Safeguard Scientifics, Inc. and Mark Herndon dated September 17, 2018

Form 8-K

9/18/18

 

99.1

10.13*

 

Key Employee Compensation Recoupment Policy

Form 10-Q

7/26/13

 

10.2

10.14

 

Purchase and Sale Agreement dated as of December 9, 2005 by and among HarbourVest VII Venture Ltd., Dover Street VI L.P. and several subsidiaries and affiliated limited partnerships of Safeguard Scientifics, Inc.

Form 10-K

3/13/06

 

10.36

10.15

 

Consent Agreement, dated as of May 17, 2011, by and among Shire Pharmaceuticals, Inc. and certain stockholders of Advanced BioHealing, Inc.

Form 8-K

5/18/11

 

10.1

10.16

 

Lease Agreement, effective February 2, 2015, between Safeguard Scientifics, Inc., a Pennsylvania corporation, and Radnor Properties-SDC, L.P., a Delaware limited partnership

Form 10-Q

4/24/15

 

10.1

10.17

 

Sublease Agreement, effective March 15, 2019, by and between Safeguard Scientifics, Inc., a Pennsylvania corporation and the subtenant named therein

Form 8-K

3/20/19

 

10.1

14.1

 

Code of Business Conduct and Ethics

Form 10-K

3/5/21 

 

14.1

21.1 †

 

List of Subsidiaries

—  

 

—  

23.1 †

 

Consent of Independent Registered Public Accounting Firm — KPMG LLP

—  

 

—  

31.1 †

 

Certification of Eric C. Salzman pursuant to Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934

—  

 

—  

31.2 †

 

Certification of Mark A. Herndon pursuant to Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934

—  

 

—  

32.1 ‡

 

Certification of Eric C. Salzman pursuant to 18 U.S.C. Section 1350, as Adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

—  

 

—  

32.2 ‡

 

Certification of Mark A. Herndon pursuant to 18 U.S.C. Section 1350, as Adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

—  

 

—  

101

 

Inline The following materials from Safeguard Scientifics, Inc. Annual Report on Form 10-K for the year ended December 31, 2020, formatted in XBRL (eXtensible Business Reporting Language); (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Operations; (iii) Consolidated Statements of Comprehensive Income (Loss); (iv) Consolidated Statements of Changes in Shareholders' Equity; (v) Consolidated Statements of Cash Flows; and (vi) Notes to Consolidated Financial Statements.

—  

 

—  
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). —    —

 

†

Filed herewith
 

‡

Furnished herewith
 

*

These exhibits relate to management contracts or compensatory plans, contracts or arrangements in which directors and/or executive officers of the Registrant may participate.

 

49
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

SAFEGUARD SCIENTIFICS, INC.

 

 

 

 

By:

 

 ERIC C. SALZMAN

 

 

 

 

Eric C. Salzman

 

 

 

 

Chief Executive Officer

 

Dated: March 5, 2021

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature

Title

Date

 

 

 

ERIC C. SALZMAN

  Chief Executive Officer
(Principal Executive Officer)

March 5, 2021

Eric C. Salzman

  

 

MARK A. HERNDON

Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)  

 March 5, 2021

Mark A. Herndon

  

 

RUSSELL D. GLASS

Director

March 5, 2021

Russell D. Glass

 

 

JOSEPH M. MANKO, JR.

Director

March 5, 2021

Joseph M. Manko, Jr.

 

 

MAUREEN F. MORRISON

Director

March 5, 2021

Maureen F. Morrison

 

 

ROBERT J. ROSENTHAL

Chairman of the Board of Directors

March 5, 2021

Robert J. Rosenthal

 

 

 

 

 

50
EX-10.7 2 ex_231367.htm EXHIBIT 10.7 COMPENSATION SUMMARY - NON-EMPLOYEE DIRECTORS ex_231367.htm

Exhibit 10.7

 

SAFEGUARD SCIENTIFICS, INC.

COMPENSATION SUMMARY - NON-EMPLOYEE DIRECTORS

 

Each of our non-employee directors is compensated for his or her service as a director through payments as shown in the table below:

 

 

 

 

 

Annual Board Retainers (for a full year of Board service):

 

 

 

Chairman of the Board

 

$110,000

 

Other Directors

 

$50,000

 

 

 

 

Additional Annual Chairperson Retainers (for a full year of committee service):

 

 

 

Audit Committee

 

$15,000

 

Compensation Committee

 

$10,000

 

Nominating & Corporate Governance Committee

 

$10,000

 

The foregoing amounts are paid in the form of our common stock based upon the average closing price of a share of our common stock on the New York Stock Exchange composite tape for the 20 consecutive trading days immediately preceding the grant date.

 

Directors’ fees are paid quarterly, in arrears, and retainers are prorated based on actual days of service relative to a full year of Board service or the service period during which the fees were in effect. We also reimburse our directors for expenses they incur to attend our Board and committee meetings and for attendance at one director continuing education program during each calendar year or the reasonable cost of one year’s membership in an organization that is focused on director education.

 

Each non-employee director also receives an annual service grant of shares of restricted stock having a value of $75,000, based upon the average closing price of a share of our common stock on the New York Stock Exchange composite tape for the 20 consecutive trading days immediately preceding the grant date. The shares of restricted stock are fully vested at grant for those directors who have reached age 65 and otherwise shall vest 100% on the earlier of the first anniversary of the grant date or the director’s attainment of age 65.

 

 
 EX-14.1 3 ex_231366.htm EXHIBIT 14.1 ex_231366.htm

Exhibit 14.1

 

SAFEGUARD SCIENTIFICS, INC.

CODE OF BUSINESS CONDUCT AND ETHICS

 

 

I.

Background - Administration

 

The reputation and integrity of Safeguard Scientifics, Inc. (“Company” or “Safeguard”) is a valuable asset that is vital to our success.

 

Each Company employee, including each of the Company’s officers, and each Company director is responsible for conducting the Company’s business in a manner that demonstrates a commitment to the highest standards of integrity. This Code of Business Conduct and Ethics (“Code”), which applies to all directors, officers and employees of the Company (collectively referred to as “Company Personnel”), has been adopted to help Company Personnel meet these standards. Specifically, the purpose of this Code is to:

 

 

●

encourage among Company Personnel a culture of honesty, accountability and mutual respect;

 

●

provide guidance to help Company Personnel recognize and deal with ethical issues; and

 

●

provide mechanisms for Company Personnel to report unethical conduct.

 

While this Code is designed to provide helpful guidelines, it is not intended to address every specific situation. Nevertheless, in every instance, we require that Company Personnel act honestly, fairly and with a view towards “doing the right thing.”

 

The Safeguard Scientifics, Inc. Board of Directors (“Safeguard Board”) is ultimately responsible for oversight of the Code. The Safeguard Board has designated G. Matthew Barnard, or his successor, to be the compliance officer (the “Compliance Officer”) for the implementation and administration of the Code. Company Personnel should feel free to direct questions concerning this Code to the Compliance Officer:

 

Safeguard Scientifics, Inc.

Attention: Compliance Officer

150 N. Radnor Chester Road, Suite F-200

Radnor, PA 19087

e-mail address: complianceofficer@safeguard.com

 

 

II.

Overview

 

It is the policy of the Company to: (a) comply with all applicable governmental laws, rules and regulations; (b) expect that all Company Personnel at all times observe honest and ethical conduct in the performance of their responsibilities, including the avoidance of conflicts of interest; (c) expect all Company Personnel to treat others with dignity, including other employees, shareholders, customers and vendors; and (d) encourage and support internal disclosure of any violation of this Code for appropriate action.

 

The Code governs the business-related conduct of all Company Personnel, including, but not limited to, the executive chairman, chief restructuring officer, chief executive officer, chief financial officer and all other officers of Safeguard. Directors of the Company who are not employees are subject to this Code only as it relates to their capacities as directors.

 

 

III.

Compliance With Law

 

A variety of laws apply to the Company and its operations. Company Personnel are expected to comply with all such laws, as well as rules and regulations adopted under such laws. Examples of criminal violations under these laws include:

 

 

●

stealing, embezzling or misapplying corporate or bank funds;

 

●

using threats, physical force or other unauthorized means to collect money;

 

●

making false entries in the books and records of the Company, or engaging in any conduct that results in the making of such false entries;

 

●

making a payment for an express purpose on the Company’s behalf to an individual who intends to use it for a different purpose;

 

●

utilizing the Company’s funds or other assets or services to make a political contribution or expenditure; and

 

●

making payments, whether corporate or personal, of cash or other items of value that are intended to influence the judgment or actions of political candidates, government officials or businesses in connection with any of the Company’s activities.

 

The Company must and will report all suspected criminal violations to the appropriate authorities for possible prosecution and will investigate, address and report to governmental or other authorities, as appropriate, non-criminal violations.

 

 

IV.

Conflicts of Interest

 

Company Personnel are expected to make or participate in business decisions and actions in the course of their service to the Company based on the best interests of the Company as a whole, and not based on personal relationships or personal benefits. A conflict of interest, which can occur or appear to occur in a wide variety of situations, can compromise the business ethics of Company Personnel. Generally speaking, a conflict of interest occurs when the personal interest of Company Personnel or members of their immediate family interferes with, or has the potential to interfere with, the interests or business of the Company. For example, a conflict of interest may occur where Company Personnel or a family member receives a gift, a unique advantage, or an improper personal benefit as a result of the Company Personnel’s position at the Company. A conflict of interest could make it difficult for such person to perform corporate duties objectively and effectively because he or she is involved in a competing interest. The following is a discussion of certain common areas that raise conflict of interest issues. However, a conflict of interest can occur in a variety of situations. Company Personnel must be alert to recognize any situation that may raise conflict of interest issues and must disclose to the Compliance Officer any material transaction or relationship that reasonably could be expected to give rise to actual or apparent conflicts of interest with the Company.

 

Outside Activities/Employment – Any outside activity must not significantly encroach on the time and attention Company Personnel devote to their corporate duties and must not adversely affect the quality or quantity of their work. In addition, Company Personnel may not make use of corporate equipment, facilities or supplies for, or imply (without the Company’s approval) the Company’s sponsorship or endorsement of, any outside activity, and under no circumstances are Company Personnel permitted to take for themselves or their family members business opportunities that are discovered or made available by virtue of their positions at the Company. Moreover, unless the Audit Committee of the Company’s Board of Directors shall have approved or ratified a particular transaction or situation in accordance with the Company’s Statement of Policy with Respect to Related Party Transactions, Company Personnel may not (i) have any financial or economic interest in (a) any entity that is, or to such person’s knowledge may become, a vendor to, or a customer or competitor of, the Company or any of the companies in which the Company has an interest; or (b) any entity that otherwise has or may have a relationship with, or might expect financial or other support from, the Company or any of the companies in which the Company has an interest; or (ii) provide services to or perform services for the benefit of any such entity, other than services performed at the request of or on behalf of the Company. For purposes of clarity and consistency, the preceding sentence shall be interpreted to include the purchase or other acquisition by any Company Personnel of any financial or economic interest in the companies in which the Company has, or is proposed to have, an interest, whether directly or through a public market transaction, or otherwise. Company employees are prohibited from taking part in any outside employment without Safeguard’s prior written approval.

 

Notwithstanding the foregoing, other than relating to the companies in which the Company has an interest, Company Personnel generally may have (i) a passive investment in up to five percent of the total outstanding shares of an entity that is listed on a national or international exchange, the OTC Bulletin Board or a similar quotation service or (ii) a limited partnership interest in a private equity, venture capital or similar fund constituting less than five percent of such fund’s committed capital, provided that the investment is not so large financially either in absolute dollars or as a percentage of the person’s total net worth that it creates the appearance of a conflict of interest.

 

Directors of the Company who are not employees of the Company must be sensitive to situations in which they may be associated with, or have business or financial interests in, corporations or other business entities that, from time to time, have business dealings with the Company or which may compete with the Company. While these relationships and interests are not prohibited, they should be avoided where reasonably practicable. Any Company director who becomes engaged in such a relationship or interest must promptly bring it to the attention of the Chairperson of the Safeguard Board. The Chairperson shall promptly refer such matter to the full Safeguard Board or an appropriately authorized committee of the Safeguard Board for consideration and appropriate disposition. If a conflict cannot be avoided, it must be managed in an ethical and responsible manner.

 

Civic/Political Activities – Company Personnel are encouraged to participate in civic, charitable or political activities so long as such participation does not encroach on the time and attention they are expected to devote to their Company-related duties. Such activities are to be conducted in a manner that does not involve the Company or its assets or facilities and does not create an appearance of the Company’s sponsorship or endorsement.

 

Inventions, Books and Publications – Company employees must receive written permission from the Compliance Officer before developing, outside of the Company, any products, software or intellectual property that may be related to the Company’s current or potential business.

 

Proper Payments – Company Personnel shall pay for and receive only that which is proper. Company Personnel must not make or promise payments to influence another’s acts or decisions, and Company employees must not give gifts beyond those extended in normal business.

 

Gifts – Company Personnel and members of their families must not give or receive valuable gifts (including gifts of equipment or money, discounts, or favored personal treatment) to or from any person associated with Safeguard’s vendors or customers. Acceptance of a gift in the nature of a memento, such as a conference gift or other inconsequential gift valued at less than five hundred dollars ($500), is permitted. Engaging in normal, occasional business-related entertainment, such as meals or the use of sporting, theatrical or other public event tickets, is permissible with the understanding that it is expected that Company Personnel will exercise sound judgment in reliance on this exception so as to avoid any situation that may otherwise be subject to question.

 

Loans to Directors and Employees – The Company will not make loans or extend credit guarantees to or for the personal benefit of directors and executive officers except as permitted by law and the listing standards of any exchange or quotation system on which the Company’s common stock is listed. Loans or guarantees may be extended to other employees only with the Company’s approval.

 

Insider Trading – Company Personnel are prohibited from trading in securities while in possession of material, nonpublic information. Among other things, trading while in possession of material, nonpublic information can subject the person to criminal or civil penalties. The Company has adopted a Statement of Company Policy for Insider Trading and Disclosure and requires all Company Personnel to sign a statement acknowledging that they have read, understand and will comply with the policies set forth therein.

 

 

V.

Fair Dealing

 

Company Personnel shall deal fairly and in good faith with each other and the Company’s customers, suppliers, regulators, business partners and others. Company Personnel may not take unfair advantage of anyone through manipulation, misrepresentation, inappropriate threats, fraud, abuse of confidential information or other related conduct.

 

 

VI.

Proper Use of Company Assets

 

As a general rule, Company assets, including facilities, equipment, materials, supplies, time, information, intellectual property, software, and other assets owned or leased by the Company, or that are otherwise in the Company’s possession, may be used only for legitimate business purposes. However, the Company makes an exception for incidental personal use (e.g., telephone calls to a friend or family member, sending a personal e-mail message, accessing the Web, etc.) provided that such incidental personal use is legal, ethical, appropriate and does not interfere with the conscientious performance of an employee's duties.

 

 

VII.

Delegation of Authority

 

Company Personnel, and particularly each of the Company’s officers and other managerial employees, must exercise due care to ensure that any delegation of authority is reasonable and appropriate in scope and includes appropriate and continuous monitoring.

 

 

VIII.

Handling Confidential Information

 

Company Personnel have an obligation to protect and keep confidential all nonpublic information related to the Company (“Confidential Information”) unless and until its disclosure is approved by the Company and one full business day has passed following its disclosure by the Company in publicly filed SEC reports, press releases, external website, other institutionalized methods of electronic communication, or where disclosure is otherwise mandated by law or regulation. Confidential Information includes all nonpublic information entrusted to or obtained by Company Personnel by virtue of their affiliation with or employment by the Company or their service on the Company’s Board of Directors. Confidential Information includes but is not limited to information relating to:

 

 

●

the Company’s strategy, business, finances, prospects, plans, and operations;

 

 

●

proposed mergers, acquisitions, divestitures, new business ventures, opportunities, partnerships or agreements;

 

 

●

news of a pending initial or secondary public offering of securities, other public or private sales of securities, stock splits or tender offers;

 

 

●

products, orders, contracts, customers, vendors or competitors;

 

 

●

employee records;

 

 

●

the proceedings, discussions and deliberations of the Board and its committees;

 

 

●

discussions relating to the Company by and among employees, officers and directors; and

 

 

●

third party confidential and proprietary information that has been provided to the Company and which the Company is under an obligation to maintain as confidential.

 

In addition, Company Personnel must safeguard proprietary information, which includes information that is not generally known to the public and has commercial value in the Company’s business. Proprietary information includes, among other things, software programs, source and object codes, trade secrets, ideas, techniques, inventions (whether patentable or not) and other information relating to designs, algorithms and research. It also includes information relating to marketing, pricing, customers, and terms of compensation for Company Personnel. The obligation to safeguard proprietary information continues even after employment or service with the Company ends.

 

Please keep in mind the following guidelines in order to protect Confidential Information:

 

 

●

Do not discuss Confidential Information in public places.

 

 

●

Do not forward Confidential Information or proprietary information to non-Company email accounts.

 

 

●

Beware of informal telephone or email requests from outsiders requesting information (including but not limited to requests for comments on expected financial performance, information about current or former employees, or requests from the media).

 

The Company’s Statement of Company Policy on Insider Trading and Disclosure contains additional information concerning confidentiality obligations for Company Personnel.

 

 

IX.

Public Disclosures

 

As a public company, the Company must ensure that its filings and submissions with the SEC and other public communications provide full, fair, timely, accurate and understandable disclosure. Company Personnel engaged in the preparation of these filings, submissions and communications (“Public Disclosure Personnel”) must endeavor to ensure that the Company’s filings, submissions, and communications meet these objectives. Depending on their duties and responsibilities, other employees may be called upon to provide information to assure that the Company’s reports are complete, fair and understandable. To this end, all transactions affecting assets, liabilities, stockholders’ equity, revenues and expenses must be recorded on a timely basis in detailed journals and must be traceable through the general ledger and resulting financial statements. Accounting and financial reporting practices must be fair and proper, in accordance with generally accepted accounting principles.

 

Company Personnel are expected to take this responsibility very seriously. Company Personnel are prohibited from (i) directly or indirectly taking any action to influence, coerce, manipulate or mislead the Company’s independent registered public accounting firm in the performance of an audit of the Company’s financial statements for the purpose of rendering the Company’s financial statements materially misleading; (ii) altering, mutilating or concealing a record, document or other object, or attempting to do so with intent to impair the object’s integrity or availability for use in an official proceeding; and (iii) using Company funds for any purpose other than as described in the documents supporting the disbursement.

 

If requested by Public Disclosure Personnel to provide information for use in such filings, submissions or communications, Company Personnel will provide, as promptly as practicable, accurate, understandable and complete information on a timely basis.

 

Complaints or concerns regarding accounting, internal accounting controls or audit matters must be reported to the Compliance Officer, to the Audit Committee of the Safeguard Board or through our external reporting system, MySafeWorkplace, as indicated in Article X of this Code. Company Personnel may choose to submit such complaints or concerns anonymously. However, we encourage Company Personnel to supply contact information with their submission to facilitate follow-up, clarification and assistance with any investigation, if necessary.

 

Special Ethics Guidelines for the Executive Chairman, Chief Executive Officer, Chief Restructuring Officer and Employees with Financial Reporting Responsibilities

 

The Executive Chairman, Chief Executive Officer, Chief Restructuring Officer and employees with financial reporting responsibilities bear a special responsibility for promoting integrity throughout the organization and have a special role both to adhere to these principles themselves and also to ensure that a culture exists throughout the Company as a whole that ensures the fair and timely reporting of Company financial results and condition, as well as other information required by SEC regulations. Because of this special role, the Executive Chairman, Chief Executive Officer, Chief Restructuring Officer and employees with financial reporting responsibilities are bound by the following additional specific policies.

 

The Executive Chairman, Chief Executive Officer, Chief Restructuring Officer and employees with financial reporting responsibilities shall:

 

 

●

Act with honesty and integrity, avoiding actual or apparent conflicts of interest in personal and professional relationships.

 

 

●

Provide to the Company’s other employees, consultants and advisors who are engaged in filing reports and documents with the SEC (“SEC Reports”) or in disseminating other public communications such as press releases, information that is accurate, complete, relevant, timely and understandable.

 

 

●

Endeavor to ensure full, fair, timely, accurate and understandable disclosure in SEC Reports.

 

 

●

Comply with laws, rules and regulations of federal, state and local governments, and appropriate self-regulatory organizations.

 

 

●

Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or allowing one’s independent judgment to be subordinated.

 

 

●

Respect the confidentiality of information acquired in the course of one’s work except when authorized or otherwise legally obligated to disclose.

 

 

●

Refrain from using Confidential Information acquired in the course of employment for personal advantage.

 

 

●

Proactively promote and be an example of ethical behavior as a responsible partner among peers in the work environment.

 

 

●

Endeavor to ensure responsible use of and control over all assets and resources employed or entrusted.

 

 

●

Record or participate in the recording of entries in the Company’s books and records that are accurate to the best of his or her knowledge.

 

Promptly report to the Compliance Officer, the Audit Committee of the Safeguard Board, or through our external reporting system, MySafeWorkplace, any conduct that he or she believes to be a violation of law or business ethics or of any provision of this Code, including any transaction or relationship that reasonably could be expected to give rise to such a violation.

 

Violations of these Special Ethics Guidelines for the Executive Chairman, Chief Executive Officer, Chief Restructuring Officer and employees with financial reporting responsibilities, including failures to report violations or suspected violations by others, will be viewed as a severe disciplinary matter that may result in personnel action, including termination of employment.

 

 

X.

Report of Violations

 

Administration – General Policy Regarding Report of Violations – Company Personnel who observe, learn of, or, in good faith, suspect a violation of the Code must immediately report the violation or suspected violation either to his or her immediate supervisor (who in turn is responsible for informing the Compliance Officer of such report) or to the Compliance Officer. Complaints or concerns regarding accounting, internal accounting controls or audit matters, must be reported to the Compliance Officer, to the Audit Committee of the Safeguard Board or through our external reporting system, MySafeWorkplace, as indicated in this Article X. You may be subject to disciplinary action, including termination of employment, for failure to do so.

 

Complaint Procedure

 

 

●

Notification of Complaint

 

 

●

To report a violation, suspected violation, complaint or concern to the Compliance Officer, provide the report to the following address or e-mail address:

 

Safeguard Scientifics, Inc.

Attention: Compliance Officer

150 N. Radnor Chester Road, Suite F-200

Radnor, PA 19087

e-mail address: complianceofficer@safeguard.com

 

 

●

To report a violation, suspected violation, complaint or concern to the Audit Committee of the Safeguard Board, provide the report to the following address:

 

Safeguard Scientifics, Inc.

Attention: Audit Committee - CONFIDENTIAL

c/o Corporate Secretary

150 N. Radnor Chester Road, Suite F-200

            Radnor, PA 19087

 

 

●

If Company Personnel are not comfortable using the procedures and protocols outlined above, they can report a violation, suspected violation, complaint or concern by providing a report via our external, anonymous and confidential reporting system, MySafeWorkplace. Such report should be provided using the following internet address or telephone number:

 

Via Internet:         www.MySafeWorkplace.com

Via telephone:         800-461-9330

 

 

●

Whenever practical, the complaint should be made in writing.

 

 

●

You may choose to submit violations, suspected violations, complaints or concerns anonymously. However, we encourage Company Personnel to supply contact information with their submission to facilitate follow-up, clarification and assistance with any investigation, if necessary. Confidentiality is respected and an individual’s identity will only be shared on a “need-to-know” basis.

 

 

●

Nothing in this Code prevents Company Personnel from reporting violations or suspected violations of law to relevant government authorities.

 

 

 

●

Investigation and Corrective Action

 

Reports of violations, suspected violations, complaints or concerns will promptly be investigated under the supervision of the Compliance Officer or, where appropriate, the Audit Committee of the Safeguard Board. Company Personnel are required to cooperate fully in such investigations and to provide truthful, complete and accurate information. The investigation will be handled as discreetly as reasonably possible, allowing for a fair investigation and any necessary corrective action. Appropriate corrective action will be taken whenever a violation of this Code is determined to have occurred. Depending on the nature of the violation, the offending individual can be subject to disciplinary action, which may include termination of employment. In addition, anyone who interferes with an investigation, or provides information in an investigation that the individual knows to be untrue or inaccurate, will be subject to disciplinary action, which may include termination of employment. Any employee who submits a complaint or concern relating to the handling of accounting, internal accounting controls or audit matters in good faith should have no fear of dismissal or retaliation of any kind. Retaliation against employees who, for lawful purposes, file a complaint or participate in an investigation is strictly prohibited.

 

The Audit Committee of the Safeguard Board will be responsible for the acceptance, investigation and management of reports of suspected violations of this Code by the Executive Chairman, Chief Executive Officer, Chief Restructuring Officer, the Compliance Officer and employees with financial reporting responsibilities and complaints or concerns regarding accounting, internal accounting controls or audit matters.

 

The Company’s Compliance Officer will be responsible for the acceptance, investigation and management of reports by attorneys regarding material violations of securities laws, fiduciary duties or similar laws.

 

 

●

Confidentiality 

 

Except as may be required by law or by the requirements of the resulting investigation or the corrective action, all notices, reports and information received under this process will be treated in a confidential manner. Every reasonable effort will be made to handle the matter with discretion and to protect the identity of those who make reports as well as those who are being investigated. However, the Compliance Officer regularly will report to the Audit Committee of the Safeguard Board any violations that have been reported. Further, if necessary to conduct a proper review or to comply with legal requirements, the Audit Committee of the Safeguard Board, the Company’s independent registered public accounting firm or others may become involved in the review process. Also, as noted above, the Company must and will report all suspected criminal violations to the appropriate authorities for possible prosecution and will investigate, address and report to governmental or other authorities, as appropriate, non-criminal violations.

 

 

XI.

Protection Against Retaliation

 

Policy - The Company prohibits any form of retaliation against employees who, for lawful purposes, report to the Company any conduct or activity that may violate this Code, any law or regulation applicable to the Company, or any other suspected improper, unethical or illegal conduct or activities by anyone at the Company. The Company also prohibits any form of retaliation against employees who provide information, cause information to be provided, or assist in an investigation conducted by the Company or any governmental body regarding a possible violation of any law or regulation relating to fraud, any labor law, or any rule or regulation of the SEC, or who file, cause to be filed, or assist, participate or give testimony in any proceeding relating to an alleged violation of any such law, rule or regulation.

 

Management Responsibility - All Company officers and other managerial employees are responsible for ensuring adherence to this Code. In addition, each Company officer and managerial employee is responsible for communicating this Code to employees under his or her supervision and for supporting programs and practices designed to develop understanding of, commitment to and compliance with this Code. In the event that any Company officer, other managerial employee or supervisor believes that a violation of this Code has occurred or receives a report of a violation, he or she must immediately contact the Compliance Officer or the Audit Committee of the Safeguard Board.

 

Procedures for Reporting Policy Violations - If an employee believes that he or she has been retaliated against (including threatened or harassed) in violation of this Code, he or she should immediately report the retaliation either to his or her immediate supervisor (who in turn is responsible for informing the Compliance Officer of such report) or to the Compliance Officer in accordance with the contact procedures for the Compliance Officer set forth above. In connection with retaliation related to complaints or concerns regarding accounting, internal accounting controls or audit matters, any retaliation in violation of this Code must be reported to the Compliance Officer, the Audit Committee of the Safeguard Board or through our external reporting system, MySafeWorkplace, in accordance with the contact procedures set forth above. Once an employee reports retaliation prohibited by this Code, the Company will promptly investigate the matter in accordance with the procedures described in Article X of this Code.

 

 

XII.

Waivers

 

Requests for a waiver of a provision of the Code must be submitted in writing to the Compliance Officer or the Audit Committee of the Safeguard Board for appropriate review, and the Compliance Officer or the Audit Committee of the Safeguard Board will decide the outcome. For conduct involving directors and executive officers, only the Audit Committee of the Safeguard Board has the authority to waive a provision of the Code. The Audit Committee of the Safeguard Board must review and approve any “related party” transaction as defined in Item 404 of Regulation S-K, promulgated by the SEC, before it is consummated. In the event of an approved waiver involving the conduct of a director or executive officer, appropriate and prompt disclosure must be made to the Company’s shareholders as required by the SEC or other regulation or by applicable listing standards of the principal exchange or interdealer quotation system on which the Company’s common stock is listed.

 

Statements in the Code to the effect that certain actions may be taken only with “the Company’s approval” or that certain items will be “designated by the Company” will be interpreted to mean that appropriate executive officers of Safeguard Scientifics, Inc. or members of the Safeguard Board must give prior written approval or make such designation before the proposed action may be undertaken or the proposed designation may be made.

 

Violations of the Special Ethics Guidelines for the Executive Chairman, Chief Executive Officer, Chief Restructuring Officer and employees with financial reporting responsibilities contained in this Code that go unaddressed are treated by the SEC as implicit waivers of this Code. Accordingly, any violation that is discovered and not addressed will have to be disclosed in accordance with the rules and regulations of the SEC and applicable listing standards with respect to a waiver of this Code. In such cases, the applicable SEC rules will require disclosure of the nature of any violation, the date of the violation and the name of the person who committed the violation. Such disclosure would not only be harmful to the Company, but also to an individual either as one who is responsible for monitoring the enforcing compliance with this Code or as one who has violated it. In either case, depending on the nature of the violation, an individual may be dismissed or his or her duties and responsibilities with the Company may be changed.

 

 

XIII.

Compliance

 

Adherence to Code; Disciplinary Action – All Company Personnel have a responsibility to understand and follow this Code. In addition, all Company Personnel are expected to perform their work with honesty and integrity in all areas not specifically addressed in this Code. A violation of this Code may result in appropriate disciplinary action, including the possible termination from employment with the Company.

 

Communications; Training; Annual Certification – The Company strongly encourages dialogue among employees and their supervisors to make everyone aware of situations that give rise to ethical questions and to articulate acceptable ways of handling those situations. Company employees will receive periodic training on the contents and importance of the Code and related policies and the manner in which violations must be reported and waivers must be requested. All Company Personnel must certify that they have read this Code and to the best of their knowledge are in compliance with all its provisions. In addition, each director, officer and other managerial employee of the Company, as may be designated by the Company from time to time, has an obligation to annually certify that he or she has reviewed this Code with his or her subordinates. Forms of these certifications are attached to this Code as Appendices I and II.

 

Responsibility of Senior Employees – All Company officers and other managerial employees will be responsible for the enforcement of, and compliance with, this Code, including necessary distribution to assure Company employee knowledge and compliance. Directors, officers and other managerial employees are expected to promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships. Managerial employees may be disciplined if they condone misconduct, do not report misconduct, do not take reasonable measures to detect misconduct, or do not demonstrate the appropriate leadership to insure compliance.

 

 

XIV.

Related Policies; Enforceable by Company Only

 

This Code should be read in conjunction with Safeguard’s other policy statements, including but not limited to the Statement of Company Policy on Insider Trading and Disclosure. This Code is for the benefit of the Company, and no other person or entity is entitled to enforce this Code. This Code does not, and should not be interpreted to, create any private cause of action or remedy in any other person or entity for a violation of the Code. In addition, this Code should not be construed as a contract of employment and does not change any person's employment status.

 

 

Adopted:          April 8, 2004

 

Last Approved: November 3, 2020

 
 

 

 

APPENDIX I

 

INITIAL CODE OF BUSINESS CONDUCT AND ETHICS DISCLOSURE STATEMENT

 

 

As a director, officer or other employee of Safeguard Scientifics, Inc. (“Company”), I have read and understand the Company’s Code of Business Conduct and Ethics (“Code”), and I hereby affirm my agreement to comply with its terms. I hereby certify as follows:

 

1.         I have received a copy of the Code.

 

2.         I have read, understand and agree to comply with the Code.

 

3.         I am currently in compliance and, as applicable, members of my family are in compliance, with the terms of the Code and all obligations imposed by it, except as disclosed to the Compliance Officer or as otherwise disclosed in accordance with the procedures contained in Article X of the Code.

 

4.         I am not aware of any conduct on the part of any person associated with the Company that may constitute a violation of the Code, except with respect to any matters that I may have disclosed to the Compliance Officer or otherwise disclosed in accordance with the procedures contained in Article X of the Code.

 

5.         I understand that none of the benefits, policies, programs, procedures or statements in the Code are intended to confer any rights or privileges upon me or entitle me to be or remain an employee of the Company. I am aware that the Code is not a contract and is subject to change at any time, without notice, at the sole discretion of the Company.

 

I understand that all Disclosure Statements may be available to the Compliance Officer, the Company’s Board of Directors, and internal and external legal counsel. Such information shall otherwise be held in confidence in accordance with Article X of the Code.

 

Each person signing a Disclosure Statement is responsible for keeping his/her Disclosure Statement current. These statements will be kept in Safeguard’s Legal Department.

 

 

____________________________

Signature

 

 

____________________________

Name

 

 

____________________________

Date

 
 

 

 

APPENDIX II

 

ANNUAL CODE OF BUSINESS CONDUCT AND ETHICS DISCLOSURE STATEMENT

 

 

As a director, officer or other employee of Safeguard Scientifics, Inc. (“Company”), I have read and understand the Company’s Code of Business Conduct and Ethics (“Code”), and I hereby reaffirm my agreement to comply with its terms. With respect to the last 12 months, I hereby certify as follows:

 

1.         I have complied and, as applicable, members of my family have complied, with the terms of the Code and all obligations imposed by it, except as disclosed to the Compliance Officer or as otherwise disclosed in accordance with the procedures contained in Article X of the Code.

 

2.         I have reviewed the Code with my subordinates and I am not aware of any conduct on the part of any person associated with the Company that may constitute a violation of the Code, except with respect to any matters that I may have disclosed to the Compliance Officer or otherwise disclosed in accordance with the procedures contained in Article X of the Code.

 

3.         I understand that none of the benefits, policies, programs, procedures or statements in the Code are intended to confer any rights or privileges upon me or entitle me to be or remain an employee of the Company. I am aware that the Code is not a contract and is subject to change at any time, without notice, at the sole discretion of the Company.

 

I understand that all Disclosure Statements may be available to the Compliance Officer, the Company’s Board of Directors, and internal and external legal counsel. Such information shall otherwise be held in confidence except in accordance with Article X of the Code.

 

Each person signing a Disclosure Statement is responsible for keeping his/her Disclosure Statement current. These statements will be kept in Safeguard’s Legal Department.

 

 

 

____________________________

Signature

 

 

____________________________

Name

 

 

____________________________

Date

 

 
 EX-21.1 4 ex_208595.htm EXHIBIT 21.1 ex_208595.htm

EXHIBIT 21.1

 

SUBSIDIARIES OF SAFEGUARD SCIENTIFICS, INC.

 

Exclusive of immaterial subsidiaries and companies in which the Registrant holds a minority interest, as of February 26, 2021, the Registrant had the following subsidiaries:

 

NAME

PLACE OF INCORPORATION

Bonfield VII, Ltd.

British Virgin Islands

Novitas Capital II Management, L.P.

Pennsylvania

Safeguard Capital Management, Inc.

Delaware

Safeguard Delaware, Inc.

Delaware

Safeguard Delaware II, Inc.

Delaware

Safeguard Fund Management, Inc.

Delaware

Safeguard PM SPV, Inc.

Delaware

Safeguard Scientifics (Delaware), Inc.

Delaware

Safeguard Technologies, Inc.

Delaware

SFE Properties, Inc.

Delaware

SSI Management Company, Inc.

Delaware

SSI Partnership Holdings (Pennsylvania), Inc.

Pennsylvania

 

 

 
 EX-23.1 5 ex_208596.htm EXHIBIT 23.1 ex_208596.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors
Safeguard Scientifics, Inc.:

 

We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 333-65092, 333-73284, 333-86777, 333-103976, 333-118046, 333-171226, and 333-198783) of Safeguard Scientifics, Inc. of our report dated March 5, 2021, with respect to the consolidated balance sheets of Safeguard Scientifics, Inc. as of December 31, 2020 and 2019, and the related consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows for the years then ended, and the related notes, which report appears in the December 31, 2020 annual report on Form 10-K of Safeguard Scientifics, Inc.

 

/s/ KPMG LLP

 

Philadelphia, Pennsylvania

March 5, 2021

 

 
 EX-31.1 6 ex_208597.htm EXHIBIT 31.1 ex_208597.htm

Exhibit 31.1

   

CERTIFICATION

   

I, Eric C. Salzman, certify that:

   

1.

I have reviewed this Annual Report on Form 10-K of Safeguard Scientifics, Inc.;

   

   

   

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

   

   

   

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

   

   

   

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

   

   

   

   

a.

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

   

   

   

b.

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

   

   

   

c.

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

   

   

   

d.

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

   

   

   

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

   

   

   

   

a.

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

   

   

   

b.

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

   

 

   

 

SAFEGUARD SCIENTIFICS, INC.

   

 

   

Date:

March 5, 2021

/s/ Eric C. Salzman

   

 

Eric C. Salzman

   

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 
 EX-31.2 7 ex_208598.htm EXHIBIT 31.2 ex_208598.htm

Exhibit 31.2

   

CERTIFICATION

   

I, Mark A. Herndon, certify that:

   

1.

I have reviewed this Annual Report on Form 10-K of Safeguard Scientifics, Inc.;

   

   

   

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

   

   

   

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

   

   

   

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

   

   

   

   

a.

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   

   

   

   

b.

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

   

   

   

   

c.

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   

   

   

   

d.

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

   

   

   

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

   

   

   

   

a.

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

   

   

   

   

b.

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

   

 

SAFEGUARD SCIENTIFICS, INC.

   

 

   

Date

March 5, 2021

/s/ Mark A. Herndon

   

 

Mark A. Herndon

   

 

Senior Vice President and Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

 

 
 EX-32.1 8 ex_208599.htm EXHIBIT 32.1 ex_208599.htm

Exhibit 32.1

   

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

   

In connection with the Annual Report of Safeguard Scientifics, Inc. (“Safeguard”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric C. Salzman, Chief Executive Officer of Safeguard, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

   

1.

The Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, (15 U.S.C. 78m(a)); and

   

   

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Safeguard.

   

   

   

 

SAFEGUARD SCIENTIFICS, INC.

   

 

   

Date:

March 5, 2021

/s/ Eric C. Salzman

   

 

Eric C. Salzman

   

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 
 EX-32.2 9 ex_208600.htm EXHIBIT 32.2 ex_208600.htm

Exhibit 32.2

   

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

   

In connection with the Annual Report of Safeguard Scientifics, Inc. (“Safeguard”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark A. Herndon, Senior Vice President and Chief Financial Officer of Safeguard, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

   

1.

The Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, (15 U.S.C. 78m(a)); and

   

   

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Safeguard.

   

   

   

 

SAFEGUARD SCIENTIFICS, INC.

   

 

   

Date:

March 5, 2021

/s/ Mark A. Herndon

   

 

Mark A. Herndon

   

 

Senior Vice President and Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

 
 EX-101.SCH 10 sfe-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - General link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Ownership Interests and Advances link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 3 - Acquisitions of Ownership Interests link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 4 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Credit Facility and Convertible Debentures link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - Equity link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 7 - Stock-Based Compensation link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 8 - Employee Benefit Plan link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 9 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 10 - Net Income (Loss) Per Share link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 11 - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 12 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 13 - Supplemental Cash Flow Information link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 14 - Segment Reporting link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 16 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 1 - General (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 2 - Ownership Interests and Advances (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 7 - Stock-Based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 9 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 10 - Net Income (Loss) Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 14 - Segment Reporting (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 1 - General (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 1 - General - Schedule of Leases (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 2 - Ownership Interests and Advances (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 3 - Acquisitions of Ownership Interests (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 5 - Credit Facility and Convertible Debentures (Details Textual) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 6 - Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 7 - Stock-Based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 8 - Employee Benefit Plan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 9 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 10 - Net Income (Loss) Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 13 - Supplemental Cash Flow Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 14 - Segment Reporting (Details Textual) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) (Details Textual) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 16 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 11 sfe-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 sfe-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 sfe-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual us-gaap_DerivativeGainLossOnDerivativeNet Income from change in fair value of derivative Significant Accounting Policies Note 1 - General Note 2 - Ownership Interests and Advances Note 7 - Stock-Based Compensation Repayment of advances and loans from ownership interests sfe_DisposalGroupIncludingDiscontinuedOperationPeriodOfContingentProceeds Disposal Group, Including Discontinued Operation, Period of Contingent Proceeds (Month) The period of contingent proceeds from disposal group. Note 9 - Income Taxes Note 10 - Net Income (Loss) Per Share Note 14 - Segment Reporting Note 15 - Selected Quarterly Financial Information (Unaudited) Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details) Income Tax Disclosure [Text Block] Note 1 - General - Schedule of Leases (Details) Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details) us-gaap_GuaranteeObligationsCurrentCarryingValue Guarantor Obligations, Current Carrying Value Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details) Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details) Current liabilities Total current liabilities Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details) Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details) Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details) Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details) Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details) Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Share-based Payment Arrangement, Option, Activity [Table Text Block] Share-based Payment Arrangement, Activity [Table Text Block] Proceeds, from sales and maturities in marketable securities Granted (in dollars per share) Vested (in dollars per share) Forfeited (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Balance (in dollars per share) Balance (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares) Forfeited (in shares) us-gaap_DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current, Total us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Balance (in shares) Balance (in shares) Granted (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) Vested (in shares) Other comprehensive income (loss) Options exercisable , weighted average exercise price (in dollars per share) Options exercisable, weighted average remaining contractual life (Year) Options exercisable, aggregative intrinsic value us-gaap_PaymentsForAdvanceToAffiliate Advances and loans to ownership interests us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance Total Equity Balance Balance Options exercisable, shares (in shares) Balance, weighted average remaining contractual life (Year) Balance, aggregative intrinsic value us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in shares) Private Equity Funds [Member] us-gaap_PaymentsToAcquireHeldToMaturitySecurities Purchase of marketable securities us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Balance, weighted average exercise price (in dollars per share) Balance, weighted average exercise price (in dollars per share) Options canceled/forfeited, weighted average exercise price (in dollars per share) Options granted, weighted average exercise price (in dollars per share) Options exercised, weighted average exercise price (in dollars per share) Accrued expenses and other current liabilities Accrued compensation and benefits us-gaap_LessorOperatingLeaseTermOfContract Lessor, Operating Lease, Term of Contract (Month) Equity Method Investment Income Adjustment [Member] Represents adjustments for equity method investment income. Accounts payable Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Balance, shares (in shares) Balance, shares (in shares) sfe_GainLossFromObservablePriceChanges Gain from observable price changes Represents gain (loss) from observable price changes. Credit Facility [Axis] Credit Facility [Domain] sfe_DebtInstrumentDebtCovenantsCashAndCashEquivalentThreshold Debt Instrument, Debt Covenants, Cash and Cash Equivalent Threshold Represents the debt instrument, debt covenants, cash and cash equivalent threshold. us-gaap_PolicyTextBlockAbstract Accounting Policies sfe_EquityMethodInvestmentsAmountInHoldbacksAndEscrows Equity Method Investments, Amount in Holdbacks and Escrows Represents amount in holdbacks and escrows under equity method investments. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares) sfe_PartnerCompaniesNotConsolidatedInFinancialStatements Partner Companies Not Consolidated In Financial Statements Represents partner companies not consolidated in financial statements. Flashtalking, Inc. [Member] Represents information related to Flashtalking, Inc. Shares available for future grant, shares (in shares) sfe_FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer Future Annual Payment To Chairman and Chief Executive Officer Represents future annual payment to chairman and CEO. sfe_DeferredCompensationArrangementWithIndividualGainLoss Deferred Compensation Arrangement with Individual Gain (Loss) Represents gain (loss) for deferred compensation arrangement with individual. Convertible Senior Debentures due 2018 [Member] Represents information related convertible senior debentures due 2018. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) sfe_LongtermIncentivePlanBonusPoolPercent Long-term Incentive Plan, Bonus Pool Percent Represents bonus pool percent for long-term incentive plan. Weighted average shares used in computing net income (loss) per share: us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss), Total Equity Method Investment Partner Company Results Of Operation [Table Text Block] Tabular disclosure for results of operation for a partnering company under the equity method investment. Current Liabilities: sfe_EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment Equity Method Investment Assets Exceed Carrying Value Of Investment Represents the value by which the carrying value exceeded the company's assets under the equity method investment. sfe_EquityMethodInvestmentAllocationOfExcessFairValue Equity Method Investment Allocation of Excess Fair Value Represents the allocation of excess fair value under the equity method investment. Intangible Assets [Member] Represents intangible assets. us-gaap_Assets Total Assets Plan Name [Axis] Plan Name [Domain] Compensation and Employee Benefit Plans [Text Block] Number of equity method ownership interests Represents the number of equity method ownership interests. High Traction Stage [Member] Information pertaining to high traction stage. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Amended Credit Facility [Member] Represents information pertaining to the amended credit facility. Share-based Payment Arrangement [Text Block] Error Correction, Type [Axis] Error Correction, Type [Domain] Credit Facility [Member] represents credit facility. Award Type [Domain] Award Type [Axis] Net loss Reclassification adjustment for sale of equity method investments The amount of reclassification adjustment for other comprehensive income (loss) arising from the sale of equity method investments. Share of other comprehensive (loss) of equity method investments The share of other comprehensive income (loss) of equity method investments. Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net The value of shares issued for restricted stock awards withheld for taxes. Payable Monthly in Arrears [Member] Represents the interest payable in monthly arrears. Restricted Stock [Member] Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares) The number of shares issued for restricted stock awards and withheld for taxes. sfe_LongtermLineOfCreditRepaymentFeatureNoncurrent Long-term Line of Credit, Repayment Feature, Noncurrent Represents the long-term line of credit, repayment feature, noncurrent. sfe_DebtInstrumentGainLossFromCovenantLiability Debt Instrument, Gain (Loss) from Covenant Liability Represents the debt instrument, gain (loss) from covenant liability. Performance Shares [Member] Payable on the Last Day of the One, Two or Three Month Interest Period [Member] Represents the interest payable on the last day of the one, two or three month interest period. Share-based Payment Arrangement, Option [Member] Performance Stock Unit [Member] Represents performance stock unit. Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] sfe_LesseeOperatingLeaseLiabilityPaymentsDueYearSix 2026, operating lease payments Amount of lessee's undiscounted obligation for lease payments for operating lease, due in sixth fiscal year following latest fiscal year. Valuation of Credit Facility Repayment Feature, Policy [Policy Text Block] The disclosure of accounting policy for the valuation of the credit facility repayment feature. 2014 Equity Compensation Plan [Member] Represents the 2014 equity compensation plan. Propeller [Member] Related to the entity Propeller. sfe_LessorOperatingLeasePaymentsToBeReceivedSixYears 2026, expected sublease receipts Amount of lease payments to be received by lessor in sixth fiscal year following latest fiscal year for operating lease. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. Commitments and Contingencies Disclosure [Text Block] sfe_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationTerm Share Based Compensation Arrangement, By Share Based Payment Award, Expiration Term (Year) Represents the share based compensation arrangement by share based payment award expiration term. Property and equipment, net NovaSom [Member] Related to the entity NovaSom. Service Based Award [Member] Represents the service based award. Transactis [Member] Related to the entity Transactis. sfe_ConvertibleBridgeLoan Convertible Bridge Loan The amount of funding for convertible bridge loans in the period. Clutch Holdings [Member] Related to the entity Clutch Holdings. sfe_CashLiabilityForPerformancebasedUnits Cash Liability for Performance-Based Units Represents the cash liability for performance based units. Syapse, Inc. [Member] Related to the entity Syapse, Inc. Zipnosis [Member] Related to the entity Zipnosis. sfe_SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes Share-based Compensation Arrangement by Share-based Payment Award, Number of Award Vesting Types Represents the number of award vesting types under share-based compensation arrangement by share-based payment award. WebLinc, Inc. [Member] Related to the entity WebLinc, Inc. Sonobi [Member] Related to the entity Sonobi. QuanticMind [Member] Related to the entity QuanticMind. sfe_PercentageOfSharesVestedInLieuOfDirectorsFeesAtTheGrantDate Percentage of Shares Vested in Lieu of Directors Fees at the Grant Date Represents the percentage of shares vested in lieu of directors fees at the grant date. Moxe Health Corporation [Member] Related to the entity Moxe Health Corporation. Long-term Debt, Type [Axis] sfe_PortionOfDirectorFeesMatchedToDeferredStockUnits Portion of Director Fees Matched to Deferred Stock Units. Represents the portion of director fees matched to deferred stock units. Aktana, Inc. [Member] Related to the entity Aktana, Inc. Long-term Debt, Type [Domain] us-gaap_Dividends Dividends, Total Dividends paid sfe_SharebasedCompensationArrangementByShareBasedPaymentDeferredAwardVestingPeriod Share-based Compensation Arrangement by Share Based Payment, Deferred award, Vesting Period (Year) Represents the share based compensation arrangement by share based payment deferred award vesting period. meQuilibrium [Member] Related to the entity meQuilibrium. Deferred Stock Units [Member] Represents deferred stock units. Disallowed interest carryforwards Represents the deferred tax assets, disallowed interest carryforwards. Change in accounting at ownership interests The cumulative effect on retained earnings resulting from a change in accounting principals used at ownership interests. 2021 Represents net operating loss carryforwards expiring in year one. Ownership Interest Under Equity Method, Percent Equity Method Investment, Ownership Percentage Schedule Of Activity For Restricted Stock Units Deferred Stock Units And Performance Units [Table Text Block] Tabular disclosure of activity for restricted stock unity. deferred stock units and performance units. Net income (loss) Net income (loss) Net income (loss) us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Total comprehensive income (loss) 2022 Represents net operating loss carryforwards expiring in year two. Investments in and Advances to Affiliates, Schedule of Investments [Text Block] 2023 Represents net operating loss carryforwards expiring in year three. Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block] sfe_LesseeOperatingLeaseLiabilityToBePaidAfterYearSix Thereafter, operating lease payments Represents the amount of lessee's undiscounted obligation for lease payment for operating lease due after sixth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Cash Flows from Investing Activities: sfe_LessorOperatingLeasePaymentToBeReceivedAfterYearSix Thereafter, expected sublease receipts Represents amount of lease payment to be received by lessor for operating lease after sixth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach) Other Companies Net income (loss) per share: us-gaap_ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount Earnings Per Share [Text Block] Advances to companies (equity method) Restricted Stock, Performance-based Stock Units, and Deferred Stock Units [Member] Represents restricted stock, performance-based stock units, and deferred stock units. Ownership interests and advances Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures, Total Equity income (loss), net Equity income (loss), net Income (Loss) from Equity Method Investments, Total Accounts payable, accrued expenses, and other current liabilities Equity Method Companies Equity Method Investments Related Party Transactions Disclosure [Text Block] Line of Credit [Member] Income tax benefit (expense) Prognos Health, Inc. [Member] Related to the entity Prognos Health, Inc. Lumesis, Inc. [Member] Related to the entity Lumesis, Inc. InfoBionic, Inc. [Member] Related to the entity InfoBionic, Inc. us-gaap_OtherNonoperatingGainsLosses Other, net MediaMath, Inc. [Member] Related to the entity MediaMath, Inc. Trice Medical, Inc. [Member] Related to the entity Trice Medical, Inc. us-gaap_DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost sfe_PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold Preferred Stock Purchase Right to be Exchanged for Common Stock Above Maximum Ownership Threshold (in shares) The number of preferred stock purchase rights which will be exchanged for each share of common stock if an owner obtains more common stock than the maximum ownership allowed. sfe_SaleOfStockIndividualOwnershipPercentMaximum Sale of Stock, Individual Ownership, Percent, Maximum The maximum percent ownership of the company's outstanding stock an individual may acquire. General and administrative expense General and administrative expense us-gaap_RestrictedCash Restricted cash us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match Schedule of Partner Company Ownership Interest [Table Text Block] The tabular disclosure of partner company ownership interests. sfe_IncomeLossFromEquityMethodInvestmentsExcludingImpairments Equity (income) loss, net Amount of income (loss) for proportionate share of equity method investee's income (loss), excluding impairments. Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Ending Balance us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax Stock-based compensation expense us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense Amendment Flag City Area Code Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal, Total us-gaap_TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired (in shares) us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate sfe_LIBORFloorRate LIBOR Floor Rate An agreed-upon rate in the lower range of the London Inter-bank Offered Rate (LIBOR) rates associated with a floating rate loan product. us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage us-gaap_DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other current assets Document Fiscal Period Focus us-gaap_OperatingLeaseCost Operating Lease, Cost Document Fiscal Year Focus sfe_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage Ownership Interest Under Other Method, Percent The percentage ownership of investment in equity security without readily determinable fair value of another entity. Document Period End Date Entity File Number Entity Emerging Growth Company Document Type Entity Small Business Entity Shell Company Document Information [Line Items] Document Information [Table] Entity Public Float Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Entity Voluntary Filers Entity Well-known Seasoned Issuer London Interbank Offered Rate (LIBOR) [Member] Variable Rate [Domain] Fed Funds Effective Rate Overnight Index Swap Rate [Member] Prime Rate [Member] us-gaap_LessorOperatingLeasePaymentsToBeReceived Total future minimum lease payments, expected sublease receipts Variable Rate [Axis] us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears 2025, expected sublease receipts Stock-based compensation Quarterly Financial Information [Text Block] Statement of Comprehensive Income [Abstract] Entity Tax Identification Number Entity Central Index Key us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths 2021, expected sublease receipts Entity Registrant Name us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears 2022, expected sublease receipts us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears 2023, expected sublease receipts Entity [Domain] us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears 2024, expected sublease receipts Legal Entity [Axis] Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block] Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province us-gaap_TreasuryStockValue Treasury stock, at cost; 688 and 930 shares at December 31, 2020 and 2019, respectively Entity Common Stock, Shares Outstanding Long-term Debt [Text Block] Investments [Domain] Trading Symbol Investment Type [Axis] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] us-gaap_LineOfCreditFacilityPeriodicPaymentInterest Line of Credit Facility, Periodic Payment, Interest Local Phone Number Options exercised, shares (in shares) Options exercised, shares (in shares) us-gaap_TableTextBlock Notes Tables Options granted, shares (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares) Options canceled/forfeited, shares (in shares) us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Equity Accumulated deficit Accumulated other comprehensive loss Non-current assets Interest expense us-gaap_InterestExpenseDebt Interest Expense, Debt, Total Interest expense Changes in assets and liabilities: us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Subsequent Event [Member] Lease liability - non-current Restrictions on Cash and Cash Equivalents [Table Text Block] us-gaap_OperatingLeaseLiability Total operating lease liabilities Subsequent Event Type [Axis] Lease liability - current Subsequent Event Type [Domain] Subsequent Events [Text Block] us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue Total future minimum lease payments, operating lease payments us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Less imputed interest us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree 2023, operating lease payments us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour 2024, operating lease payments us-gaap_UnrealizedGainLossOnInvestments Impairments of ownership interests and advances us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive 2025, operating lease payments Fair Value of Financial Instruments, Policy [Policy Text Block] us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths 2021, operating lease payments us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo 2022, operating lease payments Segment Reporting, Policy [Policy Text Block] us-gaap_DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount Stock-based compensation, including liability classified awards Other assets Lessee, Leases [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Revenue Amortization of debt discount Income Tax, Policy [Policy Text Block] us-gaap_DepreciationDepletionAndAmortization Depreciation Current assets Total current assets Stockholders' Equity Note Disclosure [Text Block] Treasury stock, shares (in shares) Common stock, $0.10 par value; 83,333 shares authorized; 21,573 issued at December 31, 2020 and 2019, respectively Adjustments to reconcile to net cash used in operating activities: Common stock, shares authorized (in shares) Common stock, shares issued (in shares) us-gaap_LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate Common stock, par value (in dollars per share) us-gaap_CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance (in shares) us-gaap_DeferredTaxAssetsValuationAllowance Valuation allowance us-gaap_OperatingLeasePayments Operating Lease, Payments Statistical Measurement [Domain] Maximum [Member] Minimum [Member] us-gaap_DeferredTaxAssetsNet Net deferred tax asset Statistical Measurement [Axis] Investment, Name [Domain] T-Rex Group, Inc [Member] Represents information related to T-Rex Group, Inc. Preferred stock, $0.10 par value; 1,000 shares authorized us-gaap_InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities Investment, Name [Axis] Cash Flow, Supplemental Disclosures [Text Block] us-gaap_IncomeTaxesPaid Income Taxes Paid Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Other us-gaap_DeferredTaxAssetsGross Deferred Tax Assets, Gross, Total Preferred stock, shares authorized (in shares) Carrying values of ownership interests and other holdings Preferred stock, par value (in dollars per share) Accrued expenses Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption, Adjustment [Member] Cash Flows from Operating Activities: Statement [Line Items] us-gaap_NumberOfOperatingSegments Number of Operating Segments us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Stock-based compensation AOCI Attributable to Parent [Member] Additional paid-in capital Property, Plant and Equipment, Policy [Policy Text Block] Other income (loss), net Other income (loss), net Segment Reporting Disclosure [Text Block] Equity: Tax loss and credit carryforwards us-gaap_DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Restricted cash Current Assets: Fair Value Disclosures [Text Block] us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Total cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash equivalents at beginning of period Cash, cash equivalents and restricted cash at end of period Interest income Interest income us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash used in financing activities us-gaap_Liabilities Total Liabilities us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Net change in cash, cash equivalents and restricted cash Commitments and contingencies (Note 12) Director [Member] Operating loss us-gaap_OperatingIncomeLoss Operating Income (Loss), Total Operating loss us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash (used in) provided by investing activities Prepaid expenses and other current assets Gross profit Accounting Standards Update 2014-09 [Member] us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent Deferred Compensation Liability, Current and Noncurrent, Total Partnership Interest [Member] Investment, Policy [Policy Text Block] us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment Equity Method Investment, Other than Temporary Impairment Accounting Standards Update [Domain] us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation Tax withholdings related to equity-based awards Accounting Standards Update [Axis] us-gaap_PaymentsOfDividends Payment of dividend Equity Method Investments [Table Text Block] Noncontrolling Interest [Member] Scenario [Domain] Retained Earnings [Member] Title of Individual [Domain] Title of Individual [Axis] Treasury Stock [Member] Scenario [Axis] us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations, Total us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock Additional Paid-in Capital [Member] Common Stock [Member] us-gaap_StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations, Total Equity Components [Axis] Equity Component [Domain] Net loss before income taxes us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Net income (loss) before income taxes Other comprehensive (loss) income: Document Annual Report Cash and Cash Equivalents, Policy [Policy Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Entity Incorporation, State or Country Code General and Administrative Expense [Member] Accounting Policies [Abstract] Document Transition Report Basis of Accounting, Policy [Policy Text Block] Entity Interactive Data Current Security Exchange Name Title of 12(b) Security Equity Method Investment, Nonconsolidated Investee [Axis] Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member] Equity Method Investment, Nonconsolidated Investee [Domain] Income Statement Location [Axis] Income Statement Location [Domain] us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) us-gaap_RepaymentsOfLinesOfCredit Repayments of Lines of Credit Repayments on credit facility Diluted (in shares) Goodwill [Member] Summary of Operating Loss Carryforwards [Table Text Block] Statement [Table] Statement of Financial Position [Abstract] Diluted (in dollars per share) Diluted (in dollars per share) Basic (in shares) Diluted: us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent, Total Basic (in dollars per share) Basic (in dollars per share) Valuation allowance Basic: Statement of Cash Flows [Abstract] Statement of Stockholders' Equity [Abstract] Income Statement [Abstract] Disposal Group Name [Axis] Disposal Group Name [Domain] Quarterly Financial Information [Table Text Block] us-gaap_RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost, Total Amortization of right of use asset Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Nondeductible expenses Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Cost and Equity Method Investments Disclosure [Text Block] Type of Restructuring [Domain] Employee Severance [Member] Non-current liabilities Restructuring Type [Axis] Cash Flows from Financing Activities: Statutory tax (benefit) expense Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Other long-term liabilities us-gaap_DividendsPayableAmountPerShare Dividends Payable, Amount Per Share (in dollars per share) Proceeds from sales and distributions from ownership interests us-gaap_ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. [Member] Represents WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. Ownership Interest, Other [Member] Represents ownership interest classified as other. Shareholders’ deficit us-gaap_PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments Acquisitions of ownership interests Class of Stock [Axis] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share) 2025 and thereafter Represent net operating loss carryforwards expiring in year five and thereafter. sfe_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumTargetPercentage Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Maximum Target Percentage the maximum target percentage for equity instruments other then options under share based payment arrangement. us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share) 2024 Represents net operating loss carryforwards expiring in year four. EX-101.PRE 14 sfe-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 15 sfe20201231_10k_htm.xml IDEA: XBRL DOCUMENT 0000086115 2020-01-01 2020-12-31 0000086115 2020-06-30 0000086115 2021-02-26 0000086115 2020-12-31 0000086115 2019-12-31 0000086115 2019-01-01 2019-12-31 0000086115 2018-12-31 0000086115 us-gaap:RetainedEarningsMember 2018-12-31 0000086115 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000086115 us-gaap:CommonStockMember 2018-12-31 0000086115 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000086115 us-gaap:TreasuryStockMember 2018-12-31 0000086115 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000086115 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000086115 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000086115 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000086115 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0000086115 us-gaap:RetainedEarningsMember 2019-12-31 0000086115 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000086115 us-gaap:CommonStockMember 2019-12-31 0000086115 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000086115 us-gaap:TreasuryStockMember 2019-12-31 0000086115 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000086115 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000086115 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000086115 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000086115 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000086115 us-gaap:RetainedEarningsMember 2020-12-31 0000086115 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000086115 us-gaap:CommonStockMember 2020-12-31 0000086115 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000086115 us-gaap:TreasuryStockMember 2020-12-31 0000086115 2019-04-30 0000086115 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0000086115 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2020-01-01 0000086115 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201409Member us-gaap:NoncontrollingInterestMember 2020-01-01 0000086115 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201409Member 2020-01-01 2020-12-31 0000086115 srt:PartnershipInterestMember 2020-12-31 0000086115 srt:PartnershipInterestMember 2019-12-31 0000086115 us-gaap:PrivateEquityFundsMember 2020-12-31 0000086115 us-gaap:PrivateEquityFundsMember 2019-12-31 0000086115 sfe:SonobiMember 2020-09-01 2020-09-30 0000086115 sfe:WebLincIncQuanticMindIncAndSonobiIncMember 2020-01-01 2020-12-31 0000086115 sfe:TrexGroupIncMember 2020-01-01 2020-12-31 0000086115 sfe:FlashtalkingIncMember 2020-01-01 2020-12-31 0000086115 sfe:OwnershipInterestOtherMember 2020-01-01 2020-12-31 0000086115 sfe:NovaSomMember 2019-01-01 2019-12-31 0000086115 sfe:PropellerMember 2019-01-01 2019-01-31 0000086115 sfe:PropellerMember 2020-01-01 2020-12-31 0000086115 sfe:TransactisMember 2019-05-01 2019-05-31 0000086115 sfe:HighTractionStageMember 2020-12-31 0000086115 sfe:HighTractionStageMember 2019-12-31 0000086115 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2020-01-01 2020-12-31 0000086115 us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember 2019-01-01 2019-12-31 0000086115 sfe:IntangibleAssetsMember 2020-12-31 0000086115 us-gaap:GoodwillMember 2020-12-31 0000086115 sfe:AktanaIncMember 2020-07-01 2020-09-30 0000086115 sfe:AktanaIncMember 2020-09-30 0000086115 sfe:SyapseIncMember 2020-01-01 2020-06-30 0000086115 sfe:SyapseIncMember 2020-01-01 2020-03-31 0000086115 sfe:SyapseIncMember 2020-06-30 0000086115 sfe:meQuilibriumMember 2020-01-01 2020-03-31 0000086115 sfe:meQuilibriumMember 2020-03-31 0000086115 sfe:TriceMedicalIncMember 2020-01-01 2020-06-30 0000086115 sfe:TriceMedicalIncMember 2020-06-30 0000086115 sfe:ClutchHoldingsMember 2020-04-01 2020-06-30 0000086115 sfe:ClutchHoldingsMember 2020-06-30 0000086115 sfe:QuanticMindMember 2020-01-01 2020-03-31 0000086115 sfe:QuanticMindMember 2020-03-31 0000086115 sfe:WebLincIncMember 2020-01-01 2020-03-31 0000086115 sfe:WebLincIncMember 2020-03-31 0000086115 sfe:SyapseIncMember 2019-01-01 2019-12-31 0000086115 sfe:MoxeHealthCorporationMember 2019-01-01 2019-12-31 0000086115 sfe:MoxeHealthCorporationMember 2019-12-31 0000086115 sfe:AktanaIncMember 2019-01-01 2019-12-31 0000086115 sfe:meQuilibriumMember 2019-01-01 2019-12-31 0000086115 sfe:ZipnosisMember 2019-01-01 2019-12-31 0000086115 sfe:ZipnosisMember 2019-12-31 0000086115 sfe:ClutchHoldingsMember 2019-01-01 2019-12-31 0000086115 sfe:SonobiMember 2019-01-01 2019-12-31 0000086115 sfe:SonobiMember 2019-12-31 0000086115 sfe:WebLincIncMember 2019-01-01 2019-12-31 0000086115 sfe:NovaSomMember 2019-12-31 0000086115 sfe:QuanticMindMember 2019-01-01 2019-12-31 0000086115 sfe:PayableOnTheLastDayOfTheOneTwoOrThreeMonthInterestPeriodMember us-gaap:RevolvingCreditFacilityMember sfe:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-05-31 2018-05-31 0000086115 srt:MinimumMember sfe:PayableOnTheLastDayOfTheOneTwoOrThreeMonthInterestPeriodMember us-gaap:RevolvingCreditFacilityMember sfe:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-05-31 0000086115 srt:MinimumMember sfe:PayableMonthlyInArrearsMember us-gaap:RevolvingCreditFacilityMember sfe:CreditFacilityMember 2018-05-31 0000086115 sfe:PayableMonthlyInArrearsMember us-gaap:RevolvingCreditFacilityMember sfe:CreditFacilityMember 2018-05-31 2018-05-31 0000086115 sfe:PayableMonthlyInArrearsMember us-gaap:RevolvingCreditFacilityMember sfe:CreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2018-05-31 2018-05-31 0000086115 sfe:PayableMonthlyInArrearsMember us-gaap:RevolvingCreditFacilityMember sfe:CreditFacilityMember us-gaap:PrimeRateMember 2018-05-31 2018-05-31 0000086115 sfe:AmendedCreditFacilityMember 2018-12-31 0000086115 sfe:AmendedCreditFacilityMember 2019-04-15 2019-04-15 0000086115 sfe:AmendedCreditFacilityMember 2019-07-31 2019-07-31 0000086115 sfe:AmendedCreditFacilityMember 2018-05-31 0000086115 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0000086115 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-31 0000086115 2015-07-31 0000086115 2018-02-28 0000086115 2019-11-07 0000086115 2019-11-07 2019-11-07 0000086115 sfe:EquityCompensationPlanMember 2020-12-31 0000086115 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0000086115 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0000086115 us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0000086115 us-gaap:PerformanceSharesMember 2019-01-01 2019-12-31 0000086115 us-gaap:PerformanceSharesMember 2020-12-31 0000086115 sfe:ServiceBasedAwardMember 2020-01-01 2020-12-31 0000086115 sfe:ServiceBasedAwardMember 2019-01-01 2019-12-31 0000086115 srt:DirectorMember 2020-01-01 2020-12-31 0000086115 srt:DirectorMember 2020-12-31 0000086115 srt:DirectorMember 2019-12-31 0000086115 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2018-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2019-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2020-12-31 0000086115 sfe:PerformanceStockUnitMember 2020-12-31 0000086115 sfe:PerformanceStockUnitMember 2020-01-01 2020-12-31 0000086115 sfe:PerformanceStockUnitMember 2019-01-01 2019-12-31 0000086115 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000086115 srt:MinimumMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000086115 srt:MaximumMember us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000086115 sfe:DeferredStockUnitsMember 2020-01-01 2020-12-31 0000086115 sfe:DeferredStockUnitsMember 2019-01-01 2019-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2020-01-01 2020-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2019-01-01 2019-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2020-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2018-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2019-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000086115 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2020-01-01 2020-12-31 0000086115 sfe:RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember 2019-01-01 2019-12-31 0000086115 sfe:ConvertibleSeniorDebenturesDue2018Member 2019-01-01 2019-12-31 0000086115 2001-10-31 0000086115 us-gaap:EmployeeSeveranceMember 2020-12-31 0000086115 srt:MinimumMember 2020-01-01 2020-12-31 0000086115 srt:MinimumMember 2019-01-01 2019-12-31 0000086115 srt:MaximumMember 2020-01-01 2020-12-31 0000086115 sfe:AktanaIncMember 2020-12-31 0000086115 sfe:AktanaIncMember 2019-12-31 0000086115 sfe:ClutchHoldingsMember 2020-12-31 0000086115 sfe:ClutchHoldingsMember 2019-12-31 0000086115 sfe:FlashtalkingIncMember 2020-12-31 0000086115 sfe:FlashtalkingIncMember 2019-12-31 0000086115 sfe:InfoBionicIncMember 2020-12-31 0000086115 sfe:InfoBionicIncMember 2019-12-31 0000086115 sfe:LumesisIncMember 2020-12-31 0000086115 sfe:LumesisIncMember 2019-12-31 0000086115 sfe:MediaMathIncMember 2020-12-31 0000086115 sfe:MediaMathIncMember 2019-12-31 0000086115 sfe:meQuilibriumMember 2020-12-31 0000086115 sfe:meQuilibriumMember 2019-12-31 0000086115 sfe:MoxeHealthCorporationMember 2020-12-31 0000086115 sfe:PrognosHealthIncMember 2020-12-31 0000086115 sfe:PrognosHealthIncMember 2019-12-31 0000086115 sfe:QuanticMindMember 2020-12-31 0000086115 sfe:QuanticMindMember 2019-12-31 0000086115 sfe:SyapseIncMember 2020-12-31 0000086115 sfe:SyapseIncMember 2019-12-31 0000086115 sfe:TrexGroupIncMember 2020-12-31 0000086115 sfe:TrexGroupIncMember 2019-12-31 0000086115 sfe:TriceMedicalIncMember 2020-12-31 0000086115 sfe:TriceMedicalIncMember 2019-12-31 0000086115 sfe:WebLincIncMember 2020-12-31 0000086115 sfe:WebLincIncMember 2019-12-31 0000086115 sfe:ZipnosisMember 2020-12-31 0000086115 2020-01-01 2020-03-31 0000086115 2020-04-01 2020-06-30 0000086115 2020-07-01 2020-09-30 0000086115 2020-10-01 2020-12-31 0000086115 2019-01-01 2019-03-31 0000086115 2019-04-01 2019-06-30 0000086115 2019-07-01 2019-09-30 0000086115 2019-10-01 2019-12-31 0000086115 sfe:EquityMethodInvestmentIncomeAdjustmentMember 2019-10-01 2019-12-31 0000086115 sfe:WebLincIncMember us-gaap:SubsequentEventMember 2021-01-01 2021-01-31 0000086115 sfe:QuanticMindMember us-gaap:SubsequentEventMember 2021-01-01 2021-01-31 0000086115 us-gaap:SubsequentEventMember sfe:SyapseIncMember 2021-02-01 2021-02-28 0000086115 sfe:SyapseIncMember us-gaap:SubsequentEventMember 2021-02-28 iso4217:USD shares thunderdome:item iso4217:USD shares pure utr:M utr:Y 0000086115 SAFEGUARD SCIENTIFICS INC false --12-31 FY 2020 0.10 0.10 1000000 1000000 0.10 0.10 83333000 83333000 21573000 21573000 688000 930000 500000 600000 -1800000 0.02 0.005 0.01 0 0 1 0 0 0 P4Y P8Y 0 0.0 0 0 P2Y P4Y P1Y 0.0 0.210 0 0.0 10-K true 2020-12-31 false 1-5620 PA 23-1609753 150 N. Radnor Chester Road Radnor PA 19087 610 293-0600 Common Stock ($.10 par value) SFE NYSE No No Yes Yes true Non-accelerated Filer false false 136021431 20944305 15601000 25028000 0 25000 462000 1297000 16063000 26350000 1790000 2101000 50398000 77129000 784000 1997000 69035000 107577000 56000 39000 2677000 1364000 410000 627000 327000 399000 3470000 2429000 637000 1027000 2053000 2380000 6160000 5836000 0 0 2157000 2157000 807582000 810856000 10200000 14024000 -736639000 -697223000 -25000 -25000 62875000 101741000 69035000 107577000 9466000 9982000 -9466000 -9982000 -7708000 12255000 261000 2044000 -0 14023000 -20702000 64267000 -37615000 54561000 0 0 -37615000 54561000 -1.81 2.64 -1.81 2.64 20751000 20636000 20751000 20636000 -37615000 54561000 0 -31000 0 6000 -37615000 54536000 66979000 -731105000 0 21573000 2157000 810928000 914000 -15001000 54561000 54561000 0 0 0 0 -236000 0 0 0 0 -1213000 16000 977000 1141000 0 0 0 1141000 0 -25000 0 -25000 0 0 0 20679000 20679000 -0 -0 -0 -0 101741000 -697223000 -25000 21573000 2157000 810856000 930000 -14024000 -37615000 -37615000 0 0 0 0 -40000 0 0 0 0 -3864000 -242000 3824000 590000 0 0 0 590000 0 -1801000 -1801000 0 0 0 0 62875000 -736639000 -25000 21573000 2157000 807582000 688000 -10200000 -37615000 54561000 0 808000 0 3454000 311000 260000 -9420000 67232000 -20039000 -3012000 -0 5060000 1224000 4526000 -175000 2315000 965000 1237000 137000 823000 -77000 -3346000 -8143000 -19970000 7534000 11640000 7903000 104302000 1638000 5055000 0 750000 -0 57243000 0 95189000 -1269000 126303000 -0 20679000 -0 68568000 40000 236000 -40000 -89483000 -9452000 16850000 25053000 8203000 15601000 25053000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">1.</em> General</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><b>Liquidity And Capital Resources </b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">As of <em style="font: inherit;"> December 31, 2020</em>, Safeguard ("the Company") had $15.6 million of cash and cash equivalents.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In <em style="font: inherit;"> January 2018, </em>Safeguard announced that, from that date forward, the Company will <em style="font: inherit;">not</em> deploy any capital into new opportunities and will focus on supporting our existing companies and maximizing monetization opportunities to return value to shareholders. In that context, the Company has, are and will consider initiatives including, among others: the sale of individual ownership interests, the sale of certain or all ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company believes that its cash and cash equivalents at <em style="font: inherit;"> December 31, 2020</em> will be sufficient to fund operations past <em style="font: inherit;">one</em> year from the issuance of these consolidated financial statements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Significant Accounting Policies</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Principles of Consolidation</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The consolidated financial statements include the accounts of Safeguard and all of its subsidiaries in which a controlling financial interest is maintained. All intercompany accounts and transactions are eliminated in consolidation.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Principles of Accounting for Ownership Interests in Companies</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company accounts for its ownership interests using <em style="font: inherit;">one</em> of the following methods: Equity or Other. The accounting method applied is generally determined by the degree of the Company's influence over the entity, primarily determined by our voting interest in the entity.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In addition to holding voting and non-voting equity and debt securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"><i>Equity Method.</i> The Company accounts for ownership interests whose results are <em style="font: inherit;">not</em> consolidated, but over which it exercises significant influence, under the equity method of accounting. Whether or <em style="font: inherit;">not</em> the Company exercises significant influence with respect to an ownership interest depends on an evaluation of several factors including, among others, representation on the board of directors and our ownership level, which is generally a <em style="font: inherit;">20%</em> to <em style="font: inherit;">50%</em> interest in the voting securities of a company, including voting rights associated with the Company’s holdings in common, preferred and other convertible instruments in the company. Under the equity method of accounting, the Company does <em style="font: inherit;">not</em> reflect a company’s financial statements within our Consolidated Financial Statements; however, our share of the income or loss of such company is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The Company includes the carrying value of equity method companies in Ownership interests and advances on the Consolidated Balance Sheets. Any excess of the Company’s cost over its underlying interest in the net assets of equity method companies that is allocated to intangible assets is amortized over the estimated useful lives of the related intangible assets. The Company reflects its share of the income or loss of the equity method companies on a <em style="font: inherit;">one</em> quarter lag. This reporting lag could result in a delay in recognition of the impact of changes in the business or operations of these companies.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">When the Company’s carrying value in an equity method company is reduced to zero, the Company records <em style="font: inherit;">no</em> further losses in its Consolidated Statements of Operations unless the Company has an outstanding guarantee obligation or has committed additional funding to such equity method company. When such equity method company subsequently reports income, the Company will <em style="font: inherit;">not</em> record its share of such income until it exceeds the amount of the Company’s share of losses <em style="font: inherit;">not</em> previously recognized.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"><i>Other Method. </i>We account for our equity interests in companies which are <em style="font: inherit;">not</em> accounted for under the equity method as equity securities without readily determinable fair values. We estimate the fair value of these securities based on our original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Under this method, our share of the income or losses of such companies is <em style="font: inherit;">not</em> included in our Consolidated Statements of Operations. We include the carrying value of these investments in Ownership interests and advances on the Consolidated Balance Sheets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Accounting Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results <em style="font: inherit;"> may </em>differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and <em style="font: inherit;"> may </em>require adjustments in the future when audits of these entities’ financial statements are completed.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At <em style="font: inherit;"> December 31, 2020</em>, the Company believes the carrying value of the Company’s ownership interests and advances is <em style="font: inherit;">not</em> impaired, although there can be <em style="font: inherit;">no</em> assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will <em style="font: inherit;">not</em> be required in the future or that a significant loss will <em style="font: inherit;">not</em> be recorded in the future upon the sale of a company.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Cash and Cash Equivalents and Marketable Securities</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company considers all highly liquid instruments with an original maturity of <em style="font: inherit;">90</em> days or less at the time of purchase to be cash equivalents. Cash and cash equivalents consist of deposits that are readily convertible into cash. The Company determines the appropriate classification of marketable securities at the time of purchase and reevaluates such designation as of each balance sheet date. Held-to-maturity securities were carried at amortized cost, which approximated fair value. Marketable securities consisted of held-to-maturity securities, primarily consisting of government agency bonds, commercial paper and certificates of deposits. Marketable securities with a maturity date greater than <em style="font: inherit;">one</em> year from the balance sheet date would be considered long-term. The Company has <em style="font: inherit;">not</em> experienced any significant losses on cash equivalents and does <em style="font: inherit;">not</em> believe it is exposed to any significant credit risk on cash and cash equivalents.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Restricted Cash </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;">Restricted cash equivalents represents cash required to be set aside by a contractual agreement as a shareholder representative. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash and cash equivalents</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15,601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Restricted cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total cash, cash equivalents and restricted cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">25,053</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Financial Instruments</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company’s financial instruments (principally cash and cash equivalents, marketable securities, accounts receivable, notes receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Property and Equipment</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Property and equipment represents right-of-use assets resulting from the adoption of Accounting Standards Update ("ASU") <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">02,</em> <i>Leases</i>, and other previously existing leasehold improvements. The leasehold improvements were amortized over the shorter of the estimated useful lives or the expected remaining term of the lease. The right-of-use assets are reduced over the remaining term of the applicable lease (principally <em style="font: inherit;"> April 2026) </em>in a manner that results in a straight-line lease expense, when combined with the interest factor on the lease liability. <b>    </b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"><i><b>Lease liability</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The initial lease liability represents the present value of the fixed escalating lease payments through <em style="font: inherit;"> April 2026 </em>associated with the Company's prior corporate headquarters operating office lease. The discount rate used to calculate the lease liability was based on the Company's incremental borrowing rate, approximately 12%, at the transition to the guidance of ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">02,</em> <i>Leases</i>. Subsequent values of the lease liability reflect the reduction in the lease liability for operating lease payments less an amount representing interest, which is included in the straight-line lease expense. There is <em style="font: inherit;">no</em> residual value guarantee associated with this operating lease arrangement. The Company has incurred operating lease expenses and operating cash outflows of $0.5 million for each of the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, and $0.6 million for each of the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> March 2019, </em>the Company entered into a sublease of its prior corporate headquarters office space. The term of the sublease is through <em style="font: inherit;"> April 2026, </em>the same as the Company's underlying lease. Fixed sublease payments to the Company are escalating over the term of the sublease and are reported as a component of general and administrative expenses.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> April 2019, </em>the Company entered into a sublease for replacement office space with a related party, an equity method ownership interest, beginning in <em style="font: inherit;"> June 2019. </em>The 18 month term of this sublease expired in <em style="font: inherit;">2020.</em> The aggregate payments under this sublease were <em style="font: inherit;">not</em> material.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">A summary of the Company's operating lease cash flows at <em style="font: inherit;"> December 31, 2020</em> follows:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Operating lease payments</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Expected sublease receipts</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">595</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">525</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">540</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">607</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">556</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">613</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">573</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">619</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">590</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">208</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total future minimum lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,243</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,983</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less imputed interest</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(863</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total operating lease liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,380</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 12pt;"><i><b/></i></p><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 12pt;"><i><b>Valuation of Credit Facility repayment feature</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The fair value of the Credit Facility repayment feature (a Level <em style="font: inherit;">3</em> measurement) was determined quarterly based on the present value of make-whole interest payments that were expected to be paid based on cash flow estimates that included a probability weighted estimate of exit transactions, estimated follow-on deployments, estimated quarterly operating cash flows and other cash commitments that would have resulted in qualified cash exceeding the $50 million threshold specified in the Credit Facility. This fair value of the Credit Facility repayment feature was eliminated in <em style="font: inherit;"> July 2019 </em>upon the repayment of the Credit Facility.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Impairment of Ownership Interests and Advances </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">On a periodic basis, but <em style="font: inherit;">no</em> less frequently than quarterly, the Company evaluates the carrying value of its ownership interests and advances for possible impairment based on achievement of business plan objectives and milestones, the estimated fair value of each company relative to its carrying value, the financial condition and prospects of the company and other relevant factors. The business plan objectives and milestones the Company considers include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are <em style="font: inherit;">not</em> primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The estimated fair value of privately held companies is generally determined based on the value at which independent <em style="font: inherit;">third</em> parties have invested or have committed to invest in these companies or based on other valuation methods, including discounted cash flows, valuation of comparable public companies and the valuation of acquisitions of similar companies.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies and funds are included in Other income (loss), net in the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The reduced cost basis of a previously impaired company accounted for using the Equity method are <em style="font: inherit;">not</em> written-up if circumstances suggest the value of the company has subsequently recovered.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Income Taxes</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company accounts for income taxes under the asset and liability method whereby deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates in effect for the year in which the temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period of the enactment date. The Company provides a valuation allowance against the net deferred tax asset for amounts which are <em style="font: inherit;">not</em> considered more likely than <em style="font: inherit;">not</em> to be realized.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Net Income (Loss) Per Share</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company computes net income (loss) per share using the weighted average number of common shares outstanding during each year. The Company includes in diluted net income (loss) per share common stock equivalents (unless anti-dilutive) which would arise from the exercise of stock options and conversion of other convertible securities and adjusted, if applicable, for the effect on net income (loss) of such transactions. Diluted net income (loss) per share calculations adjust net income (loss) for the dilutive effect of common stock equivalents and convertible securities issued by the Company’s consolidated or equity method companies.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Segment Information</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company operates as <em style="font: inherit;">one</em> operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p><p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b/></i></p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Recently Adopted Accounting Pronouncements</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> May 2014, </em>the Financial Accounting Standards Board ("FASB") issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2014</em>-<em style="font: inherit;">09,</em> <i>Revenue from Contracts with Customers (Topic <em style="font: inherit;">606</em>) </i>("ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09"</em>). ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09</em> and related subsequent amendments outline a single comprehensive model to use to account for revenue arising from contracts with customers and supersede most current revenue recognition guidance. For public companies, the guidance was effective for annual periods beginning after <em style="font: inherit;"> December 15, 2017 </em>and any interim periods that fall within that reporting period. For nonpublic companies, the guidance is effective for annual periods beginning after <em style="font: inherit;"> December 15, 2018 </em>and interim periods within annual periods beginning after <em style="font: inherit;"> December 15, 2019 </em>with early adoption permitted. Additionally, on <em style="font: inherit;"> June 3, 2020 </em>the FASB issued ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">05,</em> which extended the adoption of ASC <em style="font: inherit;">606</em> for all nonpublic business entities that have <em style="font: inherit;">not</em> issued their <em style="font: inherit;">2019</em> financial statements as of <em style="font: inherit;"> June 3, 2020, </em>until <em style="font: inherit;"> January 1, 2020.</em></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">As the new standard superseded most existing revenue guidance, it impacted revenue and cost recognition for companies in which we hold an ownership interest. Any change in revenue or cost recognition for companies in which we hold an ownership interest could affect the Company's recognition of its share of the results of its equity method companies. On <em style="font: inherit;"> July 20, 2017, </em>the SEC staff observer at the FASB’s Emerging Issues Task Force ("EITF") meeting announced that the SEC staff will <em style="font: inherit;">not</em> object if a private company equity method investee meeting the definition of a public business entity that otherwise would <em style="font: inherit;">not</em> meet the definition of a public business entity except for the inclusion of its financial statements or financial information in another entity’s filings with the SEC, uses private company adoption dates for the new revenue standard.  As a result, the Company's private, calendar year companies adopted the new revenue standard for the year ending <em style="font: inherit;"> December 31, 2019, </em>including a cumulative effect where applicable as of the <em style="font: inherit;">first</em> day of the <em style="font: inherit;">2019</em> reporting period. </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">For our ownership interests that have adopted ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09,</em> the impact of adoption of the new revenue standard is reflected in the Company’s financial results for the interim and annual reporting periods beginning in <em style="font: inherit;">2020</em> on a <em style="font: inherit;">one</em> quarter-lag basis.  The impact upon adoption resulted in an increase in accumulated deficit and a decrease in ownership interests of $1.8 million, net, due to the deferral of revenue and certain costs at our underlying ownership interests.  Our results of operations for the year ended <em style="font: inherit;"> December 31, 2020 </em>reflect a benefit of $1.8 million due primarily to the recognition of revenue in <em style="font: inherit;">2019</em> that was previously deferred as a result of the adoption of ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09.</em>  Accordingly, the cumulative impact of the adoption of ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09</em> was <em style="font: inherit;">not</em> significant. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> 15600000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Principles of Consolidation</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The consolidated financial statements include the accounts of Safeguard and all of its subsidiaries in which a controlling financial interest is maintained. All intercompany accounts and transactions are eliminated in consolidation.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Principles of Accounting for Ownership Interests in Companies</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company accounts for its ownership interests using <em style="font: inherit;">one</em> of the following methods: Equity or Other. The accounting method applied is generally determined by the degree of the Company's influence over the entity, primarily determined by our voting interest in the entity.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In addition to holding voting and non-voting equity and debt securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"><i>Equity Method.</i> The Company accounts for ownership interests whose results are <em style="font: inherit;">not</em> consolidated, but over which it exercises significant influence, under the equity method of accounting. Whether or <em style="font: inherit;">not</em> the Company exercises significant influence with respect to an ownership interest depends on an evaluation of several factors including, among others, representation on the board of directors and our ownership level, which is generally a <em style="font: inherit;">20%</em> to <em style="font: inherit;">50%</em> interest in the voting securities of a company, including voting rights associated with the Company’s holdings in common, preferred and other convertible instruments in the company. Under the equity method of accounting, the Company does <em style="font: inherit;">not</em> reflect a company’s financial statements within our Consolidated Financial Statements; however, our share of the income or loss of such company is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The Company includes the carrying value of equity method companies in Ownership interests and advances on the Consolidated Balance Sheets. Any excess of the Company’s cost over its underlying interest in the net assets of equity method companies that is allocated to intangible assets is amortized over the estimated useful lives of the related intangible assets. The Company reflects its share of the income or loss of the equity method companies on a <em style="font: inherit;">one</em> quarter lag. This reporting lag could result in a delay in recognition of the impact of changes in the business or operations of these companies.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">When the Company’s carrying value in an equity method company is reduced to zero, the Company records <em style="font: inherit;">no</em> further losses in its Consolidated Statements of Operations unless the Company has an outstanding guarantee obligation or has committed additional funding to such equity method company. When such equity method company subsequently reports income, the Company will <em style="font: inherit;">not</em> record its share of such income until it exceeds the amount of the Company’s share of losses <em style="font: inherit;">not</em> previously recognized.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"><i>Other Method. </i>We account for our equity interests in companies which are <em style="font: inherit;">not</em> accounted for under the equity method as equity securities without readily determinable fair values. We estimate the fair value of these securities based on our original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Under this method, our share of the income or losses of such companies is <em style="font: inherit;">not</em> included in our Consolidated Statements of Operations. We include the carrying value of these investments in Ownership interests and advances on the Consolidated Balance Sheets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Accounting Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results <em style="font: inherit;"> may </em>differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and <em style="font: inherit;"> may </em>require adjustments in the future when audits of these entities’ financial statements are completed.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At <em style="font: inherit;"> December 31, 2020</em>, the Company believes the carrying value of the Company’s ownership interests and advances is <em style="font: inherit;">not</em> impaired, although there can be <em style="font: inherit;">no</em> assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will <em style="font: inherit;">not</em> be required in the future or that a significant loss will <em style="font: inherit;">not</em> be recorded in the future upon the sale of a company.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Cash and Cash Equivalents and Marketable Securities</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company considers all highly liquid instruments with an original maturity of <em style="font: inherit;">90</em> days or less at the time of purchase to be cash equivalents. Cash and cash equivalents consist of deposits that are readily convertible into cash. The Company determines the appropriate classification of marketable securities at the time of purchase and reevaluates such designation as of each balance sheet date. Held-to-maturity securities were carried at amortized cost, which approximated fair value. Marketable securities consisted of held-to-maturity securities, primarily consisting of government agency bonds, commercial paper and certificates of deposits. Marketable securities with a maturity date greater than <em style="font: inherit;">one</em> year from the balance sheet date would be considered long-term. The Company has <em style="font: inherit;">not</em> experienced any significant losses on cash equivalents and does <em style="font: inherit;">not</em> believe it is exposed to any significant credit risk on cash and cash equivalents.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Restricted Cash </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;">Restricted cash equivalents represents cash required to be set aside by a contractual agreement as a shareholder representative. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash and cash equivalents</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15,601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Restricted cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total cash, cash equivalents and restricted cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">25,053</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash and cash equivalents</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15,601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Restricted cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">25</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total cash, cash equivalents and restricted cash</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">15,601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">25,053</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 15601000 25028000 0 25000 15601000 25053000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Financial Instruments</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company’s financial instruments (principally cash and cash equivalents, marketable securities, accounts receivable, notes receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Property and Equipment</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Property and equipment represents right-of-use assets resulting from the adoption of Accounting Standards Update ("ASU") <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">02,</em> <i>Leases</i>, and other previously existing leasehold improvements. The leasehold improvements were amortized over the shorter of the estimated useful lives or the expected remaining term of the lease. The right-of-use assets are reduced over the remaining term of the applicable lease (principally <em style="font: inherit;"> April 2026) </em>in a manner that results in a straight-line lease expense, when combined with the interest factor on the lease liability. <b>    </b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"><i><b>Lease liability</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The initial lease liability represents the present value of the fixed escalating lease payments through <em style="font: inherit;"> April 2026 </em>associated with the Company's prior corporate headquarters operating office lease. The discount rate used to calculate the lease liability was based on the Company's incremental borrowing rate, approximately 12%, at the transition to the guidance of ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">02,</em> <i>Leases</i>. Subsequent values of the lease liability reflect the reduction in the lease liability for operating lease payments less an amount representing interest, which is included in the straight-line lease expense. There is <em style="font: inherit;">no</em> residual value guarantee associated with this operating lease arrangement. The Company has incurred operating lease expenses and operating cash outflows of $0.5 million for each of the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, and $0.6 million for each of the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> March 2019, </em>the Company entered into a sublease of its prior corporate headquarters office space. The term of the sublease is through <em style="font: inherit;"> April 2026, </em>the same as the Company's underlying lease. Fixed sublease payments to the Company are escalating over the term of the sublease and are reported as a component of general and administrative expenses.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> April 2019, </em>the Company entered into a sublease for replacement office space with a related party, an equity method ownership interest, beginning in <em style="font: inherit;"> June 2019. </em>The 18 month term of this sublease expired in <em style="font: inherit;">2020.</em> The aggregate payments under this sublease were <em style="font: inherit;">not</em> material.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">A summary of the Company's operating lease cash flows at <em style="font: inherit;"> December 31, 2020</em> follows:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Operating lease payments</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Expected sublease receipts</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">595</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">525</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">540</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">607</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">556</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">613</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">573</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">619</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">590</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">208</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total future minimum lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,243</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,983</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less imputed interest</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(863</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total operating lease liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,380</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> 0.12 500000 600000 P18M <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Operating lease payments</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Expected sublease receipts</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">595</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">525</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">601</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">540</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">607</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">556</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">613</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">573</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">619</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">590</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2026</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">208</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total future minimum lease payments</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,243</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,983</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less imputed interest</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(863</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total operating lease liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,380</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> </tbody></table> 595000 525000 601000 540000 607000 556000 613000 573000 619000 590000 208000 199000 0 0 3243000 2983000 863000 2380000 <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 12pt;"><i><b>Valuation of Credit Facility repayment feature</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The fair value of the Credit Facility repayment feature (a Level <em style="font: inherit;">3</em> measurement) was determined quarterly based on the present value of make-whole interest payments that were expected to be paid based on cash flow estimates that included a probability weighted estimate of exit transactions, estimated follow-on deployments, estimated quarterly operating cash flows and other cash commitments that would have resulted in qualified cash exceeding the $50 million threshold specified in the Credit Facility. This fair value of the Credit Facility repayment feature was eliminated in <em style="font: inherit;"> July 2019 </em>upon the repayment of the Credit Facility.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> 50000000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Impairment of Ownership Interests and Advances </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">On a periodic basis, but <em style="font: inherit;">no</em> less frequently than quarterly, the Company evaluates the carrying value of its ownership interests and advances for possible impairment based on achievement of business plan objectives and milestones, the estimated fair value of each company relative to its carrying value, the financial condition and prospects of the company and other relevant factors. The business plan objectives and milestones the Company considers include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are <em style="font: inherit;">not</em> primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The estimated fair value of privately held companies is generally determined based on the value at which independent <em style="font: inherit;">third</em> parties have invested or have committed to invest in these companies or based on other valuation methods, including discounted cash flows, valuation of comparable public companies and the valuation of acquisitions of similar companies.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies and funds are included in Other income (loss), net in the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The reduced cost basis of a previously impaired company accounted for using the Equity method are <em style="font: inherit;">not</em> written-up if circumstances suggest the value of the company has subsequently recovered.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Income Taxes</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company accounts for income taxes under the asset and liability method whereby deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates in effect for the year in which the temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period of the enactment date. The Company provides a valuation allowance against the net deferred tax asset for amounts which are <em style="font: inherit;">not</em> considered more likely than <em style="font: inherit;">not</em> to be realized.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Net Income (Loss) Per Share</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company computes net income (loss) per share using the weighted average number of common shares outstanding during each year. The Company includes in diluted net income (loss) per share common stock equivalents (unless anti-dilutive) which would arise from the exercise of stock options and conversion of other convertible securities and adjusted, if applicable, for the effect on net income (loss) of such transactions. Diluted net income (loss) per share calculations adjust net income (loss) for the dilutive effect of common stock equivalents and convertible securities issued by the Company’s consolidated or equity method companies.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Segment Information</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company operates as <em style="font: inherit;">one</em> operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Recently Adopted Accounting Pronouncements</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> May 2014, </em>the Financial Accounting Standards Board ("FASB") issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2014</em>-<em style="font: inherit;">09,</em> <i>Revenue from Contracts with Customers (Topic <em style="font: inherit;">606</em>) </i>("ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09"</em>). ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09</em> and related subsequent amendments outline a single comprehensive model to use to account for revenue arising from contracts with customers and supersede most current revenue recognition guidance. For public companies, the guidance was effective for annual periods beginning after <em style="font: inherit;"> December 15, 2017 </em>and any interim periods that fall within that reporting period. For nonpublic companies, the guidance is effective for annual periods beginning after <em style="font: inherit;"> December 15, 2018 </em>and interim periods within annual periods beginning after <em style="font: inherit;"> December 15, 2019 </em>with early adoption permitted. Additionally, on <em style="font: inherit;"> June 3, 2020 </em>the FASB issued ASU <em style="font: inherit;">2020</em>-<em style="font: inherit;">05,</em> which extended the adoption of ASC <em style="font: inherit;">606</em> for all nonpublic business entities that have <em style="font: inherit;">not</em> issued their <em style="font: inherit;">2019</em> financial statements as of <em style="font: inherit;"> June 3, 2020, </em>until <em style="font: inherit;"> January 1, 2020.</em></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">As the new standard superseded most existing revenue guidance, it impacted revenue and cost recognition for companies in which we hold an ownership interest. Any change in revenue or cost recognition for companies in which we hold an ownership interest could affect the Company's recognition of its share of the results of its equity method companies. On <em style="font: inherit;"> July 20, 2017, </em>the SEC staff observer at the FASB’s Emerging Issues Task Force ("EITF") meeting announced that the SEC staff will <em style="font: inherit;">not</em> object if a private company equity method investee meeting the definition of a public business entity that otherwise would <em style="font: inherit;">not</em> meet the definition of a public business entity except for the inclusion of its financial statements or financial information in another entity’s filings with the SEC, uses private company adoption dates for the new revenue standard.  As a result, the Company's private, calendar year companies adopted the new revenue standard for the year ending <em style="font: inherit;"> December 31, 2019, </em>including a cumulative effect where applicable as of the <em style="font: inherit;">first</em> day of the <em style="font: inherit;">2019</em> reporting period. </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">For our ownership interests that have adopted ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09,</em> the impact of adoption of the new revenue standard is reflected in the Company’s financial results for the interim and annual reporting periods beginning in <em style="font: inherit;">2020</em> on a <em style="font: inherit;">one</em> quarter-lag basis.  The impact upon adoption resulted in an increase in accumulated deficit and a decrease in ownership interests of $1.8 million, net, due to the deferral of revenue and certain costs at our underlying ownership interests.  Our results of operations for the year ended <em style="font: inherit;"> December 31, 2020 </em>reflect a benefit of $1.8 million due primarily to the recognition of revenue in <em style="font: inherit;">2019</em> that was previously deferred as a result of the adoption of ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09.</em>  Accordingly, the cumulative impact of the adoption of ASU <em style="font: inherit;">2014</em>-<em style="font: inherit;">09</em> was <em style="font: inherit;">not</em> significant. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> 1800000 1800000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">2.</em> Ownership Interests and Advances </b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The following summarizes the carrying value of the Company’s ownership interests and advances.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Equity Method:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Companies</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,550</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">34,271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Private equity funds</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,821</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">34,542</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other Method:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Companies</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">19,683</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,031</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Private equity funds</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">268</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">453</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">19,951</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,484</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Advances to companies (equity method)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,626</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15,103</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">50,398</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">77,129</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">In <em style="font: inherit;"> September 2020, </em>Sonobi, Inc. was acquired by another entity for cash. The Company received $6.6 million in cash proceeds in connection with this transaction, excluding holdbacks and escrows. The Company recognized an insignificant gain on the sale, which is included in Equity income (loss), net in the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company recorded impairments of $11.3 million related to the ownership interests of WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. accounted for under the equity method, which are reflected in Equity income (loss), net in the Consolidated Statement of Operations.  During the year ended <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2020,</em> the Company also recorded impairments of $8.8 million related to the ownership interests of T-REX Group, Inc., <em style="font: inherit;">b8ta</em> and others accounted for under the Other method, which are reflected in Other income (loss), net in the Consolidated Statement of Operations. The impairments were determined based on declines in the fair value of our ownership interests resulting from reduced valuation expectations and extended exit timelines resulting from the more challenging mergers and acquisitions environment related to COVID-<em style="font: inherit;">19</em> and the related uncertain economic impact. The measurement of fair value for these impairments was estimated based on evaluating several valuation inputs available for each of the applicable ownership interests, primarily including the value at which independent <em style="font: inherit;">third</em> parties have invested, the valuation of comparable public companies, the valuation of acquisitions of similar companies and the present value of our expected outcomes. Assumptions considered within these methods include determining which public companies are comparable, projecting forward revenues for the measured ownership interest, discounts to apply for the lack of marketability or lack of comparability, other factors and the relative weight to apply to each valuation input available. Due to the unobservable nature of some of these inputs, we have determined these fair value estimates to be non-recurring Level <em style="font: inherit;">3</em> fair value measurements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company recorded a $1.5 million non-cash gain based upon an observable price change related to our ownership interest in Flashtalking Inc. accounted for under the Other method, which is reflected in Other income (loss), net in the Consolidated Statement of Operations. During the year ended <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2020,</em> the Company also recorded a $0.3 million non-cash Other loss based on an observable price change for another ownership interest accounted for under the Other method.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">During <em style="font: inherit;">2019,</em> the Company recognized an impairment of $3.0 million related to NovaSom, which is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The impairment was the result of NovaSom Inc.'s <em style="font: inherit;"> August 2019 </em>bankruptcy filing.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> January 2019, </em>Propeller was acquired by another entity for cash. The Company received $41.5 million in cash proceeds in connection with the transaction, and $0.7 million in <em style="font: inherit;">2020</em> for amounts held in escrow. The Company recognized a gain of $35.1 million, which is included in Equity income (loss), net in the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> January 2019, </em>Brickwork merged into another privately-held company. The Company received a preferred equity interest in the acquiror and accounts for this interest as an equity interest without a readily determinable fair value. The Company did <em style="font: inherit;">not</em> recognize a gain or loss in <em style="font: inherit;">2019</em> as a result of this transaction.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> May 2019, </em>Transactis was acquired by another entity for cash. To date, the Company received $57.5 million in cash proceeds in connection with the transaction, excluding certain amounts that continue to be held in escrow that <em style="font: inherit;"> may </em>be released on various dates on or before <em style="font: inherit;"> May 2020. </em>The Company has recognized gains of $50.7 million, which are included in Equity income (loss), net in the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">During <em style="font: inherit;">2019,</em> the Company ceased accounting for T-REX Group, Inc. and Hoopla Software, Inc. under the equity method as a result of losing our ability to exercise significant influence.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.75pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">During <em style="font: inherit;">2019,</em> the Company recorded $4.5 million of non-cash gains in Other income (loss), net related to the increase in the value of certain equity securities based upon observable price changes.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:12pt;"><i><b>Summarized Financial Information </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The following table provides summarized financial information for ownership interests accounted for under the equity method for the periods presented and has been compiled from respective company financial statements, reflect certain historical adjustments, and are reported on a <em style="font: inherit;">one</em> quarter lag. Results of operations are excluded for periods prior to their acquisition and subsequent to their disposition. Historical results are <em style="font: inherit;">not</em> adjusted when the Company exits or writes-off a company. </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24.75pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">As of December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Balance Sheets:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">104,024</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">91,968</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-current assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">26,352</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">26,231</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">130,376</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">118,199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,972</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">80,783</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-current liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">105,506</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">87,081</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Shareholders’ deficit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(48,102</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(49,665</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total liabilities and shareholders’ deficit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">130,376</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">118,199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Number of equity method ownership interests</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Results of Operations:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revenue</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">153,875</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">145,632</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Gross profit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">92,039</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">78,465</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(82,216</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(127,007</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">As of <em style="font: inherit;"> December 31, 2020</em>, the Company’s carrying value in equity method companies, in the aggregate, exceeded the Company’s share of the net assets of such companies by approximately $17.9 million. Of this excess, $15.0 million was allocated to goodwill and $2.9 million was allocated to intangible assets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31, 2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Equity Method:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Companies</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,550</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">34,271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Private equity funds</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">271</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,821</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">34,542</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other Method:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Companies</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">19,683</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,031</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Private equity funds</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">268</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">453</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">19,951</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27,484</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Advances to companies (equity method)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,626</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">15,103</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">50,398</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">77,129</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 27550000 34271000 271000 271000 27821000 34542000 19683000 27031000 268000 453000 19951000 27484000 2626000 15103000 50398000 77129000 6600000 11300000 8800000 1500000 300000 3000000.0 41500000 700000 35100000 57500000 50700000 4500000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">As of December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Balance Sheets:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">104,024</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">91,968</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-current assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">26,352</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">26,231</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total assets</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">130,376</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">118,199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,972</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">80,783</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-current liabilities</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">105,506</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">87,081</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Shareholders’ deficit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(48,102</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(49,665</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total liabilities and shareholders’ deficit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">130,376</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">118,199</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Number of equity method ownership interests</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 104024000 91968000 26352000 26231000 130376000 118199000 72972000 80783000 105506000 87081000 -48102000 -49665000 130376000 118199000 12 13 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Results of Operations:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revenue</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">153,875</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">145,632</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Gross profit</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">92,039</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">78,465</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(82,216</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(127,007</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> </tbody></table> 153875000 145632000 92039000 78465000 -82216000 -127007000 17900000 15000000.0 2900000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">3.</em> Acquisitions of Ownership Interests </b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><em style="font: inherit;">2020</em> Transactions</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">The Company deployed an additional $2.5 million to Aktana, Inc. during the <em style="font: inherit;">three</em> month period ended <em style="font: inherit;"> September 30, 2020. </em>The Company had previously deployed an aggregate of $11.7 million. Aktana leverages big data and machine learning to enable pharmaceutical brands to dynamically optimize their strategy and<br/> enhance sales execution.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 36pt;"><br/>        The Company deployed an additional $4.4 million to Syapse, Inc. during the <em style="font: inherit;">six</em> month period ended <em style="font: inherit;"> June 30, 2020, </em>including the $0.6 million of convertible loans deployed in the <em style="font: inherit;">first</em> quarter of <em style="font: inherit;">2020</em> which was converted to equity in the <em style="font: inherit;">second</em> quarter. The Company had previously deployed $20.6 million. Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 36pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">The Company deployed an additional $1.0 million to meQuilibrium during the <em style="font: inherit;">three</em> month period ended <em style="font: inherit;"> March 31, 2020. </em>The Company had previously deployed an aggregate of $13.0 million. meQuilibrium is a digital coaching platform that delivers clinically validated and highly personalized resilience solutions to employers, health plans, wellness providers, and consumers increasing engagement, productivity and performance, as well as improving outcomes in managing stress, health and well-being.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">The Company funded an additional $0.7 million of convertible loans to Trice Medical, Inc. during the <em style="font: inherit;">six</em> month period ended <em style="font: inherit;"> June 30, 2020. </em>The Company had previously deployed an aggregate of $10.2 million. Trice is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">The Company deployed an aggregate of $0.2 million to Clutch Holdings during the <em style="font: inherit;">three</em> month period ended <em style="font: inherit;"> June 30, 2020. </em>The Company had previously deployed an aggregate of $16.7 million. Clutch provides customer intelligence and personalized engagements that empower consumer-focused businesses to identify, understand and motivate each segment of their customer base.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">The Company funded an additional $0.2 million of convertible loans to QuanticMind during the <em style="font: inherit;">three</em> month period ended <em style="font: inherit;"> March 31, 2020. </em>The Company had previously deployed an aggregate of $13.5 million. QuanticMind delivers an intelligent, scalable and fast platform for maximizing digital marketing performance, including paid search and social, for enterprises.  See Note <em style="font: inherit;">2</em> for impairment recorded in <em style="font: inherit;">2020</em> and Note <em style="font: inherit;">16</em> for the sale of this ownership interest in <em style="font: inherit;">2021.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: 18pt;">The Company funded an aggregate of $0.1 million of convertible loans to WebLinc, Inc. during the <em style="font: inherit;">three</em> month period ended <em style="font: inherit;"> March 31, 2020.  </em>The Company had previously deployed an aggregate of $16.1 million.  WebLinc is an e-commerce platform for online retailers.  See Note <em style="font: inherit;">2</em> for impairment recorded in <em style="font: inherit;">2020</em> and Note <em style="font: inherit;">16</em> for the sale of this ownership interest in <em style="font: inherit;">2021.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><em style="font: inherit;">2019</em> Transactions</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company deployed an additional $5.0 million to Syapse, Inc. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company deployed an additional $2.0 million to Moxe Health Corporation, including $0.3 million that was funded initially as a convertible loan. The Company had previously deployed $5.5 million in Moxe Health.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company deployed an additional $1.5 million to Aktana, Inc. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company deployed an additional $1.5 million to meQuilibrium.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24.75pt;">The Company deployed an additional $1.5 million to Zipnosis, Inc. The Company had previously deployed $8.5 million in Zipnosis. Zipnosis provides health systems with a white-labeled, fully integrated virtual care platform.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company deployed an aggregate of $0.4 million to Clutch Holdings. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company funded an additional $2.0 million of convertible loans to Sonobi, Inc. The Company had previously deployed $11.4 million in Sonobi. Sonobi is an advertising technology developer that was acquired during <em style="font: inherit;">2020.</em>  See Note <em style="font: inherit;">2</em> for impairment and sale recorded in <em style="font: inherit;">2020.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company funded an aggregate of $1.1 million of convertible loans to WebLinc, Inc. See Note <em style="font: inherit;">2</em> for impairment recorded in <em style="font: inherit;">2020</em> and Note <em style="font: inherit;">16</em> for the sale of this ownership interest in <em style="font: inherit;">2021.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company funded an aggregate of $1.0 million of convertible loans to NovaSom, Inc. The Company had previously deployed an aggregate of $26.4 million in NovaSom. See Note <em style="font: inherit;">2</em> for impairment recorded during the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2019.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company funded an additional $0.6 million of convertible loans to QuanticMind.  See Note <em style="font: inherit;">2</em> for impairment recorded in <em style="font: inherit;">2020</em> and Note <em style="font: inherit;">16</em> for the sale of this ownership interest in <em style="font: inherit;">2021.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"/> 2500000 11700000 4400000 600000 20600000 1000000.0 13000000.0 700000 10200000 200000 16700000 200000 13500000 100000 16100000 5000000.0 2000000.0 300000 5500000 1500000 1500000 1500000 8500000 400000 2000000.0 11400000 1100000 1000000.0 26400000 600000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">4.</em> Fair Value Measurements</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company categorizes its financial instruments into a <em style="font: inherit;">three</em>-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets (Level <em style="font: inherit;">1</em>) and the lowest priority to unobservable inputs (Level <em style="font: inherit;">3</em>). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Cash equivalents approximate fair value due to their short term nature.  The Company did <em style="font: inherit;">not</em> have any Level <em style="font: inherit;">2</em> or Level <em style="font: inherit;">3</em> financial assets and liabilities measured at fair value on a recurring basis as of <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">5.</em> Credit Facility and Convertible Debentures</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Credit Facility     </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company's credit facility was with HPS Investment Partners, LLC (“Lender”), and was amended in <em style="font: inherit;"> May 2018 (</em>"Credit Facility"). The Credit Facility had a scheduled maturity of <em style="font: inherit;"> May 11, 2020 </em>and interest at a rate of either: (A) LIBOR plus 8.5% (subject to a LIBOR floor of 1%), payable on the last day of the one, <em style="font: inherit;">two</em> or <em style="font: inherit;">three</em> month interest period applicable to the LIBOR rate advance, or (B) 7.5% plus the greater of: <span style="-sec-ix-hidden:c70135111">2%;</span> the Federal Funds Rate plus <span style="-sec-ix-hidden:c70135112">0.5%;</span> LIBOR plus <span style="-sec-ix-hidden:c70135113">1%;</span> or the U.S. Prime Rate, payable monthly in arrears. The Credit Facility was secured by all of the Company's assets in accordance with the terms of the Credit Facility.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The terms of the Credit Facility included a requirement that if the aggregate amount of the Company’s qualified cash at any quarter end date exceeded $50.0 million, the Company would be required to prepay outstanding principal amounts under the Credit Facility, plus any applicable interest and prepayment fees, in an amount equal to such excess. Based on this requirement, the Company made a principal payment of $24.0 million and a make-whole interest payment of $2.9 million on <em style="font: inherit;"> April 15, 2019 </em>based on the Company's qualified cash at <em style="font: inherit;"> March 31, 2019. </em>Additionally, the Company repaid the remaining principal of $44.5 million and make-whole interest of $4.1 million in <em style="font: inherit;"> July 2019.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company was subject to certain debt covenants under the Credit Facility including maintaining a specified level of liquidity threshold, maintaining an appraised value of ownership interests, limiting deployments to our remaining ownership interests, limiting certain expenses, and restricting any repurchases of outstanding common stock or issuing dividends until such time as the Credit Facility was repaid in full. The Company was in compliance with all applicable covenants.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Credit Facility required prepayments of outstanding principal and interest amounts when the Company’s qualified cash at any quarter end date exceeded $50.0 million. This provision in the Credit Facility was an embedded derivative that was accounted for separately from the Credit Facility. A liability of $0.5 million was recorded on the <em style="font: inherit;">2018</em> amendment date for the fair value of potential future prepayments based upon management's probability weighted cash forecast. This amount was also included in debt issuance costs and had been amortized over the remaining term of the Credit Facility. The liability was adjusted to fair value at each balance sheet date based upon management's updated probability weighted cash forecast. During <em style="font: inherit;">2019,</em> the Company recorded a decrease in the liability of $5.1 million, which is included in Other income (loss), net on the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company recorded interest expense under the Credit Facility of $14.0 million for the year ended <em style="font: inherit;"> December 31, 2019. </em>The effective interest rate on the Credit Facility was 15.1%. The Company made interest payments under the Credit Facility of $11.5 million for the year ended <em style="font: inherit;"> December 31, 2019.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> 0.085 0.01 0.075 50000000.0 24000000.0 2900000 44500000 4100000 50000000.0 500000 5100000 14000000.0 0.151 11500000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">6.</em> Equity</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> July 2015, </em>the Company's Board of Directors authorized the Company, from time to time and depending on market conditions, to repurchase up to $25.0 million of the Company's outstanding common stock. During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, the Company did <span style="-sec-ix-hidden:c70135130"><span style="-sec-ix-hidden:c70135131">not</span></span> repurchase any shares under the existing authorization. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">In <em style="font: inherit;"> February 2018, </em>the Company's Board of Directors adopted a tax benefits preservation plan (the "Plan") designed to protect and preserve the Company's ability to utilize its net operating loss carryforwards ("NOLs") which was ratified by shareholders at its <em style="font: inherit;">2018</em> Annual Meeting of Shareholders. The purpose of the Plan was to preserve the Company's ability to use its NOLs, which would be substantially limited if the Company experienced an "ownership change" as defined under Section <em style="font: inherit;">382</em> of the Internal Revenue Code. In general, an ownership change would occur if the Company's shareholders who are treated as owning <em style="font: inherit;">five</em> percent or more of the outstanding shares of Safeguard for purposes of Section <em style="font: inherit;">382</em> ("five-percent shareholders") collectively increase their aggregate ownership in the Company's overall shares outstanding by more than <em style="font: inherit;">50</em> percentage points. Whether this change has occurred would be measured by comparing each <em style="font: inherit;">five</em>-percent shareholder's current ownership as of the measurement date to such shareholders' lowest ownership percentage during the <em style="font: inherit;">three</em>-year period preceding the measurement date. To protect the Company's NOLs from being limited or permanently lost under Section <em style="font: inherit;">382,</em> the Plan was intended to deter any person or group from acquiring beneficial ownership of 4.99% or more of the Company's outstanding common stock without the approval of the Board, reducing the likelihood of an unintended ownership change. Under the Plan, the Company would issue <span style="-sec-ix-hidden:c70135142">one</span> preferred stock purchase right (the "Rights") for each share of Safeguard's common stock held by shareholders of record on <em style="font: inherit;"> March 2, 2018. </em>The issuance of the Rights would <em style="font: inherit;">not</em> be taxable to Safeguard or its shareholders and would <em style="font: inherit;">not</em> affect Safeguard's reported earnings per share. The Rights would have traded with Safeguard's common shares and would have expired <em style="font: inherit;">no</em> later than <em style="font: inherit;"> February 19, 2021. </em>Accordingly, the Plan has now expired.  </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">On <em style="font: inherit;"> November 7, 2019, </em>the Board of Directors declared a special cash dividend of $1.00 per share, payable on <em style="font: inherit;"> December 30, 2019 </em>to shareholders of record as of the close of business on <em style="font: inherit;"> December 23, 2019, </em>resulting in total dividends paid of $20.7 million.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> 25000000.0 0.0499 1.00 20700000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">7.</em> Stock-Based Compensation</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Equity Compensation Plans</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The <em style="font: inherit;">2014</em> Equity Compensation Plan has 4.1 million shares authorized for issuance. During <em style="font: inherit;">2020</em> and <em style="font: inherit;">2019</em>, the Company issued <em style="font: inherit;">no</em> stock-based awards outside of existing plans. To the extent allowable, service-based options are incentive stock options. Options granted under the plans are at prices equal to or greater than the fair market value at the date of grant. Upon exercise of stock options, the Company issues shares <em style="font: inherit;">first</em> from treasury stock, if available, then from authorized but unissued shares. At <em style="font: inherit;"> December 31, 2020</em>, the Company had reserved 2.8 million shares of common stock for possible future issuance under its <em style="font: inherit;">2014</em> Equity Compensation Plan and other previously expired equity compensation plans.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i><b>Classification of Stock-Based Compensation Expense</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Stock-based compensation expense was recognized in the Consolidated Statements of Operations as follows: </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 22.5pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">965</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,237</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">965</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,237</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">At <em style="font: inherit;"> December 31, 2020</em>, the Company had outstanding options that vest based on two different types of vesting schedules:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:72.75pt;"><em style="font: inherit;">1</em>) performance-based; and</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:72.75pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:72.75pt;"><em style="font: inherit;">2</em>) service-based.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:72.75pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Performance-based awards entitle participants to vest in a number of awards determined by achievement by the Company of target capital returns based on net cash proceeds received by the Company upon the sale, merger or other exit transaction of certain identified companies. Vesting <em style="font: inherit;"> may </em>occur, if at all, once per year. The requisite service periods for the performance-based awards are based on the Company’s estimate of when the performance conditions will be met. Compensation expense is recognized for performance-based awards for which the performance condition is considered probable of achievement. Compensation expense is recognized over the requisite service periods using the straight-line method but is accelerated if capital return targets are achieved earlier than estimated.  The Company did <span style="-sec-ix-hidden:c70135161"><span style="-sec-ix-hidden:c70135162">not</span></span> issue any performance-based units during the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>.  During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, there were no performance-based options that vested.  During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, 72 thousand and 174 thousand performance-based options were canceled or forfeited. The Company recorded a reduction of compensation expense related to performance-based options of $0.0 million and $0.1 million for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> respectively. The maximum number of unvested options at <em style="font: inherit;"> December 31, 2020</em> attainable under these grants was 21 thousand shares.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Service-based awards generally vest over <span style="-sec-ix-hidden:c70135174">four</span> years after the date of grant and expire <span style="-sec-ix-hidden:c70135175">eight</span> years after the date of grant. Compensation expense is recognized over the requisite service period using the straight-line method. The requisite service period for service-based awards is the period over which the award vests. During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, the Company issued no service-based options to employees and recorded $0.0 million compensation expense from the vesting of previously issued awards. During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, 62 thousand and 57 thousand service-based options were canceled or forfeited.  </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">There were no options granted during <em style="font: inherit;">2020</em> and <em style="font: inherit;">2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Stock-based compensation expense of $1.0 million was recognized during the year ended <em style="font: inherit;"> December 31, 2020</em> related to Board fees and management bonuses earned in <em style="font: inherit;">2020</em> that were subsequently settled in stock.  The Company had liabilities of $0.5 million and $0.1 million as of <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;">2019,</em> respectively, that were settled through the issuance of common stock in the subsequent period. Compensation expense of $0.1 million was also recognized during the year ended <em style="font: inherit;"> December 31, 2019 </em>related to the dividend payments made to holders of unvested restricted stock awards pursuant to the terms of those instruments.  </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Option activity of the Company is summarized below: </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Weighted Average Exercise Price</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Weighted Average Remaining Contractual Life</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Aggregate Intrinsic Value</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In years)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at January 1, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">410</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.66</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options exercised</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options canceled/forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(231</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.19</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">179</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.27</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options exercised</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options canceled/forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(134</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.36</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2020</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">45</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.20</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2.29</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options exercisable at December 31, 2020</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">22</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Shares available for future grant</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,515</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">At <em style="font: inherit;"> December 31, 2020</em>, total unrecognized compensation cost related to non-vested service-based options was immaterial. At <em style="font: inherit;"> December 31, 2020</em>, total unrecognized compensation cost related to non-vested performance-based options was immaterial.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:22.5pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Performance-based stock units vest based on achievement by the Company of target capital returns based on net cash proceeds received by the Company on the sale, merger or other exit transaction of certain identified companies, as described above related to performance-based awards. During <em style="font: inherit;">2020,</em> the Company also initiated a <em style="font: inherit;">2021</em> CEO bonus award that will be settled in the vesting of performance-based units based on criteria determined by the Board of Directors.  Performance-based stock units represent the right to receive shares of the Company’s common stock, on a <em style="font: inherit;">one</em>-for-<em style="font: inherit;">one</em> basis at target or up to 120% for certain specified thresholds.  The maximum fair value associated with this award is $0.7 million, <em style="font: inherit;">none</em> of which has been recognized during the year ended <em style="font: inherit;"> December 31, 2020.  </em>During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, 100 thousand and 0 performance-based stock units were issued. No performance-based stock units vested during the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>. During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, 129 thousand and 339 thousand performance-based stock units were canceled or forfeited. Under the terms of the <em style="font: inherit;">2016</em> and <em style="font: inherit;">2015</em> performance-based awards, once performance-based stock units are fully vested, participants are entitled to receive cash payments based on their initial performance grant values as target capital returns described above are exceeded. At <em style="font: inherit;"> December 31, 2020</em>, the liability associated with such potential cash payments was $0.0 million.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, the Company issued 193 thousand and 31 thousand restricted shares to employees and directors. Restricted shares generally vest over a period of approximately <span style="-sec-ix-hidden:c70135217">two</span> to <span style="-sec-ix-hidden:c70135218">four</span> years, or are vested at issuance for directors <em style="font: inherit;">65</em> or older. During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, 10 thousand and 75 thousand restricted shares were canceled or forfeited.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively, the Company issued 20 thousand to an employee, and 0 deferred stock units to non-employee directors for annual service grants or fees earned during the preceding quarter. Deferred stock units issued to directors in lieu of directors fees are 100% vested at the grant date; matching deferred stock units equal to 25% of directors’ fees deferred vest <span style="-sec-ix-hidden:c70135228">one</span> year following the grant date or, if earlier, upon reaching age <em style="font: inherit;">65.</em> Deferred stock units are payable in stock on a <em style="font: inherit;">one</em>-for-<em style="font: inherit;">one</em> basis. Payments related to the deferred stock units are generally distributable following termination of service, death or permanent disability.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Total compensation expense for deferred stock units, performance-based stock units and restricted stock was $0.5 million and $1.2 million, for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, respectively. Unrecognized compensation expense related to deferred stock units, performance stock units and restricted stock at <em style="font: inherit;"> December 31, 2020</em> was $0.5 million. The total fair value of deferred stock units, performance stock units and restricted stock vested during the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> was $1.1 million and $1.2 million, respectively.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">Deferred stock unit, performance-based stock unit and restricted stock activity are summarized below: </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Weighted Average Grant Date Fair Value</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at January 1, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">777</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">31</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">12.12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(107</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(414</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.28</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at December 31, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">287</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.44</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">313</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.89</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(174</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(139</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.24</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at December 31, 2020</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">287</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8.78</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> 4100000 2800000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">965</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,237</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">965</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,237</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 965000 1237000 965000 1237000 2 0 72000 174000 0.0 100000 21000 0 0.0 62000 57000 0 1000000.0 500000 100000 100000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Weighted Average Exercise Price</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Weighted Average Remaining Contractual Life</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Aggregate Intrinsic Value</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In years)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at January 1, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">410</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.66</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options exercised</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options canceled/forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(231</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.19</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">179</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.27</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options exercised</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options canceled/forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(134</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.36</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2020</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">45</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.20</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2.29</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Options exercisable at December 31, 2020</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">22</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Shares available for future grant</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,515</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><em style="font: inherit;"> </em></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> </tbody></table> 410000 14.66 0 0 -0 0 231000 14.19 179000 15.27 0 0 0 0 134000 14.36 45000 14.20 P2Y3M14D 0 22000 14.48 P3Y29D 0 2515000 1.20 700000 100000 0 0 129000 339000 0.0 193000 31000 10000 75000 20000 0 1 0.25 500000 1200000 500000 1100000 1200000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Shares</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b><em style="font: inherit;">Weighted Average Grant Date Fair Value</em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at January 1, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">777</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.08</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">31</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">12.12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(107</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11.79</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(414</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.28</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at December 31, 2019</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">287</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.44</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">313</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.89</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(174</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(139</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.24</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unvested at December 31, 2020</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">287</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8.78</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 777000 14.08 31000 12.12 107000 11.79 414000 14.28 287000 14.44 313000 5.89 174000 7.77 139000 15.24 287000 8.78 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">8.</em> Employee Benefit Pla</b><b>n</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company maintains a qualified <em style="font: inherit;">401</em>(k) retirement plan for eligible employees. The Plan’s matching formula is 100% of the <em style="font: inherit;">first</em> 5% of participants’ qualified compensation. Compensation expense related to our matching contributions to the Plan for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, were $0.2 million and $0.2 million, respectively.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> 1 0.05 200000 200000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">9.</em> Income Taxes</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The federal and state provision (benefit) for income taxes was $0.0 million for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The total income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21.0% for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> to net income (loss) before income taxes as a result of the following:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Statutory tax (benefit) expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Increase (decrease) in taxes resulting from:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Nondeductible expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(4.1</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.4</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(16.9</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(21.4</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">0.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">0.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">As of December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax asset:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Carrying values of ownership interests and other holdings</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38,361</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32,760</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Tax loss and credit carryforwards</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">76,023</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">70,914</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Disallowed interest carryforwards</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,292</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,292</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accrued expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">213</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Stock-based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">302</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">432</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">482</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">604</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">122,957</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">112,215</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(122,957</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(112,215</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net deferred tax asset</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">As of <em style="font: inherit;"> December 31, 2020</em>, the Company and its subsidiaries had federal net operating and capital loss carryforwards for tax purposes of approximately $362 million, of which approximately $37 million have an indefinite life. These carryforwards expire as follows: </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Total</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,728</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">48,848</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52,512</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">50,140</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025 and thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">170,189</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">325,417</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In assessing the recoverability of deferred tax assets, the Company considers whether it is more likely than <em style="font: inherit;">not</em> that some portion or all of the deferred tax assets will <em style="font: inherit;">not</em> be realized. The Company has determined that it is more likely than <em style="font: inherit;">not</em> that certain future tax benefits <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized as a result of current and future income. Accordingly, a valuation allowance has been recorded against substantially all of the Company’s deferred tax assets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company recognizes in its Consolidated Financial Statements the impact of a tax position if that position is more likely than <em style="font: inherit;">not</em> to be sustained upon examination, based on the technical merits of the position. All uncertain tax positions relate to unrecognized tax benefits that would impact the effective tax rate when recognized.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company does <em style="font: inherit;">not</em> expect any material increase or decrease in its income tax expense, in the next <em style="font: inherit;">twelve</em> months, related to examinations or changes in uncertain tax positions.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">There were no changes in the Company’s uncertain tax positions for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company files income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Tax years <em style="font: inherit;">2015</em> and forward remain open for examination for federal tax purposes and the Company’s more significant state tax jurisdictions. To the extent utilized in future years’ tax returns, net operating loss carryforwards at <em style="font: inherit;"> December 31, 2020</em> will remain subject to examination until the respective tax year is closed. The Company recognizes penalties and interest accrued related to income tax liabilities in income tax benefit (expense) in the Consolidated Statements of Operations.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> 0.0 0.210 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Statutory tax (benefit) expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Increase (decrease) in taxes resulting from:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Nondeductible expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(4.1</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0.4</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(16.9</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(21.4</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">0.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">0.0</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td></tr> </tbody></table> 0.210 0.210 -0.041 0.004 -0.169 -0.214 0.000 0.000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">As of December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax asset:</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Carrying values of ownership interests and other holdings</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38,361</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32,760</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Tax loss and credit carryforwards</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">76,023</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">70,914</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Disallowed interest carryforwards</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,292</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,292</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accrued expenses</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">213</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Stock-based compensation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">302</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">432</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">482</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">604</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">122,957</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">112,215</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation allowance</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(122,957</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(112,215</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net deferred tax asset</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">—</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 38361000 32760000 76023000 70914000 7292000 7292000 497000 213000 302000 432000 482000 604000 122957000 112215000 122957000 112215000 0 0 362000000 37000000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Total</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2021</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,728</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2022</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">48,848</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2023</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52,512</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2024</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">50,140</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2025 and thereafter</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">170,189</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">325,417</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td></tr> </tbody></table> 3728000 48848000 52512000 50140000 170189000 325417000 0 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">10.</em> Net Income (Loss) Per Share</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The calculations of net income (loss) per share were: </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands, except per share data)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Basic:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(37,615</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">54,561</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,751</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,636</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1.81</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.64</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Diluted:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(37,615</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">54,561</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,751</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,636</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1.81</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.64</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Basic and diluted average common shares outstanding for purposes of computing net income (loss) per share includes outstanding common shares and vested deferred stock units (DSUs).</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">If an equity method company has dilutive stock options, unvested restricted stock, DSUs, or warrants, diluted net income (loss) per share is computed by <em style="font: inherit;">first</em> deducting from net income (loss) the income attributable to the potential exercise of the dilutive securities of the company from net income (loss). Any impact is shown as an adjustment to net income (loss) for purposes of calculating diluted net income (loss) per share.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Diluted income (loss) per share for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> do <em style="font: inherit;">not</em> reflect the following potential shares of common stock that would have an anti-dilutive effect or have unsatisfied performance or market conditions:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">At <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, options to purchase 45 thousand and 179 thousand shares of common stock, respectively, at prices ranging from $10.37 to $17.11 per share, and $10.37 to $18.45 per share per share, respectively, were excluded from the calculation.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">At <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, unvested restricted stock, performance-based stock units and DSUs convertible into 0.3 million and 0.3 million shares of stock, respectively, were excluded from the calculations.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">For the year ended <em style="font: inherit;"> December 31, 2019</em>, 0.8 million shares of common stock, respectively, representing the effect of assumed conversion of the <em style="font: inherit;">2019</em> Debentures were excluded from the calculations.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">Year Ended December 31,</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2020</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">2019</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands, except per share data)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Basic:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(37,615</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">54,561</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,751</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,636</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1.81</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.64</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>Diluted:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(37,615</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">54,561</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average common shares outstanding</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,751</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,636</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1.81</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.64</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> -37615000 54561000 20751000 20636000 -1.81 2.64 -37615000 54561000 20751000 20636000 -1.81 2.64 45000 179000 10.37 17.11 10.37 18.45 300000 300000 800000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">11.</em> Related Party Transactions</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In the normal course of business, the Company’s officers and employees hold board positions with companies in which the Company has a direct or indirect ownership interest.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">12.</em> Commitments and Contingencies</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company and the companies in which it holds ownership interests are involved in various claims and legal actions arising in the ordinary course of business. In the current opinion of the Company, the ultimate disposition of these matters will <em style="font: inherit;">not</em> have a material adverse effect on the Company’s consolidated financial position or results of operations, however, <em style="font: inherit;">no</em> assurance can be given as to the outcome of these actions, and <em style="font: inherit;">one</em> or more adverse rulings could have a material adverse effect on the Company’s consolidated financial position and results of operations or that of its companies. The Company records costs associated with legal fees as such services are rendered.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"/> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company had outstanding guarantees of $3.8 million at <em style="font: inherit;"> December 31, 2020</em> which related to <em style="font: inherit;">one</em> of the Company's private equity holdings.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In <em style="font: inherit;"> October 2001, </em>the Company entered into an agreement with a former Chairman and Chief Executive Officer of the Company, to provide for annual payments of $0.65 million per year and certain health care and other benefits for life. The former executive passed away in <em style="font: inherit;">2019.</em> Accordingly, the Company recorded a $1.7 million gain in Other income (loss), net which also eliminated the remaining projected benefits related to this agreement that were previously included in Accrued expenses and other current liabilities and Other long-term liabilities on the Consolidated Balance Sheets.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">The Company has agreements with certain employees that provide for severance payments to the employee in the event the employee is terminated without cause or an employee terminates his employment for “good reason.” The maximum aggregate exposure under severance agreements for remaining employees is approximately $2.3 million at <em style="font: inherit;"> December 31, 2020</em>.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In <em style="font: inherit;">2018,</em> the Board of Directors (the “Board”) of the Company adopted a long-term incentive plan, which was amended in <em style="font: inherit;"> February 2019 </em>and <em style="font: inherit;"> June 2020, </em>known as the Amended and Restated Safeguard Scientifics Transaction Bonus Plan (the “LTIP”). The purpose of the LTIP is to promote the interests of the Company and its shareholders by providing an additional incentive to employees to maximize the value of the Company in connection with the execution of the business strategy that the Company adopted and announced in <em style="font: inherit;"> January 2018. </em>The <em style="font: inherit;"> June 2020 </em>amendment lowered the level of the <em style="font: inherit;">first</em> threshold and the resulting bonus pool percentage as an incentive to employees to accelerate actions consistent with the business strategy.  Under the LTIP, participants, which include certain current and former employees, have received awards that <em style="font: inherit;"> may </em>result in cash payments in connection with sales of the Company’s ownership interests (“Sale Transaction(s)”). The LTIP provides for a bonus pool corresponding to: (i) specified vesting thresholds or (ii) specified events. In the <em style="font: inherit;">first</em> case, the bonus pool will range from an amount equal to 0.2% (previously 1.0%) of received proceeds at the <em style="font: inherit;">first</em> threshold to 1.3% at higher thresholds and <em style="font: inherit;">no</em> bonus pool will be created if the transaction consideration is less than certain minimum thresholds. In the <em style="font: inherit;">second</em> case, a minimum pool will be created and paid under specified circumstances. The bonus pool will be allocated and paid to participants in the LTIP based on the product of (i) the participant’s applicable bonus pool percentage and (ii) the bonus pool calculated as of the vesting date, minus any previously paid portion of the bonus pool. Any portion of the bonus pool available as of the applicable vesting date that is reserved will be allocated in connection with each vesting date so that the entire bonus pool available as of such vesting date is allocated and payable to participants. Subject to the terms of the LTIP, payments under the LTIP will be paid in cash within <em style="font: inherit;">60</em> days of the applicable vesting date. All current officers and employees of the Company are eligible to participate in the LTIP. The Board, in its sole discretion, will determine the participants to whom awards are granted under the LTIP. The Company has accrued approximately $1.8 million under the LTIP as of  <em style="font: inherit;"> December 31, 2020</em>, which $1.5 million is estimated as current accrued compensation.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In <em style="font: inherit;"> June 2011, </em>Advanced BioHealing, Inc. (“ABH”) was acquired by Shire plc (“Shire”).  Prior to the expiration of the escrow period in <em style="font: inherit;"> March 2012, </em>Shire filed a claim against all amounts held in escrow related to the sale based principally upon a United States Department of Justice (“DOJ”) false claims act investigation relating to ABH (the “Investigation”). In connection with the Investigation, in <em style="font: inherit;"> July 2015 </em>the Company received a Civil Investigation Demand-Documentary Material (“CID”) from the DOJ regarding ABH and Safeguard’s relationship with ABH. Pursuant to the CID, the Company provided the requested materials and information.  To the Company’s knowledge, the CID was related to multiple qui tam (“whistleblower”) actions, <em style="font: inherit;">one</em> of which was filed in <em style="font: inherit;">2014</em> by an ex-employee of ABH that named the Company and <em style="font: inherit;">one</em> of the Company’s employees along with other entities and individuals as defendants.  At this time, the DOJ has declined to pursue the qui tam action as it relates to the Company and such Company employee. In addition, in connection with the above matters, the Company and other former equity holders in ABH entered into a settlement and release with Shire, which resulted in the release to Shire of all amounts held in escrow related to the sale of ABH.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> 3800000 650000 1700000 2300000 0.002 0.010 0.013 1800000 1500000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">13.</em> Supplemental Cash Flow Information</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">During the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, the Company converted $6.8 million and $2.3 million, respectively, of advances into ownership interests. Cash paid for interest for the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> was $0.0 million and $11.5 million, respectively. Cash paid for taxes in each of the years ended <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> was $0.0 million.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> 6800000 2300000 0.0 11500000 0.0 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">14.</em> Segment Reporting</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 24pt;">The Company operates as one operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">As of <em style="font: inherit;"> December 31, 2020</em>, the Company held ownership interests accounted for using the equity method in 12 non-consolidated companies. During <em style="font: inherit;">2019</em> we ceased using the equity method of accounting for Hoopla Software, Inc. and T-REX Group, Inc. as a result of other new investors diluting our interest. We have retained our ownership interests in those companies under the Other accounting method.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">Certain of the Company’s ownership interests as of <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em> included the following:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="7" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 17%;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Safeguard Primary Ownership as of December 31,</em></em></em></em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;"><em style="font: inherit;"> </em></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%; border-bottom: thin solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Company Name</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">2020</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">2019</em></em></b></p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%; border-bottom: thin solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Accounting Method</em></b></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Aktana, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.1</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">17.8</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Clutch Holdings, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">42.3</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">41.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Flashtalking, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.4</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10.1</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Other</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">InfoBionic, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Lumesis, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">43.4</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">43.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">MediaMath, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.3</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.3</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Other</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">meQuilibrium</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32.0</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Moxe Health Corporation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27.6</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">29.9</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Prognos Health Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">28.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">28.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">QuanticMind, Inc. *</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">24.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">24.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Syapse, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18.9</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">20.0</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">T-REX Group, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Other</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Trice Medical, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16.6</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16.6</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">WebLinc, Inc. *</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">39.9</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Zipnosis, Inc</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">* These entities were sold subsequent to <em style="font: inherit;"> December 31, 2020.  </em>See Note <em style="font: inherit;">16</em> - Subsequent Events, of the consolidated financials statements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">As of <em style="font: inherit;"> December 31, 2020</em> and <em style="font: inherit;">2019</em>, all of the Company’s assets were located in the United States.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"/> 1 12 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="7" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 17%;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Safeguard Primary Ownership as of December 31,</em></em></em></em></b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 16%;"><em style="font: inherit;"> </em></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%; border-bottom: thin solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Company Name</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">2020</em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;">2019</em></em></b></p> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%; border-bottom: thin solid rgb(0, 0, 0);"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">Accounting Method</em></b></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Aktana, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.1</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">17.8</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Clutch Holdings, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">42.3</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">41.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Flashtalking, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.4</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10.1</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Other</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">InfoBionic, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Lumesis, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">43.4</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">43.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">MediaMath, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.3</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.3</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Other</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">meQuilibrium</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32.0</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Moxe Health Corporation</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">27.6</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">29.9</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Prognos Health Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">28.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">28.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">QuanticMind, Inc. *</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">24.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">24.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Syapse, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18.9</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">20.0</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">T-REX Group, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Other</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Trice Medical, Inc.</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16.6</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16.6</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">WebLinc, Inc. *</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">39.9</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38.5</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 51%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Zipnosis, Inc</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37.2</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37.7</td><td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">%</em></td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> </td><td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 16%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><em style="font: inherit;">Equity</em></p> </td></tr> </tbody></table> 0.151 0.178 0.423 0.412 0.134 0.101 0.252 0.252 0.434 0.435 0.133 0.133 0.320 0.327 0.276 0.299 0.285 0.287 0.242 0.242 0.189 0.200 0.135 0.137 0.166 0.166 0.399 0.385 0.372 0.377 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">15.</em> Selected Quarterly Financial Information (Unaudited)</b>  </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 43%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Three Months Ended</em></em></em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">March 31</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">June 30</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">September 30 (b)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31 (b)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 43%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands, except per share data)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>2020:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,532</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,275</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,631</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3,532</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,275</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1,631</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3,567</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,658</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(820</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(663</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Interest income</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">105</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Equity income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(9,014</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,277</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,300</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,111</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net loss before income taxes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(16,008</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(9,911</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(4,343</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(7,353</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Income tax benefit (expense)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(16,008</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(9,911</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(4,343</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(7,353</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss per share (a)</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Basic</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.21</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.35</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Diluted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.21</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.35</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>2019:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,057</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,603</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,262</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,060</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3,057</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,603</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,262</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,060</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1,885</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,118</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,777</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,245</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Interest income</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">873</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">763</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">234</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">174</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Interest expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,535</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(5,682</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(5,806</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Equity income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">28,267</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,440</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,057</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net income (loss) before income taxes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21,663</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">36,093</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(698</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Income tax benefit (expense)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">21,663</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">36,093</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(2,497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(698</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share (a)</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Basic</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.05</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.75</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.03</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Diluted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.05</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.75</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.03</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(a)</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests.</p> </td></tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 18pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(b)</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> December 31, 2019 </em>includes equity income of $1.4 million related to an equity method investment that should have been recorded during the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2019. </em>There was <em style="font: inherit;">no</em> impact on the full year results.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"/> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"><tbody><tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 43%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">Three Months Ended</em></em></em></em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">March 31</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">June 30</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">September 30 (b)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><em style="font: inherit;">December 31 (b)</em></b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 43%;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(In thousands, except per share data)</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>2020:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,532</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,275</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,631</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3,532</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,028</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,275</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1,631</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3,567</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,658</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(820</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(663</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Interest income</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">105</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">52</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Equity income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(9,014</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,277</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,300</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(5,111</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net loss before income taxes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(16,008</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(9,911</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(4,343</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(7,353</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Income tax benefit (expense)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(16,008</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(9,911</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(4,343</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(7,353</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss per share (a)</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Basic</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.21</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.35</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Diluted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.77</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.48</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.21</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.35</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><b>2019:</b></p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">General and administrative expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,057</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,603</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,262</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,060</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating loss</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3,057</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,603</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,262</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,060</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1,885</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,118</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,777</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,245</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Interest income</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">873</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">763</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">234</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">174</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Interest expense</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,535</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(5,682</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(5,806</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Equity income (loss), net</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">28,267</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">40,497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,440</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,057</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Net income (loss) before income taxes</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21,663</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">36,093</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2,497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(698</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Income tax benefit (expense)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">—</em></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss)</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">21,663</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">36,093</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(2,497</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(698</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net income (loss) per share (a)</p> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td><td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;"> </td><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;"> </td></tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Basic</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.05</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.75</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.03</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"><td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Diluted</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.05</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.75</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.12</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">)</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.03</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td></tr> </tbody></table> 3532000 2028000 2275000 1631000 -3532000 -2028000 -2275000 -1631000 -3567000 -2658000 -820000 -663000 105000 52000 52000 52000 -9014000 -5277000 -1300000 -5111000 -16008000 -9911000 -4343000 -7353000 -16008000 -9911000 -4343000 -7353000 -0.77 -0.48 -0.21 -0.35 -0.77 -0.48 -0.21 -0.35 3057000 2603000 2262000 2060000 -3057000 -2603000 -2262000 -2060000 -1885000 3118000 8777000 2245000 873000 763000 234000 174000 2535000 5682000 5806000 28267000 40497000 -3440000 -1057000 21663000 36093000 -2497000 -698000 21663000 36093000 -2497000 -698000 1.05 1.75 -0.12 -0.03 1.05 1.75 -0.12 -0.03 1400000 <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">16.</em> Subsequent Events</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">In <em style="font: inherit;"> January 2021, </em>WebLinc, Inc. was acquired by another entity.  To date, the Company received $3.2 million in cash proceeds and <em style="font: inherit;"> may </em>receive additional amounts over the next 24 months based on certain transitional performance activities, which could be partially offset by indemnifiable claims.  During <em style="font: inherit;"> February 2021, </em>QuanticMind, Inc. was acquired by another entity, however there were no resultant proceeds.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24pt;">During <em style="font: inherit;"> February 2021, </em>Syapse raised $68 million of preferred capital which reduced our ownership interest to approximately 11%.</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> 3200000 P24M 0 68000000 0.11 These entities were sold subsequent to December 31, 2020. See Note 16 - Subsequent Events, of the consolidated financials statements. The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results. Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts may not add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts may not add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests. XML 16 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2020
Feb. 26, 2021
Jun. 30, 2020
Document Information [Line Items]      
Entity Central Index Key 0000086115    
Entity Registrant Name SAFEGUARD SCIENTIFICS INC    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2020    
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2020    
Document Transition Report false    
Entity File Number 1-5620    
Entity Incorporation, State or Country Code PA    
Entity Tax Identification Number 23-1609753    
Entity Address, Address Line One 150 N. Radnor Chester Road    
Entity Address, City or Town Radnor    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 19087    
City Area Code 610    
Local Phone Number 293-0600    
Title of 12(b) Security Common Stock ($.10 par value)    
Trading Symbol SFE    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Small Business true    
Entity Filer Category Non-accelerated Filer    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 136,021,431
Entity Common Stock, Shares Outstanding   20,944,305  
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 15,601 $ 25,028
Restricted cash 0 25
Prepaid expenses and other current assets 462 1,297
Total current assets 16,063 26,350
Property and equipment, net 1,790 2,101
Ownership interests and advances 50,398 77,129
Other assets 784 1,997
Total Assets 69,035 107,577
Current Liabilities:    
Accounts payable 56 39
Accrued compensation and benefits 2,677 1,364
Accrued expenses and other current liabilities 410 627
Lease liability - current 327 399
Total current liabilities 3,470 2,429
Other long-term liabilities 637 1,027
Lease liability - non-current 2,053 2,380
Total Liabilities 6,160 5,836
Commitments and contingencies (Note 12)
Equity:    
Preferred stock, $0.10 par value; 1,000 shares authorized 0 0
Common stock, $0.10 par value; 83,333 shares authorized; 21,573 issued at December 31, 2020 and 2019, respectively 2,157 2,157
Additional paid-in capital 807,582 810,856
Treasury stock, at cost; 688 and 930 shares at December 31, 2020 and 2019, respectively (10,200) (14,024)
Accumulated deficit (736,639) (697,223)
Accumulated other comprehensive loss (25) (25)
Total Equity 62,875 101,741
Total Liabilities and Equity $ 69,035 $ 107,577
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parentheticals) - $ / shares
shares in Thousands
Dec. 31, 2020
Dec. 31, 2019
Preferred stock, par value (in dollars per share) $ 0.10 $ 0.10
Preferred stock, shares authorized (in shares) 1,000 1,000
Common stock, par value (in dollars per share) $ 0.10 $ 0.10
Common stock, shares authorized (in shares) 83,333 83,333
Common stock, shares issued (in shares) 21,573 21,573
Treasury stock, shares (in shares) 688 930
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
General and administrative expense $ 9,466 $ 9,982
Operating loss (9,466) (9,982)
Other income (loss), net (7,708) 12,255
Interest income 261 2,044
Interest expense 0 (14,023)
Equity income (loss), net (20,702) 64,267
Net income (loss) before income taxes (37,615) 54,561
Income tax benefit (expense) 0 0
Net income (loss) $ (37,615) $ 54,561
Net income (loss) per share:    
Basic (in dollars per share) $ (1.81) $ 2.64
Diluted (in dollars per share) $ (1.81) $ 2.64
Weighted average shares used in computing net income (loss) per share:    
Basic (in shares) 20,751 20,636
Diluted (in shares) 20,751 20,636
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net income (loss) $ (37,615) $ 54,561
Other comprehensive (loss) income:    
Share of other comprehensive (loss) of equity method investments 0 (31)
Reclassification adjustment for sale of equity method investments 0 6
Total comprehensive income (loss) $ (37,615) $ 54,536
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Total
Balance at Dec. 31, 2018 $ (731,105) $ 0 $ 2,157 $ 810,928 $ (15,001) $ 66,979
Balance (in shares) at Dec. 31, 2018     21,573   914  
Net income (loss) 54,561 0 $ 0 0 $ 0 54,561
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net 0 0 $ 0 (1,213) $ 977 (236)
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)     0   16  
Stock-based compensation 0 0 $ 0 1,141 $ 0 1,141
Other comprehensive income (loss) 0 (25) 0 0 0 (25)
Dividends paid (20,679) 0 0 0 0 (20,679)
Balance at Dec. 31, 2019 (697,223) (25) $ 2,157 810,856 $ (14,024) 101,741
Balance (in shares) at Dec. 31, 2019     21,573   930  
Net income (loss) (37,615) 0 $ 0 0 $ 0 (37,615)
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net 0 0 $ 0 (3,864) $ 3,824 (40)
Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)     0   (242)  
Stock-based compensation 0 0 $ 0 590 $ 0 590
Change in accounting at ownership interests (1,801) 0 0 0 0 (1,801)
Balance at Dec. 31, 2020 $ (736,639) $ (25) $ 2,157 $ 807,582 $ (10,200) $ 62,875
Balance (in shares) at Dec. 31, 2020     21,573   688  
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities:    
Net income (loss) $ (37,615) $ 54,561
Adjustments to reconcile to net cash used in operating activities:    
Depreciation 0 808
Amortization of debt discount 0 3,454
Amortization of right of use asset 311 260
Equity (income) loss, net 9,420 (67,232)
Impairments of ownership interests and advances 20,039 3,012
Income from change in fair value of derivative 0 (5,060)
Gain from observable price changes (1,224) (4,526)
Other, net 175 (2,315)
Stock-based compensation, including liability classified awards 965 1,237
Changes in assets and liabilities:    
Prepaid expenses and other current assets (137) (823)
Accounts payable, accrued expenses, and other current liabilities (77) (3,346)
Net cash used in operating activities (8,143) (19,970)
Cash Flows from Investing Activities:    
Acquisitions of ownership interests (7,534) (11,640)
Proceeds from sales and distributions from ownership interests 7,903 104,302
Advances and loans to ownership interests (1,638) (5,055)
Repayment of advances and loans from ownership interests 0 750
Purchase of marketable securities 0 (57,243)
Proceeds, from sales and maturities in marketable securities 0 95,189
Net cash (used in) provided by investing activities (1,269) 126,303
Cash Flows from Financing Activities:    
Payment of dividend 0 (20,679)
Repayments on credit facility 0 (68,568)
Tax withholdings related to equity-based awards (40) (236)
Net cash used in financing activities (40) (89,483)
Net change in cash, cash equivalents and restricted cash (9,452) 16,850
Cash, cash equivalents and restricted cash equivalents at beginning of period 25,053 8,203
Cash, cash equivalents and restricted cash at end of period $ 15,601 $ 25,053
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Note 1 - General
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1. General

 

Liquidity And Capital Resources

 

As of December 31, 2020, Safeguard ("the Company") had $15.6 million of cash and cash equivalents.

 

In January 2018, Safeguard announced that, from that date forward, the Company will not deploy any capital into new opportunities and will focus on supporting our existing companies and maximizing monetization opportunities to return value to shareholders. In that context, the Company has, are and will consider initiatives including, among others: the sale of individual ownership interests, the sale of certain or all ownership interests in secondary market transactions, or a combination thereof, as well as other opportunities to maximize shareholder value.

 

The Company believes that its cash and cash equivalents at December 31, 2020 will be sufficient to fund operations past one year from the issuance of these consolidated financial statements.

 

Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Safeguard and all of its subsidiaries in which a controlling financial interest is maintained. All intercompany accounts and transactions are eliminated in consolidation.

 

Principles of Accounting for Ownership Interests in Companies

 

The Company accounts for its ownership interests using one of the following methods: Equity or Other. The accounting method applied is generally determined by the degree of the Company's influence over the entity, primarily determined by our voting interest in the entity.

 

In addition to holding voting and non-voting equity and debt securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets.

 

Equity Method. The Company accounts for ownership interests whose results are not consolidated, but over which it exercises significant influence, under the equity method of accounting. Whether or not the Company exercises significant influence with respect to an ownership interest depends on an evaluation of several factors including, among others, representation on the board of directors and our ownership level, which is generally a 20% to 50% interest in the voting securities of a company, including voting rights associated with the Company’s holdings in common, preferred and other convertible instruments in the company. Under the equity method of accounting, the Company does not reflect a company’s financial statements within our Consolidated Financial Statements; however, our share of the income or loss of such company is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The Company includes the carrying value of equity method companies in Ownership interests and advances on the Consolidated Balance Sheets. Any excess of the Company’s cost over its underlying interest in the net assets of equity method companies that is allocated to intangible assets is amortized over the estimated useful lives of the related intangible assets. The Company reflects its share of the income or loss of the equity method companies on a one quarter lag. This reporting lag could result in a delay in recognition of the impact of changes in the business or operations of these companies.

 

When the Company’s carrying value in an equity method company is reduced to zero, the Company records no further losses in its Consolidated Statements of Operations unless the Company has an outstanding guarantee obligation or has committed additional funding to such equity method company. When such equity method company subsequently reports income, the Company will not record its share of such income until it exceeds the amount of the Company’s share of losses not previously recognized.

 

Other Method. We account for our equity interests in companies which are not accounted for under the equity method as equity securities without readily determinable fair values. We estimate the fair value of these securities based on our original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Under this method, our share of the income or losses of such companies is not included in our Consolidated Statements of Operations. We include the carrying value of these investments in Ownership interests and advances on the Consolidated Balance Sheets.

 

Accounting Estimates

 

The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.

 

Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities’ financial statements are completed.

 

It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At December 31, 2020, the Company believes the carrying value of the Company’s ownership interests and advances is not impaired, although there can be no assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future or that a significant loss will not be recorded in the future upon the sale of a company.

 

Cash and Cash Equivalents and Marketable Securities

 

The Company considers all highly liquid instruments with an original maturity of 90 days or less at the time of purchase to be cash equivalents. Cash and cash equivalents consist of deposits that are readily convertible into cash. The Company determines the appropriate classification of marketable securities at the time of purchase and reevaluates such designation as of each balance sheet date. Held-to-maturity securities were carried at amortized cost, which approximated fair value. Marketable securities consisted of held-to-maturity securities, primarily consisting of government agency bonds, commercial paper and certificates of deposits. Marketable securities with a maturity date greater than one year from the balance sheet date would be considered long-term. The Company has not experienced any significant losses on cash equivalents and does not believe it is exposed to any significant credit risk on cash and cash equivalents.

 

Restricted Cash

 

Restricted cash equivalents represents cash required to be set aside by a contractual agreement as a shareholder representative. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets:

 

  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Cash and cash equivalents

 $15,601  $25,028 

Restricted cash

  —   25 

Total cash, cash equivalents and restricted cash

 $15,601  $25,053 

 

Financial Instruments

 

The Company’s financial instruments (principally cash and cash equivalents, marketable securities, accounts receivable, notes receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. 

 

Property and Equipment

 

Property and equipment represents right-of-use assets resulting from the adoption of Accounting Standards Update ("ASU") No. 2016-02, Leases, and other previously existing leasehold improvements. The leasehold improvements were amortized over the shorter of the estimated useful lives or the expected remaining term of the lease. The right-of-use assets are reduced over the remaining term of the applicable lease (principally April 2026) in a manner that results in a straight-line lease expense, when combined with the interest factor on the lease liability.     

 

Lease liability

 

The initial lease liability represents the present value of the fixed escalating lease payments through April 2026 associated with the Company's prior corporate headquarters operating office lease. The discount rate used to calculate the lease liability was based on the Company's incremental borrowing rate, approximately 12%, at the transition to the guidance of ASU No. 2016-02, Leases. Subsequent values of the lease liability reflect the reduction in the lease liability for operating lease payments less an amount representing interest, which is included in the straight-line lease expense. There is no residual value guarantee associated with this operating lease arrangement. The Company has incurred operating lease expenses and operating cash outflows of $0.5 million for each of the years ended December 31, 2020 and 2019, respectively, and $0.6 million for each of the years ended December 31, 2020 and 2019.

 

In March 2019, the Company entered into a sublease of its prior corporate headquarters office space. The term of the sublease is through April 2026, the same as the Company's underlying lease. Fixed sublease payments to the Company are escalating over the term of the sublease and are reported as a component of general and administrative expenses.

 

In April 2019, the Company entered into a sublease for replacement office space with a related party, an equity method ownership interest, beginning in June 2019. The 18 month term of this sublease expired in 2020. The aggregate payments under this sublease were not material.

 

A summary of the Company's operating lease cash flows at December 31, 2020 follows:

 

  Operating lease payments  

Expected sublease receipts

 
  

(In thousands)

 

2021

 $595  $525 

2022

  601   540 

2023

  607   556 

2024

  613   573 

2025

  619   590 

2026

  208   199 

Thereafter

  —   — 

Total future minimum lease payments

  3,243   2,983 

Less imputed interest

  (863)    

Total operating lease liabilities

 $2,380     

 

Valuation of Credit Facility repayment feature

 

The fair value of the Credit Facility repayment feature (a Level 3 measurement) was determined quarterly based on the present value of make-whole interest payments that were expected to be paid based on cash flow estimates that included a probability weighted estimate of exit transactions, estimated follow-on deployments, estimated quarterly operating cash flows and other cash commitments that would have resulted in qualified cash exceeding the $50 million threshold specified in the Credit Facility. This fair value of the Credit Facility repayment feature was eliminated in July 2019 upon the repayment of the Credit Facility.

 

Impairment of Ownership Interests and Advances

 

On a periodic basis, but no less frequently than quarterly, the Company evaluates the carrying value of its ownership interests and advances for possible impairment based on achievement of business plan objectives and milestones, the estimated fair value of each company relative to its carrying value, the financial condition and prospects of the company and other relevant factors. The business plan objectives and milestones the Company considers include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are not primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships.

 

Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value.

 

The estimated fair value of privately held companies is generally determined based on the value at which independent third parties have invested or have committed to invest in these companies or based on other valuation methods, including discounted cash flows, valuation of comparable public companies and the valuation of acquisitions of similar companies.

 

Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies and funds are included in Other income (loss), net in the Consolidated Statements of Operations.

 

The reduced cost basis of a previously impaired company accounted for using the Equity method are not written-up if circumstances suggest the value of the company has subsequently recovered.

 

Income Taxes

 

The Company accounts for income taxes under the asset and liability method whereby deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates in effect for the year in which the temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period of the enactment date. The Company provides a valuation allowance against the net deferred tax asset for amounts which are not considered more likely than not to be realized.

 

Net Income (Loss) Per Share

 

The Company computes net income (loss) per share using the weighted average number of common shares outstanding during each year. The Company includes in diluted net income (loss) per share common stock equivalents (unless anti-dilutive) which would arise from the exercise of stock options and conversion of other convertible securities and adjusted, if applicable, for the effect on net income (loss) of such transactions. Diluted net income (loss) per share calculations adjust net income (loss) for the dilutive effect of common stock equivalents and convertible securities issued by the Company’s consolidated or equity method companies.

 

Segment Information

 

The Company operates as one operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 

Recently Adopted Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09"). ASU 2014-09 and related subsequent amendments outline a single comprehensive model to use to account for revenue arising from contracts with customers and supersede most current revenue recognition guidance. For public companies, the guidance was effective for annual periods beginning after December 15, 2017 and any interim periods that fall within that reporting period. For nonpublic companies, the guidance is effective for annual periods beginning after December 15, 2018 and interim periods within annual periods beginning after December 15, 2019 with early adoption permitted. Additionally, on June 3, 2020 the FASB issued ASU 2020-05, which extended the adoption of ASC 606 for all nonpublic business entities that have not issued their 2019 financial statements as of June 3, 2020, until January 1, 2020.

 

As the new standard superseded most existing revenue guidance, it impacted revenue and cost recognition for companies in which we hold an ownership interest. Any change in revenue or cost recognition for companies in which we hold an ownership interest could affect the Company's recognition of its share of the results of its equity method companies. On July 20, 2017, the SEC staff observer at the FASB’s Emerging Issues Task Force ("EITF") meeting announced that the SEC staff will not object if a private company equity method investee meeting the definition of a public business entity that otherwise would not meet the definition of a public business entity except for the inclusion of its financial statements or financial information in another entity’s filings with the SEC, uses private company adoption dates for the new revenue standard.  As a result, the Company's private, calendar year companies adopted the new revenue standard for the year ending December 31, 2019, including a cumulative effect where applicable as of the first day of the 2019 reporting period. 

 

For our ownership interests that have adopted ASU 2014-09, the impact of adoption of the new revenue standard is reflected in the Company’s financial results for the interim and annual reporting periods beginning in 2020 on a one quarter-lag basis.  The impact upon adoption resulted in an increase in accumulated deficit and a decrease in ownership interests of $1.8 million, net, due to the deferral of revenue and certain costs at our underlying ownership interests.  Our results of operations for the year ended December 31, 2020 reflect a benefit of $1.8 million due primarily to the recognition of revenue in 2019 that was previously deferred as a result of the adoption of ASU 2014-09.  Accordingly, the cumulative impact of the adoption of ASU 2014-09 was not significant. 

 
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Ownership Interests and Advances
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]

2. Ownership Interests and Advances

 

The following summarizes the carrying value of the Company’s ownership interests and advances.

 

  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Equity Method:

        

Companies

 $27,550  $34,271 

Private equity funds

  271   271 
   27,821   34,542 

Other Method:

        

Companies

  19,683   27,031 

Private equity funds

  268   453 
   19,951   27,484 

Advances to companies (equity method)

  2,626   15,103 
  $50,398  $77,129 

 

In September 2020, Sonobi, Inc. was acquired by another entity for cash. The Company received $6.6 million in cash proceeds in connection with this transaction, excluding holdbacks and escrows. The Company recognized an insignificant gain on the sale, which is included in Equity income (loss), net in the Consolidated Statements of Operations.

 

During the year ended December 31, 2020, the Company recorded impairments of $11.3 million related to the ownership interests of WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. accounted for under the equity method, which are reflected in Equity income (loss), net in the Consolidated Statement of Operations.  During the year ended December 31, 2020, the Company also recorded impairments of $8.8 million related to the ownership interests of T-REX Group, Inc., b8ta and others accounted for under the Other method, which are reflected in Other income (loss), net in the Consolidated Statement of Operations. The impairments were determined based on declines in the fair value of our ownership interests resulting from reduced valuation expectations and extended exit timelines resulting from the more challenging mergers and acquisitions environment related to COVID-19 and the related uncertain economic impact. The measurement of fair value for these impairments was estimated based on evaluating several valuation inputs available for each of the applicable ownership interests, primarily including the value at which independent third parties have invested, the valuation of comparable public companies, the valuation of acquisitions of similar companies and the present value of our expected outcomes. Assumptions considered within these methods include determining which public companies are comparable, projecting forward revenues for the measured ownership interest, discounts to apply for the lack of marketability or lack of comparability, other factors and the relative weight to apply to each valuation input available. Due to the unobservable nature of some of these inputs, we have determined these fair value estimates to be non-recurring Level 3 fair value measurements.

 

During the year ended December 31, 2020, the Company recorded a $1.5 million non-cash gain based upon an observable price change related to our ownership interest in Flashtalking Inc. accounted for under the Other method, which is reflected in Other income (loss), net in the Consolidated Statement of Operations. During the year ended December 31, 2020, the Company also recorded a $0.3 million non-cash Other loss based on an observable price change for another ownership interest accounted for under the Other method.

 

During 2019, the Company recognized an impairment of $3.0 million related to NovaSom, which is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The impairment was the result of NovaSom Inc.'s August 2019 bankruptcy filing.

 

In January 2019, Propeller was acquired by another entity for cash. The Company received $41.5 million in cash proceeds in connection with the transaction, and $0.7 million in 2020 for amounts held in escrow. The Company recognized a gain of $35.1 million, which is included in Equity income (loss), net in the Consolidated Statements of Operations.

 

In January 2019, Brickwork merged into another privately-held company. The Company received a preferred equity interest in the acquiror and accounts for this interest as an equity interest without a readily determinable fair value. The Company did not recognize a gain or loss in 2019 as a result of this transaction.

 

In May 2019, Transactis was acquired by another entity for cash. To date, the Company received $57.5 million in cash proceeds in connection with the transaction, excluding certain amounts that continue to be held in escrow that may be released on various dates on or before May 2020. The Company has recognized gains of $50.7 million, which are included in Equity income (loss), net in the Consolidated Statements of Operations.

 

During 2019, the Company ceased accounting for T-REX Group, Inc. and Hoopla Software, Inc. under the equity method as a result of losing our ability to exercise significant influence.

 

During 2019, the Company recorded $4.5 million of non-cash gains in Other income (loss), net related to the increase in the value of certain equity securities based upon observable price changes.

 

Summarized Financial Information

 

The following table provides summarized financial information for ownership interests accounted for under the equity method for the periods presented and has been compiled from respective company financial statements, reflect certain historical adjustments, and are reported on a one quarter lag. Results of operations are excluded for periods prior to their acquisition and subsequent to their disposition. Historical results are not adjusted when the Company exits or writes-off a company. 

 

  

As of December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Balance Sheets:

        

Current assets

 $104,024  $91,968 

Non-current assets

  26,352   26,231 

Total assets

 $130,376  $118,199 

Current liabilities

 $72,972  $80,783 

Non-current liabilities

  105,506   87,081 

Shareholders’ deficit

  (48,102)  (49,665)

Total liabilities and shareholders’ deficit

 $130,376  $118,199 
         

Number of equity method ownership interests

  12   13 

 

  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Results of Operations:

        

Revenue

 $153,875  $145,632 

Gross profit

 $92,039  $78,465 

Net loss

 $(82,216) $(127,007)

 

As of December 31, 2020, the Company’s carrying value in equity method companies, in the aggregate, exceeded the Company’s share of the net assets of such companies by approximately $17.9 million. Of this excess, $15.0 million was allocated to goodwill and $2.9 million was allocated to intangible assets.

 
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Note 3 - Acquisitions of Ownership Interests
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Cost and Equity Method Investments Disclosure [Text Block]

3. Acquisitions of Ownership Interests

 

2020 Transactions

 

The Company deployed an additional $2.5 million to Aktana, Inc. during the three month period ended September 30, 2020. The Company had previously deployed an aggregate of $11.7 million. Aktana leverages big data and machine learning to enable pharmaceutical brands to dynamically optimize their strategy and
enhance sales execution.


       The Company deployed an additional $4.4 million to Syapse, Inc. during the six month period ended June 30, 2020, including the $0.6 million of convertible loans deployed in the first quarter of 2020 which was converted to equity in the second quarter. The Company had previously deployed $20.6 million. Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models.

 

The Company deployed an additional $1.0 million to meQuilibrium during the three month period ended March 31, 2020. The Company had previously deployed an aggregate of $13.0 million. meQuilibrium is a digital coaching platform that delivers clinically validated and highly personalized resilience solutions to employers, health plans, wellness providers, and consumers increasing engagement, productivity and performance, as well as improving outcomes in managing stress, health and well-being.

 

The Company funded an additional $0.7 million of convertible loans to Trice Medical, Inc. during the six month period ended June 30, 2020. The Company had previously deployed an aggregate of $10.2 million. Trice is focused on orthopedic diagnostics using fully integrated camera-enabled technologies to provide clinical solutions to physicians.

 

The Company deployed an aggregate of $0.2 million to Clutch Holdings during the three month period ended June 30, 2020. The Company had previously deployed an aggregate of $16.7 million. Clutch provides customer intelligence and personalized engagements that empower consumer-focused businesses to identify, understand and motivate each segment of their customer base.

 

The Company funded an additional $0.2 million of convertible loans to QuanticMind during the three month period ended March 31, 2020. The Company had previously deployed an aggregate of $13.5 million. QuanticMind delivers an intelligent, scalable and fast platform for maximizing digital marketing performance, including paid search and social, for enterprises.  See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 

The Company funded an aggregate of $0.1 million of convertible loans to WebLinc, Inc. during the three month period ended March 31, 2020.  The Company had previously deployed an aggregate of $16.1 million.  WebLinc is an e-commerce platform for online retailers.  See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 

2019 Transactions

 

The Company deployed an additional $5.0 million to Syapse, Inc. 

 

The Company deployed an additional $2.0 million to Moxe Health Corporation, including $0.3 million that was funded initially as a convertible loan. The Company had previously deployed $5.5 million in Moxe Health.

 

The Company deployed an additional $1.5 million to Aktana, Inc. 

 

The Company deployed an additional $1.5 million to meQuilibrium.

 

The Company deployed an additional $1.5 million to Zipnosis, Inc. The Company had previously deployed $8.5 million in Zipnosis. Zipnosis provides health systems with a white-labeled, fully integrated virtual care platform.

 

The Company deployed an aggregate of $0.4 million to Clutch Holdings. 

 

The Company funded an additional $2.0 million of convertible loans to Sonobi, Inc. The Company had previously deployed $11.4 million in Sonobi. Sonobi is an advertising technology developer that was acquired during 2020.  See Note 2 for impairment and sale recorded in 2020.

 

The Company funded an aggregate of $1.1 million of convertible loans to WebLinc, Inc. See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 

The Company funded an aggregate of $1.0 million of convertible loans to NovaSom, Inc. The Company had previously deployed an aggregate of $26.4 million in NovaSom. See Note 2 for impairment recorded during the second quarter of 2019.

 

The Company funded an additional $0.6 million of convertible loans to QuanticMind.  See Note 2 for impairment recorded in 2020 and Note 16 for the sale of this ownership interest in 2021.

 
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Note 4 - Fair Value Measurements
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

4. Fair Value Measurements

 

The Company categorizes its financial instruments into a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.

 

Cash equivalents approximate fair value due to their short term nature.  The Company did not have any Level 2 or Level 3 financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020 and 2019.

 
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Note 5 - Credit Facility and Convertible Debentures
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Long-term Debt [Text Block]

5. Credit Facility and Convertible Debentures

 

Credit Facility     

 

The Company's credit facility was with HPS Investment Partners, LLC (“Lender”), and was amended in May 2018 ("Credit Facility"). The Credit Facility had a scheduled maturity of May 11, 2020 and interest at a rate of either: (A) LIBOR plus 8.5% (subject to a LIBOR floor of 1%), payable on the last day of the one, two or three month interest period applicable to the LIBOR rate advance, or (B) 7.5% plus the greater of: 2%; the Federal Funds Rate plus 0.5%; LIBOR plus 1%; or the U.S. Prime Rate, payable monthly in arrears. The Credit Facility was secured by all of the Company's assets in accordance with the terms of the Credit Facility.

 

The terms of the Credit Facility included a requirement that if the aggregate amount of the Company’s qualified cash at any quarter end date exceeded $50.0 million, the Company would be required to prepay outstanding principal amounts under the Credit Facility, plus any applicable interest and prepayment fees, in an amount equal to such excess. Based on this requirement, the Company made a principal payment of $24.0 million and a make-whole interest payment of $2.9 million on April 15, 2019 based on the Company's qualified cash at March 31, 2019. Additionally, the Company repaid the remaining principal of $44.5 million and make-whole interest of $4.1 million in July 2019.

 

The Company was subject to certain debt covenants under the Credit Facility including maintaining a specified level of liquidity threshold, maintaining an appraised value of ownership interests, limiting deployments to our remaining ownership interests, limiting certain expenses, and restricting any repurchases of outstanding common stock or issuing dividends until such time as the Credit Facility was repaid in full. The Company was in compliance with all applicable covenants.

 

The Credit Facility required prepayments of outstanding principal and interest amounts when the Company’s qualified cash at any quarter end date exceeded $50.0 million. This provision in the Credit Facility was an embedded derivative that was accounted for separately from the Credit Facility. A liability of $0.5 million was recorded on the 2018 amendment date for the fair value of potential future prepayments based upon management's probability weighted cash forecast. This amount was also included in debt issuance costs and had been amortized over the remaining term of the Credit Facility. The liability was adjusted to fair value at each balance sheet date based upon management's updated probability weighted cash forecast. During 2019, the Company recorded a decrease in the liability of $5.1 million, which is included in Other income (loss), net on the Consolidated Statements of Operations.

 

The Company recorded interest expense under the Credit Facility of $14.0 million for the year ended December 31, 2019. The effective interest rate on the Credit Facility was 15.1%. The Company made interest payments under the Credit Facility of $11.5 million for the year ended December 31, 2019.

 
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Note 6 - Equity
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

6. Equity

 

In July 2015, the Company's Board of Directors authorized the Company, from time to time and depending on market conditions, to repurchase up to $25.0 million of the Company's outstanding common stock. During the years ended December 31, 2020 and 2019, the Company did not repurchase any shares under the existing authorization. 

 

In February 2018, the Company's Board of Directors adopted a tax benefits preservation plan (the "Plan") designed to protect and preserve the Company's ability to utilize its net operating loss carryforwards ("NOLs") which was ratified by shareholders at its 2018 Annual Meeting of Shareholders. The purpose of the Plan was to preserve the Company's ability to use its NOLs, which would be substantially limited if the Company experienced an "ownership change" as defined under Section 382 of the Internal Revenue Code. In general, an ownership change would occur if the Company's shareholders who are treated as owning five percent or more of the outstanding shares of Safeguard for purposes of Section 382 ("five-percent shareholders") collectively increase their aggregate ownership in the Company's overall shares outstanding by more than 50 percentage points. Whether this change has occurred would be measured by comparing each five-percent shareholder's current ownership as of the measurement date to such shareholders' lowest ownership percentage during the three-year period preceding the measurement date. To protect the Company's NOLs from being limited or permanently lost under Section 382, the Plan was intended to deter any person or group from acquiring beneficial ownership of 4.99% or more of the Company's outstanding common stock without the approval of the Board, reducing the likelihood of an unintended ownership change. Under the Plan, the Company would issue one preferred stock purchase right (the "Rights") for each share of Safeguard's common stock held by shareholders of record on March 2, 2018. The issuance of the Rights would not be taxable to Safeguard or its shareholders and would not affect Safeguard's reported earnings per share. The Rights would have traded with Safeguard's common shares and would have expired no later than February 19, 2021. Accordingly, the Plan has now expired.  

 

On November 7, 2019, the Board of Directors declared a special cash dividend of $1.00 per share, payable on December 30, 2019 to shareholders of record as of the close of business on December 23, 2019, resulting in total dividends paid of $20.7 million.

 
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Stock-Based Compensation
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

7. Stock-Based Compensation

 

Equity Compensation Plans

 

The 2014 Equity Compensation Plan has 4.1 million shares authorized for issuance. During 2020 and 2019, the Company issued no stock-based awards outside of existing plans. To the extent allowable, service-based options are incentive stock options. Options granted under the plans are at prices equal to or greater than the fair market value at the date of grant. Upon exercise of stock options, the Company issues shares first from treasury stock, if available, then from authorized but unissued shares. At December 31, 2020, the Company had reserved 2.8 million shares of common stock for possible future issuance under its 2014 Equity Compensation Plan and other previously expired equity compensation plans.

 

Classification of Stock-Based Compensation Expense

 

Stock-based compensation expense was recognized in the Consolidated Statements of Operations as follows: 

 

  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

General and administrative expense

 $965  $1,237 
  $965  $1,237 

 

At December 31, 2020, the Company had outstanding options that vest based on two different types of vesting schedules:

 

1) performance-based; and

 

2) service-based.

 

Performance-based awards entitle participants to vest in a number of awards determined by achievement by the Company of target capital returns based on net cash proceeds received by the Company upon the sale, merger or other exit transaction of certain identified companies. Vesting may occur, if at all, once per year. The requisite service periods for the performance-based awards are based on the Company’s estimate of when the performance conditions will be met. Compensation expense is recognized for performance-based awards for which the performance condition is considered probable of achievement. Compensation expense is recognized over the requisite service periods using the straight-line method but is accelerated if capital return targets are achieved earlier than estimated.  The Company did not issue any performance-based units during the years ended December 31, 2020 and 2019.  During the years ended December 31, 2020 and 2019, there were no performance-based options that vested.  During the years ended December 31, 2020 and 2019, respectively, 72 thousand and 174 thousand performance-based options were canceled or forfeited. The Company recorded a reduction of compensation expense related to performance-based options of $0.0 million and $0.1 million for the years ended December 31, 2020 and 2019 respectively. The maximum number of unvested options at December 31, 2020 attainable under these grants was 21 thousand shares.

 

Service-based awards generally vest over four years after the date of grant and expire eight years after the date of grant. Compensation expense is recognized over the requisite service period using the straight-line method. The requisite service period for service-based awards is the period over which the award vests. During the years ended December 31, 2020 and 2019, respectively, the Company issued no service-based options to employees and recorded $0.0 million compensation expense from the vesting of previously issued awards. During the years ended December 31, 2020 and 2019, respectively, 62 thousand and 57 thousand service-based options were canceled or forfeited.  

 

There were no options granted during 2020 and 2019.

 

Stock-based compensation expense of $1.0 million was recognized during the year ended December 31, 2020 related to Board fees and management bonuses earned in 2020 that were subsequently settled in stock.  The Company had liabilities of $0.5 million and $0.1 million as of December 31, 2020 and 2019, respectively, that were settled through the issuance of common stock in the subsequent period. Compensation expense of $0.1 million was also recognized during the year ended December 31, 2019 related to the dividend payments made to holders of unvested restricted stock awards pursuant to the terms of those instruments.  

 

Option activity of the Company is summarized below: 

 

  

Shares

  Weighted Average Exercise Price  

Weighted Average Remaining Contractual Life

  Aggregate Intrinsic Value 
  

(In thousands)

      

(In years)

  

(In thousands)

 

Outstanding at January 1, 2019

  410   14.66         

Options granted

  —   —         

Options exercised

  —   —         

Options canceled/forfeited

  (231)  14.19         

Outstanding at December 31, 2019

  179   15.27         

Options granted

  —   —         

Options exercised

  —   —         

Options canceled/forfeited

  (134)  14.36         

Outstanding at December 31, 2020

  45   14.20   2.29  $— 

Options exercisable at December 31, 2020

  22   14.48   3.08   — 

Shares available for future grant

  2,515             

 

At December 31, 2020, total unrecognized compensation cost related to non-vested service-based options was immaterial. At December 31, 2020, total unrecognized compensation cost related to non-vested performance-based options was immaterial.

 

Performance-based stock units vest based on achievement by the Company of target capital returns based on net cash proceeds received by the Company on the sale, merger or other exit transaction of certain identified companies, as described above related to performance-based awards. During 2020, the Company also initiated a 2021 CEO bonus award that will be settled in the vesting of performance-based units based on criteria determined by the Board of Directors.  Performance-based stock units represent the right to receive shares of the Company’s common stock, on a one-for-one basis at target or up to 120% for certain specified thresholds.  The maximum fair value associated with this award is $0.7 million, none of which has been recognized during the year ended December 31, 2020.  During the years ended December 31, 2020 and 2019, respectively, 100 thousand and 0 performance-based stock units were issued. No performance-based stock units vested during the years ended December 31, 2020 and 2019. During the years ended December 31, 2020 and 2019, respectively, 129 thousand and 339 thousand performance-based stock units were canceled or forfeited. Under the terms of the 2016 and 2015 performance-based awards, once performance-based stock units are fully vested, participants are entitled to receive cash payments based on their initial performance grant values as target capital returns described above are exceeded. At December 31, 2020, the liability associated with such potential cash payments was $0.0 million.

 

During the years ended December 31, 2020 and 2019, respectively, the Company issued 193 thousand and 31 thousand restricted shares to employees and directors. Restricted shares generally vest over a period of approximately two to four years, or are vested at issuance for directors 65 or older. During the years ended December 31, 2020 and 2019, respectively, 10 thousand and 75 thousand restricted shares were canceled or forfeited.

 

During the years ended December 31, 2020 and 2019, respectively, the Company issued 20 thousand to an employee, and 0 deferred stock units to non-employee directors for annual service grants or fees earned during the preceding quarter. Deferred stock units issued to directors in lieu of directors fees are 100% vested at the grant date; matching deferred stock units equal to 25% of directors’ fees deferred vest one year following the grant date or, if earlier, upon reaching age 65. Deferred stock units are payable in stock on a one-for-one basis. Payments related to the deferred stock units are generally distributable following termination of service, death or permanent disability.

 

Total compensation expense for deferred stock units, performance-based stock units and restricted stock was $0.5 million and $1.2 million, for the years ended December 31, 2020 and 2019, respectively. Unrecognized compensation expense related to deferred stock units, performance stock units and restricted stock at December 31, 2020 was $0.5 million. The total fair value of deferred stock units, performance stock units and restricted stock vested during the years ended December 31, 2020 and 2019 was $1.1 million and $1.2 million, respectively.

 

Deferred stock unit, performance-based stock unit and restricted stock activity are summarized below: 

 

  

Shares

  Weighted Average Grant Date Fair Value 
  

(In thousands)

     

Unvested at January 1, 2019

  777  $14.08 

Granted

  31   12.12 

Vested

  (107)  11.79 

Forfeited

  (414)  14.28 

Unvested at December 31, 2019

  287   14.44 

Granted

  313   5.89 

Vested

  (174)  7.77 

Forfeited

  (139)  15.24 

Unvested at December 31, 2020

  287   8.78 

 
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Note 8 - Employee Benefit Plan
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Compensation and Employee Benefit Plans [Text Block]

8. Employee Benefit Plan

 

The Company maintains a qualified 401(k) retirement plan for eligible employees. The Plan’s matching formula is 100% of the first 5% of participants’ qualified compensation. Compensation expense related to our matching contributions to the Plan for the years ended December 31, 2020 and 2019, were $0.2 million and $0.2 million, respectively.

 
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Income Taxes
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

9. Income Taxes

 

The federal and state provision (benefit) for income taxes was $0.0 million for the years ended December 31, 2020 and 2019.

 

The total income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21.0% for the years ended December 31, 2020 and 2019 to net income (loss) before income taxes as a result of the following:

 

  

Year Ended December 31,

 
  

2020

  

2019

 

Statutory tax (benefit) expense

  21.0%  21.0%

Increase (decrease) in taxes resulting from:

        

Nondeductible expenses

  (4.1)  0.4 

Valuation allowance

  (16.9)  (21.4)
   0.0%  0.0%

 

The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets were as follows: 

 

  

As of December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Deferred tax asset:

        

Carrying values of ownership interests and other holdings

 $38,361  $32,760 

Tax loss and credit carryforwards

  76,023   70,914 

Disallowed interest carryforwards

  7,292   7,292 

Accrued expenses

  497   213 

Stock-based compensation

  302   432 

Other

  482   604 
   122,957   112,215 

Valuation allowance

  (122,957)  (112,215)

Net deferred tax asset

 $—  $— 

 

As of December 31, 2020, the Company and its subsidiaries had federal net operating and capital loss carryforwards for tax purposes of approximately $362 million, of which approximately $37 million have an indefinite life. These carryforwards expire as follows: 

 

  

Total

 
  

(In thousands)

 

2021

 $3,728 

2022

  48,848 

2023

  52,512 

2024

  50,140 

2025 and thereafter

  170,189 
  $325,417 

 

In assessing the recoverability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that it is more likely than not that certain future tax benefits may not be realized as a result of current and future income. Accordingly, a valuation allowance has been recorded against substantially all of the Company’s deferred tax assets.

 

The Company recognizes in its Consolidated Financial Statements the impact of a tax position if that position is more likely than not to be sustained upon examination, based on the technical merits of the position. All uncertain tax positions relate to unrecognized tax benefits that would impact the effective tax rate when recognized.

 

The Company does not expect any material increase or decrease in its income tax expense, in the next twelve months, related to examinations or changes in uncertain tax positions.

 

There were no changes in the Company’s uncertain tax positions for the years ended December 31, 2020 and 2019.

 

The Company files income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Tax years 2015 and forward remain open for examination for federal tax purposes and the Company’s more significant state tax jurisdictions. To the extent utilized in future years’ tax returns, net operating loss carryforwards at December 31, 2020 will remain subject to examination until the respective tax year is closed. The Company recognizes penalties and interest accrued related to income tax liabilities in income tax benefit (expense) in the Consolidated Statements of Operations.

 
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Note 10 - Net Income (Loss) Per Share
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Earnings Per Share [Text Block]

10. Net Income (Loss) Per Share

 

The calculations of net income (loss) per share were: 

 

  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands, except per share data)

 

Basic:

        

Net income (loss)

 $(37,615) $54,561 

Weighted average common shares outstanding

  20,751   20,636 

Net income (loss) per share

 $(1.81) $2.64 

Diluted:

        

Net income (loss)

 $(37,615) $54,561 

Weighted average common shares outstanding

  20,751   20,636 

Net income (loss) per share

 $(1.81) $2.64 

 

Basic and diluted average common shares outstanding for purposes of computing net income (loss) per share includes outstanding common shares and vested deferred stock units (DSUs).

 

If an equity method company has dilutive stock options, unvested restricted stock, DSUs, or warrants, diluted net income (loss) per share is computed by first deducting from net income (loss) the income attributable to the potential exercise of the dilutive securities of the company from net income (loss). Any impact is shown as an adjustment to net income (loss) for purposes of calculating diluted net income (loss) per share.

 

Diluted income (loss) per share for the years ended December 31, 2020 and 2019 do not reflect the following potential shares of common stock that would have an anti-dilutive effect or have unsatisfied performance or market conditions:

 

 

•

At December 31, 2020 and 2019, options to purchase 45 thousand and 179 thousand shares of common stock, respectively, at prices ranging from $10.37 to $17.11 per share, and $10.37 to $18.45 per share per share, respectively, were excluded from the calculation.

 

 

•

At December 31, 2020 and 2019, unvested restricted stock, performance-based stock units and DSUs convertible into 0.3 million and 0.3 million shares of stock, respectively, were excluded from the calculations.

 

 

•

For the year ended December 31, 2019, 0.8 million shares of common stock, respectively, representing the effect of assumed conversion of the 2019 Debentures were excluded from the calculations.

 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Note 11 - Related Party Transactions
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

11. Related Party Transactions

 

In the normal course of business, the Company’s officers and employees hold board positions with companies in which the Company has a direct or indirect ownership interest.

 
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Note 12 - Commitments and Contingencies
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]

12. Commitments and Contingencies

 

The Company and the companies in which it holds ownership interests are involved in various claims and legal actions arising in the ordinary course of business. In the current opinion of the Company, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations, however, no assurance can be given as to the outcome of these actions, and one or more adverse rulings could have a material adverse effect on the Company’s consolidated financial position and results of operations or that of its companies. The Company records costs associated with legal fees as such services are rendered.

 

The Company had outstanding guarantees of $3.8 million at December 31, 2020 which related to one of the Company's private equity holdings.

 

In October 2001, the Company entered into an agreement with a former Chairman and Chief Executive Officer of the Company, to provide for annual payments of $0.65 million per year and certain health care and other benefits for life. The former executive passed away in 2019. Accordingly, the Company recorded a $1.7 million gain in Other income (loss), net which also eliminated the remaining projected benefits related to this agreement that were previously included in Accrued expenses and other current liabilities and Other long-term liabilities on the Consolidated Balance Sheets.

 

The Company has agreements with certain employees that provide for severance payments to the employee in the event the employee is terminated without cause or an employee terminates his employment for “good reason.” The maximum aggregate exposure under severance agreements for remaining employees is approximately $2.3 million at December 31, 2020.

 

In 2018, the Board of Directors (the “Board”) of the Company adopted a long-term incentive plan, which was amended in February 2019 and June 2020, known as the Amended and Restated Safeguard Scientifics Transaction Bonus Plan (the “LTIP”). The purpose of the LTIP is to promote the interests of the Company and its shareholders by providing an additional incentive to employees to maximize the value of the Company in connection with the execution of the business strategy that the Company adopted and announced in January 2018. The June 2020 amendment lowered the level of the first threshold and the resulting bonus pool percentage as an incentive to employees to accelerate actions consistent with the business strategy.  Under the LTIP, participants, which include certain current and former employees, have received awards that may result in cash payments in connection with sales of the Company’s ownership interests (“Sale Transaction(s)”). The LTIP provides for a bonus pool corresponding to: (i) specified vesting thresholds or (ii) specified events. In the first case, the bonus pool will range from an amount equal to 0.2% (previously 1.0%) of received proceeds at the first threshold to 1.3% at higher thresholds and no bonus pool will be created if the transaction consideration is less than certain minimum thresholds. In the second case, a minimum pool will be created and paid under specified circumstances. The bonus pool will be allocated and paid to participants in the LTIP based on the product of (i) the participant’s applicable bonus pool percentage and (ii) the bonus pool calculated as of the vesting date, minus any previously paid portion of the bonus pool. Any portion of the bonus pool available as of the applicable vesting date that is reserved will be allocated in connection with each vesting date so that the entire bonus pool available as of such vesting date is allocated and payable to participants. Subject to the terms of the LTIP, payments under the LTIP will be paid in cash within 60 days of the applicable vesting date. All current officers and employees of the Company are eligible to participate in the LTIP. The Board, in its sole discretion, will determine the participants to whom awards are granted under the LTIP. The Company has accrued approximately $1.8 million under the LTIP as of   December 31, 2020, which $1.5 million is estimated as current accrued compensation.

 

In June 2011, Advanced BioHealing, Inc. (“ABH”) was acquired by Shire plc (“Shire”).  Prior to the expiration of the escrow period in March 2012, Shire filed a claim against all amounts held in escrow related to the sale based principally upon a United States Department of Justice (“DOJ”) false claims act investigation relating to ABH (the “Investigation”). In connection with the Investigation, in July 2015 the Company received a Civil Investigation Demand-Documentary Material (“CID”) from the DOJ regarding ABH and Safeguard’s relationship with ABH. Pursuant to the CID, the Company provided the requested materials and information.  To the Company’s knowledge, the CID was related to multiple qui tam (“whistleblower”) actions, one of which was filed in 2014 by an ex-employee of ABH that named the Company and one of the Company’s employees along with other entities and individuals as defendants.  At this time, the DOJ has declined to pursue the qui tam action as it relates to the Company and such Company employee. In addition, in connection with the above matters, the Company and other former equity holders in ABH entered into a settlement and release with Shire, which resulted in the release to Shire of all amounts held in escrow related to the sale of ABH.

 
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Note 13 - Supplemental Cash Flow Information
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Cash Flow, Supplemental Disclosures [Text Block]

13. Supplemental Cash Flow Information

 

During the years ended December 31, 2020 and 2019, the Company converted $6.8 million and $2.3 million, respectively, of advances into ownership interests. Cash paid for interest for the years ended December 31, 2020 and 2019 was $0.0 million and $11.5 million, respectively. Cash paid for taxes in each of the years ended December 31, 2020 and 2019 was $0.0 million.

 
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Note 14 - Segment Reporting
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

14. Segment Reporting

 

The Company operates as one operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 

As of December 31, 2020, the Company held ownership interests accounted for using the equity method in 12 non-consolidated companies. During 2019 we ceased using the equity method of accounting for Hoopla Software, Inc. and T-REX Group, Inc. as a result of other new investors diluting our interest. We have retained our ownership interests in those companies under the Other accounting method.

 

Certain of the Company’s ownership interests as of December 31, 2020 and 2019 included the following:

 

  Safeguard Primary Ownership as of December 31,  

Company Name

 

2020

 

2019

 

Accounting Method

Aktana, Inc.

  15.1%  17.8% 

Equity

Clutch Holdings, Inc.

  42.3%  41.2% 

Equity

Flashtalking, Inc.

  13.4%  10.1% 

Other

InfoBionic, Inc.

  25.2%  25.2% 

Equity

Lumesis, Inc.

  43.4%  43.5% 

Equity

MediaMath, Inc.

  13.3%  13.3% 

Other

meQuilibrium

  32.0%  32.7% 

Equity

Moxe Health Corporation

  27.6%  29.9% 

Equity

Prognos Health Inc.

  28.5%  28.7% 

Equity

QuanticMind, Inc. *

  24.2%  24.2% 

Equity

Syapse, Inc.

  18.9%  20.0% 

Equity

T-REX Group, Inc.

  13.5%  13.7% 

Other

Trice Medical, Inc.

  16.6%  16.6% 

Equity

WebLinc, Inc. *

  39.9%  38.5% 

Equity

Zipnosis, Inc

  37.2%  37.7% 

Equity

 

* These entities were sold subsequent to December 31, 2020.  See Note 16 - Subsequent Events, of the consolidated financials statements.

 

As of December 31, 2020 and 2019, all of the Company’s assets were located in the United States.

 
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Note 15 - Selected Quarterly Financial Information (Unaudited)
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Quarterly Financial Information [Text Block]

15. Selected Quarterly Financial Information (Unaudited)  

 

  

Three Months Ended

 
  

March 31

  

June 30

  

September 30 (b)

  

December 31 (b)

 
  

(In thousands, except per share data)

 

2020:

                

General and administrative expense

 $3,532  $2,028  $2,275  $1,631 

Operating loss

  (3,532)  (2,028)  (2,275)  (1,631)

Other income (loss), net

  (3,567)  (2,658)  (820)  (663)

Interest income

  105   52   52   52 

Equity income (loss), net

  (9,014)  (5,277)  (1,300)  (5,111)

Net loss before income taxes

  (16,008)  (9,911)  (4,343)  (7,353)

Income tax benefit (expense)

  —   —   —   — 

Net loss

 $(16,008) $(9,911) $(4,343) $(7,353)

Net loss per share (a)

                

Basic

 $(0.77) $(0.48) $(0.21) $(0.35)

Diluted

 $(0.77) $(0.48) $(0.21) $(0.35)

2019:

                

General and administrative expense

 $3,057  $2,603  $2,262  $2,060 

Operating loss

  (3,057)  (2,603)  (2,262)  (2,060)

Other income (loss), net

  (1,885)  3,118   8,777   2,245 

Interest income

  873   763   234   174 

Interest expense

  (2,535)  (5,682)  (5,806)  — 

Equity income (loss), net

  28,267   40,497   (3,440)  (1,057)

Net income (loss) before income taxes

  21,663   36,093   (2,497)  (698)

Income tax benefit (expense)

  —   —   —   — 

Net income (loss)

 $21,663  $36,093  $(2,497) $(698)

Net income (loss) per share (a)

                

Basic

 $1.05  $1.75  $(0.12) $(0.03)

Diluted

 $1.05  $1.75  $(0.12) $(0.03)

 

 

(a)

Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts may not add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts may not add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests.

 

(b)

The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.

 
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Note 16 - Subsequent Events
 12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Subsequent Events [Text Block]

16. Subsequent Events

 

In January 2021, WebLinc, Inc. was acquired by another entity.  To date, the Company received $3.2 million in cash proceeds and may receive additional amounts over the next 24 months based on certain transitional performance activities, which could be partially offset by indemnifiable claims.  During February 2021, QuanticMind, Inc. was acquired by another entity, however there were no resultant proceeds.

 

During February 2021, Syapse raised $68 million of preferred capital which reduced our ownership interest to approximately 11%.

 
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]

Principles of Consolidation

 

The consolidated financial statements include the accounts of Safeguard and all of its subsidiaries in which a controlling financial interest is maintained. All intercompany accounts and transactions are eliminated in consolidation.

 
Investment, Policy [Policy Text Block]

Principles of Accounting for Ownership Interests in Companies

 

The Company accounts for its ownership interests using one of the following methods: Equity or Other. The accounting method applied is generally determined by the degree of the Company's influence over the entity, primarily determined by our voting interest in the entity.

 

In addition to holding voting and non-voting equity and debt securities, the Company also periodically makes advances to its companies in the form of promissory notes which are included in the Ownership interests and advances on the Consolidated Balance Sheets.

 

Equity Method. The Company accounts for ownership interests whose results are not consolidated, but over which it exercises significant influence, under the equity method of accounting. Whether or not the Company exercises significant influence with respect to an ownership interest depends on an evaluation of several factors including, among others, representation on the board of directors and our ownership level, which is generally a 20% to 50% interest in the voting securities of a company, including voting rights associated with the Company’s holdings in common, preferred and other convertible instruments in the company. Under the equity method of accounting, the Company does not reflect a company’s financial statements within our Consolidated Financial Statements; however, our share of the income or loss of such company is reflected in Equity income (loss), net in the Consolidated Statements of Operations. The Company includes the carrying value of equity method companies in Ownership interests and advances on the Consolidated Balance Sheets. Any excess of the Company’s cost over its underlying interest in the net assets of equity method companies that is allocated to intangible assets is amortized over the estimated useful lives of the related intangible assets. The Company reflects its share of the income or loss of the equity method companies on a one quarter lag. This reporting lag could result in a delay in recognition of the impact of changes in the business or operations of these companies.

 

When the Company’s carrying value in an equity method company is reduced to zero, the Company records no further losses in its Consolidated Statements of Operations unless the Company has an outstanding guarantee obligation or has committed additional funding to such equity method company. When such equity method company subsequently reports income, the Company will not record its share of such income until it exceeds the amount of the Company’s share of losses not previously recognized.

 

Other Method. We account for our equity interests in companies which are not accounted for under the equity method as equity securities without readily determinable fair values. We estimate the fair value of these securities based on our original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Under this method, our share of the income or losses of such companies is not included in our Consolidated Statements of Operations. We include the carrying value of these investments in Ownership interests and advances on the Consolidated Balance Sheets.

 
Use of Estimates, Policy [Policy Text Block]

Accounting Estimates

 

The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests and advances, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.

 

Certain amounts recorded to reflect the Company’s share of income or losses for companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities’ financial statements are completed.

 

It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests and advances could change in the near term and that the effect of such changes on the consolidated financial statements could be material. At December 31, 2020, the Company believes the carrying value of the Company’s ownership interests and advances is not impaired, although there can be no assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future or that a significant loss will not be recorded in the future upon the sale of a company.

 
Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents and Marketable Securities

 

The Company considers all highly liquid instruments with an original maturity of 90 days or less at the time of purchase to be cash equivalents. Cash and cash equivalents consist of deposits that are readily convertible into cash. The Company determines the appropriate classification of marketable securities at the time of purchase and reevaluates such designation as of each balance sheet date. Held-to-maturity securities were carried at amortized cost, which approximated fair value. Marketable securities consisted of held-to-maturity securities, primarily consisting of government agency bonds, commercial paper and certificates of deposits. Marketable securities with a maturity date greater than one year from the balance sheet date would be considered long-term. The Company has not experienced any significant losses on cash equivalents and does not believe it is exposed to any significant credit risk on cash and cash equivalents.

 
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]

Restricted Cash

 

Restricted cash equivalents represents cash required to be set aside by a contractual agreement as a shareholder representative. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets:

 

  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Cash and cash equivalents

 $15,601  $25,028 

Restricted cash

  —   25 

Total cash, cash equivalents and restricted cash

 $15,601  $25,053 

 
Fair Value of Financial Instruments, Policy [Policy Text Block]

Financial Instruments

 

The Company’s financial instruments (principally cash and cash equivalents, marketable securities, accounts receivable, notes receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. 

 
Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

 

Property and equipment represents right-of-use assets resulting from the adoption of Accounting Standards Update ("ASU") No. 2016-02, Leases, and other previously existing leasehold improvements. The leasehold improvements were amortized over the shorter of the estimated useful lives or the expected remaining term of the lease. The right-of-use assets are reduced over the remaining term of the applicable lease (principally April 2026) in a manner that results in a straight-line lease expense, when combined with the interest factor on the lease liability.     

 
Lessee, Leases [Policy Text Block]

Lease liability

 

The initial lease liability represents the present value of the fixed escalating lease payments through April 2026 associated with the Company's prior corporate headquarters operating office lease. The discount rate used to calculate the lease liability was based on the Company's incremental borrowing rate, approximately 12%, at the transition to the guidance of ASU No. 2016-02, Leases. Subsequent values of the lease liability reflect the reduction in the lease liability for operating lease payments less an amount representing interest, which is included in the straight-line lease expense. There is no residual value guarantee associated with this operating lease arrangement. The Company has incurred operating lease expenses and operating cash outflows of $0.5 million for each of the years ended December 31, 2020 and 2019, respectively, and $0.6 million for each of the years ended December 31, 2020 and 2019.

 

In March 2019, the Company entered into a sublease of its prior corporate headquarters office space. The term of the sublease is through April 2026, the same as the Company's underlying lease. Fixed sublease payments to the Company are escalating over the term of the sublease and are reported as a component of general and administrative expenses.

 

In April 2019, the Company entered into a sublease for replacement office space with a related party, an equity method ownership interest, beginning in June 2019. The 18 month term of this sublease expired in 2020. The aggregate payments under this sublease were not material.

 

A summary of the Company's operating lease cash flows at December 31, 2020 follows:

 

  Operating lease payments  

Expected sublease receipts

 
  

(In thousands)

 

2021

 $595  $525 

2022

  601   540 

2023

  607   556 

2024

  613   573 

2025

  619   590 

2026

  208   199 

Thereafter

  —   — 

Total future minimum lease payments

  3,243   2,983 

Less imputed interest

  (863)    

Total operating lease liabilities

 $2,380     

 
Valuation of Credit Facility Repayment Feature, Policy [Policy Text Block]

Valuation of Credit Facility repayment feature

 

The fair value of the Credit Facility repayment feature (a Level 3 measurement) was determined quarterly based on the present value of make-whole interest payments that were expected to be paid based on cash flow estimates that included a probability weighted estimate of exit transactions, estimated follow-on deployments, estimated quarterly operating cash flows and other cash commitments that would have resulted in qualified cash exceeding the $50 million threshold specified in the Credit Facility. This fair value of the Credit Facility repayment feature was eliminated in July 2019 upon the repayment of the Credit Facility.

 
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Ownership Interests and Advances

 

On a periodic basis, but no less frequently than quarterly, the Company evaluates the carrying value of its ownership interests and advances for possible impairment based on achievement of business plan objectives and milestones, the estimated fair value of each company relative to its carrying value, the financial condition and prospects of the company and other relevant factors. The business plan objectives and milestones the Company considers include, among others, those related to financial performance, such as achievement of planned financial results or completion of capital raising activities, and those that are not primarily financial in nature, such as hiring of key employees or the establishment of strategic relationships.

 

Management then determines whether there has been an other than temporary decline in the value of its ownership interest in the company. Impairment is measured as the amount by which the carrying value of an asset exceeds its estimated fair value.

 

The estimated fair value of privately held companies is generally determined based on the value at which independent third parties have invested or have committed to invest in these companies or based on other valuation methods, including discounted cash flows, valuation of comparable public companies and the valuation of acquisitions of similar companies.

 

Impairment charges related to equity method companies are included in Equity income (loss), net in the Consolidated Statements of Operations. Impairment charges related to non-equity method companies and funds are included in Other income (loss), net in the Consolidated Statements of Operations.

 

The reduced cost basis of a previously impaired company accounted for using the Equity method are not written-up if circumstances suggest the value of the company has subsequently recovered.

 
Income Tax, Policy [Policy Text Block]

Income Taxes

 

The Company accounts for income taxes under the asset and liability method whereby deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. The Company measures deferred tax assets and liabilities using enacted tax rates in effect for the year in which the temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period of the enactment date. The Company provides a valuation allowance against the net deferred tax asset for amounts which are not considered more likely than not to be realized.

 
Earnings Per Share, Policy [Policy Text Block]

Net Income (Loss) Per Share

 

The Company computes net income (loss) per share using the weighted average number of common shares outstanding during each year. The Company includes in diluted net income (loss) per share common stock equivalents (unless anti-dilutive) which would arise from the exercise of stock options and conversion of other convertible securities and adjusted, if applicable, for the effect on net income (loss) of such transactions. Diluted net income (loss) per share calculations adjust net income (loss) for the dilutive effect of common stock equivalents and convertible securities issued by the Company’s consolidated or equity method companies.

 
Segment Reporting, Policy [Policy Text Block]

Segment Information

 

The Company operates as one operating segment based upon the similar nature of its technology-driven companies, the functional alignment of the organizational structure, and the reports that are regularly reviewed by the chief operating decision maker for the purpose of assessing performance and allocating resources.

 
New Accounting Pronouncements, Policy [Policy Text Block]

Recently Adopted Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASU 2014-09"). ASU 2014-09 and related subsequent amendments outline a single comprehensive model to use to account for revenue arising from contracts with customers and supersede most current revenue recognition guidance. For public companies, the guidance was effective for annual periods beginning after December 15, 2017 and any interim periods that fall within that reporting period. For nonpublic companies, the guidance is effective for annual periods beginning after December 15, 2018 and interim periods within annual periods beginning after December 15, 2019 with early adoption permitted. Additionally, on June 3, 2020 the FASB issued ASU 2020-05, which extended the adoption of ASC 606 for all nonpublic business entities that have not issued their 2019 financial statements as of June 3, 2020, until January 1, 2020.

 

As the new standard superseded most existing revenue guidance, it impacted revenue and cost recognition for companies in which we hold an ownership interest. Any change in revenue or cost recognition for companies in which we hold an ownership interest could affect the Company's recognition of its share of the results of its equity method companies. On July 20, 2017, the SEC staff observer at the FASB’s Emerging Issues Task Force ("EITF") meeting announced that the SEC staff will not object if a private company equity method investee meeting the definition of a public business entity that otherwise would not meet the definition of a public business entity except for the inclusion of its financial statements or financial information in another entity’s filings with the SEC, uses private company adoption dates for the new revenue standard.  As a result, the Company's private, calendar year companies adopted the new revenue standard for the year ending December 31, 2019, including a cumulative effect where applicable as of the first day of the 2019 reporting period. 

 

For our ownership interests that have adopted ASU 2014-09, the impact of adoption of the new revenue standard is reflected in the Company’s financial results for the interim and annual reporting periods beginning in 2020 on a one quarter-lag basis.  The impact upon adoption resulted in an increase in accumulated deficit and a decrease in ownership interests of $1.8 million, net, due to the deferral of revenue and certain costs at our underlying ownership interests.  Our results of operations for the year ended December 31, 2020 reflect a benefit of $1.8 million due primarily to the recognition of revenue in 2019 that was previously deferred as a result of the adoption of ASU 2014-09.  Accordingly, the cumulative impact of the adoption of ASU 2014-09 was not significant. 

 
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Note 1 - General (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Restrictions on Cash and Cash Equivalents [Table Text Block]
  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Cash and cash equivalents

 $15,601  $25,028 

Restricted cash

  —   25 

Total cash, cash equivalents and restricted cash

 $15,601  $25,053 
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]
  Operating lease payments  

Expected sublease receipts

 
  

(In thousands)

 

2021

 $595  $525 

2022

  601   540 

2023

  607   556 

2024

  613   573 

2025

  619   590 

2026

  208   199 

Thereafter

  —   — 

Total future minimum lease payments

  3,243   2,983 

Less imputed interest

  (863)    

Total operating lease liabilities

 $2,380     
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Ownership Interests and Advances (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]
  

December 31, 2020

  

December 31, 2019

 
  

(In thousands)

 

Equity Method:

        

Companies

 $27,550  $34,271 

Private equity funds

  271   271 
   27,821   34,542 

Other Method:

        

Companies

  19,683   27,031 

Private equity funds

  268   453 
   19,951   27,484 

Advances to companies (equity method)

  2,626   15,103 
  $50,398  $77,129 
Equity Method Investment Partner Company Results Of Operation [Table Text Block]
  

As of December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Balance Sheets:

        

Current assets

 $104,024  $91,968 

Non-current assets

  26,352   26,231 

Total assets

 $130,376  $118,199 

Current liabilities

 $72,972  $80,783 

Non-current liabilities

  105,506   87,081 

Shareholders’ deficit

  (48,102)  (49,665)

Total liabilities and shareholders’ deficit

 $130,376  $118,199 
         

Number of equity method ownership interests

  12   13 
Equity Method Investments [Table Text Block]
  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Results of Operations:

        

Revenue

 $153,875  $145,632 

Gross profit

 $92,039  $78,465 

Net loss

 $(82,216) $(127,007)
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Share-based Payment Arrangement, Activity [Table Text Block]
  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

General and administrative expense

 $965  $1,237 
  $965  $1,237 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
  

Shares

  Weighted Average Exercise Price  

Weighted Average Remaining Contractual Life

  Aggregate Intrinsic Value 
  

(In thousands)

      

(In years)

  

(In thousands)

 

Outstanding at January 1, 2019

  410   14.66         

Options granted

  —   —         

Options exercised

  —   —         

Options canceled/forfeited

  (231)  14.19         

Outstanding at December 31, 2019

  179   15.27         

Options granted

  —   —         

Options exercised

  —   —         

Options canceled/forfeited

  (134)  14.36         

Outstanding at December 31, 2020

  45   14.20   2.29  $— 

Options exercisable at December 31, 2020

  22   14.48   3.08   — 

Shares available for future grant

  2,515             
Schedule Of Activity For Restricted Stock Units Deferred Stock Units And Performance Units [Table Text Block]
  

Shares

  Weighted Average Grant Date Fair Value 
  

(In thousands)

     

Unvested at January 1, 2019

  777  $14.08 

Granted

  31   12.12 

Vested

  (107)  11.79 

Forfeited

  (414)  14.28 

Unvested at December 31, 2019

  287   14.44 

Granted

  313   5.89 

Vested

  (174)  7.77 

Forfeited

  (139)  15.24 

Unvested at December 31, 2020

  287   8.78 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

Year Ended December 31,

 
  

2020

  

2019

 

Statutory tax (benefit) expense

  21.0%  21.0%

Increase (decrease) in taxes resulting from:

        

Nondeductible expenses

  (4.1)  0.4 

Valuation allowance

  (16.9)  (21.4)
   0.0%  0.0%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

As of December 31,

 
  

2020

  

2019

 
  

(In thousands)

 

Deferred tax asset:

        

Carrying values of ownership interests and other holdings

 $38,361  $32,760 

Tax loss and credit carryforwards

  76,023   70,914 

Disallowed interest carryforwards

  7,292   7,292 

Accrued expenses

  497   213 

Stock-based compensation

  302   432 

Other

  482   604 
   122,957   112,215 

Valuation allowance

  (122,957)  (112,215)

Net deferred tax asset

 $—  $— 
Summary of Operating Loss Carryforwards [Table Text Block]
  

Total

 
  

(In thousands)

 

2021

 $3,728 

2022

  48,848 

2023

  52,512 

2024

  50,140 

2025 and thereafter

  170,189 
  $325,417 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Note 10 - Net Income (Loss) Per Share (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
  

Year Ended December 31,

 
  

2020

  

2019

 
  

(In thousands, except per share data)

 

Basic:

        

Net income (loss)

 $(37,615) $54,561 

Weighted average common shares outstanding

  20,751   20,636 

Net income (loss) per share

 $(1.81) $2.64 

Diluted:

        

Net income (loss)

 $(37,615) $54,561 

Weighted average common shares outstanding

  20,751   20,636 

Net income (loss) per share

 $(1.81) $2.64 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Note 14 - Segment Reporting (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Partner Company Ownership Interest [Table Text Block]
  Safeguard Primary Ownership as of December 31,  

Company Name

 

2020

 

2019

 

Accounting Method

Aktana, Inc.

  15.1%  17.8% 

Equity

Clutch Holdings, Inc.

  42.3%  41.2% 

Equity

Flashtalking, Inc.

  13.4%  10.1% 

Other

InfoBionic, Inc.

  25.2%  25.2% 

Equity

Lumesis, Inc.

  43.4%  43.5% 

Equity

MediaMath, Inc.

  13.3%  13.3% 

Other

meQuilibrium

  32.0%  32.7% 

Equity

Moxe Health Corporation

  27.6%  29.9% 

Equity

Prognos Health Inc.

  28.5%  28.7% 

Equity

QuanticMind, Inc. *

  24.2%  24.2% 

Equity

Syapse, Inc.

  18.9%  20.0% 

Equity

T-REX Group, Inc.

  13.5%  13.7% 

Other

Trice Medical, Inc.

  16.6%  16.6% 

Equity

WebLinc, Inc. *

  39.9%  38.5% 

Equity

Zipnosis, Inc

  37.2%  37.7% 

Equity
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Note 15 - Selected Quarterly Financial Information (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2020
Notes Tables  
Quarterly Financial Information [Table Text Block]
  

Three Months Ended

 
  

March 31

  

June 30

  

September 30 (b)

  

December 31 (b)

 
  

(In thousands, except per share data)

 

2020:

                

General and administrative expense

 $3,532  $2,028  $2,275  $1,631 

Operating loss

  (3,532)  (2,028)  (2,275)  (1,631)

Other income (loss), net

  (3,567)  (2,658)  (820)  (663)

Interest income

  105   52   52   52 

Equity income (loss), net

  (9,014)  (5,277)  (1,300)  (5,111)

Net loss before income taxes

  (16,008)  (9,911)  (4,343)  (7,353)

Income tax benefit (expense)

  —   —   —   — 

Net loss

 $(16,008) $(9,911) $(4,343) $(7,353)

Net loss per share (a)

                

Basic

 $(0.77) $(0.48) $(0.21) $(0.35)

Diluted

 $(0.77) $(0.48) $(0.21) $(0.35)

2019:

                

General and administrative expense

 $3,057  $2,603  $2,262  $2,060 

Operating loss

  (3,057)  (2,603)  (2,262)  (2,060)

Other income (loss), net

  (1,885)  3,118   8,777   2,245 

Interest income

  873   763   234   174 

Interest expense

  (2,535)  (5,682)  (5,806)  — 

Equity income (loss), net

  28,267   40,497   (3,440)  (1,057)

Net income (loss) before income taxes

  21,663   36,093   (2,497)  (698)

Income tax benefit (expense)

  —   —   —   — 

Net income (loss)

 $21,663  $36,093  $(2,497) $(698)

Net income (loss) per share (a)

                

Basic

 $1.05  $1.75  $(0.12) $(0.03)

Diluted

 $1.05  $1.75  $(0.12) $(0.03)
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Note 1 - General (Details Textual) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
 [1]
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
 [1]
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Jan. 01, 2020
Apr. 30, 2019
Dec. 31, 2018
Cash and Cash Equivalents, at Carrying Value, Ending Balance $ 15,601       $ 25,028       $ 15,601 $ 25,028      
Lessee, Operating Lease, Discount Rate 12.00%               12.00%        
Operating Lease, Cost                 $ 500 500      
Operating Lease, Payments                 600 600      
Lessor, Operating Lease, Term of Contract (Month)                       18 months  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance $ 62,875       101,741       62,875 101,741     $ 66,979
Operating Income (Loss), Total (1,631) [1] $ (2,275) $ (2,028) $ (3,532) (2,060) [1] $ (2,262) $ (2,603) $ (3,057) (9,466) (9,982)      
Retained Earnings [Member]                          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance (736,639)       $ (697,223)       (736,639) $ (697,223)     $ (731,105)
Cumulative Effect, Period of Adoption, Adjustment [Member] | Accounting Standards Update 2014-09 [Member]                          
Operating Income (Loss), Total                 1,800        
Cumulative Effect, Period of Adoption, Adjustment [Member] | Accounting Standards Update 2014-09 [Member] | Retained Earnings [Member]                          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance                     $ 1,800    
Cumulative Effect, Period of Adoption, Adjustment [Member] | Accounting Standards Update 2014-09 [Member] | Noncontrolling Interest [Member]                          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance                     $ (1,800)    
Revolving Credit Facility [Member]                          
Debt Instrument, Debt Covenants, Cash and Cash Equivalent Threshold $ 50,000               $ 50,000        
[1] The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash and Cash Equivalents, at Carrying Value, Ending Balance $ 15,601 $ 25,028  
Restricted cash 0 25  
Total cash, cash equivalents and restricted cash $ 15,601 $ 25,053 $ 8,203
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Note 1 - General - Schedule of Leases (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
2021, operating lease payments $ 595
2021, expected sublease receipts 525
2022, operating lease payments 601
2022, expected sublease receipts 540
2023, operating lease payments 607
2023, expected sublease receipts 556
2024, operating lease payments 613
2024, expected sublease receipts 573
2025, operating lease payments 619
2025, expected sublease receipts 590
2026, operating lease payments 208
2026, expected sublease receipts 199
Thereafter, operating lease payments 0
Thereafter, expected sublease receipts 0
Total future minimum lease payments, operating lease payments 3,243
Total future minimum lease payments, expected sublease receipts 2,983
Less imputed interest (863)
Total operating lease liabilities $ 2,380
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Ownership Interests and Advances (Details Textual) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Sep. 30, 2020
May 31, 2019
Jan. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Equity Securities, FV-NI, Unrealized Gain (Loss), Total         $ 4.5
Equity Method Investment Assets Exceed Carrying Value Of Investment       $ 17.9  
Intangible Assets [Member]          
Equity Method Investment Allocation of Excess Fair Value       15.0  
Goodwill [Member]          
Equity Method Investment Allocation of Excess Fair Value       2.9  
Sonobi [Member]          
Proceeds from Sale of Equity Method Investments $ 6.6        
WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. [Member]          
Equity Method Investment, Other than Temporary Impairment       11.3  
T-Rex Group, Inc [Member]          
Equity Method Investment, Other than Temporary Impairment       8.8  
Flashtalking, Inc. [Member]          
Equity Securities, FV-NI, Unrealized Gain (Loss), Total       1.5  
Ownership Interest, Other [Member]          
Equity Securities, FV-NI, Unrealized Gain (Loss), Total       0.3  
NovaSom [Member]          
Equity Method Investment, Other than Temporary Impairment         $ 3.0
Propeller [Member]          
Proceeds from Sale of Equity Method Investments     $ 41.5    
Equity Method Investments, Amount in Holdbacks and Escrows       0.7  
Equity Method Investment, Realized Gain (Loss) on Disposal, Total       $ 35.1  
Transactis [Member]          
Proceeds from Sale of Equity Method Investments   $ 57.5      
Equity Method Investment, Realized Gain (Loss) on Disposal, Total   $ 50.7      
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Equity Method Companies $ 27,821 $ 34,542
Other Companies 19,951 27,484
Advances to companies (equity method) 2,626 15,103
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures, Total 50,398 77,129
Partnership Interest [Member]    
Equity Method Companies 27,550 34,271
Other Companies 19,683 27,031
Private Equity Funds [Member]    
Equity Method Companies 271 271
Other Companies $ 268 $ 453
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Current assets $ 16,063 $ 26,350
Total Assets 69,035 107,577
Current liabilities 3,470 2,429
Total Liabilities and Equity 69,035 107,577
High Traction Stage [Member]    
Current assets 104,024 91,968
Non-current assets 26,352 26,231
Total Assets 130,376 118,199
Current liabilities 72,972 80,783
Non-current liabilities 105,506 87,081
Shareholders’ deficit (48,102) (49,665)
Total Liabilities and Equity $ 130,376 $ 118,199
Number of equity method ownership interests 12 13
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details) - Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue $ 153,875 $ 145,632
Gross profit 92,039 78,465
Net loss $ (82,216) $ (127,007)
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Note 3 - Acquisitions of Ownership Interests (Details Textual) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Payments to Acquire Equity Method Investments         $ 7,534 $ 11,640
Equity Method Investments         $ 27,821 34,542
Aktana, Inc. [Member]            
Payments to Acquire Equity Method Investments $ 2,500         1,500
Equity Method Investments $ 11,700          
Syapse, Inc. [Member]            
Payments to Acquire Equity Method Investments       $ 4,400   5,000
Equity Method Investments   $ 20,600   20,600    
Convertible Bridge Loan     $ 600      
meQuilibrium [Member]            
Payments to Acquire Equity Method Investments     1,000     1,500
Equity Method Investments     13,000      
Trice Medical, Inc. [Member]            
Equity Method Investments   10,200   10,200    
Convertible Bridge Loan       700    
Clutch Holdings [Member]            
Payments to Acquire Equity Method Investments   200       400
Equity Method Investments   $ 16,700   $ 16,700    
QuanticMind [Member]            
Equity Method Investments     13,500      
Convertible Bridge Loan     200     600
WebLinc, Inc. [Member]            
Equity Method Investments     16,100      
Convertible Bridge Loan     $ 100     1,100
Moxe Health Corporation [Member]            
Payments to Acquire Equity Method Investments           2,000
Equity Method Investments           5,500
Convertible Bridge Loan           300
Zipnosis [Member]            
Payments to Acquire Equity Method Investments           1,500
Equity Method Investments           8,500
Sonobi [Member]            
Equity Method Investments           11,400
Convertible Bridge Loan           2,000
NovaSom [Member]            
Equity Method Investments           26,400
Convertible Bridge Loan           $ 1,000
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Note 5 - Credit Facility and Convertible Debentures (Details Textual) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jul. 31, 2019
Apr. 15, 2019
May 31, 2018
Sep. 30, 2019
 [1]
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Repayments of Lines of Credit             $ (0) $ 68,568  
Interest Expense, Debt, Total       $ 5,806 $ 5,682 $ 2,535 (0) 14,023  
Debt Instrument, Gain (Loss) from Covenant Liability               5,100  
Interest Paid, Excluding Capitalized Interest, Operating Activities             0 $ 11,500  
Revolving Credit Facility [Member]                  
Debt Instrument, Debt Covenants, Cash and Cash Equivalent Threshold             50,000    
Revolving Credit Facility [Member] | Line of Credit [Member]                  
Interest Expense, Debt, Total             $ 14,000    
Debt Instrument, Interest Rate, Effective Percentage             15.10%    
Interest Paid, Excluding Capitalized Interest, Operating Activities             $ 11,500    
Credit Facility [Member] | Revolving Credit Facility [Member] | Payable on the Last Day of the One, Two or Three Month Interest Period [Member] | London Interbank Offered Rate (LIBOR) [Member]                  
Debt Instrument, Basis Spread on Variable Rate     8.50%            
Credit Facility [Member] | Revolving Credit Facility [Member] | Payable on the Last Day of the One, Two or Three Month Interest Period [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]                  
LIBOR Floor Rate     1.00%            
Credit Facility [Member] | Revolving Credit Facility [Member] | Payable Monthly in Arrears [Member]                  
Debt Instrument, Basis Spread on Variable Rate     2.00%            
Credit Facility [Member] | Revolving Credit Facility [Member] | Payable Monthly in Arrears [Member] | Minimum [Member]                  
Debt Instrument, Interest Rate, Stated Percentage     7.50%            
Credit Facility [Member] | Revolving Credit Facility [Member] | Payable Monthly in Arrears [Member] | Fed Funds Effective Rate Overnight Index Swap Rate [Member]                  
Debt Instrument, Basis Spread on Variable Rate     0.50%            
Credit Facility [Member] | Revolving Credit Facility [Member] | Payable Monthly in Arrears [Member] | Prime Rate [Member]                  
Debt Instrument, Basis Spread on Variable Rate     1.00%            
Amended Credit Facility [Member]                  
Debt Instrument, Debt Covenants, Cash and Cash Equivalent Threshold     $ 50,000           $ 50,000
Repayments of Lines of Credit   $ 24,000              
Line of Credit Facility, Periodic Payment, Interest   $ 2,900              
Extinguishment of Debt, Amount $ 44,500                
Interest Expense, Debt, Total $ 4,100                
Long-term Line of Credit, Repayment Feature, Noncurrent     $ 500            
[1] The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Note 6 - Equity (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Nov. 07, 2019
Dec. 31, 2020
Dec. 31, 2019
Feb. 28, 2018
Jul. 31, 2015
Stock Repurchase Program, Authorized Amount         $ 25,000
Treasury Stock, Shares, Acquired (in shares)   0 0    
Sale of Stock, Individual Ownership, Percent, Maximum       4.99%  
Preferred Stock Purchase Right to be Exchanged for Common Stock Above Maximum Ownership Threshold (in shares)       1  
Dividends Payable, Amount Per Share (in dollars per share) $ 1.00        
Dividends, Total $ 20,700   $ 20,679    
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Stock-Based Compensation (Details Textual)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award, Number of Award Vesting Types 2  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) 0 0
Share-based Payment Arrangement, Expense | $ $ 965 $ 1,237
Cash Liability for Performance-Based Units | $ 0  
Director [Member]    
Share-based Payment Arrangement, Expense | $ 1,000  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ $ 500 $ 100
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in shares) 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares) 72 174
Share-based Payment Arrangement, Expense, after Tax | $ $ 0 $ 100
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance (in shares) 21  
Service Based Award [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares) 62 57
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) 4 years  
Share Based Compensation Arrangement, By Share Based Payment Award, Expiration Term (Year) 8 years  
Share-based Payment Arrangement, Expense | $ $ 0 $ 0
Restricted Stock [Member]    
Share-based Payment Arrangement, Expense | $   $ 100
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares) 193 31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares) 10 75
Restricted Stock [Member] | Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) 2 years  
Restricted Stock [Member] | Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) 4 years  
Performance Stock Unit [Member]    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ $ 700  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Maximum Target Percentage 120.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares) 100 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) 0 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares) 129 339
Deferred Stock Units [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares) 20 0
Percentage of Shares Vested in Lieu of Directors Fees at the Grant Date 100.00%  
Portion of Director Fees Matched to Deferred Stock Units. 25.00%  
Share-based Compensation Arrangement by Share Based Payment, Deferred award, Vesting Period (Year) 1 year  
Restricted Stock, Performance-based Stock Units, and Deferred Stock Units [Member]    
Share-based Payment Arrangement, Expense, after Tax | $ $ 500 $ 1,200
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ $ 500  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) 174 107
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares) 139 414
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ $ 1,100 $ 1,200
2014 Equity Compensation Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) 4,100  
Common Stock, Capital Shares Reserved for Future Issuance (in shares) 2,800  
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Stock-based compensation expense $ 965 $ 1,237
General and Administrative Expense [Member]    
Stock-based compensation expense $ 965 $ 1,237
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Options granted, shares (in shares) 0 0
Share-based Payment Arrangement, Option [Member]    
Balance, shares (in shares) 179 410
Balance, weighted average exercise price (in dollars per share) $ 15.27 $ 14.66
Options granted, shares (in shares) 0 0
Options granted, weighted average exercise price (in dollars per share) $ 0 $ 0
Options exercised, shares (in shares) 0 0
Options exercised, weighted average exercise price (in dollars per share) $ 0 $ 0
Options canceled/forfeited, shares (in shares) (134) (231)
Options canceled/forfeited, weighted average exercise price (in dollars per share) $ 14.36 $ 14.19
Options exercised, shares (in shares) 0 (0)
Balance, shares (in shares) 45 179
Balance, weighted average exercise price (in dollars per share) $ 14.20 $ 15.27
Balance, weighted average remaining contractual life (Year) 2 years 3 months 14 days  
Balance, aggregative intrinsic value $ 0  
Options exercisable, shares (in shares) 22  
Options exercisable , weighted average exercise price (in dollars per share) $ 14.48  
Options exercisable, weighted average remaining contractual life (Year) 3 years 29 days  
Options exercisable, aggregative intrinsic value $ 0  
Shares available for future grant, shares (in shares) 2,515  
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details) - Restricted Stock, Performance-based Stock Units, and Deferred Stock Units [Member] - $ / shares
shares in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Balance (in shares) 287 777
Balance (in dollars per share) $ 14.44 $ 14.08
Granted (in shares) 313 31
Granted (in dollars per share) $ 5.89 $ 12.12
Vested (in shares) (174) (107)
Vested (in dollars per share) $ 7.77 $ 11.79
Forfeited (in shares) (139) (414)
Forfeited (in dollars per share) $ 15.24 $ 14.28
Balance (in shares) 287 287
Balance (in dollars per share) $ 8.78 $ 14.44
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Note 8 - Employee Benefit Plan (Details Textual) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Defined Contribution Plan, Employer Matching Contribution, Percent of Match 100.00%  
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 5.00%  
Defined Contribution Plan, Cost $ 0.2 $ 0.2
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Income Taxes (Details Textual) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Federal Income Tax Expense (Benefit), Continuing Operations, Total $ 0 $ 0
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00% 21.00%
Deferred Tax Assets, Operating Loss Carryforwards, Total $ 362,000  
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration 37,000  
State and Local Income Tax Expense (Benefit), Continuing Operations, Total $ 0 $ 0
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Statutory tax (benefit) expense 21.00% 21.00%
Nondeductible expenses (4.10%) 0.40%
Valuation allowance (16.90%) (21.40%)
Effective Income Tax Rate Reconciliation, Percent, Total 0.00% 0.00%
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Carrying values of ownership interests and other holdings $ 38,361 $ 32,760
Tax loss and credit carryforwards 76,023 70,914
Disallowed interest carryforwards 7,292 7,292
Accrued expenses 497 213
Stock-based compensation 302 432
Other 482 604
Deferred Tax Assets, Gross, Total 122,957 112,215
Valuation allowance (122,957) (112,215)
Net deferred tax asset $ 0 $ 0
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
2021 $ 3,728
2022 48,848
2023 52,512
2024 50,140
2025 and thereafter 170,189
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $ 325,417
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Note 10 - Net Income (Loss) Per Share (Details Textual) - $ / shares
shares in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Share-based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 45 179
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share) $ 10.37 $ 10.37
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share) $ 17.11 $ 18.45
Restricted Stock, Performance-based Stock Units, and Deferred Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 300 300
Convertible Senior Debentures due 2018 [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)   800
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2020
 [1]
Sep. 30, 2020
 [1]
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
 [1]
Sep. 30, 2019
 [1]
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Basic:                    
Net income (loss) $ (7,353) $ (4,343) $ (9,911) $ (16,008) $ (698) $ (2,497) $ 36,093 $ 21,663 $ (37,615) $ 54,561
Basic (in shares)                 20,751 20,636
Basic (in dollars per share) $ (0.35) [2] $ (0.21) [2] $ (0.48) [2] $ (0.77) [2] $ (0.03) [2] $ (0.12) [2] $ 1.75 [2] $ 1.05 [2] $ (1.81) $ 2.64
Diluted:                    
Net income (loss) $ (7,353) $ (4,343) $ (9,911) $ (16,008) $ (698) $ (2,497) $ 36,093 $ 21,663 $ (37,615) $ 54,561
Diluted (in shares)                 20,751 20,636
Basic (in dollars per share) $ (0.35) [2] $ (0.21) [2] $ (0.48) [2] $ (0.77) [2] $ (0.03) [2] $ (0.12) [2] $ 1.75 [2] $ 1.05 [2] $ (1.81) $ 2.64
[1] The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.
[2] Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts may not add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts may not add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests.
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Note 12 - Commitments and Contingencies (Details Textual) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Oct. 31, 2001
Future Annual Payment To Chairman and Chief Executive Officer     $ 650
Deferred Compensation Arrangement with Individual Gain (Loss)     $ 1,700
Deferred Compensation Liability, Current and Noncurrent, Total $ 1,800    
Deferred Compensation Liability, Current, Total $ 1,500    
Minimum [Member]      
Long-term Incentive Plan, Bonus Pool Percent 0.20% 1.00%  
Maximum [Member]      
Long-term Incentive Plan, Bonus Pool Percent 1.30%    
Employee Severance [Member]      
Restructuring and Related Cost, Expected Cost, Total $ 2,300    
Private Equity Funds [Member]      
Guarantor Obligations, Current Carrying Value $ 3,800    
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Note 13 - Supplemental Cash Flow Information (Details Textual) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Debt Conversion, Converted Instrument, Amount $ 6,800 $ 2,300
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 11,500
Income Taxes Paid $ 0 $ 0
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Note 14 - Segment Reporting (Details Textual)
 12 Months Ended
Dec. 31, 2020
Number of Operating Segments 1
Partner Companies Not Consolidated In Financial Statements 12
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details)
Dec. 31, 2020
Dec. 31, 2019
Aktana, Inc. [Member]    
Ownership Interest Under Equity Method, Percent 15.10% 17.80%
Clutch Holdings [Member]    
Ownership Interest Under Equity Method, Percent 42.30% 41.20%
Flashtalking, Inc. [Member]    
Ownership Interest Under Other Method, Percent 13.40% 10.10%
InfoBionic, Inc. [Member]    
Ownership Interest Under Equity Method, Percent 25.20% 25.20%
Lumesis, Inc. [Member]    
Ownership Interest Under Equity Method, Percent 43.40% 43.50%
MediaMath, Inc. [Member]    
Ownership Interest Under Other Method, Percent 13.30% 13.30%
meQuilibrium [Member]    
Ownership Interest Under Equity Method, Percent 32.00% 32.70%
Moxe Health Corporation [Member]    
Ownership Interest Under Equity Method, Percent 27.60% 29.90%
Prognos Health, Inc. [Member]    
Ownership Interest Under Equity Method, Percent 28.50% 28.70%
QuanticMind [Member]    
Ownership Interest Under Equity Method, Percent [1] 24.20% 24.20%
Syapse, Inc. [Member]    
Ownership Interest Under Equity Method, Percent 18.90% 20.00%
T-Rex Group, Inc [Member]    
Ownership Interest Under Other Method, Percent 13.50% 13.70%
Trice Medical, Inc. [Member]    
Ownership Interest Under Equity Method, Percent 16.60% 16.60%
WebLinc, Inc. [Member]    
Ownership Interest Under Equity Method, Percent [1] 39.90% 38.50%
Zipnosis [Member]    
Ownership Interest Under Equity Method, Percent 37.20% 37.70%
[1] These entities were sold subsequent to December 31, 2020. See Note 16 - Subsequent Events, of the consolidated financials statements.
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Note 15 - Selected Quarterly Financial Information (Unaudited) (Details Textual) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2020
 [1]
Sep. 30, 2020
 [1]
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
 [1]
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income (Loss) from Equity Method Investments, Total $ (5,111) $ (1,300) $ (5,277) $ (9,014) $ (1,057) [1] $ (3,440) $ 40,497 $ 28,267 $ (20,702) $ 64,267
Equity Method Investment Income Adjustment [Member]                    
Income (Loss) from Equity Method Investments, Total         $ 1,400          
[1] The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2020
 [1]
Sep. 30, 2020
 [1]
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
 [1]
Sep. 30, 2019
 [1]
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
General and administrative expense $ 1,631 $ 2,275 $ 2,028 $ 3,532 $ 2,060 $ 2,262 $ 2,603 $ 3,057 $ 9,466 $ 9,982
Operating loss (1,631) (2,275) (2,028) (3,532) (2,060) (2,262) (2,603) (3,057) (9,466) (9,982)
Other income (loss), net (663) (820) (2,658) (3,567) 2,245 8,777 3,118 (1,885) (7,708) 12,255
Interest income 52 52 52 105 174 234 763 873 261 2,044
Equity income (loss), net (5,111) (1,300) (5,277) (9,014) (1,057) (3,440) 40,497 28,267 (20,702) 64,267
Net loss before income taxes (7,353) (4,343) (9,911) (16,008) (698) (2,497) 36,093 21,663 (37,615) 54,561
Net income (loss) $ (7,353) $ (4,343) $ (9,911) $ (16,008) $ (698) $ (2,497) $ 36,093 $ 21,663 $ (37,615) $ 54,561
Basic (in dollars per share) $ (0.35) [2] $ (0.21) [2] $ (0.48) [2] $ (0.77) [2] $ (0.03) [2] $ (0.12) [2] $ 1.75 [2] $ 1.05 [2] $ (1.81) $ 2.64
Diluted (in dollars per share) $ (0.35) [2] $ (0.21) [2] $ (0.48) [2] $ (0.77) [2] $ (0.03) [2] $ (0.12) [2] $ 1.75 [2] $ 1.05 [2] $ (1.81) $ 2.64
Interest expense           $ 5,806 $ 5,682 $ 2,535 $ (0) $ 14,023
[1] The three months ended December 31, 2019 includes equity income of $1.4 million related to an equity method investment that should have been recorded during the three months ended September 30, 2019. There was no impact on the full year results.
[2] Per share amounts for the quarters have each been calculated separately. Accordingly, quarterly amounts may not add to the annual amounts because of differences in the average common shares outstanding during each period. Additionally, in regard to diluted per share amounts only, quarterly amounts may not add to the annual amounts because of the inclusion of the effect of potentially dilutive securities only in the periods in which such effect would have been dilutive, and because of the adjustments to net income (loss) for the dilutive effect of common stock equivalents and convertible securities at our ownership interests.
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Note 16 - Subsequent Events (Details Textual) - USD ($)
$ in Thousands
 1 Months Ended
Feb. 28, 2021
Jan. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Syapse, Inc. [Member]        
Equity Method Investment, Ownership Percentage     18.90% 20.00%
Subsequent Event [Member] | Syapse, Inc. [Member]        
Equity Method Investment, Ownership Percentage 11.00%      
Subsequent Event [Member] | Syapse, Inc. [Member]        
Proceeds from Issuance of Preferred Stock and Preference Stock $ 68,000      
Subsequent Event [Member] | WebLinc, Inc. [Member]        
Proceeds from Sale of Equity Method Investments   $ 3,200    
Disposal Group, Including Discontinued Operation, Period of Contingent Proceeds (Month)   24 months    
Subsequent Event [Member] | QuanticMind [Member]        
Proceeds from Sale of Equity Method Investments   $ 0    
EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 76 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 181 358 1 true 65 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.safeguard.com/20201231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity Consolidated Statements of Changes in Shareholders' Equity Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Note 1 - General Sheet http://www.safeguard.com/20201231/role/statement-note-1-general Note 1 - General Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Ownership Interests and Advances Sheet http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances- Note 2 - Ownership Interests and Advances Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Acquisitions of Ownership Interests Sheet http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests Note 3 - Acquisitions of Ownership Interests Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Fair Value Measurements Sheet http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements Note 4 - Fair Value Measurements Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Credit Facility and Convertible Debentures Sheet http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures Note 5 - Credit Facility and Convertible Debentures Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Equity Sheet http://www.safeguard.com/20201231/role/statement-note-6-equity Note 6 - Equity Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Stock-Based Compensation Sheet http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation Note 7 - Stock-Based Compensation Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Employee Benefit Plan Sheet http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan Note 8 - Employee Benefit Plan Notes 15 false false R16.htm 015 - Disclosure - Note 9 - Income Taxes Sheet http://www.safeguard.com/20201231/role/statement-note-9-income-taxes Note 9 - Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Note 10 - Net Income (Loss) Per Share Sheet http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share Note 10 - Net Income (Loss) Per Share Notes 17 false false R18.htm 017 - Disclosure - Note 11 - Related Party Transactions Sheet http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions Note 11 - Related Party Transactions Notes 18 false false R19.htm 018 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies Note 12 - Commitments and Contingencies Notes 19 false false R20.htm 019 - Disclosure - Note 13 - Supplemental Cash Flow Information Sheet http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information Note 13 - Supplemental Cash Flow Information Notes 20 false false R21.htm 020 - Disclosure - Note 14 - Segment Reporting Sheet http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting Note 14 - Segment Reporting Notes 21 false false R22.htm 021 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) Sheet http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited- Note 15 - Selected Quarterly Financial Information (Unaudited) Notes 22 false false R23.htm 022 - Disclosure - Note 16 - Subsequent Events Sheet http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events Note 16 - Subsequent Events Notes 23 false false R24.htm 023 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies 24 false false R25.htm 024 - Disclosure - Note 1 - General (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-1-general-tables Note 1 - General (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-1-general 25 false false R26.htm 025 - Disclosure - Note 2 - Ownership Interests and Advances (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables Note 2 - Ownership Interests and Advances (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances- 26 false false R27.htm 026 - Disclosure - Note 7 - Stock-Based Compensation (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables Note 7 - Stock-Based Compensation (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation 27 false false R28.htm 027 - Disclosure - Note 9 - Income Taxes (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables Note 9 - Income Taxes (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-9-income-taxes 28 false false R29.htm 028 - Disclosure - Note 10 - Net Income (Loss) Per Share (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables Note 10 - Net Income (Loss) Per Share (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share 29 false false R30.htm 029 - Disclosure - Note 14 - Segment Reporting (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables Note 14 - Segment Reporting (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting 30 false false R31.htm 030 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) (Tables) Sheet http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables Note 15 - Selected Quarterly Financial Information (Unaudited) (Tables) Tables http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited- 31 false false R32.htm 031 - Disclosure - Note 1 - General (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual Note 1 - General (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-1-general-tables 32 false false R33.htm 032 - Disclosure - Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details) Details 33 false false R34.htm 033 - Disclosure - Note 1 - General - Schedule of Leases (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details Note 1 - General - Schedule of Leases (Details) Details 34 false false R35.htm 034 - Disclosure - Note 2 - Ownership Interests and Advances (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual Note 2 - Ownership Interests and Advances (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables 35 false false R36.htm 035 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details) Details 36 false false R37.htm 036 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details) Details 37 false false R38.htm 037 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details) Details 38 false false R39.htm 038 - Disclosure - Note 3 - Acquisitions of Ownership Interests (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual Note 3 - Acquisitions of Ownership Interests (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests 39 false false R40.htm 039 - Disclosure - Note 5 - Credit Facility and Convertible Debentures (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual Note 5 - Credit Facility and Convertible Debentures (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures 40 false false R41.htm 040 - Disclosure - Note 6 - Equity (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual Note 6 - Equity (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-6-equity 41 false false R42.htm 041 - Disclosure - Note 7 - Stock-Based Compensation (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual Note 7 - Stock-Based Compensation (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables 42 false false R43.htm 042 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) Details 43 false false R44.htm 043 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details) Details 44 false false R45.htm 044 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details) Details 45 false false R46.htm 045 - Disclosure - Note 8 - Employee Benefit Plan (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual Note 8 - Employee Benefit Plan (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan 46 false false R47.htm 046 - Disclosure - Note 9 - Income Taxes (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual Note 9 - Income Taxes (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables 47 false false R48.htm 047 - Disclosure - Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 48 false false R49.htm 048 - Disclosure - Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details) Details 49 false false R50.htm 049 - Disclosure - Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details) Details 50 false false R51.htm 050 - Disclosure - Note 10 - Net Income (Loss) Per Share (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual Note 10 - Net Income (Loss) Per Share (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables 51 false false R52.htm 051 - Disclosure - Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details) Details http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables 52 false false R53.htm 052 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies 53 false false R54.htm 053 - Disclosure - Note 13 - Supplemental Cash Flow Information (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual Note 13 - Supplemental Cash Flow Information (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information 54 false false R55.htm 054 - Disclosure - Note 14 - Segment Reporting (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual Note 14 - Segment Reporting (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables 55 false false R56.htm 055 - Disclosure - Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details) Details 56 false false R57.htm 056 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual Note 15 - Selected Quarterly Financial Information (Unaudited) (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables 57 false false R58.htm 057 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details) Sheet http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details) Details http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables 58 false false R59.htm 058 - Disclosure - Note 16 - Subsequent Events (Details Textual) Sheet http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual Note 16 - Subsequent Events (Details Textual) Details http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events 59 false false All Reports Book All Reports sfe20201231_10k.htm ex_208595.htm ex_208596.htm ex_208597.htm ex_208598.htm ex_208599.htm ex_208600.htm sfe-20201231.xsd sfe-20201231_cal.xml sfe-20201231_def.xml sfe-20201231_lab.xml sfe-20201231_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true JSON 81 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sfe20201231_10k.htm": { "axisCustom": 0, "axisStandard": 23, "contextCount": 181, "dts": { "calculationLink": { "local": [ "sfe-20201231_cal.xml" ] }, "definitionLink": { "local": [ "sfe-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "sfe20201231_10k.htm" ] }, "labelLink": { "local": [ "sfe-20201231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "sfe-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "sfe-20201231.xsd" ], "remote": [ "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 451, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 36, "http://www.safeguard.com/20201231": 3, "http://xbrl.sec.gov/dei/2019-01-31": 6, "total": 45 }, "keyCustom": 45, "keyStandard": 313, "memberCustom": 34, "memberStandard": 26, "nsprefix": "sfe", "nsuri": "http://www.safeguard.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.safeguard.com/20201231/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Note 3 - Acquisitions of Ownership Interests", "role": "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "shortName": "Note 3 - Acquisitions of Ownership Interests", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Note 4 - Fair Value Measurements", "role": "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements", "shortName": "Note 4 - Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Note 5 - Credit Facility and Convertible Debentures", "role": "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "shortName": "Note 5 - Credit Facility and Convertible Debentures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Note 6 - Equity", "role": "http://www.safeguard.com/20201231/role/statement-note-6-equity", "shortName": "Note 6 - Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Note 7 - Stock-Based Compensation", "role": "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "shortName": "Note 7 - Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Note 8 - Employee Benefit Plan", "role": "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan", "shortName": "Note 8 - Employee Benefit Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Note 9 - Income Taxes", "role": "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes", "shortName": "Note 9 - Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Note 10 - Net Income (Loss) Per Share", "role": "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "shortName": "Note 10 - Net Income (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Note 11 - Related Party Transactions", "role": "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions", "shortName": "Note 11 - Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Note 12 - Commitments and Contingencies", "role": "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "shortName": "Note 12 - Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Consolidated Balance Sheets", "role": "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Note 13 - Supplemental Cash Flow Information", "role": "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information", "shortName": "Note 13 - Supplemental Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Note 14 - Segment Reporting", "role": "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting", "shortName": "Note 14 - Segment Reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited)", "role": "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "shortName": "Note 15 - Selected Quarterly Financial Information (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Note 16 - Subsequent Events", "role": "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "shortName": "Note 16 - Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Note 1 - General (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-1-general-tables", "shortName": "Note 1 - General (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Note 2 - Ownership Interests and Advances (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables", "shortName": "Note 2 - Ownership Interests and Advances (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Note 7 - Stock-Based Compensation (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables", "shortName": "Note 7 - Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Note 9 - Income Taxes (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables", "shortName": "Note 9 - Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Note 10 - Net Income (Loss) Per Share (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables", "shortName": "Note 10 - Net Income (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "role": "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "sfe:ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Note 14 - Segment Reporting (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables", "shortName": "Note 14 - Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "sfe:ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) (Tables)", "role": "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables", "shortName": "Note 15 - Selected Quarterly Financial Information (Unaudited) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Note 1 - General (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "shortName": "Note 1 - General (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeLeasesPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details", "shortName": "Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:RestrictedCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "us-gaap:LesseeLeasesPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Note 1 - General - Schedule of Leases (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details", "shortName": "Note 1 - General - Schedule of Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "us-gaap:LesseeLeasesPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2019-01-01_2019-12-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Note 2 - Ownership Interests and Advances (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "shortName": "Note 2 - Ownership Interests and Advances (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2019-01-01_2019-12-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "shortName": "Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "shortName": "Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "sfe:EquityMethodInvestmentPartnerCompanyResultsOfOperationTableTextBlock", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31_EquityMethodInvestmentNonconsolidatedInvesteeAxis-HighTractionStageMember", "decimals": "-3", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31_EquityMethodInvestmentNonconsolidatedInvesteeAxis-EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details", "shortName": "Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31_EquityMethodInvestmentNonconsolidatedInvesteeAxis-EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Note 3 - Acquisitions of Ownership Interests (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual", "shortName": "Note 3 - Acquisitions of Ownership Interests (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-07-01_2020-09-30_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis-AktanaIncMember", "decimals": "-5", "lang": null, "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Statements of Operations", "role": "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfLinesOfCredit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Note 5 - Credit Facility and Convertible Debentures (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "shortName": "Note 5 - Credit Facility and Convertible Debentures (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2019-12-31", "decimals": "-5", "lang": null, "name": "sfe:DebtInstrumentGainLossFromCovenantLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2015-07-31", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Note 6 - Equity (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual", "shortName": "Note 6 - Equity (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2015-07-31", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "sfe:SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Note 7 - Stock-Based Compensation (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "shortName": "Note 7 - Stock-Based Compensation (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "sfe:SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details", "shortName": "Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31_IncomeStatementLocationAxis-GeneralAndAdministrativeExpenseMember", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details", "shortName": "Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2018-12-31_AwardTypeAxis-EmployeeStockOptionMember", "decimals": "-4", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "sfe:ScheduleOfActivityForRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2019-12-31_AwardTypeAxis-RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "shortName": "Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "sfe:ScheduleOfActivityForRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2018-12-31_AwardTypeAxis-RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Note 8 - Employee Benefit Plan (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual", "shortName": "Note 8 - Employee Benefit Plan (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Note 9 - Income Taxes (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual", "shortName": "Note 9 - Income Taxes (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "shortName": "Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "3", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "shortName": "Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Statements of Comprehensive Income (Loss)", "role": "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss", "shortName": "Consolidated Statements of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "lang": null, "name": "sfe:OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "sfe:NetOperatingLossCarryforwardsExpiringInYearOne", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details", "shortName": "Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "sfe:NetOperatingLossCarryforwardsExpiringInYearOne", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Note 10 - Net Income (Loss) Per Share (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "shortName": "Note 10 - Net Income (Loss) Per Share (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-10-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "shortName": "Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R53": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2001-10-31", "decimals": "-4", "first": true, "lang": null, "name": "sfe:FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "shortName": "Note 12 - Commitments and Contingencies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2001-10-31", "decimals": "-4", "first": true, "lang": null, "name": "sfe:FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Note 13 - Supplemental Cash Flow Information (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual", "shortName": "Note 13 - Supplemental Cash Flow Information (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - Note 14 - Segment Reporting (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual", "shortName": "Note 14 - Segment Reporting (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "sfe:ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis-AktanaIncMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "shortName": "Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "sfe:ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis-AktanaIncMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-10-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual", "shortName": "Note 15 - Selected Quarterly Financial Information (Unaudited) (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2019-10-01_2019-12-31_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis-EquityMethodInvestmentIncomeAdjustmentMember", "decimals": "-5", "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-10-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details)", "role": "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "shortName": "Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-10-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "sfe:ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2020-12-31_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis-SyapseIncMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "058 - Disclosure - Note 16 - Subsequent Events (Details Textual)", "role": "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "shortName": "Note 16 - Subsequent Events (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2021-02-28_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis-SyapseIncMember_SubsequentEventTypeAxis-SubsequentEventMember", "decimals": "2", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2018-12-31_StatementEquityComponentsAxis-RetainedEarningsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "role": "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "i_2018-12-31_StatementEquityComponentsAxis-AccumulatedOtherComprehensiveIncomeMember", "decimals": "-3", "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Note 1 - General", "role": "http://www.safeguard.com/20201231/role/statement-note-1-general", "shortName": "Note 1 - General", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Note 2 - Ownership Interests and Advances", "role": "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "shortName": "Note 2 - Ownership Interests and Advances", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "sfe20201231_10k.htm", "contextRef": "d_2020-01-01_2020-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 65, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-document-and-entity-information", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-tables", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables", "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual", "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-6-equity", "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables", "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-document-and-entity-information", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-tables", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables", "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual", "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-6-equity", "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables", "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "sfe_AktanaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Aktana, Inc.", "label": "Aktana, Inc. [Member]" } } }, "localname": "AktanaIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_AmendedCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the amended credit facility.", "label": "Amended Credit Facility [Member]" } } }, "localname": "AmendedCreditFacilityMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "sfe_CashLiabilityForPerformancebasedUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the cash liability for performance based units.", "label": "sfe_CashLiabilityForPerformancebasedUnits", "terseLabel": "Cash Liability for Performance-Based Units" } } }, "localname": "CashLiabilityForPerformancebasedUnits", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_ClutchHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Clutch Holdings.", "label": "Clutch Holdings [Member]" } } }, "localname": "ClutchHoldingsMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_ConvertibleBridgeLoan": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of funding for convertible bridge loans in the period.", "label": "sfe_ConvertibleBridgeLoan", "terseLabel": "Convertible Bridge Loan" } } }, "localname": "ConvertibleBridgeLoan", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_ConvertibleSeniorDebenturesDue2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related convertible senior debentures due 2018.", "label": "Convertible Senior Debentures due 2018 [Member]" } } }, "localname": "ConvertibleSeniorDebenturesDue2018Member", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual" ], "xbrltype": "domainItemType" }, "sfe_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "represents credit facility.", "label": "Credit Facility [Member]" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "sfe_CumulativeEffectOfChangeInAccountingAtOwnershipInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative effect on retained earnings resulting from a change in accounting principals used at ownership interests.", "label": "Change in accounting at ownership interests" } } }, "localname": "CumulativeEffectOfChangeInAccountingAtOwnershipInterests", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "monetaryItemType" }, "sfe_DebtInstrumentDebtCovenantsCashAndCashEquivalentThreshold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the debt instrument, debt covenants, cash and cash equivalent threshold.", "label": "sfe_DebtInstrumentDebtCovenantsCashAndCashEquivalentThreshold", "terseLabel": "Debt Instrument, Debt Covenants, Cash and Cash Equivalent Threshold" } } }, "localname": "DebtInstrumentDebtCovenantsCashAndCashEquivalentThreshold", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_DebtInstrumentGainLossFromCovenantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the debt instrument, gain (loss) from covenant liability.", "label": "sfe_DebtInstrumentGainLossFromCovenantLiability", "terseLabel": "Debt Instrument, Gain (Loss) from Covenant Liability" } } }, "localname": "DebtInstrumentGainLossFromCovenantLiability", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_DeferredCompensationArrangementWithIndividualGainLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents gain (loss) for deferred compensation arrangement with individual.", "label": "sfe_DeferredCompensationArrangementWithIndividualGainLoss", "terseLabel": "Deferred Compensation Arrangement with Individual Gain (Loss)" } } }, "localname": "DeferredCompensationArrangementWithIndividualGainLoss", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_DeferredStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents deferred stock units.", "label": "Deferred Stock Units [Member]" } } }, "localname": "DeferredStockUnitsMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "sfe_DeferredTaxAssetDisallowedInterestCarryforwards": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the deferred tax assets, disallowed interest carryforwards.", "label": "Disallowed interest carryforwards" } } }, "localname": "DeferredTaxAssetDisallowedInterestCarryforwards", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "sfe_DisposalGroupIncludingDiscontinuedOperationPeriodOfContingentProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of contingent proceeds from disposal group.", "label": "sfe_DisposalGroupIncludingDiscontinuedOperationPeriodOfContingentProceeds", "terseLabel": "Disposal Group, Including Discontinued Operation, Period of Contingent Proceeds (Month)" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPeriodOfContingentProceeds", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "durationItemType" }, "sfe_EquityCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the 2014 equity compensation plan.", "label": "2014 Equity Compensation Plan [Member]" } } }, "localname": "EquityCompensationPlanMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "sfe_EquityMethodInvestmentAllocationOfExcessFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the allocation of excess fair value under the equity method investment.", "label": "sfe_EquityMethodInvestmentAllocationOfExcessFairValue", "terseLabel": "Equity Method Investment Allocation of Excess Fair Value" } } }, "localname": "EquityMethodInvestmentAllocationOfExcessFairValue", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the value by which the carrying value exceeded the company's assets under the equity method investment.", "label": "sfe_EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment", "terseLabel": "Equity Method Investment Assets Exceed Carrying Value Of Investment" } } }, "localname": "EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_EquityMethodInvestmentIncomeAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents adjustments for equity method investment income.", "label": "Equity Method Investment Income Adjustment [Member]" } } }, "localname": "EquityMethodInvestmentIncomeAdjustmentMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual" ], "xbrltype": "domainItemType" }, "sfe_EquityMethodInvestmentPartnerCompanyResultsOfOperationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for results of operation for a partnering company under the equity method investment.", "label": "Equity Method Investment Partner Company Results Of Operation [Table Text Block]" } } }, "localname": "EquityMethodInvestmentPartnerCompanyResultsOfOperationTableTextBlock", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables" ], "xbrltype": "textBlockItemType" }, "sfe_EquityMethodInvestmentsAmountInHoldbacksAndEscrows": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount in holdbacks and escrows under equity method investments.", "label": "sfe_EquityMethodInvestmentsAmountInHoldbacksAndEscrows", "terseLabel": "Equity Method Investments, Amount in Holdbacks and Escrows" } } }, "localname": "EquityMethodInvestmentsAmountInHoldbacksAndEscrows", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage ownership of investment in equity security without readily determinable fair value of another entity.", "label": "sfe_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage", "terseLabel": "Ownership Interest Under Other Method, Percent" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details" ], "xbrltype": "percentItemType" }, "sfe_FlashtalkingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related to Flashtalking, Inc.", "label": "Flashtalking, Inc. [Member]" } } }, "localname": "FlashtalkingIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents future annual payment to chairman and CEO.", "label": "sfe_FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer", "terseLabel": "Future Annual Payment To Chairman and Chief Executive Officer" } } }, "localname": "FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_GainLossFromObservablePriceChanges": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents gain (loss) from observable price changes.", "label": "sfe_GainLossFromObservablePriceChanges", "negatedLabel": "Gain from observable price changes" } } }, "localname": "GainLossFromObservablePriceChanges", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "sfe_HighTractionStageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to high traction stage.", "label": "High Traction Stage [Member]" } } }, "localname": "HighTractionStageMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "domainItemType" }, "sfe_IncludedPartnerCompanies": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of equity method ownership interests.", "label": "Number of equity method ownership interests" } } }, "localname": "IncludedPartnerCompanies", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "integerItemType" }, "sfe_IncomeLossFromEquityMethodInvestmentsExcludingImpairments": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss), excluding impairments.", "label": "sfe_IncomeLossFromEquityMethodInvestmentsExcludingImpairments", "negatedLabel": "Equity (income) loss, net" } } }, "localname": "IncomeLossFromEquityMethodInvestmentsExcludingImpairments", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "sfe_InfoBionicIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity InfoBionic, Inc.", "label": "InfoBionic, Inc. [Member]" } } }, "localname": "InfoBionicIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details" ], "xbrltype": "domainItemType" }, "sfe_IntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents intangible assets.", "label": "Intangible Assets [Member]" } } }, "localname": "IntangibleAssetsMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_LIBORFloorRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An agreed-upon rate in the lower range of the London Inter-bank Offered Rate (LIBOR) rates associated with a floating rate loan product.", "label": "sfe_LIBORFloorRate", "terseLabel": "LIBOR Floor Rate" } } }, "localname": "LIBORFloorRate", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "percentItemType" }, "sfe_LesseeOperatingLeaseLiabilityPaymentsDueYearSix": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in sixth fiscal year following latest fiscal year.", "label": "sfe_LesseeOperatingLeaseLiabilityPaymentsDueYearSix", "terseLabel": "2026, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearSix", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "sfe_LesseeOperatingLeaseLiabilityToBePaidAfterYearSix": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of lessee's undiscounted obligation for lease payment for operating lease due after sixth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "sfe_LesseeOperatingLeaseLiabilityToBePaidAfterYearSix", "terseLabel": "Thereafter, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearSix", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "sfe_LessorOperatingLeasePaymentToBeReceivedAfterYearSix": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents amount of lease payment to be received by lessor for operating lease after sixth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)", "label": "sfe_LessorOperatingLeasePaymentToBeReceivedAfterYearSix", "terseLabel": "Thereafter, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentToBeReceivedAfterYearSix", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "sfe_LessorOperatingLeasePaymentsToBeReceivedSixYears": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 3.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor in sixth fiscal year following latest fiscal year for operating lease. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "sfe_LessorOperatingLeasePaymentsToBeReceivedSixYears", "terseLabel": "2026, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedSixYears", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "sfe_LongtermIncentivePlanBonusPoolPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents bonus pool percent for long-term incentive plan.", "label": "sfe_LongtermIncentivePlanBonusPoolPercent", "terseLabel": "Long-term Incentive Plan, Bonus Pool Percent" } } }, "localname": "LongtermIncentivePlanBonusPoolPercent", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "percentItemType" }, "sfe_LongtermLineOfCreditRepaymentFeatureNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the long-term line of credit, repayment feature, noncurrent.", "label": "sfe_LongtermLineOfCreditRepaymentFeatureNoncurrent", "terseLabel": "Long-term Line of Credit, Repayment Feature, Noncurrent" } } }, "localname": "LongtermLineOfCreditRepaymentFeatureNoncurrent", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "sfe_LumesisIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Lumesis, Inc.", "label": "Lumesis, Inc. [Member]" } } }, "localname": "LumesisIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details" ], "xbrltype": "domainItemType" }, "sfe_MediaMathIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity MediaMath, Inc.", "label": "MediaMath, Inc. [Member]" } } }, "localname": "MediaMathIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details" ], "xbrltype": "domainItemType" }, "sfe_MoxeHealthCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Moxe Health Corporation.", "label": "Moxe Health Corporation [Member]" } } }, "localname": "MoxeHealthCorporationMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_NetOperatingLossCarryforwardsExpiringInYearFiveAndThereafter": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represent net operating loss carryforwards expiring in year five and thereafter.", "label": "2025 and thereafter" } } }, "localname": "NetOperatingLossCarryforwardsExpiringInYearFiveAndThereafter", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details" ], "xbrltype": "monetaryItemType" }, "sfe_NetOperatingLossCarryforwardsExpiringInYearFour": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents net operating loss carryforwards expiring in year four.", "label": "2024" } } }, "localname": "NetOperatingLossCarryforwardsExpiringInYearFour", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details" ], "xbrltype": "monetaryItemType" }, "sfe_NetOperatingLossCarryforwardsExpiringInYearOne": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents net operating loss carryforwards expiring in year one.", "label": "2021" } } }, "localname": "NetOperatingLossCarryforwardsExpiringInYearOne", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details" ], "xbrltype": "monetaryItemType" }, "sfe_NetOperatingLossCarryforwardsExpiringInYearThree": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents net operating loss carryforwards expiring in year three.", "label": "2023" } } }, "localname": "NetOperatingLossCarryforwardsExpiringInYearThree", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details" ], "xbrltype": "monetaryItemType" }, "sfe_NetOperatingLossCarryforwardsExpiringInYearTwo": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents net operating loss carryforwards expiring in year two.", "label": "2022" } } }, "localname": "NetOperatingLossCarryforwardsExpiringInYearTwo", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details" ], "xbrltype": "monetaryItemType" }, "sfe_NoteToFinancialStatementDetailsTextual": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "localname": "NoteToFinancialStatementDetailsTextual", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_NotesToFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "localname": "NotesToFinancialStatementsAbstract", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_NovaSomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity NovaSom.", "label": "NovaSom [Member]" } } }, "localname": "NovaSomMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of reclassification adjustment for other comprehensive income (loss) arising from the sale of equity method investments.", "label": "Reclassification adjustment for sale of equity method investments" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentOnSaleOfEquityMethodInvestments", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss" ], "xbrltype": "monetaryItemType" }, "sfe_OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The share of other comprehensive income (loss) of equity method investments.", "label": "Share of other comprehensive (loss) of equity method investments" } } }, "localname": "OtherComprehensiveIncomeLossShareOfOtherComprehensiveIncomeLossOfEquityMethodInvestments", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss" ], "xbrltype": "monetaryItemType" }, "sfe_OwnershipInterestOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents ownership interest classified as other.", "label": "Ownership Interest, Other [Member]" } } }, "localname": "OwnershipInterestOtherMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_PartnerCompaniesNotConsolidatedInFinancialStatements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents partner companies not consolidated in financial statements.", "label": "sfe_PartnerCompaniesNotConsolidatedInFinancialStatements", "terseLabel": "Partner Companies Not Consolidated In Financial Statements" } } }, "localname": "PartnerCompaniesNotConsolidatedInFinancialStatements", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual" ], "xbrltype": "integerItemType" }, "sfe_PayableMonthlyInArrearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the interest payable in monthly arrears.", "label": "Payable Monthly in Arrears [Member]" } } }, "localname": "PayableMonthlyInArrearsMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "sfe_PayableOnTheLastDayOfTheOneTwoOrThreeMonthInterestPeriodMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the interest payable on the last day of the one, two or three month interest period.", "label": "Payable on the Last Day of the One, Two or Three Month Interest Period [Member]" } } }, "localname": "PayableOnTheLastDayOfTheOneTwoOrThreeMonthInterestPeriodMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "sfe_PercentageOfSharesVestedInLieuOfDirectorsFeesAtTheGrantDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares vested in lieu of directors fees at the grant date.", "label": "sfe_PercentageOfSharesVestedInLieuOfDirectorsFeesAtTheGrantDate", "terseLabel": "Percentage of Shares Vested in Lieu of Directors Fees at the Grant Date" } } }, "localname": "PercentageOfSharesVestedInLieuOfDirectorsFeesAtTheGrantDate", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "percentItemType" }, "sfe_PerformanceStockUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents performance stock unit.", "label": "Performance Stock Unit [Member]" } } }, "localname": "PerformanceStockUnitMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "sfe_PortionOfDirectorFeesMatchedToDeferredStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the portion of director fees matched to deferred stock units.", "label": "sfe_PortionOfDirectorFeesMatchedToDeferredStockUnits", "terseLabel": "Portion of Director Fees Matched to Deferred Stock Units." } } }, "localname": "PortionOfDirectorFeesMatchedToDeferredStockUnits", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "percentItemType" }, "sfe_PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of preferred stock purchase rights which will be exchanged for each share of common stock if an owner obtains more common stock than the maximum ownership allowed.", "label": "sfe_PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold", "terseLabel": "Preferred Stock Purchase Right to be Exchanged for Common Stock Above Maximum Ownership Threshold (in shares)" } } }, "localname": "PreferredStockPurchaseRightToBeExchangedForCommonStockAboveMaximumOwnershipThreshold", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual" ], "xbrltype": "sharesItemType" }, "sfe_PrognosHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Prognos Health, Inc.", "label": "Prognos Health, Inc. [Member]" } } }, "localname": "PrognosHealthIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details" ], "xbrltype": "domainItemType" }, "sfe_PropellerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Propeller.", "label": "Propeller [Member]" } } }, "localname": "PropellerMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_QuanticMindMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity QuanticMind.", "label": "QuanticMind [Member]" } } }, "localname": "QuanticMindMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents restricted stock, performance-based stock units, and deferred stock units.", "label": "Restricted Stock, Performance-based Stock Units, and Deferred Stock Units [Member]" } } }, "localname": "RestrictedStockPerformanceBasedStockUnitsAndDeferredStockUnitsMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "domainItemType" }, "sfe_SaleOfStockIndividualOwnershipPercentMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum percent ownership of the company's outstanding stock an individual may acquire.", "label": "sfe_SaleOfStockIndividualOwnershipPercentMaximum", "terseLabel": "Sale of Stock, Individual Ownership, Percent, Maximum" } } }, "localname": "SaleOfStockIndividualOwnershipPercentMaximum", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual" ], "xbrltype": "percentItemType" }, "sfe_ScheduleOfActivityForRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for restricted stock unity. deferred stock units and performance units.", "label": "Schedule Of Activity For Restricted Stock Units Deferred Stock Units And Performance Units [Table Text Block]" } } }, "localname": "ScheduleOfActivityForRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsTableTextBlock", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "sfe_ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of partner company ownership interests.", "label": "Schedule of Partner Company Ownership Interest [Table Text Block]" } } }, "localname": "ScheduleOfPartnerCompanyOwnershipInterestTableTextBlock", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables" ], "xbrltype": "textBlockItemType" }, "sfe_ServiceBasedAwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the service based award.", "label": "Service Based Award [Member]" } } }, "localname": "ServiceBasedAwardMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "sfe_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the share based compensation arrangement by share based payment award expiration term.", "label": "sfe_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationTerm", "terseLabel": "Share Based Compensation Arrangement, By Share Based Payment Award, Expiration Term (Year)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationTerm", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "durationItemType" }, "sfe_SharebasedCompensationArrangementByShareBasedPaymentDeferredAwardVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the share based compensation arrangement by share based payment deferred award vesting period.", "label": "sfe_SharebasedCompensationArrangementByShareBasedPaymentDeferredAwardVestingPeriod", "terseLabel": "Share-based Compensation Arrangement by Share Based Payment, Deferred award, Vesting Period (Year)" } } }, "localname": "SharebasedCompensationArrangementByShareBasedPaymentDeferredAwardVestingPeriod", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "durationItemType" }, "sfe_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumTargetPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "the maximum target percentage for equity instruments other then options under share based payment arrangement.", "label": "sfe_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumTargetPercentage", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Maximum Target Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumTargetPercentage", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "percentItemType" }, "sfe_SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of award vesting types under share-based compensation arrangement by share-based payment award.", "label": "sfe_SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Award Vesting Types" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfAwardVestingTypes", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "integerItemType" }, "sfe_SonobiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Sonobi.", "label": "Sonobi [Member]" } } }, "localname": "SonobiMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_StockIssuedDuringPeriodSharesRestrictedStockWithheldForTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued for restricted stock awards and withheld for taxes.", "label": "Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockWithheldForTaxes", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "sharesItemType" }, "sfe_StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of shares issued for restricted stock awards withheld for taxes.", "label": "Restricted stock awards, forfeitures and shares repurchased for tax withholdings, net" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "monetaryItemType" }, "sfe_SyapseIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Syapse, Inc.", "label": "Syapse, Inc. [Member]" } } }, "localname": "SyapseIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_TransactisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Transactis.", "label": "Transactis [Member]" } } }, "localname": "TransactisMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_TrexGroupIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information related to T-Rex Group, Inc.", "label": "T-Rex Group, Inc [Member]" } } }, "localname": "TrexGroupIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_TriceMedicalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Trice Medical, Inc.", "label": "Trice Medical, Inc. [Member]" } } }, "localname": "TriceMedicalIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_ValuationOfCreditFacilityRepaymentFeaturePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for the valuation of the credit facility repayment feature.", "label": "Valuation of Credit Facility Repayment Feature, Policy [Policy Text Block]" } } }, "localname": "ValuationOfCreditFacilityRepaymentFeaturePolicyPolicyTextBlock", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "sfe_WebLincIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity WebLinc, Inc.", "label": "WebLinc, Inc. [Member]" } } }, "localname": "WebLincIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_WebLincIncQuanticMindIncAndSonobiIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc.", "label": "WebLinc, Inc., QuanticMind, Inc. and Sonobi, Inc. [Member]" } } }, "localname": "WebLincIncQuanticMindIncAndSonobiIncMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "sfe_ZipnosisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity Zipnosis.", "label": "Zipnosis [Member]" } } }, "localname": "ZipnosisMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_meQuilibriumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the entity meQuilibrium.", "label": "meQuilibrium [Member]" } } }, "localname": "meQuilibriumMember", "nsuri": "http://www.safeguard.com/20201231", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "sfe_statement-statement-note-1-general-schedule-of-leases-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 1 - General - Schedule of Leases (Details)" } } }, "localname": "statement-statement-note-1-general-schedule-of-leases-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 1 - General - Schedule of Restrictions on Cash and Cash Equivalents (Details)" } } }, "localname": "statement-statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-1-general-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 1 - General" } } }, "localname": "statement-statement-note-1-general-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 10 - Net Income (Loss) Per Share - Schedule of Calculations of Net Income (Loss) Per Share (Details)" } } }, "localname": "statement-statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-10-net-income-loss-per-share-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 10 - Net Income (Loss) Per Share" } } }, "localname": "statement-statement-note-10-net-income-loss-per-share-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 14 - Segment Reporting - Schedule of Active Partner Companies by Segment (Details)" } } }, "localname": "statement-statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-14-segment-reporting-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 14 - Segment Reporting" } } }, "localname": "statement-statement-note-14-segment-reporting-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 15 - Selected Quarterly Financial Information (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details)" } } }, "localname": "statement-statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-15-selected-quarterly-financial-information-unaudited-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 15 - Selected Quarterly Financial Information (Unaudited)" } } }, "localname": "statement-statement-note-15-selected-quarterly-financial-information-unaudited-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 - Ownership Interests and Advances - Schedule of Carrying Value of Ownership Interests (Details)" } } }, "localname": "statement-statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 - Ownership Interests and Advances - Schedule of Equity Method Investment Partner Company Results Of Operation (Details)" } } }, "localname": "statement-statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 - Ownership Interests and Advances - Schedule of Results of Operations (Details)" } } }, "localname": "statement-statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-2-ownership-interests-and-advances-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 - Ownership Interests and Advances" } } }, "localname": "statement-statement-note-2-ownership-interests-and-advances-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock-Based Compensation - Schedule of Restricted Stock Units Deferred Stock Units And Performance Units (Details)" } } }, "localname": "statement-statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock-Based Compensation - Schedule of Stock Options Activity (Details)" } } }, "localname": "statement-statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details)" } } }, "localname": "statement-statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-7-stockbased-compensation-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock-Based Compensation" } } }, "localname": "statement-statement-note-7-stockbased-compensation-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Income Taxes -Schedule of Deferred Tax Assets and Liabilities (Details)" } } }, "localname": "statement-statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)" } } }, "localname": "statement-statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Income Taxes - Schedule of Summary of Operating Loss Carryforwards (Details)" } } }, "localname": "statement-statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-note-9-income-taxes-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Income Taxes" } } }, "localname": "statement-statement-note-9-income-taxes-tables", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "sfe_statement-statement-significant-accounting-policies-policies": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "localname": "statement-statement-significant-accounting-policies-policies", "nsuri": "http://www.safeguard.com/20201231", "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r111", "r118", "r197", "r268", "r269", "r270", "r295", "r296" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r111", "r118", "r197", "r268", "r269", "r270", "r295", "r296" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r111", "r118", "r197", "r268", "r269", "r270", "r295", "r296" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r233", "r236", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r403", "r404" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r233", "r236", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r403", "r404" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "srt_PartnershipInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Partnership Interest [Member]" } } }, "localname": "PartnershipInterestMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r229", "r233", "r236", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r403", "r404" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r229", "r233", "r236", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r403", "r404" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r212", "r234", "r358" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r183", "r353" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201409Member": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).", "label": "Accounting Standards Update 2014-09 [Member]" } } }, "localname": "AccountingStandardsUpdate201409Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r26", "r50", "r51", "r52", "r389", "r412", "r416" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r49", "r52", "r53", "r107", "r108", "r110", "r312", "r407", "r408" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r24" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r107", "r108", "r110", "r268", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [ "r109", "r116", "r117", "r120", "r121", "r122", "r123" ], "lang": { "en-us": { "role": { "documentation": "Type of error correction.", "label": "Error Correction, Type [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r112", "r113", "r114", "r115", "r194", "r195", "r196", "r197", "r198", "r199", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r293", "r294", "r295", "r296", "r368", "r369", "r370", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r238", "r240", "r273", "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvancesToAffiliate": { "auth_ref": [ "r5", "r417" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details": { "order": 1.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.", "label": "Advances to companies (equity method)" } } }, "localname": "AdvancesToAffiliate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r240", "r261", "r272" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "us-gaap_AllocatedShareBasedCompensationExpense", "terseLabel": "Share-based Payment Arrangement, Expense", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "terseLabel": "Share-based Payment Arrangement, Expense, after Tax" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r75", "r91", "r336" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r102", "r157", "r168", "r174", "r192", "r308", "r313", "r326", "r373", "r387" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r3", "r4", "r48", "r102", "r192", "r308", "r313", "r326" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r10", "r11", "r12", "r13", "r14", "r15", "r16", "r17", "r102", "r192", "r308", "r313", "r326" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r241", "r263" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r319", "r321" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r32", "r93" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "terseLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r9", "r94", "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r9", "r94", "r100", "r372" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r86", "r93", "r98" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash equivalents at beginning of period", "totalLabel": "Total cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r86", "r327" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "totalLabel": "Net change in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r211", "r377", "r393" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 12)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r208", "r209", "r210", "r213" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "terseLabel": "Common Stock, Capital Shares Reserved for Future Issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r107", "r108" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r23" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.10 par value; 83,333 shares authorized; 21,573 issued at December 31, 2020 and 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r227", "r228", "r237", "r275" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r56", "r58", "r66", "r307", "r317", "r382", "r397" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "totalLabel": "Total comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).", "label": "Cost and Equity Method Investments Disclosure [Text Block]" } } }, "localname": "CostAndEquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r96", "r97" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "us-gaap_DebtConversionConvertedInstrumentAmount1", "terseLabel": "Debt Conversion, Converted Instrument, Amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r374", "r375", "r386" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1", "terseLabel": "Debt Instrument, Basis Spread on Variable Rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r41", "r216", "r337" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "us-gaap_DebtInstrumentInterestRateEffectivePercentage", "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "us-gaap_DebtInstrumentInterestRateStatedPercentage", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationLiabilityCurrent": { "auth_ref": [ "r225", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "us-gaap_DeferredCompensationLiabilityCurrent", "terseLabel": "Deferred Compensation Liability, Current, Total" } } }, "localname": "DeferredCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent", "terseLabel": "Deferred Compensation Liability, Current and Noncurrent, Total" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsEquityMethodInvestments": { "auth_ref": [ "r290", "r291" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.", "label": "Carrying values of ownership interests and other holdings" } } }, "localname": "DeferredTaxAssetsEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r283" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "us-gaap_DeferredTaxAssetsGross", "totalLabel": "Deferred Tax Assets, Gross, Total" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r285" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "us-gaap_DeferredTaxAssetsNet", "totalLabel": "Net deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r290", "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards", "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r290", "r291" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r288", "r290", "r291" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Tax loss and credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r290", "r291" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r290", "r291" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r284" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "us-gaap_DeferredTaxAssetsValuationAllowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "us-gaap_DefinedContributionPlanCostRecognized", "terseLabel": "Defined Contribution Plan, Cost" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.", "label": "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent", "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r91", "r154" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "us-gaap_DepreciationDepletionAndAmortization", "terseLabel": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r320" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "us-gaap_DerivativeGainLossOnDerivativeNet", "negatedLabel": "Income from change in fair value of derivative" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-6-equity", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r232", "r235" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_Dividends": { "auth_ref": [ "r220", "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.", "label": "us-gaap_Dividends", "negatedLabel": "Dividends paid", "terseLabel": "Dividends, Total" } } }, "localname": "Dividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "us-gaap_DividendsPayableAmountPerShare", "terseLabel": "Dividends Payable, Amount Per Share (in dollars per share)" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net income (loss) per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r67", "r116", "r117", "r118", "r119", "r120", "r124", "r126", "r128", "r129", "r130", "r134", "r135", "r383", "r398" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic (in dollars per share)", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r67", "r116", "r117", "r118", "r119", "r120", "r126", "r128", "r129", "r130", "r134", "r135", "r383", "r398" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted (in dollars per share)", "verboseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Diluted:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r100", "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r131", "r132", "r133", "r136" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r279" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r279", "r299" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory tax (benefit) expense", "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r279", "r299" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details": { "order": 0.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "auth_ref": [ "r279", "r299" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.", "label": "Nondeductible expenses" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r262" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r107", "r108", "r110", "r113", "r121", "r123", "r139", "r197", "r219", "r220", "r268", "r269", "r270", "r295", "r296", "r328", "r329", "r330", "r331", "r332", "r334", "r407", "r408", "r409" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r0", "r102", "r192", "r326" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r0", "r102", "r192", "r326" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": { "auth_ref": [ "r0", "r102", "r192", "r326" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment", "terseLabel": "Equity Method Investment, Other than Temporary Impairment" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Ownership Interest Under Equity Method, Percent", "terseLabel": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "auth_ref": [ "r69", "r70", "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.", "label": "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal", "terseLabel": "Equity Method Investment, Realized Gain (Loss) on Disposal, Total" } } }, "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r33", "r158", "r189" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details": { "order": 0.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Companies", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "auth_ref": [ "r187", "r400" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss", "terseLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r186" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details": { "order": 2.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Other Companies" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r109", "r116", "r117", "r120", "r121", "r122", "r123" ], "lang": { "en-us": { "role": { "documentation": "Information by type of error correction.", "label": "Error Correction, Type [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "us-gaap_ExtinguishmentOfDebtAmount", "terseLabel": "Extinguishment of Debt, Amount" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r100", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r104", "r278" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations", "terseLabel": "Federal Income Tax Expense (Benefit), Continuing Operations, Total" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r339", "r343", "r347" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Amortization of right of use asset" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r72" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expense", "verboseLabel": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r71", "r102", "r157", "r167", "r170", "r173", "r176", "r192", "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsCurrentCarryingValue": { "auth_ref": [ "r214" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.", "label": "us-gaap_GuaranteeObligationsCurrentCarryingValue", "terseLabel": "Guarantor Obligations, Current Carrying Value" } } }, "localname": "GuaranteeObligationsCurrentCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r100", "r200", "r203" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r62", "r157", "r167", "r170", "r173", "r176", "r371", "r379", "r384", "r401" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "totalLabel": "Net income (loss) before income taxes", "verboseLabel": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r63", "r91", "r155", "r189", "r378", "r394" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Equity income (loss), net", "terseLabel": "Income (Loss) from Equity Method Investments, Total", "verboseLabel": "Equity income (loss), net" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r232", "r235" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r280", "r281", "r287", "r297", "r300", "r302", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r105", "r122", "r123", "r156", "r278", "r298", "r301", "r402" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 0.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax benefit (expense)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r59", "r100", "r276", "r277", "r281", "r282", "r286", "r292", "r434" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r88", "r95" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "us-gaap_IncomeTaxesPaid", "terseLabel": "Income Taxes Paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Accounts payable, accrued expenses, and other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r90" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r75", "r217" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "us-gaap_InterestExpenseDebt", "negatedLabel": "Interest expense", "terseLabel": "Interest Expense, Debt, Total", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r84", "r87", "r95" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "us-gaap_InterestPaidNet", "terseLabel": "Interest Paid, Excluding Capitalized Interest, Operating Activities" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r73", "r153" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Interest income", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r191", "r399" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r33" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Ownership interests and advances", "totalLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures, Total" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.", "label": "Investments in and Advances to Affiliates, Schedule of Investments [Text Block]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "us-gaap_LesseeOperatingLeaseDiscountRate", "terseLabel": "Lessee, Operating Lease, Discount Rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r346" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "totalLabel": "Total future minimum lease payments, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r346" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "terseLabel": "2021, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r346" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "terseLabel": "2025, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r346" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "terseLabel": "2024, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r346" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "terseLabel": "2023, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r346" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "terseLabel": "2022, operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r346" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "negatedTerseLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r348" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "totalLabel": "Total future minimum lease payments, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r348" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 4.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears", "terseLabel": "2025, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r348" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 5.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears", "terseLabel": "2024, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r348" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 1.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "terseLabel": "2021, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r348" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 6.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears", "terseLabel": "2023, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r348" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details": { "order": 0.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears", "terseLabel": "2022, expected sublease receipts" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_LessorOperatingLeaseTermOfContract", "terseLabel": "Lessor, Operating Lease, Term of Contract (Month)" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38", "r102", "r169", "r192", "r309", "r313", "r314", "r326" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "us-gaap_Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r102", "r192", "r326", "r376", "r391" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r102", "r192", "r309", "r313", "r314", "r326" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r6", "r7", "r8", "r20", "r21", "r102", "r192", "r309", "r313", "r314", "r326" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payment applied to interest.", "label": "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest", "terseLabel": "Line of Credit Facility, Periodic Payment, Interest" } } }, "localname": "LineOfCreditFacilityPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r42", "r215" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r86" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "totalLabel": "Net cash (used in) provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r86", "r89", "r92" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r54", "r57", "r64", "r92", "r102", "r112", "r116", "r117", "r118", "r119", "r122", "r123", "r127", "r157", "r167", "r170", "r173", "r176", "r192", "r326", "r380", "r395" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r107", "r108", "r110", "r220", "r305" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "us-gaap_NumberOfOperatingSegments", "terseLabel": "Number of Operating Segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r157", "r167", "r170", "r173", "r176" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "us-gaap_OperatingIncomeLoss", "terseLabel": "Operating Income (Loss), Total", "totalLabel": "Operating loss", "verboseLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r344", "r347" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "us-gaap_OperatingLeaseCost", "terseLabel": "Operating Lease, Cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r338" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "us-gaap_OperatingLeaseLiability", "terseLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r338" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Lease liability - current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r338" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liability - non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r340", "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "us-gaap_OperatingLeasePayments", "terseLabel": "Operating Lease, Payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r318" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r55", "r58", "r60", "r65", "r219", "r328", "r333", "r334", "r381", "r396" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive (loss) income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingGainsLosses": { "auth_ref": [ "r74" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.", "label": "us-gaap_OtherNonoperatingGainsLosses", "negatedLabel": "Other, net" } } }, "localname": "OtherNonoperatingGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r76" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income (loss), net", "verboseLabel": "Other income (loss), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForAdvanceToAffiliate": { "auth_ref": [ "r79" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity).", "label": "us-gaap_PaymentsForAdvanceToAffiliate", "negatedLabel": "Advances and loans to ownership interests" } } }, "localname": "PaymentsForAdvanceToAffiliate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r82" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "us-gaap_PaymentsOfDividends", "negatedLabel": "Payment of dividend" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r82" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "negatedLabel": "Tax withholdings related to equity-based awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r80" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "us-gaap_PaymentsToAcquireEquityMethodInvestments", "negatedLabel": "Acquisitions of ownership interests", "terseLabel": "Payments to Acquire Equity Method Investments" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "auth_ref": [ "r79", "r185" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.", "label": "us-gaap_PaymentsToAcquireHeldToMaturitySecurities", "negatedLabel": "Purchase of marketable securities" } } }, "localname": "PaymentsToAcquireHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r241", "r263" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_PolicyTextBlockAbstract", "terseLabel": "Accounting Policies" } } }, "localname": "PolicyTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r22" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.10 par value; 1,000 shares authorized" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r3", "r30", "r31" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_PrivateEquityFundsMember": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Investments held in private equity funds.", "label": "Private Equity Funds [Member]" } } }, "localname": "PrivateEquityFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromCollectionOfAdvanceToAffiliate": { "auth_ref": [ "r77" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the collection of money previously advanced to an entity that is related to it but not strictly controlled.", "label": "Repayment of advances and loans from ownership interests" } } }, "localname": "ProceedsFromCollectionOfAdvanceToAffiliate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": { "auth_ref": [ "r78" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).", "label": "Proceeds from sales and distributions from ownership interests" } } }, "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.", "label": "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "terseLabel": "Proceeds from Issuance of Preferred Stock and Preference Stock" } } }, "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "auth_ref": [ "r77", "r185" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.", "label": "Proceeds, from sales and maturities in marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": { "auth_ref": [ "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "us-gaap_ProceedsFromSaleOfEquityMethodInvestments", "terseLabel": "Proceeds from Sale of Equity Method Investments" } } }, "localname": "ProceedsFromSaleOfEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r0", "r54", "r57", "r85", "r102", "r112", "r122", "r123", "r157", "r167", "r170", "r173", "r176", "r192", "r307", "r310", "r311", "r316", "r317", "r326", "r384" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income (loss)", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r13", "r14", "r201", "r392" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r34", "r100", "r201", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r350", "r351", "r352", "r354", "r355" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r83", "r106" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "us-gaap_RepaymentsOfLinesOfCredit", "negatedLabel": "Repayments on credit facility", "terseLabel": "Repayments of Lines of Credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r98", "r372", "r388" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "us-gaap_RestrictedCash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r2", "r9", "r98" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "auth_ref": [ "r204", "r205", "r206", "r207" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.", "label": "us-gaap_RestructuringAndRelatedCostExpectedCost1", "terseLabel": "Restructuring and Related Cost, Expected Cost, Total" } } }, "localname": "RestructuringAndRelatedCostExpectedCost1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r220", "r271", "r390", "r411", "r416" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r107", "r108", "r110", "r113", "r121", "r123", "r197", "r268", "r269", "r270", "r295", "r296", "r407", "r409" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r61", "r102", "r151", "r152", "r166", "r171", "r172", "r178", "r179", "r181", "r192", "r326", "r384" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates.", "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]" } } }, "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r9", "r98", "r372", "r388" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r251", "r256", "r258" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Activity [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r245", "r256", "r258" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r147", "r149", "r150", "r157", "r159", "r170", "r174", "r175", "r176", "r177", "r178", "r180", "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r100", "r160", "r161", "r162", "r163", "r164", "r165", "r179" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r90" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation, including liability classified awards" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "negatedLabel": "Forfeited (in shares)", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "periodEndLabel": "Balance (in dollars per share)", "periodStartLabel": "Balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "negatedLabel": "Vested (in shares)", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Shares available for future grant, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Options exercisable, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Options exercisable , weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "negatedLabel": "Options canceled/forfeited, shares (in shares)", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Options granted, shares (in shares)", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Balance, aggregative intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r247", "r263" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "periodEndLabel": "Balance, shares (in shares)", "periodStartLabel": "Balance, shares (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Balance, weighted average exercise price (in dollars per share)", "periodStartLabel": "Balance, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r239", "r244" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Options exercised, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Options canceled/forfeited, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Options granted, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Options exercisable, aggregative intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Options exercisable, weighted average remaining contractual life (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Balance, weighted average remaining contractual life (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "us-gaap_SharesOutstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "sharesItemType" }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r103", "r278", "r298" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.", "label": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "terseLabel": "State and Local Income Tax Expense (Benefit), Continuing Operations, Total" } } }, "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r47", "r107", "r108", "r110", "r113", "r121", "r123", "r139", "r197", "r219", "r220", "r268", "r269", "r270", "r295", "r296", "r328", "r329", "r330", "r331", "r332", "r334", "r407", "r408", "r409" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-tables", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables", "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual", "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-6-equity", "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables", "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r107", "r108", "r110", "r139", "r367" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-comprehensive-income-loss", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-leases-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-schedule-of-restrictions-on-cash-and-cash-equivalents-details", "http://www.safeguard.com/20201231/role/statement-note-1-general-tables", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-details-textual", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables", "http://www.safeguard.com/20201231/role/statement-note-11-related-party-transactions", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information", "http://www.safeguard.com/20201231/role/statement-note-13-supplemental-cash-flow-information-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-details-textual", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-schedule-of-active-partner-companies-by-segment-details", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-details-textual", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-schedule-of-selected-quarterly-financial-information-unaudited-details", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-details-textual", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-carrying-value-of-ownership-interests-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-results-of-operations-details", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests", "http://www.safeguard.com/20201231/role/statement-note-3-acquisitions-of-ownership-interests-details-textual", "http://www.safeguard.com/20201231/role/statement-note-4-fair-value-measurements", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual", "http://www.safeguard.com/20201231/role/statement-note-6-equity", "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-details-textual", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-restricted-stock-units-deferred-stock-units-and-performance-units-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stockbased-compensation-expense-details", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan", "http://www.safeguard.com/20201231/role/statement-note-8-employee-benefit-plan-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-details-textual", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-deferred-tax-assets-and-liabilities-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-effective-income-tax-rate-reconciliation-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-schedule-of-summary-of-operating-loss-carryforwards-details", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables", "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r22", "r23", "r219", "r220", "r249" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Options exercised, shares (in shares)", "negatedLabel": "Options exercised, shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-schedule-of-stock-options-activity-details" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "us-gaap_StockRepurchaseProgramAuthorizedAmount1", "terseLabel": "Stock Repurchase Program, Authorized Amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r23", "r27", "r28", "r102", "r184", "r192", "r326" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Shareholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-schedule-of-equity-method-investment-partner-company-results-of-operation-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r102", "r107", "r108", "r110", "r113", "r121", "r192", "r197", "r220", "r268", "r269", "r270", "r295", "r296", "r305", "r306", "r315", "r326", "r328", "r329", "r334", "r408", "r409" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance", "totalLabel": "Total Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets", "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r101", "r220", "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-6-equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r335", "r357" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r335", "r357" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r335", "r357" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events", "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r356", "r359" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-16-subsequent-events" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "localname": "TableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general-tables", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-tables", "http://www.safeguard.com/20201231/role/statement-note-14-segment-reporting-tables", "http://www.safeguard.com/20201231/role/statement-note-15-selected-quarterly-financial-information-unaudited-tables", "http://www.safeguard.com/20201231/role/statement-note-2-ownership-interests-and-advances-tables", "http://www.safeguard.com/20201231/role/statement-note-7-stockbased-compensation-tables", "http://www.safeguard.com/20201231/role/statement-note-9-income-taxes-tables" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r46", "r221" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-changes-in-shareholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r46", "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r23", "r219", "r220" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "us-gaap_TreasuryStockSharesAcquired", "terseLabel": "Treasury Stock, Shares, Acquired (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-6-equity-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r46", "r221", "r222" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "us-gaap_TreasuryStockValue", "negatedLabel": "Treasury stock, at cost; 688 and 930 shares at December 31, 2020 and 2019, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r112", "r113", "r114", "r115", "r194", "r195", "r196", "r197", "r198", "r199", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r293", "r294", "r295", "r296", "r368", "r369", "r370", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-1-general", "http://www.safeguard.com/20201231/role/statement-note-1-general-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies", "http://www.safeguard.com/20201231/role/statement-note-12-commitments-and-contingencies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r91" ], "calculation": { "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "us-gaap_UnrealizedGainLossOnInvestments", "negatedLabel": "Impairments of ownership interests and advances" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r140", "r141", "r142", "r143", "r144", "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures", "http://www.safeguard.com/20201231/role/statement-note-5-credit-facility-and-convertible-debentures-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r125", "r130" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average shares used in computing net income (loss) per share:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r124", "r130" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.safeguard.com/20201231/role/statement-consolidated-statements-of-operations", "http://www.safeguard.com/20201231/role/statement-note-10-net-income-loss-per-share-schedule-of-calculations-of-net-income-loss-per-share-details" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363" }, "r227": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r275": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121607252&loc=SL5864739-113975" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r355": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r359": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.2)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r433": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r437": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r438": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r439": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r441": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r442": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7,9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "http://asc.fasb.org/topic&trid=2134446" } }, "version": "2.1" } ZIP 82 0001437749-21-005171-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-21-005171-xbrl.zip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

\RQ+<$M82756$% 8+1MTOF$CH2RSK A MW,ZPN4?;>;2=1]MMW1N@T78>A68OP*XT4$'%P#P0K=6'5MI"8&)(YG+5*?M@ MXD1-P"^UYB.8T)"Y=/6^*3!!('/A:CPM8"(];0"M1P8UTW8-:LK8?2T@J0H'^.CA5L9&@8=;=0RW:N0@ J,IVP"F-),-"J1* M,[;H'&?Q8Q 6+U8$L\V3%45IM_"94WY>3#EUSMH6N[,QDCO4A3UN/?C"@R^^ MC1;%&M!X+U*3NCT@0H^53GEH7?IUCU%+962M2;/%3PJ ]):3*X*FQ3S6\J_5 MNC7'5YECK.!4;B5!6%;G/& MJFLH-NN@?7DYM!8:Y357<^?Q^I+K&0PC)L<5:-';XFJ<3.;X"J79&5J/9_SG M<8(GCW3,Q$HO>=BF2I:O]]2QW;)#-\'S:W[M+V3P"MG?W;!VAY('69#^U=\< MLB2=JXJ_ F.K+X &/W_Y O^:I$LI#AB1KU 4G4XF"- M6L@IZZ!O(:7(4%WRP0K0_WEW_B1>]LA).B\R9V>"TS+!4B)*?0/W0ES@"#,4 M7^1)E.XV\_TC6HI5KZP+:=#2O5C;O7O^M,1)BL5,2\104/;']BTBT0VN8_F MRCV[^[Z*K392VLTDW(1W#I_S.1"E00_]BJG<$G+"'IBF24238O*F*/ESS'7%IR8>)//]W]FWC"QP[=4F MH7+/[LX!G(YGXG!)MZ>+A/%:^CY$6-%XQ?4>C>B,41N?,-)GPD@WS.[;S(I3 M74;6+\/* U%.."BF34YPGU-D):?H=5R%UL0V($F@X?.CIMX*B/(I7.#4Q.,, M43:E$DW--%:(\DFO$ZI_?D.2JSZ41(TB>X/++M0--(#)&]0^_Z@NA D4GMO. M)0 A)=#BXJP+FH);G,K+BS:RWD"NTN97>:L5"JK%6HI"=O2 2N!2X)9 MEC(/ ZT%H8):;[H>% C*I>4K3@>C#49 LU/0&'L +FU03TYE( K\W*U[.4BNM6H;'VH35A16[O0VO2737% MH&K*"^7-%%,8NJ9XW=?9,A.O%M"M*5?WA;8,+H\6R>&ZBH$[4\/TN#6H'* K M+&PUR"C#2E=D*,J05A;#LU".B@;]%."B1%.[@D!UO;@K]J/'B2_DXPOY?+OE M?\+\XHCN,QK^>9NS<(Y2?$<>YMF$GN#S)_[OY %'%Y2=TL6")@7=:,I/XFOT M)*( NX?+5=5LNARF]1R4[WT6(UXF$5F1B.^5W7B;HW?#1H5L39KWD'DI&./[ M79J7??CW'EG.^*](_Z5 M2 T.PX'YX8U/R8$YYMNIH@-TRW=O4PS48V^B$@_4;2^Q5IQ[CGX.4K&HIGSA MB6K*"^%U+MZN:.=*,N[6G6^I(6O>V>2=3=]$F'3GN^?',C^29I0M4!+B8CU] MY2OU56E$TW86ZA[O72M%U]+*LG6DK7DIGPXXW=MFMS&2O["M0][>9;B+17!5 MH]"??A>/J427_(C!^7AVQE6ID/>=7F"N6F63.?["4)*=59=DMM";#8FVZVGW M)>75A&N)V_-#F?AVS\(+V:]1)A[@F]#7BZZ*RX9=M.;]CG\]1L)LJY8]S]:) MV*K/(XZ2R&"GV>RVO<,8LQ79C#QZY->F_!%T-65[3L2.*7K?W_0CQH3F6X"J MUL\D&SQ#PQ.2"9?> MLS=/\E&5=#VQ^@?)YGF M"G?^12XPKY=IF@L#4").XW[2S>T?+2V-#;2">42[?_] ME*;9#G(:J)!,-O_I7O@Z:JIE:N@[0&1U=1G]-I_(H5M=3#$@":JUJ'";[49 M)H7_O-+3U2,'QS3-VQA%3W-R>YJ[]>/-+QI*R*V.SF^,)I*P?#=C32@:2LWC+!+ MN[MC5&, G*I4J=<57HLDTM+WNQS*3YSA4/V;6XV#=YL39^7G;J>:PN]&& M-WV_NYL[U5 ^/ZS/_#"?>=1:D.-Y+*0Z#$%=7N 0IZ72_4OU?*Z0Y*D/5E,+ MP>#!)076>_D=?\3Z3 W)BJ.F4&10Z8[-MAN$ L(6%Z$B$@QN%79Z&U##D"'( MI=S+A0IA1P!8/=H8<+?)M);*V&N SL"<%VU4"EH/@P6U\[O2L2 \<0-@4QM$ MW^'ED#LX\'0SI-Q.CG^ZPS_=X5S/J/L:\N0%> 49')P<>IE[\,HR.)@:^PF0 M;E>8+YSD"R<=8>&D;K$Q\%1KK5EI";V'IS37%U[J. 44GC;0[?;0A?/ 4P7T MYZ734/9 ZSIU#IO3G!=HSS:TR3/3%!G:4PY.H#*:

.T?%H7\)\$9!#:8XX8-EP3)&+4M#&W;JKC!T(\9\6>BW51;: MTD-18NV*HR3)&)GF6W"QL.1J:]\8M04CVL;29<7%R>^&%W\OU0LS>0TZ'-(D MC&?%'ZW/Q4&_/EW,IXL!3Q?S> N/MS@^O(7E$WR@^ I;=_K @!8M5#CGMM_G M@"2<" <9>L)I.Y-/KR]WEIX)/][ \P9>(P.@<(=-T-,H37&6CKDR@X13[(JF MZ2EB;#VCK(CGR55]TQY BWE#L_M\^D\<9A/Z'+9N+[RZWQY*XRPI?% M$<,EN.-GCSC6DY#$I'0;9A>87TPH%M=%SCE;OR"63(K%GMU/RX:M'3>;,/Y) MZ6@3-R%)Z/?&_W>Z/=&OV-[ MK^V=-5 KW[K",EQSOYDJ/]"D"8BJ7X86(&V6$:ZRW..$4':&IWQMB3R>LQQS MXE^D3ZR:-FW-ZY&]<&OI@2F^)B(2YT)?N<=ASOCA@M/SIS#.^=Z^X!> '[E M&2K!@.>()?S83KF4!>YKM*"Y%,)@M>_!3W8\(91IKJU;K-CL: M@?HOJ;U+RQ&G4PG35+YB5$L/I:SZ8;+^5ZZWL#VN1122;S/,0I+B6WZ8XZ+V MRQ5]Q*S\B2R([)1S,>3 )_+KE^P]P4#]P5K5MMVH"K0IK?QX)SG MSA4PQTNJWKFC_8&KTGC5]S^HP /0_0.\'%Z35=)K\3-W,0'3*6GF]G"[$GPX MTHFJ/M UZ> TW ^BJS< "51$!;AN >< MA*0MY+EI[PX#7JTX]$$O'_3:!?HE*?&B%O]S9?XO?&ZN7C^5<6_6O736HHKFCQDF"TN M$Y$FPP<0A_ )3?+TEM*X.L76N%UK!US*LCWG&__7H>--6E1\R[*ZZ'CGK%55 MG]]G35Z=OFO67A6;WV-+4O/?"4O2N9(^Z@>&K?XC454GXZ[@T&G._Z3*F]=N M"E,P?F;>T"1L+65E/SU&%?$*,^'ZT8LI5E.[9_\+5RL1-\GQ>!J3AQ*KMIG@ M M+'%<<7-6L.Y#%M[E[ RZ+,8G%MKY=5)VD]8=],GW(-_T'89*@V9JW?\*B$ MZO](Y_;PBC-6UH6ZR).H&E&E2^Y>@,*7G8=5[EI^MQ7-;X@1.,X%N#3<_ M?Y0(9-J\9P$%+P671>5_Q:F@VL MAT&T%N1XGDU7:%6TN=H"45+=FX(:GQB#Q9O4J=3@8"(&ZY":*G.@(L*VMR<$ M@(?%A6ND]8%;Q?7'2N5C!0J/!,BU:_/ A?"$L'\)UK\$ZQQCTOE+L'">2?:8 M+>--[S%;W0)QFKG/!P;+LA1%'QC6RA("0E-J:,4BFKF#-86%4A.B(=!"4TIH M3PBUC,EJ2@WE':#F\7;WD,?O@S1?+LO;&<5!B-)Y,(OI8T"2(A\A*Y6,-KC' M-D,X!#^V9],C(-\6 M(6[F6:E9DO0J'?Y,"(YW^V[P.5Z'I9\-2T>1^Q^TVE M(YS>(B)[Q$1"U0>[_$[F*HC@X@;+4$82*A_+]4G4P*.'WAOBO2''YPUI=@T. MS!NB=?D,S->A=?^[MXM^"#9[,V!X*=[[3!Y:FD$&/3JT>HRY\D;.VS)R*E.+ M;A'+$LR$8P,E(J>?BL,WI3&)4''J7I $)2$IB_@6ZZTJRZM--^Z5UIM"-!6\L>&/!L:ZI>3(/S#JP0^EB7>4G3-&^2G)F'B.A";JZL3Z+8],K/Y3 M(P_8$L7P;AFA[!;S_T9[(@C0R.:P/%GO_6-#F$2E_T^1K=?E4'T%W00F2%3O MJMZB\FQF@[;>B/5&+' C5B\'J]/]3UM<)X.S^-V=J& 2$YI\7-I6?0+E. &X MC2"D3W@'FG>@'9\#K8&&Z-ZO]%.0YM,4_RL7O\(KP5)+MY%!CPZ]0L9<>:>/ M=_I\.R/IDJ8H_L)HON3[.' M_%KOM[64O^6(]QU>DR22^J^D-*U'OU^C92K>NI6.+:%H/?(?>,J/EU UM(S$ M3<7%UW<&QM)WPO0;#))YZVXV+2'NPSF.\AB/9]7WMXQG24%1&]WU +[?/ZU2 M]7%5_XY=R][>J/@ O,R5*W;\F&"6SLERDXF''F1^.^/V??F#=]K]"8I%O8[[ M.<8B\6X4185*BF+QL;B)(=Y<.5D;?5!E>4R7@_=1P+%46X0Q=)FFN9!N/+ME M^\_V%'X0\0LL1!>_D4Q6N\[Z%?X>R2\ V>(P;N\C#L=7+_%^9\&>KV2Q9BW: MWEFOJ11<0PV"?>4E7TL_8!%\I4KGE2JMF W4W$2$- ^Z9P,UWH40I72L#%++ MYME@H[%:-P^X@&K]0I>+.)B8J8V-?R3!SCY-1G"+O^V!174\O2!WQ. N"0C; MS]V*J@F9N$V< 2QZ/YHD&KW5".@!&JKNP2*P"DD:C=4 F99&IA?@UNH;LU4 M#XB"=6/JB=30B3W #,,.\!UN#_%.OGG30(VFZ-!*M#8,>+K$ (9[::_![M=I M0&?/I1UWLM7B_XQZK3;]2:/RUH\?G3YMZY7"Q%'?"*\+*5OGK-YYS0.\QW>4AB?(.S9UDF])1O M<'[[K C?S"?KKZE([-_5,AB%&5GQ0P:GHVF:,13*2EAV.50/$[<0U:O*=X7& M,U$.KM!)@(C- 5YI&9L(H.( O9[,N"-":+*^&&)G3+G-#[4J'X2;^E3I,>P/GE>VFB M1,(H6@E=;T)'LQF_Z[F=(9%$JTU_HG C7;QZAI-7Z:<:E/VQO7G%;$(GZ$D\ MWC:GL;#[^"3?SQ'#)UQ'>?%05(UL3;OK;P+X(@JY.'AR/#O) M4Y)@<9!S:V'[]D)ZF>QXUDEM:MAC__E3? M.'IVM]8K"IJM?$Y7_R!(7]',^!MY %_'3P*T]$Z 0>):$(C6*SP# R[N@OV= M0Q[ K8-.17[Q )]IY!?<2>%JJ@PA)^#VFJMY:A2=!@H);]MI46WG= M6]_55F0<^6HK;ZO:BJ6G:!!+^&$A3L?BGJU)JJHC[U\ KBB04)/[%[3]LWY& MXISO=TWF#ZC=L_\%)_PDBHOZN M^\HF5( *SFQB"1 S-5GV]6+2-I98UY'(^ MX<_U:4_PC#)M"W/OAB8",\E/\U@ 'S:N0,E4.!BQ M[VDTR[UJ\,RK>]'X=]BLU1.^E&?2/(@:ZC[8+]?&AA^! Y.R+J7L@^V7;Y37 M;BHU>0_)O=N0V?/REO"NH 20DUPRI3[=]1KY3"N?Z=,+LW]@ >O$T6C%E^<# MOLF%>2W\C84J5:A5Z3C/N,&5")^ 1)J&O8 1]Q6'-4I_TV[@"JPR$AKUX;.\ M?):7S_+R65X'(AD9N^ "/'HRUBJMX&(SFG(9J++@XBVZJ%@=6PE#?]DL8V2:9\+S-Z%&*(J.1NDIX"KYNEN)JD&L-?$; M>QW[P*T/W-8PZZ-=/MKEHUUO,MIU9,7[;%^;X)PD%@6D+G58<-O#[41:LHK M[4J[L^C$/(#BU2HK?05\@E.QRT3N)&9I@(MU8,6UI35"[_XM R[UG%R53H'3 M?)'')8ZC2!0!@]\N767"[C+MV; M>7P=E6L,1[(#]OK%H7SX7K%I^QY$C*+B;$'Q+2+\"PVT_0P'_Y.''(IR? ]9BL2XG*!BFJ!#^7)6ZQ5Z6RX&;87'^2")L7&5*X' M*9U[ENN>&P/PR%BI8(IU0!.^:"IC)UJT V2];0S(C:.XA2O8.WN53-[AC*\" M'&WA(,IC14W(S+X.;:2E M@?,<:W_.AF8X.">OML U!AFXI"+]+ZGO>0"75J0M9.T%TEMTN@(X8/?D\3%K M&$>KKDCV=3IPAZ[F5.@BN(& A2,,YCO(8"Q0" MVQQ$(D$YX"IGB-)YP&_4\@?\7#Z7VZC<1H_U%R):*A+N-U.VS)(W051'YV)#/ M(?$Y)#Z'Q/OC'-LT#6[7@;K;5!?/0'UM WU,1&&=Q"*]P*JA5MUCWU:8BBMO M8KTM$ZL24W\EGC?%NUJ/5V*];)]"7F_?\#K+\?]@Q.[)(?RP10_=S#+.&O*OZL,(]92]'WDR6&/<.AYBLL [_#7OI4H)T?W ^IABZ*ONB:1?N M#2+=12XQE4R;PQ7PAM\:DT<J%9$/^X$KLH$:TJ8[N!-07"PV M/OKKC@ +_4BMB'S038]/A[V\5B1RU5#[F):/:?F8EH]I^9B6X["('2?'0,-< M=E2K@0;$6EG$ T.HV]&N!H9*M^3K&2@3M7YD#!YBV= P,#I=MQ MT^OJ*] >*VKI^](5&XJ>UCHZK2LP%-VL?4Q55V(H"IF%(+ZNR%#T,2MQ?UVA MAZJ/-9-VJ'I8,VD'I7[I1=QT18>FA&EY>)U#)W\.4I%Q6^2<%F],;9-.7T , M"YJ +LM,+Q1F9,59;P:MM#FB.^BE?:X]-/-M03,M%9D5Q0$F?%A%!;U*FAZJ M=?)=2=<8%RG]XV)/* N7U=+W5'+QY# ??\282' 6A\/)^IEDN;IQ!CUE!Z]^;OZ" M;QD)I<%1MZ,/;WKYGIIADN5\GUTF926.CJ92,=+PIJTXAW9R?&'R.L$=CC2\ M:=NKZ'299(PD*0E5">Z=CS?H*>ST"I&.,^@IZ^$*,1P=X/2F,@F?-?,DNHU1 MQ'NI(WY4S6JG PYZ$@]6R1T6=PU7?DY%K5H4 M9CF*)Y@M',RN*2?#FW:Y;BD3]E-'T]Z"$Y\,<*2/G\C*X^YYQ'?*D]3KU+@C MGP'AI%)]=73FL)9WIS;?X!)#-");CC^U!BJ@R\](C<-FH%)G>MT+$)Z7\KJTS4_T(2P MSE$: \T9ZS?L,-"4L]Z=@D/-6G.$6QE:=ILC>./0-=\/:MX# MR#V W /(00'(N_%&@D(=>YRYQYE[G+G'F=MQJ;PU_'EG+I"W!DYOY+9>_&D'2L*OA^GUUL#R+>-8A\K<+Z'F+-S\-SG@"2<" <9>L+I"\P6 MGLVP*(R-]T@"QEL'#'.5.20Q*8%>C8!Q'0SL#O36&?,>T/:V &V6"GAOU]QE ML>0FZ.F.+S@!\B9)3I*'S8L&_&22N(G-.X BY-V+337*+C"_:U L;H"<<[9^ M06PD?:.>84[+Z5Q<:9?)UC'(B49IBK-4W$"E>'%,'X4WL<44-1@%YG1Q:YD? MP3DGF\;X_$FH!KBXXEM,3FV?/NKEHU[ HU[>1^U]U,?GH[9^^P_4^VSQ%ANH MV[A3)6>@WN&FE@$D1T::+Q:(K<6/=/NV6\!G-PU"Q-AZ1IGPZC1,\+,_+@@W M1BO>O1?C;7DQ*M/R;G#V_)(B7SBG^^N&WQV$%34@MH\ZCY)HPB\2C,0SJ0=L MVNK.J4Q[;Y(W%./5J^9N.!\GAW95\PY<\CWAW;3D_$473GE_I"TY?^[ O5'^ M2AF2)$6^G4^]6\6X5[U;Q;A7O5G%D.+;5%0;F/6E[ M30_,5=)>GQJ8'Z2USCXP')M=4VN@N#2;JJ=S1]C''X+-+18PO*2L\-SLNW90 M"4]9(I8EF!4UFU!"'>;=8=]&?V8H09=)*"TX M):%H/?)IG&?A_%<:BZ*K\GI7*K+6/)20R7L-'OLO2.5G>D3 M_A6C.)N?4L8ODD(ID#-23]V:HUM&'Q*:EL.H9D5-V)J/WW+$#];PFB21E 4I M3>O1[]=HF6*5^!**UB-/&'[ZPFB^5 TN)[(P/@FQ6/$ABM4L*.A:<_$'GG)5 M37DDR4A:C_T/LN3KFLAOOVJ"UN,N\&\YBZ]7 QNU];,C'AH#'AM2"6-OKU/Q<'UR,S.[!Z'@9R#V;!M^-:O@9 M0 4*W:YO"&5@K'[H>H\.F&";N7 :'A0PL35SZ6I],V#":.:RJ1T_8.)EYH+5 M^93 1,/,1:LS4<&43&CPU70=<&#*')C+J./7TQ2O^Y?\S,6K\1GJ7N$0E36E M2U)7,(C*29V[4U%"H!X4>#RBT MI8L6C)FJCZ'K I?@$DK&]T!*8Q(A\63?%,7%2WSI'.-,'Q2FT8<3>)V@M#FB=9>HO68C^?YHSMW1:';^XIB7MAGI^1T15!4V[?BY.JEG\U M?2\BY(L\%KN[J$4@JODQ/!?*QC9M7^=9A M^9#6/>NG*)V/DDC\GU">5B@6I35'60&W)\F#ZO4DH[8]B,:W&"E47?$\0UD\ MXP$G(3\]90+5M^A'C,U)H?P8$K(>$"5R&>T] P2O&6 MP[7Z*^@U B/,#4W")O*\;M>#2,)P*-6J>C%4M#VQOK?F]?A7-G OQ"W;?_E* MI:,H*'MA>\DMLDT]/7[:[ZT-]=XV:-F'6*)R6+86CVUEG#=Q;RV%EL%M:*D\ M]4W<"_+\]IHP,-1?1$G;!^L9(@F.SA%+! ALS\MQAF+PYS8JHW%

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end